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Abstract
Previous introductions of highly pathogenic avian inﬂuenza virus (HPAIV) to the EU were most likely via
migratory wild birds. A mathematical model has been developed which indicated that virus
ampliﬁcation and spread may take place when wild bird populations of sufﬁcient size within EU
become infected. Low pathogenic avian inﬂuenza virus (LPAIV) may reach similar maximum prevalence
levels in wild bird populations to HPAIV but the risk of LPAIV infection of a poultry holding was
estimated to be lower than that of HPAIV. Only few non-wild bird pathways were identiﬁed having a
non-negligible risk of AI introduction. The transmission rate between animals within a ﬂock is assessed
to be higher for HPAIV than LPAIV. In very few cases, it could be proven that HPAI outbreaks were
caused by intrinsic mutation of LPAIV to HPAIV but current knowledge does not allow a prediction as
to if, and when this could occur. In gallinaceous poultry, passive surveillance through notiﬁcation of
suspicious clinical signs/mortality was identiﬁed as the most effective method for early detection of
HPAI outbreaks. For effective surveillance in anseriform poultry, passive surveillance through
notiﬁcation of suspicious clinical signs/mortality needs to be accompanied by serological surveillance
and/or a virological surveillance programme of birds found dead (bucket sampling). Serosurveillance is
unﬁt for early warning of LPAI outbreaks at the individual holding level but could be effective in tracing
clusters of LPAIV-infected holdings. In wild birds, passive surveillance is an appropriate method for
HPAIV surveillance if the HPAIV infections are associated with mortality whereas active wild bird
surveillance has a very low efﬁciency for detecting HPAIV. Experts estimated and emphasised the
effect of implementing speciﬁc biosecurity measures on reducing the probability of AIV entering into a
poultry holding. Human diligence is pivotal to select, implement and maintain speciﬁc, effective
biosecurity measures.
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Summary
As a follow-up to the highly pathogenic avian inﬂuenza (HPAI) H5N8 virus outbreaks in
2014/2015, the European Food Safety Authority (EFSA) has been requested by the European
Commission to assess the risk of HPAI introduction into the European Union (EU) and into poultry
holdings via wild birds and other possible entry routes, to assess the risk of low pathogenic avian
inﬂuenza virus (LPAIV) introduction from the wild bird reservoir into poultry holdings and to assess
the suitability of biosecurity, early detection and protection measures in poultry if there is HPAI
occurrence in wild birds and the surveillance strategy. Additional questions were submitted to EFSA
after the avian inﬂuenza (AI) outbreaks in France in 2015/2016, mainly to assess AI transmission
characteristics and to analyse the mutation of LPAI to HPAI viruses as well as widening the questions
on AI introduction and analysis of surveillance tools.
Mapping of HPAI and LPAI outbreaks
In the last decade, several clades of highly pathogenic avian inﬂuenza virus (HPAIV) H5 and
members of the Eurasian lineage of HPAIV H7 have been detected in Europe. HPAIV H5 affected
poultry and wild birds, whereas HPAIV H7 was only found in poultry. Distinct HPAI clades of goose/
Guangdong-like H5 subtype viruses are present in poultry populations in several subcontinental regions
outside the EU, e.g. in South-East and possibly Central Asia, China, Egypt and West Africa. None of the
HPAI viruses recently detected in the EU revealed signiﬁcant zoonotic potential, although highly
zoonotic HPAIV are circulating in Asia (H7N9, H5N6 and H5N1) and in Egypt (H5N1) that may be
introduced into Europe. The descendants of the original goose/Guangdong (gs/GD) HPAIV H5 clades
2.2.1.2, 2.3.2.1c and 2.3.4.4 were selected for detailed analysis of introduction via wild birds as these
were considered the main virus types that could cause outbreaks in the EU in the near future.
H5 and H7 LPAI viruses are endemic in the European wild bird population. Potentially zoonotic
LPAI viruses of subtype H9N2 (G1 lineage) are endemic in poultry in many parts of Asia, the Middle
East and northern Africa. Although these viruses have not been detected so far in Europe, introduction
is possible. LPAI viruses were analysed as one further group as in this scientiﬁc opinion they all have a
similar impact on poultry.
Establishing a harmonised data collection system, integrating outbreak notiﬁcation data, wild bird
ﬁndings and epidemiological parameters, will aid in providing timely epidemiological analysis within the
EU. It is also recommended that observations of global AI-related epidemiology fare shared in due
time to inform competent authorities and guide strategic preventive measures.
HPAI introduction via migratory and residential wild birds
Outbreaks of HPAI H5 in poultry in the EU since 2006 were initiated by primary incursions of
infected migratory wild birds into Europe, but intrinsic generation from an LPAI precursor virus and
secondary spread between poultry holdings has also been observed. Four potential different
geographical routes for the entry of wild birds into the EU were deﬁned here: the north-eastern route
(NE; EU border with Russia and Belarus), eastern route (E, EU border with Ukraine, Moldova, Black
Sea, Turkey until the southern border of Turkey), southern route (S, EU border from the southern
border of Turkey to the northern border of Portugal) and north-western route (NW; EU border from
north Portugal to north Russia). According to results obtained from the epizootic model generated in
this opinion, the NE and E routes have been associated with a high risk of H5 HPAIV-infected wild
birds entering the EU. No H5 HPAIV incursion has been observed so far from the S and NW routes.
Upon introduction of HPAIV into a wild bird population within the EU, a critical number of wild birds
is required before virus ampliﬁcation and further wild bird-associated geographical spread of the virus
may take place. The lower the number of susceptible water birds entering daily, the later the
prevalence starts to increase. Some scenarios are described in detail in the opinion to relative
importance of different parameters, whereas extrapolation of the numbers to the real world is difﬁcult
given the model assumptions and high uncertainty around the data. An association was identiﬁed
between the HPAIV occurrence in wild birds and the likelihood of infection of poultry holdings, which is
supported by the association between detections in wild birds and poultry in the ﬁeld. According to
expert opinion, prevention of access of poultry to water bodies could result in a threefold reduction in
HPAI entry probability. Combining this biosecurity measure with conﬁning poultry to indoor housing
was estimated to further reduce the HPAI entry probability twofold, and adding routine or high
biosecurity would result in a further reduction of 4- and 44-fold, respectively. The estimated effect of
biosecurity measures was considered independently of the HPAI virus characteristics.
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LPAI introduction via migratory and/or residential wild birds
For LPAIV, endemically infected wild bird populations play an important role as a source of primary
incursions, but secondary spread by undiagnosed infected poultry ﬂocks must be considered as well.
According to results obtained from the epizootic model, LPAIV can reach similar maximum prevalence
levels in wild bird populations when compared with HPAIV. At the same prevalence in the wild bird
reservoir, the risk of LPAIV infection of a poultry holding was estimated to be lower than that of HPAIV.
Experts considered the effect of implementing biosecurity on lowering the probability of LPAIV entry
into a holding similar to that of HPAIV.
HPAI and LPAI introduction via non-wild bird pathways
The risk of HPAIV and LPAIV introduction into the EU through non-wild bird pathways is estimated
to be lower compared with the wild bird pathway. The only non-wild bird pathways that were
considered to have a non-negligible risk of HPAI introduction are intra-EU movements and Third
country trade of semen, intra-EU movements of manure originating from holdings with Anseriformes
species. For LPAI, the only non-wild bird pathways that were considered to have a non-negligible risk
of introduction are intra-EU movements of live poultry and day-old chicks, intra-EU movements of
manure originating from holdings with any species. Introduction of AI into a poultry holding via feed
and bedding was considered non-negligible when accessible by wild birds during storage or any point
during the transport route. Illegal introductions of HPAIV-infected commodities (e.g. birds of prey, pet
birds, unprocessed poultry meat) have been detected at the EU border. Risk assessments would
beneﬁt from studies analysing virus perseverance in semen and faeces/manure (unprocessed, storage,
composting, effect of cleaning and disinfection procedures). It is also recommended that Member
States (MSs) trading poultry semen report their national rules (based on OIE recommendations) and
an estimate of the volumes traded so that a risk-based approach can be developed to assess the risk
of AI introduction and spread via semen.
HPAI and LPAI transmission and spread
The transmission rate between animals within a ﬂock is assessed to be higher for HPAI viruses than
LPAI viruses. In most cases, LPAIV remains restricted to a single farm, although horizontal spread has
been observed in several occasions. Spread of HPAI viruses between farms is highly likely in the
absence of control measures. It is recommended to perform epidemiological studies to obtain
quantitative information on between-ﬂock transmission and to assess the effect of risk factors
inﬂuencing between-ﬂock and between-farm spread. Collection of standardised epidemiological data at
the EU level from the holdings (e.g. location) and their houses (e.g. affected or not, number of
susceptible birds, population structure) would be required on an ongoing basis.
Mutation from LPAI to HPAI
In very few cases, it could be proven that HPAI outbreaks were caused by intrinsic mutation of
LPAIV to HPAIV and since 2005 the secondary spread of such HPAI viruses in the EU was limited
except for one event, which has led to recurrent HPAIV outbreaks in a single region of France. No
speciﬁc factors related to host species, environmental conditions or viral lineage were identiﬁed and
likewise no molecular markers that would be useful predictors of increased risk of a speciﬁc LPAIV to
mutate to an HPAI phenotype were identiﬁed. However, emergence of HPAI viruses from LPAI
precursors in Europe has occurred more frequently for LPAI viruses of the H7 subtype than H5.
Current knowledge does not allow a prediction as to if, and when, LPAI will mutate to HPAI.
Standardising and connecting virological and epidemiological data collections across the EU and
supporting research that applies a holistic approach to increase our ability to assess the role of speciﬁc
viral, environmental and host factors on the pathogenicity evolution is recommended.
HPAI and LPAI surveillance and early detection
Introduction of HPAIV in gallinaceous poultry populations inevitably results in severe clinical disease
and high mortality, whereas the clinical manifestation and mortality in anseriform poultry depends on
the phenotypic characteristics of a HPAI virus. Passive surveillance through notiﬁcation of suspicious
clinical signs/mortality is the most effective method for early detection of HPAI outbreaks in
gallinaceous poultry. For effective surveillance in anseriform poultry, passive surveillance through
notiﬁcation of suspicious clinical signs/mortality needs to be accompanied by active serological
surveillance and/or a virological surveillance programme of birds found dead (bucket sampling).
Pooling of such samples for polymerase chain reaction (PCR)-directed diagnosis may be useful.
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Subclinically infected domestic Anseriformes have a higher likelihood of continued spreading of HPAIV
when compared with clinically infected gallinaceous poultry, because it may go unnoticed. Therefore,
MSs are recommended to focus their annual serological surveillance programme on Anseriformes and
game bird populations.
Recognition and reporting of suspicion, sampling, testing and reporting of results is required to be
done in a timely manner. Risk-based surveillance is useful as it targets ﬂocks where the likelihood of
avian inﬂuenza virus (AIV) introduction is considered to be higher than average, although there is
limited quantitative (EU-wide) evidence to weigh the risk factors. Reporting of risk-based surveillance
approaches are not currently detailed enough to allow robust analysis and comparison of the results
among MSs. There is currently a lack of data on non-affected holdings and houses within the affected
regions, which is required in order to establish the magnitudes of risk of infection for the various
potential risk factors, such as location, holding- and ﬂock sizes, biosecurity measures, etc. It is
recommended to quantify the weighting of the risk factors used to design risk-based surveillance and
implement a detailed description of their use in national surveillance plans to facilitate analysis of the
results and comparison of results among MSs.
The current serological surveillance programme is useful to detect major changes in regional LPAIV
occurrence but results in the detection of active H5 or H7 infection only in a minority (around 20%) of
follow-ups conducted. The serological surveillance is unﬁt for early warning of LPAI outbreaks at the
individual holding level but could be effective in tracing clusters of LPAIV-infected holdings. Therefore,
serosurveillance should aim at detecting clusters of LPAIV-infected farms in order to identify those LPAI
events with continuous between farm spread. Epidemiological follow-up (tracing on/back) of
serologically positive holdings should be carried out to determine if there is clustering of AIV-infected
holdings/ﬂocks in space and/or time regardless of whether the seropositive birds are still at the holding
or whether active virus infection has been detected. If the group (i.e. epidemiological unit such as
shed or ﬂock) of poultry that were sampled for serology are not available for PCR testing, then any
other poultry (in particular seronegative birds) still remaining on that holding should be tested.
Passive surveillance is an appropriate method for HPAI surveillance in wild birds if the HPAIV
infections are associated with mortality. Active wild bird surveillance efﬁciency is very low in detecting
HPAI. When HPAIV has been detected in poultry within a given geographical area, active wild bird
surveillance could play a role in detecting HPAIV infections in wild birds that are not associated with
mortality as a possible source of virus introduction. A relative risk map of predicted H5 HPAIV
occurrences in wild birds in Europe has been generated based on the wild bird events reported
between 2005 and 2017, which could contribute to identiﬁcation of priority locations in the EU where
targeted active wild bird surveillance could be implemented during wild bird migration periods.
Targeted active wild bird surveillance through virology tests (swabbing) combined with enhanced
passive surveillance at a few priority regions in the EU may detect, if infection prevalence and sample
sizes are sufﬁcient, the presence of circulating AIV when these do not cause massive mortality among
these birds. Serological analysis would be useful to increase our understanding of HPAIV dynamics in
wild bird populations.
Biosecurity to prevent HPAI and LPAI entry and spread
Experts indicated that biosecurity measures play a key role in preventing AI spread from wild birds
to poultry. Human diligence is pivotal to select, implement and maintain effective biosecurity measures.
While certain general biosecurity principles universally apply to poultry holdings, unique features for
each holding need to be considered for optimised protection.
According to expert opinion, the most feasible, sustainable and efﬁcient measure to reduce the risk
of AI entry in indoor poultry holdings is to prevent direct and indirect wild bird contact. Other
measures with a high feasibility and sustainability are separation of waterfowl from other poultry
species, provision of potable drinking water instead of surface water, the implementation of a hygiene
lock for each poultry house, and biosecurity training of staff.
Outdoor poultry holdings bear an increased risk of AI incursions and the applicable biosecurity
measures are more limited. According to expert opinion, restricting access of persons and providing
biosecurity training are the most feasible, sustainable and efﬁcient measures to reduce the risk of AI
entry and spread in commercial holdings where poultry have access to outdoor areas.
For backyard holdings, experts assigned biosecurity training the highest overall rank to prevent
AI entry and spread.
According to expert opinion, the highest ranked measures to prevent secondary spread of the
virus are: to contain poultry and fomites (i.e. materials that were in contact with poultry) during
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transport, cleaning and disinfection of equipment, biosecurity training, cleaning and disinfection of
transport vehicles, and the use of a hygiene lock for each poultry house. The risk of avian inﬂuenza
virus (AIV) introduction and spread will remain high in production processes when: movement of
animals, restricting access throughout the whole production cycle, and/or contact with wild birds is not
reduced.
It is recommended at all times to restrict wild bird access to poultry holdings, avoiding the
presence of open water bodies on the premises, feed should be provided indoors only, to implement
hygiene locks, restrict access of people, and to limit contacts to other poultry holdings. Professional
staff of poultry holdings should attend general biosecurity training but also receive holding-speciﬁc
biosecurity advice ideally from an expert (e.g. veterinarian) familiar with the particular holding. Also
hobby keepers should receive information to achieve at least a minimal understanding of biosecurity to
prevent entry and/or spread of AIV in their backyards and during markets and/or shows. Game bird
hunting activities must be fully separated from rearing poultry and game birds should be tested for AI
before release. Online biosecurity questionnaires could be used by farmers to check their current
biosecurity level and subsequently to improve it based on the received feedback.
During high-risk periods, it is recommended to prevent direct contact between wild birds and
poultry through conﬁnement, netting, or at least limitation of outdoor access area of domestic birds.
Feed and water should be provided under a roof or a horizontal fabric. Biosecurity training and
improved control of catching crews and other ‘mobile’ staff may be useful to limit indirect spread of
HPAIV and LPAIV during large-scale operations in commercialised poultry holdings.
Establishment of a control and monitoring area and risk zones
There is no scientiﬁc evidence to guide the sizes of a control and monitoring zone upon ﬁnding
HPAIV in wild birds because it depends on the dynamics of the epizootic and the infected bird species.
It is recommended that control and in particular monitoring areas are set up based on the ecological
habitat and ﬂight distance of the infected wild bird species. Setting up small-sized restriction zones for
the ﬁrst cases at the beginning of a new wild bird epidemic may be instrumental in being able to
implement increased surveillance activities in poultry in this zone. Informing poultry keepers on the
detection of HPAIV in wild birds in the region will increase their awareness of the risk of virus
introduction into their holding. In the progression of a wild bird epidemic, setting up wider zones,
rather than a succession of small, restricted zones may be more appropriate. During an epidemic of
HPAIV in wild birds, it is recommended that samples from new species and non-previously reported
areas be tested. Testing in reported areas can be restricted to check viral presence in relation to an
‘exit strategy’ from measures implemented. Sharing data and expert opinion at national and EU level
on exit strategies would aid in terms of harmonised and structured approaches as well as
interpretation of available data. Collaboration between authorities and stakeholders is crucial.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. EFSA-Q-2015-00214 (April 2015)
The occurrence of highly pathogenic avian inﬂuenza (HPAI) outbreaks of the H5N8 subtype in
Member States (MSs) triggered the immediate implementation of control measures according to
Council Directive 2005/94/EC1. The Commission asked the European Food Safety Authority (EFSA) to
issue a scientiﬁc report on the disease situation world-wide and to assess possible virus entry routes
into the European Union (EU) poultry holdings with a particular view to the role played by wild
migratory birds.
Although there is knowledge about the direct or indirect migration routes from East Asia to Europe,
several theories of HPAI H5N8 virus (and possibly other HPAI viruses) entry routes from East Asia into
Europe involving infected migratory birds appear plausible. Transmission of HPAI H5N8 virus between
different wild bird species at breeding and stopover places seems likely, but this theory needs further
assessment. Also, the role of other virus entry routes such as through material contaminated by
infected wild birds, human activities, movement of vehicles or equipment needs to be further
examined for a more complete risk assessment on avian inﬂuenza virus (AIV) introduction into EU
poultry holdings.
EU legislation on biosecurity and early detection measures to reduce the risk of HPAI H5N1
introduction into poultry holdings are laid down in Decision 2005/734/EC2, which sets out the criteria
and risk factors to be considered by MSs when deﬁning areas with an increased risk for avian inﬂuenza
(AI) introduction into poultry holdings. The measures are intended to prevent contact between poultry
and wild birds as well as separating domestic waterfowl from other poultry species. As the scope of
those measures is limited to HPAI H5N1 it is necessary to assess the risk posed by other HPAI viruses
and speciﬁcally HPAI H5N8 to verify if the provisions of Decision 2005/734/EC are suitable when facing
further HPAI H5N8 outbreaks. In addition, Decision 2006/563/EC3 also provides for a comprehensive
set of protection measures following HPAI H5N1 virus ﬁndings in wild birds. EFSA should assess if the
measures in that Decision are properly addressing risks posed to poultry holdings when HPAI H5N8
and other HPAI viruses are detected in wild birds.
EU-wide surveillance programmes for avian inﬂuenza in poultry and wild birds have been in place
since 2003. Directive 2005/94/EC introduced a new legal basis for avian inﬂuenza surveillance which is
ﬁrst aimed at identifying the circulation of low pathogenic avian inﬂuenza (LPAI) viruses in different
poultry species before they become widespread in the poultry population. It should contribute to the
basis of a regularly updated risk assessment and to the current knowledge on the threats posed by
wild birds in relation to any inﬂuenza virus of avian origin in birds. Following the HPAI H5N1 epidemic
in 2006 and subsequent years, avian inﬂuenza surveillance was reviewed in the light of several EFSA
Scientiﬁc Opinions, the work of the OIE-FAO OFFLU initiative, the reports of the EU Reference
Laboratory (EURL) for avian inﬂuenza and the input of the Task Force for Animal Disease Surveillance.
The revised guidelines for avian inﬂuenza surveillance laid down in Decision 2010/367/EU4 follow a
risk-based approach. The objectives shall provide for the most suitable surveillance strategy informing
competent veterinary authorities on disease prevention and control purposes aimed at protecting
poultry and other captive bird holdings from avian inﬂuenza infection. Following the current HPAI H5N8
outbreaks, it is deemed appropriate to assess if the EU strategy and guidelines for avian inﬂuenza
surveillance are still suitable and sufﬁcient, considering that active surveillance by laboratory testing of
wild birds trapped or hunted is currently not foreseen in the EU-approved surveillance programmes.
To this end, alternative surveillance designs based on active sampling of healthy wild birds to study
the many different aspects of virus presence and characteristics should be considered within the
1 Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian inﬂuenza and repealing
Directive 92/40/EEC. OJ L 10, 14.1.2006, p. 16–65.
2 Commission Decision 2005/734/EC of 19 October 2005 laying down biosecurity measures to reduce the risk of transmission of
highly pathogenic avian inﬂuenza caused by Inﬂuenza virus A subtype H5N1 from birds living in the wild to poultry and other
captive birds and providing for an early detection system in areas at particular risk. OJ L 274, 20.10.2005, p. 105–107.
3 Commission Decision 2006/563/EC of 11 August 2006 concerning certain protection measures in relation to highly pathogenic
avian inﬂuenza of subtype H5N1 in wild birds in the Community and repealing Decision 2006/115/EC. OJ L 222, 15.8.2006,
p. 11.
4 Commission Decision 2020/367/EC of 25 June 2010 on the implementation by Member States of surveillance programmes for
avian inﬂuenza in poultry and wild birds. OJ L 166, 1.7.2010, p. 22–32.
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context of risk management targeted to inform the risk manager in an efﬁcient manner. Therefore,
some principles of surveillance in wild birds and in poultry holdings need to be revised. In the light of
the recent outbreaks, it is also necessary that EFSA studies certain aspects of the epidemiology of
HPAI H5N8 virus which are related to biosecurity and conﬁnement of poultry.
Control measures for LPAI outbreaks of the H5 and H7 subtypes were included in Directive 2005/94/EC
as those avian inﬂuenza viruses have the potential to mutate to HPAI virus with possibly severe
consequences for animal health and the poultry industry. The presence of LPAI viruses in the wild bird
reservoir poses an ongoing risk for LPAI virus introduction into poultry holdings. A speciﬁc challenge for
the management of biosecurity measures is to prevent contacts of wild birds with poultry constitutes
holdings where poultry is kept in open air runs.
EFSA is therefore also requested to assess the risks of LPAI virus introduction into poultry holdings
taking into account the conditions under which poultry is housed and the appropriate surveillance and
biosecurity measures to be applied.
EFSA is requested to provide a scientiﬁc opinion in accordance with Article 29 of Regulation (EC)
No 178/20025:
1) Assess the risks of introduction of HPAI H5N8 and possibly other HPAI viruses considering the
possible entry routes into the EU.
2) Assess the risks posed by HPAI H5N8 and possibly other HPAI viruses for public and animal
health and speciﬁcally with a view to assess the suitability of the provisions on:
a) biosecurity and early detection measures to reduce the risk of its introduction into poultry
holdings laid down in Decision 2005/734/EC;
b) protection measures in poultry in case of its occurrence in wild birds laid down in Decision
2006/563/EC;
c) the surveillance strategy, in particular objectives and methodology, laid down in Decision
2010/367/EU.
3) Assess the current situation in the EU and elsewhere as regards the risk of a possible
introduction of HPAI (H5N8) virus and possibly other HPAI viruses to EU poultry holdings.
4) Assess the continuous risk posed by LPAI (subtypes H5 and H7) for the introduction from the
wild bird reservoir into poultry holdings taking into account risks for holdings where poultry is
kept in open air runs and the suitability of surveillance and biosecurity measures aimed at
protection of poultry against LPAI infection.
1.1.2. EFSA-Q-2016-00348 (May 2016)
Highly pathogenic avian inﬂuenza is a highly contagious viral disease and causes high mortality in
most bird and poultry species (except in many ducks and geese species). LPAI viruses mainly cause
mild disease and may even remain undetected. Wild migratory birds are the natural reservoir for LPAI
viruses. LPAI viruses of the H5 and H7 subtypes have the potential to mutate to HPAI viruses.
Until the adoption of Council Directive 2005/94/EC, EU control measures for avian inﬂuenza were
only directed against HPAI.
Large HPAI epidemics world-wide (e.g. USA/Pennsylvania 1983, Italy 1999/2000, the Netherlands
2003) that emerged by mutation from a circulating LPAI virus strain into its highly pathogenic form
caused death and killing of more than 60 million poultry with devastating socioeconomic
consequences. These experiences, supported by science including EFSA (2005) led to the introduction
of control measures against LPAI viruses of the H5 and H7 subtypes into EU legislation.
Also, the World Organization for Animal Health (OIE) introduced in its Terrestrial Animal Health
Code in addition to the existing recommendations for international trade for HPAI standards for LPAI
and developed guidance on surveillance (OIE, 2010).
The EU control measures for LPAI and HPAI foresee the killing of all poultry on HPAI-infected
holdings. In case of LPAI infection, poultry may either be killed or be quarantined, further tested and
may then go for slaughter under biosecure conditions. However, recently no MS has made use of the
latter option.
5 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in
matters of food safety. OJ L 31, 1.2.2002, p. 1–24.
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LPAI-infected poultry may not show clinical signs. It was therefore necessary to introduce
compulsory EU-wide active surveillance programmes to detect circulating LPAI virus and, in addition,
circulating HPAI in domestic waterfowl as these species may not show disease even when infected
with HPAI. The programmes are based on serosurveillance with virological follow-up of positive results
and are not aimed at early detection of infection. The surveillance programmes have been reﬁned over
the years deﬁning the objectives and enabling targeting risk-based strategies. Passive surveillance and
early detection systems are complementing those active surveillance programmes. The variety of risk
factors associated with different poultry species and production systems continues to make meaningful
and affordable surveillance a challenge.
Surveillance for avian inﬂuenza has been carried out by MSs under coﬁnanced programmes since
2003, Directive 2005/94/EC with new control measures for HPAI and LPAI had to be implemented
since mid-2007. During these last 10 years, many MSs have made their own experiences with HPAI or
LPAI outbreaks or have rehearsed the control measures in the framework of simulation exercises. Also,
the entry of the HPAI H5N1 virus into Europe in 2005/2006, constituted an unprecedented event
involving HPAI virus transmission mainly via wild migratory birds that became a prominent pathway for
HPAI incursions prompting the adoption of a series of control measures.
The EU measures for the control of avian inﬂuenza have worked well so far, but the proportionality
of some measures applied for HPAI and especially for LPAI remains a concern and should be based on
risk assessment.
With respect to surveillance, the number of LPAI outbreaks in a country is considered to be
primarily related to the monitoring intensity and quality of early warning procedures. Countries that
have the most elaborate surveillance systems tend to detect LPAI incursions more frequently. This has
also consequences for international trade. The OIE’s LPAI free status in the Terrestrial Animal Health
Code may not properly reﬂect the real LPAI status of a country considering the heterogeneity of LPAI
surveillance systems implemented world-wide ranging from almost non-existing to the well-structured
active and passive surveillance programmes implemented in the EU. This status must also be seen
against the background of the number of countries actually notifying LPAI to the OIE.
A question remains open as regards the extent intensive active and passive surveillance
implemented in the EU has effectively led to preventing or reducing HPAI outbreaks by surveillance
and control of LPAI outbreaks.
The new Animal Health Law Regulation (EU) 2016/4296 and its future delegated and implementing
acts offer now the opportunity to review certain disease prevention and control measures.
Because of the above, and in accordance with Article 29 of Regulation (EC) 2002/178, the
Commission asks EFSA for a scientiﬁc opinion and to speciﬁcally:
5) assess the different pathways, the most important routes and risk factors for avian inﬂuenza
viruses ((a) HPAI and (b) LPAI) to enter poultry holdings in the EU including the threat
posed by viruses circulating in wild birds;
6) assess the within-ﬂock, within-farm and between-farm transmission characteristics for both
(a) HPAI and (b) LPAI viruses;
7) assess and, if possible, quantify the risk of mutation of a LPAI viruses to HPAI viruses and to
identify the factors that inﬂuence the mutation frequency of avian inﬂuenza viruses in
poultry ﬂocks;
8) indicate which avian inﬂuenza surveillance tools are most suitable and which factors need to
be taken into account for optimising an avian inﬂuenza surveillance programme.
1.2. Interpretation of the Terms of Reference
INTRODUCTION (Terms of Reference (TOR) 1, TOR 3, TOR 4 and TOR 5)
There is ample scientiﬁc evidence that HPAIV arises following adaptation and spontaneous mutation
from LP precursor viruses, in particular during extended circulation and efﬁcient replication in poultry.
Metapopulations of wild birds, mainly of the Anseriformes and Charadriiformes orders, constitute the
natural reservoir of LPAIVs, and virus transmission out of these reservoirs into poultry populations may
start a sequence of events that culminates in the generation of AIV with an HP phenotype. Lateral
spread of HPAI viruses in poultry may in turn lead to spill-over transmission to wild bird species.
6 Regulation EU 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and
amending and repealing certain acts in the area of animal health (‘Animal Health Law’). OJ L 84, 31.3.2016, p. 1–208.
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Evidence has now accumulated indicating that HPAIV-infected wild birds, depending on virus- and host
species-speciﬁc factors, may be responsible for long-distance translocation of HPAIV leading to
transmission to and outbreaks of HPAI in geographically distant poultry populations from outside the
EU and among European countries (Lee et al., 2015; Verhagen et al., 2015).
Long-distance geographical translocation of HPAIV by wild birds is envisaged to be associated with
seasonal migration movements but may also be linked to shorter, regional movements of individuals
within wild bird populations during the moulting period of some species (Reperant et al., 2010), or that
are initiated by adverse weather conditions (cold spells, e.g. Ridgill and Fox, 1990).
The focus of the TOR 5 analysis is to present a global overview of HPAI and LPAI outbreaks
during the previous 5 years, to underpin AI viruses that are included in a more detailed assessment of
their risk of introduction during the next migration season(s) (TOR 1, TOR 2 and TOR 3). For HPAI,
HPAI H7 viruses (including the recently emerged Chinese HPAIV H7N9) and three clades of Asian origin
HPAI H5 viruses have been selected as they have already been reported within the EU (EU annual
reports7 on active surveillance). On the LPAI side, viruses of subtypes H5 and H7 circulating in the EU
were selected. LP viruses of subtype H7N9 of Chinese origin, and LPAI viruses of subtype H9N2,
genogroup G1, are also taken into account. Although the latter two have not been reported in the EU
so far, subtype H7N9 of Chinese origin bears substantial zoonotic potential and has recently mutated to
a highly pathogenic phenotype that has spread among poultry in China and has already caused human
cases of infection (Khan et al., 2015; Zhu et al., 2016, 2017). H9N2 genogroup G1 viruses, although
they are not likely to mutate to HPAI, might well exert an economic impact on the European poultry
industry if they were to be introduced (Pu et al., 2015). H9N2 viruses from other genogroups have been
reported in Europe (Slomka et al., 2013; Lindh et al., 2014; Smietanka et al., 2014).
Different entry pathways are described via which infected wild birds can reach EU territory
(HPAI, TOR 1 to TOR 5; LPAI, TOR 5) and the probability of introduction of the selected viruses during
the next migration season is analysed by quantitative means when possible to estimate the probability
of introduction. Furthermore, a map depicting the infection exposure likelihood in wild birds across the
EU is provided (Si et al., 2010).
Assessing the risk of introduction into poultry holdings from wild bird reservoir is carried out
quantitatively for those viruses for which data are available in the scientiﬁc literature. These will be used
as a blueprint for comparison of viruses where data are insufﬁcient to perform a quantitative assessment
(HPAI, TOR 3 to TOR 5; LPAI, TOR 4 and TOR 5). In addition, a general model is generated to determine
the inﬂuence of wild bird population density and composition on the probability of AIV incursion into a
worst-case poultry holding. Experts estimated the fold reduction of this probability when implementing
four different levels of biosecurity. The model takes into account HPAIV ampliﬁcation cycles in local wild
bird populations after the introduction from sites outside the EU territory while LPAIV is considered to be
endemic within the wild bird reservoirs of the EU territory, even though their subtypes may vary.
A qualitative assessment on the risk of AI introduction via non-wild bird pathways is provided
as well (HPAI, TOR 1 to TOR 3; LPAI, TOR 5), considering imported captive birds (for approved
premises), pet birds, birds for competitions/exhibitions, imported live poultry (hatching eggs, day-old
and older birds) and imported poultry products (meat, eggs for consumption, semen, bedding,
manure, feathers and down and poultry feed) as deﬁned in previous EFSA Scientiﬁc Opinions (EFSA,
2006a,b, 2008). For manure, only movements, of unprocessed manure, within the EU are considered
as the animal by-product Regulation (EU) No 2011/1428 Article 25 prohibits imports from Third
countries. The volume of traded/imported commodities is taken into account where data are available.
TRANSMISSION AND SPREAD (TOR 6)
Transmission of infection depends on characteristics of both the virus and the host. Combined they
shape the likelihood of a bird becoming infected (dose–response curve) and the infectivity of a bird
upon infection (excretion kinetics and total amount of virus shed by the bird). In concert with the
contact network between birds, they determine the rate of transmission between individual birds. In
addition, between-ﬂock transmission is determined by the number of birds infected in a ﬂock (measure
of the infectivity of a ﬂock) and the contact network between ﬂocks. Finally, at the level of farms, the
7 http://ec.europa.eu/food/animals/animal-diseases/control-measures/avian-influenza/index_en.htm, last accessed on 13 June 2016
(European Commission, 2016).
8 Commission Regulation (EU) No 2011/142 of 25 February 2011 implementing Regulation 2009/1069/EC of the European
Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for
human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from
veterinary checks at the border under that Directive. OJ L 54, 26.2.2011, p. 1–254.
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total number of infected ﬂocks on a farm is determining the infectivity of a farm and the contact
network between farms links this to susceptible farms. To address TOR 6, it is assessed whether there
are differences between HPAI and LPAI transmission dynamics in poultry.
Transmission parameters are identiﬁed for LPAIV and HPAIV between animals, between houses and
between farms (different locations). Likely transmission parameters to be used are the transmission rate
parameter (number of new infections per infectious bird/ﬂock/farm per day), reproduction ratio (number
of new infections per infectious bird/ﬂock/farm during its entire infectious period) and the duration of
infection. In addition, factors inﬂuencing transmission at the three levels will be identiﬁed. At the within-
ﬂock (= between-animal level), these are virus strain, poultry type (species/genotype, age, constitution,
etc.) and possibly housing factors like population density/outdoor access, caging systems, etc. At the
level of ﬂocks (= between houses on a farm), these are (in addition to the factors inﬂuencing transmission
between animals) ﬂock size and information on the contact network between the houses (outdoor access
or not) and biosecurity measures applied. At the level of farms (= between farms), these are (in addition
to the factors inﬂuencing transmission between animals and ﬂocks) farm size and information on the
spatial relation and contact network between the farms and biosecurity measures applied.
This assessment does not include modelling the transmission across Europe because available models
do not allow extrapolation beyond the local situation they have been developed for (Lycett et al., 2016).
In Section 3.5, a One Health perspective is brieﬂy mentioned, since collection of data on AI spread
among animals will also facilitate assessing human exposure risks to AI. Assessment on the zoonotic
aspects of AI is beyond the mandate and will not be further analysed.
LPAI MUTATION TO HPAI (TOR 7)
Pathogenicity of AIV is measured by the intravenous pathogenicity index (IVPI) as laid down in
Commission Decision 2006/437/EC9. HPAIVs can cause massive mortality, in particular in gallinaceous
poultry. The amino acid sequence at the endoproteolytical cleavage site (CS) in the viral
haemagglutinin protein (HA) can alternatively be used as a molecular marker of the HP phenotype for
viruses of subtypes H5 and H7 (Commission Decision 2006/437/EC; Franҫa and Brown, 2014). All HP
AIV found in the ﬁeld so far were of the H5 or H7 subtype.
Published experimental data and outbreak analyses were screened and data were extracted (i) to
describe the current understanding of the mechanisms that govern pathogenicity of AIV in poultry and
(ii) to identify intrinsic and extrinsic factors which might inﬂuence LP-to-HP mutation rates.
SURVEILLANCE AND EARLY DETECTION (TOR 2, TOR 4 and TOR 8)
HPAI but not LPAI viruses can cause devastating disease and gross economic losses in most poultry
species except domestic waterfowl. Therefore, HPAI detection in the EU historically was based on
passive surveillance. In gallinaceous poultry, HPAI is mainly identiﬁed via passive surveillance as the
virus causes overwhelming clinical disease and high mortality that is easily detectable (Franҫa and
Brown, 2014). Conversely, HPAIV infections in Anseriformes may or may not lead to clinical signs (Kim
et al., 2011; Lee et al., 2011), hence, passive surveillance may miss clinically mild or inapparent forms
of infection and a more crucial role of active surveillance in domestic Anseriformes ensues. The
surveillance components are described and the suitability of the current10 HPAI serosurveillance
in gallinaceous and Anseriformes poultry (Commission Decision 2010/367/EU) is analysed.
AI surveillance in both wild birds and poultry in the EU was broadened following outbreaks of HPAI
which arose by mutating from LPAIV precursors in poultry (Italy 1999–2001, see; Netherlands 2003, see
Stegeman et al., 2004; Monne et al., 2014) and following outbreaks caused by HPAIV H5N1 which was
most likely introduced by wild birds (Starick et al., 2008) (Commission Decision 2010/367/EU). HPAI
surveillance in wild birds was introduced, ﬁrst in an active and passive manner but was later reduced to
passive surveillance only as based on previous ﬁeld experience which was, however, restricted to a
single HPAIV H5 clade only (H5N1, clade 2.2). The suitability of the current HPAI surveillance
system in wild birds (Commission Decision 2010/367/EU) is analysed (TOR 2 to TOR 8).
The ultimate objective of implementing LPAI surveillance in poultry is the detection of LPAIV of
subtypes H5 and H7 before they mutate to HPAIV, as it was formulated in Commission Decision 2007/
268/EC11. The current Decision 2010/367/EU describes LPAIV surveillance of subtypes H5 and H7 in
9 Commission Decision 2006/437/EC of 4 August 2006 approving a Diagnostic Manual for avian inﬂuenza as provided for in
Council Directive 2005/94/EC. OJ L 237, 31.8.2006, p. 1–27.
10 What is in the EU Regulation to date: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32010D0367&rid=1
11 Commission Decision 2007/268/EC of 13 April 2007 on the implementation of surveillance programmes for avian inﬂuenza in
poultry and wild birds to be carried out in the Member States and amending Decision 2004/450/EC. OJ L 115, 3.5.2007, p. 3–17.
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gallinaceous birds (namely chickens, turkeys, guinea fowl, pheasants, partridges and quails) to support
disease control. H9 surveillance is not included in the EU legislation nor OIE standards since it has not
been reported to mutate into HPAIV and hence is not considered to induce HPAI-like disease in poultry
although tangible economic losses may ensue.12 The suitability of the current LPAI surveillance
system to detect H5 and H7 LPAIV in poultry to prevent HPAI outbreaks is analysed (TOR 4 to TOR 8).
Recommendations to optimise detection of circulating AI viruses in the EU are provided, in
particular regarding annual serosurveillance programs. The absence of detailed scientiﬁc data (at least
at EU level) hampers the ability to weight the relative importance of risk factors and hence provide
recommendations to harmonise risk-based surveillance (RBS) approaches. Further development of risk-
based methodology could be possible after a period of detailed reporting by the MSs on the relative
weights of risk factors currently used and the scientiﬁc evidence available at national level to underpin
these weights. Establishing a RBS framework at EU level would help the analysis of RBS outcomes and
their comparison among MSs. However, it is not expected that scientiﬁc evidence will become available
to support a uniform AI surveillance approach for all MSs given the difference in AI history between
MSs and the heterogeneity of poultry populations across the EU.
The early detection measures described in Commission Decision 2005/734/EC have been reviewed
mainly based on the HPAI H5N8 outbreaks in the period October–November 2016 (EFSA, 2016a)
taking into account the global processes of HPAI H5 evolution. In the present scientiﬁc opinion,
recommendations are provided aimed at reﬁning the existing early detection systems using voluntary
surveillance components like poultry production parameter monitoring, bucket sampling and testing to
exclude notiﬁable avian diseases.
BIOSECURITY (HPAI, TOR 2; LPAI, TOR 4)
The effects of biosecurity measures on mitigating the risk of HPAI/LPAI introduction into a poultry
holding are pleiotropic in character and, so, difﬁcult to quantify. Expert knowledge has been elicited
(EKE) to identify and rank biosecurity measures applicable in commercial chicken holdings (EFSA,
2016a). In this opinion, an additional EKE has been performed to further analyse effects of biosecurity
measures in indoor versus outdoor commercial and non-commercial chicken production. The main
objective was to identify and describe a set of biosecurity measures that can be applied in practice to
reduce risks of AI entry and spread in high-risk periods, for instance when an infected wild bird has been
found in the area. Biosecurity should therefore aim at improving bioexclusion and biocontainment of
poultry holdings. Biosecurity implementation in zoos and by poultry dealers have been discussed, as well
as the effect of hunting and use of live decoys. Finally, a brief gap analysis is provided on data required
to underpin future assessments on the effect of biosecurity measures in an evidence-based way.
ESTABLISHMENT OF A CONTROL AND MONITORING AREA (TOR 2)
The provisions regarding the establishment of a control and monitoring area after HPAI detection in
a wild bird (Commission Decision 2006/563/EC) have been analysed and described in the AI Statement
(EFSA, 2016a). In this scientiﬁc opinion, the zoning around wild bird cases and poultry outbreaks are
assessed based on the analysis of the AI outbreaks occurring in the EU between October 2016 and
April 2017 (EFSA, 2017b). Recommendations are provided on how to perform a risk assessment on the
actual usefulness of zoning measures, the timing and lifting of protection measures, aiming to provide
science-based advice to risk managers.
2. Data and methodologies
2.1. Approach to map HPAI and LPAI outbreaks (TOR 5)
The objective was to map the HPAI and LPAI outbreaks over the last 5 years with the aim of
underpinning viruses selected for detailed analysis as they might cause outbreaks in the EU in the near
future. Presenting ﬁndings in wild birds is included as scientiﬁc evidence when explaining why the
opinion focuses on the AI introduction pathway via wild birds.
12 MSs using an enzyme-linked immunosorbent assay (ELISA) to detect AI in serum will likely detect H9-speciﬁc antibodies but
do not have the obligation to notify H9 ﬁndings. If H9N2 would be identiﬁed, sequencing would be required to differentiate
genogroup G1 viruses from other genogroups. Analysis of H9 viruses would be more relevant for human health aspects, but
this is beyond the current objectives of AI surveillance in poultry.
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Data sources used were the Animal Disease Notiﬁcation System (ADNS); EMPRES-i database; OIE
WAHID database; AI Consortium database; scientiﬁc literature, in particular observational studies; FAO
Empres-i situation update reports and ECDC rapid risk assessments, in particular for H7N9.
Viruses were selected to be assessed in TOR 1 and TOR 3 (might cause outbreaks in the EU in the
near future): merging or dissecting separately certain virus groups and clades in the analysis such as
HPAI viruses with distinct pathogenicity (e.g. H5N8 2.3.4.4), HPAIV with distinct geographic bindings
(e.g. H5N1 2.2.1.2; G1-like H9N2), and HPAIV that evolved from a common group of LPAI precursor
viruses already endemic in the EU territory (e.g. all HPAIV of subtype H7 reported in the EU). The
outcome is described in Section 3.1.
2.2. Approach to assess AI introduction into the EU by migratory wild
birds (HPAI, TOR 1 and TOR 5; LPAI, TOR 5) and subsequently into
a poultry holding (HPAI, TOR 3 and TOR 5; LPAI, TOR 5)
For HPAI, the objective was to assess the risk of virus introduction as the probability that at least
one infected wild bird enters the EU and to provide a predictive risk map of HPAI occurrences in wild
birds in Europe. Subsequently, the cumulative (seasonal) probability of poultry holdings without
biosecurity becoming infected with HPAI was determined.
Four different risk pathways were deﬁned, based on the entry routes of migratory wild birds
crossing the EU border (Section 3.2.1). A mathematical (epizootic) model was generated, consisting of
three components: entry assessment, AI dynamics in the wild bird reservoir, and exposure assessment
with poultry holding incursions (see detailed description in Appendix C).
The parameters were informed based on: (i) data from experimental and observational studies
collected by the Consortium ((Duncan et al., 2017a,b; data received as per procurement, Erasmus
University Medical Centre, OC/EFSA/ALPHA2015/01, unpublished Gonzales; and data received as per
procurement, coordinated by Linnaeus University SE) and Erasmus Medical Centre (NL), OC/EFSA/
ALPHA 2015/01 supplemented with NP/EFSA/ALPHA/2015/04, unpublished) and the Working Group
(WG) experts (see Appendix D), and (ii) EKE (semi-formal and formal), performed using the Shefﬁeld
method. Parameters have been estimated by experts as probability distribution reﬂecting the
uncertainty around the unknown true values (see Section C.6 in Appendix C). The model was used to
assess entry of HPAIVs via the NE entry route and the outcomes are described in Section 3.2.2.
The probability of HPAIV entry via the E, S and NW routes was assessed in a comparative manner,
considering the model outcome for HPAI clade 2.3.4.4. for the NE route as the benchmark. The
probability terms used are deﬁned in Table 1. The outcomes are described in Sections 3.2.3–3.2.6.
For LPAI, entry into the EU was not assessed as it is considered to be endemic. Only a description
of new viruses that could enter the EU in the future is provided (see Section 3.3.1). The epizootic
model was also used to simulate entry of LPAIV introduction into a new foraging area and the
resulting probability of a poultry holding to become infected. The parameters were also informed on
extracted data and EKE (see Section C.7 in Appendix C). The results are described in Section 3.3.2.
A sensitivity analysis was run for HPAI and LPAI to assess the importance of input variables on the
model outcome (see Appendix E).
Table 1: Deﬁnitions of probability terms used to describe the risk of HPAI introduction for a given
clade and entry route in comparison to the benchmark (HPAI clade 2.3.4.4 entry via the
NE route)
Probability term Subjective probability range
Extremely high/low > 1,000-fold the benchmark value(a)
Much higher/lower Between 10- and 1,000-fold the benchmark value(a)
Higher/lower Between 3- and 10-fold the benchmark value(a)
Slightly higher/lower Between 1.5- and 3-fold the benchmark value(a)
Similar Up to 1.5-fold the benchmark value(a)
(a): The benchmark value is the model outcome on HPAI clade 2.3.4.4 entry into the EU via the NE route (see Section 3.2.2).
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2.3. Approach to assess AI introduction by non-wild bird pathways
The objective was to perform a brief qualitative assessment on the risk of AI introduction via non-
wild bird pathways in two scenarios: (i) Third country trade and (ii) intra-EU movements. The focus of
the current scientiﬁc opinion is on analysing scientiﬁc evidence suggesting a reduction in efﬁcacy of
HPAI/LPAI passive surveillance in: (i) wild bird and (ii) poultry populations due to altered pathogenesis
and or epidemiology of the selected HPAI viruses. The exposure of such groups to the different trade
pathways will therefore be part of the evidence assessment for surveillance.
Ten pathways and the corresponding commodities other than wild birds, by which there is potential
to introduce AIV into a commercial poultry holding have been identiﬁed and qualitatively assessed for
the two pathogenic groups of viruses (HPAI and LPAI), in two scenarios (third country trade and intra-
EU movements) with a description of the entry and exposure to poultry pathways, given the EU rules
and requirements for trade (see Section 3.4). Illegal import is brieﬂy described in the text but is not
included in the qualitative assessment due to a lack of data.
Data were extracted from the UN ComTrade database (the United Nations International Trade
Statistics Database) for various commodity codes related to trade in live poultry, captive birds,
hatching eggs, day-old chicks, birds as pets, products of poultry origin for human consumption, poultry
by-products, pharmaceuticals, germinal products, manure, bedding and poultry feed. The EUR-LEX
database for all relevant legislation related to the legal trade and intra-EU movement of such
commodities. An average of 3 years annual trade was used to give an average annual volume for
either import into the EU or intra-EU movements. Literature searches have been performed for the
identiﬁed commodities and information was extracted on HPAI ﬁndings in different matrices,
preservation of HPAIV in such matrices and clinical signs. The EU legislation and OIE documents have
been used to identify checks and certiﬁcate requirements for consignments. Detailed information is
provided in Appendix F.
For each scenario (commodity, HPAI or LPAI, Third country or intra-EU trade), the WG identiﬁed
the tests that can be used and assessed the probability of testing, the probability of virus detection,
the probability of virus preservation during transport, the probability of poultry exposure to the
commodity (see Table F.1, Appendix F) and the probability of AIV introduction into a commercial
poultry holding (see Section 3.4). Each probability was assessed separately13 by discussion among the
experts and reaching consensus. The used probability terms and corresponding subjective probability
ranges are shown in Table 2.
In terms of the levels of categorisation for the risk level, it was assumed that most risk managers
will not distinguish between 10% and 100% likelihood; anything within this range will be managed.
This reduces the levels of complexity in terms of assessing the risk, but it can lead to large boundaries
of subjectivity where probability of occurrence of the ‘non-negligible’ risk level is anything between
10% and 100%.
2.4. Approach to assess AI transmission and spread
The objective was to determine the transmission parameters (e.g. transmission rate parameter and
reproduction ratio) for HPAI and LPAI transfer between animals, between houses and between sites
and associated risk factors (virus, host, contact network). Also, the role of wild birds in AI transmission
between houses and holdings is assessed.
Table 2: Probability terms and subjective probability ranges used to describe the probability of AI
introduction via non-wild bird pathways
Probability term Subjective probability range
Non-negligible From 10% up to 100%
Unlikely From 2% up to 10%
Very unlikely From 1% up to 2%
Extreme unlikely Up to 1%
Negligible Indistinguishable from 0
13 There is no sound algorithm available to combine qualitative risk scores.
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Data have been extracted by the AI Consortium from the scientiﬁc literature (Duncan et al., 2017a,b).
A descriptive analysis of the data is provided in Section 3.5 and tables with transmission characteristics
are included in Appendix E.
2.5. Approach to assess mutation from LPAI to HPAI
The objective was to describe the current understanding of the mechanisms that govern
pathogenicity of AIV in poultry and to identify factors that might inﬂuence LP-to-HP mutation rates
with respect to virus, environmental and host species-speciﬁc aspects. Data have been extracted by
the AI Consortium from the scientiﬁc literature (Richard et al., 2017) and several databases have been
used (GISAID, 2017; data collected by the Consortium as reported by Duncan et al., 2017a,b).
Data collected from experimental trials related to the LPAI/HPAI switch, from the genetic
comparison between HPAI and LPAI precursors, as well as the genome sequences downloaded from
public databases were used to evaluate the possible existence of molecular markers associated with
the evolution of LPAIV to HPAIV.
Epidemiological information referring to documented and conﬁrmed HPAI outbreaks since 1959
were analysed to evaluate the possible existence of environmental factors associated with the LPAIV
evolution into HPAIV.
Information from the documented HPAI outbreaks as well as from the experimental trials on LPAI/
HPAI switch were analysed to explore the possible existence of a host contribution (i.e. age of the
animal, type of poultry, immune status) in the evolution of LPAIV to HPAIV.
Genetic sequences from GISAID were used to evaluate the overall degree of pathogenicity
clustering among the HA genes. Sequences of the HA gene segment of HP and LP avian inﬂuenza
viruses were retrieved from GISAID (online14). All the H5 and H7 sequences of avian origin for which
at least 70% of the total length was available were downloaded. Based on phylogenetic clustering of
avian inﬂuenza viruses (Krauss et al., 2007) and on computational needs, for each HA subtype, two
distinct data sets, one including sequences from Eurasia, Africa and Oceania and one with the
American sequences (H5 Eurasia–Africa–Oceania, H5 Americas, H7 Eurasia–Africa–Oceania and H7
Americas), were generated for a total of four distinct data sets (Table 3). As the HA genes of all the
HPAI H5 viruses originating from A/goose/Guangdong/1/96 clustered all together, only 10
representative sequences belonging to this lineage were selected for the H5 data set.
Nucleotide sequence alignments were constructed for each data set using the online version of
MAFFT v.7 program (MAFFT version 7, 201715). Alignments were manually curated to remove low
quality sequences and the non-coding regions. To infer the evolutionary relationships for each gene
segment, we employed the Bayesian method available in the MrBayes v.3.2.6 program (Ronquist and
Huelsenbeck, 2003), incorporating a GTR model of nucleotide substitution with a gamma distribution
of among-site rate variation (with four rate categories, Γ4). All the trees were run for sufﬁcient time to
achieve an average standard deviation of split frequencies below 0.05. Posterior probabilities values
were used to depict support for individual groupings. The consensus trees were visualised using
FigTree v. 1.4.2 (Rambaut, 200716) and the online tool iTOL (Letunic and Bork, 201617).
Table 3: Description of the data set used to assess mutation from LPAI to HPAI
Data set Segment No. of sequences Date
H5 Eurasia–Africa–Oceania 4 464(a) 1959–2016
H5 America 4 594 1966–2016
H7 Eurasia–Africa–Oceania 4 1,746 1902–2016
H7 America 4 894 1927–2016
(a): No. of sequences after the partial removal of the HPAI A/goose/Guangdong/1/96 lineage.
14 http://platform.gisaid.org (GISAID, 2017)
15 http://mafft.cbrc.jp/alignment/server/
16 http://tree.bio.ed.ac.uk/software/ﬁgtree/
17 http://itol.embl.de
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Taxa in each tree were labelled according to:
• Virus pathogenicity (LP and HP). All the HPAI viruses were identiﬁed based on: (i) the insertion
of multiple basic amino acids at the cleavage site of the HA; (ii) the literature review or (iii)
OIE reports.
• Type of host (wild or domestic). Chickens, geese, turkeys, quails, guinea fowls, domestic ducks
and ostriches were considered as domestic birds, while all the remaining species were
categorised as wild birds.
• Main genetic groups, deﬁned by long branches and posterior probabilities higher than 90.
The outcomes are described in Section 3.6 whereas the ﬁgures and tables are provided in
Appendix H.
2.6. Approach to assess AI surveillance
The poultry data from surveillance activities presented in the report are restricted to data that were
collected between 2014 and 2016 according to the guidelines laid down in Commission Decision 2010/
367/EU.
MS submitted data to the European Commission database in a standardised format, containing
laboratory testing information and more detailed information on the positive holdings found for each
poultry category. The data submitted by MS were extracted from the European Commission database
and checked and analysed by the EURL. The standardised format for submission of data ensured that
in the majority of MS the data were complete and could be analysed effectively.
Some MS sample holdings more than once within their approved surveillance programmes for the
survey period. This was assumed to be the case where the reported number of holdings sampled for a
poultry category exceeded the total number of holdings reported for that category.
The data from the 2016/2017 HPAI H5 epizootic was taken from ADNS which is uploaded by MS
shortly after disease conﬁrmation. These data are not subject to rigorous checks and some data entry
errors may occur.
These data sets were visualised using ArcGIS 10.2.218 and qGIS 2.18.7.19
2.7. Approach to generate a risk map for HPAI H5 in wild birds
The methodology used to generate the risk map for HPAI H5 in wild birds is described in Si et al.
(2010). Data on wild bird events are used from the EMPRES-I database (HPAI H5, 2005–2017.5.31)
and data provided by the AI consortium and MSs to EFSA (HPAI H5 2006–2017.5.19). Data were
available on 1,841 outbreaks in wild birds. After removing duplicated records within 1 km distance,
there were 1,271 locations left. Then, locations with Null data were removed, if they fall into Null data
area in environmental layers, resulting in 1,127 locations left. Seventy per cent of the locations of H5
HPAI presence were used for model training (789), 30% for model validation (338). Five thousand
locations of absence were created from the background, 1,000 training subsets were used in further
calculation, each training subset contained 789 presence and 789 absence points. The ﬁnal model was
generated conducting univariate regression models, considering multicollinearity and autocorrelation,
using stepwise regression to select important variable, and running multiple logistic regression models
to determine the core variables and the ﬁnal model (see Table 4). 338 independent validating samples
were used to validate the risk map, and 89.65% of samples fell into a predictive high-risk area.
18 http://www.arcgis.com
19 http://www.qgis.org
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Table 4: Summary of the multiple logistic regression models for the occurrence of the highly pathogenic avian inﬂuenza (HPAI) H5 virus in wild birds in
Europe. All values in the table are mean values obtained from 1,000 runs of the model
Parameter Description Unit Original data source B OR 95% CIs OR p-value
Intercept Intercept of the model No unit NA 2.801973 17.57614 5.643299 54.78154 1.93E-05
City Distance to the nearest city km ESRI 4.25E-05 0.999958 0.999938 0.999977 0.000522
GLWD Distance to the nearest lake or wetland km ESRI 2.04E-05 0.99998 0.999971 0.999989 0.000195
Metropolis Distance to the nearest metropolis km ESRI 5.91E-06 0.999994 0.999992 0.999996 6.45E-08
prec_12 Mean monthly precipitation in December mm WORLDCLIM 0.02637 0.973983 0.963299 0.984785 5.49E-05
Ramsa Distance to the nearest Ramsa site km Wetlands International 9.68E-06 0.99999 0.999987 0.999994 1.19E-05
roads Distance to the nearest road km ESRI 8.71E-05 0.999913 0.999876 0.999949 3.70E-05
tmin_12 Mean monthly minimum temperature in
December
°C*10 WORLDCLIM 0.023218 1.023499 1.009271 1.037928 0.005659
Slope Slope gradient ° WORLDCLIM 0.17368 0.840889 0.769036 0.919467 0.000754
prec_07 Mean monthly precipitation in July mm WORLDCLIM 0.033028 1.033585 1.022292 1.045002 3.65E-07
Stmin_12 Square term of mean monthly minimum
temperature in December
No unit WORLDCLIM 0.00081 0.999187 0.998936 0.999438 1.32E-08
SNDVI01 Square term of monthly NDVI (normalised
difference vegetation index) in January
No unit NASA 7.06245 0.004311 3.38E-05 0.561924 0.016615
NDVI01 Monthly NDVI in January No unit NASA 3.363269 65.55596 1.255973 3446.199 0.165909
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2.8. Approach to assess biosecurity in relation to AI
The biosecurity measures described in the AI Statement (EFSA, 2017a) served as a basis and were
differentiated for commercial and non-commercial (backyard) holdings with indoor housing only or with
outdoor access. An EKE meeting was organised where two WG members and eight hearing experts
discussed and edited the biosecurity measures to achieve a common understanding and to prevent
overlap between the measures. The experts also ranked the measures for feasibility, sustainable
implementation, effectiveness to prevent entry and effectiveness to contain the virus. For each
parameter, the measures were ranked from highest (high rank) to lowest (low rank) importance. The
experts were able to judge measures as equally important. Then, these were equally set to the middle
rank of their positions:
• Feasibility: proportion of the farmers willing to start implementing the given biosecurity
measure.
• Sustainable implementation: proportion of the farmers to maintain the given biosecurity
measure continuously during 90 days of high risk.
• Effectiveness to reduce entry: reduction in the amount of virus coming from the outside to the
holding, able to reach poultry within the holding and cause infection by implementing the
given biosecurity measure.
• Effectiveness to contain the virus: reduction in the amount of virus that can be transferred
between epidemiology units within (poultry houses) and outside of the affected holding by
implementing the given biosecurity measure.
Average ranks were calculated from the individual rankings of the 10 experts (Figure J.1A,
Appendix J). During the elicitation the deviation of the individual versus the average judgements
(Figure J.1B, Appendix J), the variation of judgements on each statement and the conformance of
each expert with the group were assessed and discussed. The ﬁnal ranking was concluded by the
group.
The deﬁnitions of commercial and non-commercial poultry holdings described in the EU legislation
were used:
• Commercial poultry holding means a holding where poultry is kept for commercial purposes.
– Non-commercial holding/pet bird holding means a holding where poultry or other birds
are kept by their owners: (a) for their own consumption of the poultry or other birds or
their products or (b) as pets.
2.9. Uncertainty assessment
EFSA’s Scientiﬁc Committee is developing a Guidance document (EFSA, 2016b) to offer a toolbox of
methodologies – both quantitative and qualitative – for analysing scientiﬁc uncertainties in all its
scientiﬁc assessments. Through the application of these tools, EFSA aims to give decision-makers a
clearer picture of the scientiﬁc uncertainties affecting each assessment.
The mandates on AI have been chosen as a case study for testing the applicability of the approach
proposed in the draft Guidance on Uncertainty in EFSA scientiﬁc assessments. The experience gained
with this speciﬁc risk assessment and the other case studies identiﬁed in each Unit in EFSA will be
used to ﬁne-tune the Guidance document.
The draft Guidance identiﬁes the following steps to be followed to analyse uncertainties in EFSA
scientiﬁc assessments:
1) Identify sources of uncertainty.
2) Select which sources of uncertainty to assess individually.
3) Assess individual sources of uncertainty.
4) Quantify combined uncertainty (from individual sources).
5) Describe unquantiﬁed uncertainties.
6) Investigate inﬂuence/sensitivity.
7) Decide whether to reﬁne the uncertainty analysis.
8) Document and report the uncertainty analysis.
The draft Guidance on uncertainty in scientiﬁc assessment was pilot-tested on the entry of HPAI
and LPAI via wild birds. The latter subquestions were deemed an adequate example to evaluate
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applicability and appropriateness of both the overall approach proposed in the Guidance and the
methodologies suggested for performing the various steps of the U analysis.
For the introduction of HPAI via non-wild bird pathways, bounded probabilities instead of probability
distributions were used to describe the uncertain estimate of the probability of introduction into the EU
since the evidence available was scarce and not very accurate.
For the other TORs, the approach for uncertainty analysis consisted in the identiﬁcation and listing
of the potential sources of uncertainty.
Steps recommended in the Uncertainty Guidance were followed with some adaptations since all
uncertainties affecting a single parameter in the AI epizootic model were assessed jointly (for instance
all limitations in the knowledge related to the HPAI prevalence at the EU border) and then combined
with the overall uncertainty affecting each of the other parameters. Therefore, an uncertainty
distribution was set up around each parameter instead of an individual source of uncertainty as
suggested in steps 3 and 4.
The uncertainty analysis included two main types of uncertainty:
• limitations in the evidence used to support the estimate of the assessment parameters;
• assumptions made in the assessment and the structure of the assessment itself (including
model structure if any).
Effect of the assumptions/structure of the assessment as source of uncertainty was assessed only
for TOR 1 and TOR 3 addressed with the mathematical models, once the results of the quantiﬁcation
of the ﬁrst type of uncertainty were available.
The approach taken to analyse the second type of uncertainty varies depending on the level of
realism of the assumption, the expected effect on the outcome and the feasibility of quantifying it.
The effects of assumptions were not further analysed when belonging to the following categories:
having a limited effect, representing the worst-case scenario or representing the most realistic
scenario.
The assumptions expected to introduce a high uncertainty on the results, have been investigated
further either via scenario analyses (running model with different formulations of the assumptions) or
via semi-formal EKE (see Appendix C).
Risk of AI introduction via wild birds
An AI epizootic model (described in Appendix C) has been generated to simulate HPAI entry into
the EU and HPAI/LPAI into poultry holdings via wild birds.
The following steps were followed to analyse the uncertainty:
1) An a priori sensitivity analysis was performed aimed at prioritising components (parameters
and variables) of each model whose uncertainty is expected to be collectively more inﬂuential
on the uncertainty of the outcome. To this scope, for each parameter and variable, the
sources of uncertainty collectively affecting each of them (uncertainty on inputs) were
expressed in the form of a range (minimal assessment step).
2) Based on the prioritisation exercise performed in the ﬁrst step, for each component of the
model, the uncertainty assessment (quantifying collectively the effect of various sources of
uncertainty on each component) was expressed as probability distribution derived using a:
a) semi-formal EKE conducted among WG members for inputs with overall uncertainty
expected to have limited inﬂuence on the model outcome;
b) formal EKE conducted among WG members and hearing experts for inputs expected to
have high inﬂuence on the outcome uncertainty.
3) Uncertainty distributions around each component of the models were combined using Monte
Carlo techniques ((EFSA, 2016a – Guidance Document Uncertainty EFSA, 2016b)).
4) The uncertainty sources related to the structure/assumptions of each model were investigated
once the uncertainties related to the model inputs were quantitatively combined. The sources
of uncertainty were listed and the expected direction and magnitude of the effect on the
uncertainty of each model outcome were assessed with a semi-formal EKE among WG
members if sufﬁcient evidence/knowledge was available to carry out this assessment.
Otherwise the sources of uncertainty were simply listed. Scenario analyses were performed for
some assumptions to assess the effect on the outcome of different formulations.
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For HPAI entry via E, S or NW routes, the following steps were followed to estimate uncertainties:
1) The model outcome of the HPAI clade 2.3.4.4 entry was used as a benchmark.
2) Uncertainties identiﬁed in the extrapolation of the outcome of the reference scenario to
other scenarios (other routes of wild bird exposure and clades) have been listed.
3) Whenever possible, the identiﬁed sources of uncertainty have been assessed collectively via
a semi-formal EKE process carried with WG members and an adjusted probability
distribution has been derived as output for each route/clade.
To address the issue of separating uncertainty from variability in the inputs, the model inputs were
deﬁned as variability distribution centiles or location parameters (e.g. median, mean) or reference was
made to the occurrence of a variable at a speciﬁc point in time (e.g. day of the migration season
2016–2017).
For each scenario and model, a summary table describes sources of uncertainty broadly classiﬁed,
steps taken to assess uncertainty, components of the model considered in each step, method used to
analyse uncertainty with reference to the Uncertainty Guidance.
Risk of AI introduction via non-wild bird pathways
Evidence was collected on the following features: import volume and probabilities of testing, virus
detection, virus preservation during transport and poultry exposure to the commodity. They were
expressed in terms of ranges as available data were poor in quantity and quality. Uncertainties
pertaining to the limitations in the evidence were used to derive probabilities of introduction via these
pathways using a semi-formal elicitation performed among WG members.
3. Assessment
3.1. Mapping of HPAI and LPAI outbreaks during the last 5 years
(TOR 5)
The scientiﬁc opinion focuses on the introduction pathways of HPAI viruses into Europe and the
assessments of the different TORs aimed to provide science-based advice to risk managers on how to
be prepared for future HPAI and LPAI (H5 and H7) outbreaks in Europe. This section of the opinion
gives an overview of the HPAI and LPAI outbreaks in Europe and the other continents during the last
5 years, with the purpose of identifying HPAI and LPAI virus types that could cause outbreaks in the
EU in the next years. These virus types are then assessed in more detail in the following chapters of
the opinion.
3.1.1. HPAI detections in Europe and other continents
So far, only HPAI viruses of subtype H5 have been introduced into Europe from abroad while viruses
of subtype H7 causing outbreaks of HPAI were intrinsically generated within Europe from European low
pathogenic precursor viruses (see Appendix A for overview since 2010). The focus in the HPAI
introduction assessment (Section 3.2) will therefore be on HPAIV H5 clades that are descendants of the
original goose/Guangdong (gs/GD) H5N1 HPAI virus, which arose in 1996 in South China. Gs/GD
representatives that were found circulating in Europe in the last decade were restricted to clades 2.2.1.x
(HPAIV H5N1) 2.3.2.1c (HPAIV H5N1), and 2.3.4.4 (includes HPAIV subtypes H5N8, H5N5 and H5N6).
HP H5N2 viruses of clade 2.3.4.4 caused widespread outbreaks in the United States in 2014/2015 but
have not yet been found in Europe. Some recent papers (Kim et al., 2014; Pulit-Penaloza et al., 2015;
Richard et al., 2015) point out differences in virulence of new H5N8 and H5N2 2.3.4.4a strains as
compared with previously circulating clades, in particular 2.2 descendants.
Apart from the clades/lineages that were selected for detailed incursion analysis here (2.2.1.2,
2.3.2.1c and 2.3.4.4), there are further clades of gs/GD HPAIV subtype H5(N1) which circulate
endemically in SE Asian countries but have not escaped to other continents. Currently, these include
clades 1.X (southern Vietnam), 2.1.3 (Indonesia), 2.3.2.1a (India, Bangladesh), 2.3.4.2 (Myanmar)
and 7.X (China) (FAO/EMPRES-i). These viruses remained conﬁned to a geographic region within
South-east and South Asia. Likewise, HPAI viruses of subtype H5N6 belonging to clades 2.3.4.4c and
d, which have been detected ﬁrst in China in 2014 continued to spread in poultry in China, Laos,
Cambodia, South Korea, Vietnam and Japan but not beyond (Heine et al., 2015). Some members of
the 2.3.4.4c clade have shown zoonotic potential and a limited number of human cases (currently 19
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 22 EFSA Journal 2017;15(10):4991
in China) have been conﬁrmed (Yang et al., 2017). It should be noted that the HPAI H5N6 virus of
clade 2.3.4.4b detected 2017 in Greece is not related to the former zoonotic lineage! So, there seem
to exist clades of gs/GD viruses that are highly mobile in geographical terms while other clades remain
largely sessile even over more than a decade. The molecular or epidemiological basis for this
behaviour remains unclear. So, in the future, other viruses of the gs/GD lineage may acquire
geographic mobility for reasons that are not known or foreseeable at present. In addition, further
evolution of these viruses in their epicentres is ongoing and will surely lead to the emergence of new,
but unpredictable clades and phenotypes.
To build a risk analysis on incursions of such viruses into the EU, extrapolations into future viral
developments are not regarded a ﬁrm base. Therefore, the range of gs/GD HPAIV H5 clades to be
analysed here was restricted to 2.2.1.2, 2.3.2.1c and 2.3.4.4 for the following reasons:
• Viruses of these clades, or their predecessors (2.2.1), have already been detected in the EU.
So, they have proven geographic mobility potential.
• The listed clades also had an out-of-Asia origin and are still in circulation in SE Asia (2.3.2.1,
H5N1; 2.3.4.4, H5N8, H5N5, H5N6).
• 2.2-like viruses also originated from an Asian reservoir and caused the ﬁrst European
outbreaks of HPAI viruses of the gs/GD lineage in 2005/2006. Nowadays, they seem to be
extant in Egypt only. Descendants of clade 2.2.X therefore have shifted from a highly mobile
behaviour, which brought them to Europe and Africa in 2005/2006, to a rather stationary but
not static existence in Egypt and a few neighbouring countries such as Libya, Israel and
Palestinian Auton. Territories (Soliman et al., 2012; El-Zoghby et al., 2013; Sheta et al., 2014;
Abdelwhab et al., 2016). Nevertheless, these viruses were included as they may be remobilised
from Egypt which is situated at a crossing point of several avian migratory ﬂyways. In addition,
these viruses also bear substantial zoonotic potential, which has, so far, not been associated
with representatives of above-mentioned 2.3.4.4 lineage detected in Europe, and only rarely
for viruses of the 2.3.2.1 clade (Figure 1).
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Figure 1: World-wide distribution of inﬂuenza HPAI H5 and H7 subtypes and clades in domestic birds,
wild birds and humans (1 January 2016–31 August 2017)
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Further in the opinion, emphasis is put on distinctive phenotypic characteristics of the different
clades and subtypes as these are important to consider when reviewing the legislation. Using clades
based on the phylogenetic relationship of the HA gene to classify H5 viruses may not be perfect when
assessing pathogenicity and transmissibility, but it is considered to be more appropriate than
comparing subtypes. An internationally accepted and harmonised clade designation system currently in
use for Asian origin H5 HPAI viruses has not yet been developed for H7 viruses, or viruses of other
subtypes, although several proposals have been made, mainly from regional perspectives (Kang et al.,
2014; Van der Auwera et al., 2014). This may, in part, be due to a stricter geographical restriction of
outbreaks of subtype H7 HPAI: Although limited transboundary spread of these viruses has been
observed in the past (e.g. during the 2003 outbreak of H7N7 HPAI in the Netherlands transmissions to
Belgium and Germany occurred), no transcontinental avian-associated spread as seen repeatedly with
the gs/GD-like H5 viruses has ever been reported for H7 HPAIV. Probably for the same reason, data on
the comparative pathogenicity of the different H7 HPAIV subtypes and lineages are scarce (Post et al.,
2013; Kalthoff et al., 2014a; Shichinohe et al., 2016). It is, therefore, conceivable to treat in this
assessment all H7 HPAI viruses as a uniform group.
Cases of gs/GD-like HPAIV H5 infection during the last 5 years in Europe have always been associated
with infected wild birds. In most episodes, poultry holdings were affected as well although usually after
the detection of infected wild birds (2005/2006; 2016/2017). An exception are outbreaks in 2014/2015
when the ﬁrst poultry outbreak was detected slightly earlier than the ﬁrst wild bird case. Nevertheless,
detection of gs/GD-like HPAIV H5 in both poultry and wild birds in Europe was always closely associated,
both geographically and temporally, indicating a tight epidemiological link (Munster et al., 2005; Steensels
et al., 2006; Starick et al., 2008; Artois et al., 2009; Brochet et al., 2009; Globig et al., 2009; Reid et al.,
2011; Saito et al., 2015; Bi et al., 2016; Claes et al., 2016; Muzyka et al., 2016). Thoroughly conducted
epidemiological tracing back studies of the index cases of each gs/GD-related poultry outbreak failed to
generate evidence that might have indicated an infection source within European poultry populations.
Also, no epidemiological links were evident between the index cases of HPAIV H5N8 (2.3.4.4a) in poultry
holdings in Germany, the Netherlands, the United Kingdom and Italy which had all occurred in a narrow
timeframe in 2014 (Bouwstra et al., 2015; Conraths et al., 2016; Nunez et al., 2016). Instead, wild bird
surveillance data and phylogenetic analyses of the viruses detected in wild birds and in poultry
corroborated scientiﬁcally sound evidence that identiﬁed migratory wild birds as a more likely source of
transboundary virus spread; this circumstantial evidence has been massively supported by recent
analyses of the origin of the North American outbreaks of HPAIV H5N8 and its American reassortant,
H5N2: migrating wild birds picked up the infection in Far East Asia during spring 2014 and set up a
transmission chain across Beringia into Alaska and northern Canada. During autumn migration the same
year, the virus was translocated further south into California and other southern US States (Adlhoch et al.,
2014; Dalby and Iqbal, 2015; Ip et al., 2015; Lee et al., 2015; Verhagen et al., 2015). Therefore, the
conclusion may be drawn that transboundary spread by infected migratory wild birds constitutes the
highest likelihood of an introduction of Asian origin H5 HPAI viruses. Both South Korea in September 2014
and Japan in November that year reported ﬁndings of H5N8 in Tundra swans (Cygnus columbianus).
These birds migrate to the Arctic and subarctic tundra for winter breeding grounds while the subspecies,
the Bewick swan (C. c. bewicki) also visits breeding grounds in the tundra and coastal areas of Siberia,
wintering in Northern Europe. The Whistling swan (C. c. columbianus) breeds in coastal plains of Alaska
and Canada then moving to wintering grounds in north-west USA. Although these are separate
subspecies, their common breeding grounds may overlap, which could potentially lead to transmission of
the H5N8 virus across three continents within one single breeding season (JNCC, 2001). There is limited
evidence for migratory swans being implicated in the large geographic expansion of avian inﬂuenza
viruses, and it should be noted that comingling with other migratory duck species may also be involved in
a complex pattern of virus transmission (Newman et al., 2009).
Based on the results of passive surveillance and phylogenetic investigations, infected wild birds
have also been implicated in the westward spread of clade 2.3.2.1c viruses from Asia. Between 2014
and 2016, the virus showed an apparently expanding range of geographical dispersal following
conﬁrmation of infections in wild birds and poultry in African, Middle Eastern and European countries
(Naguib et al., 2015; Tassoni et al., 2016). Nevertheless, human-related factors, including falconry may
have been involved as well (Naguib et al., 2015). The 2.3.2.1c clade continues to spread in poultry
across West and Central Africa, with Cameroon and Togo becoming the latest African countries to
detect the disease in May and August 2016, respectively. The lack of a structured surveillance system
in these territories and the limited number of genetic and epidemiological data available make it
difﬁcult to pin-point how these viruses may have spread across the African regions.
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Autochthonal generation of HPAI from LPAI precursor viruses in poultry populations must of course
also be considered as a possible introductory pathway. The recently on-going outbreaks of HPAIV H5 in
south-west France are caused by at least three reassortants (H5N1, H5N2 and H5N9) which all have
their common origin in a single (unknown) H5 LPAI virus of European ancestry (Anonymous, 2016). In
2016/2017 the already complex situation further exacerbated with the introduction of HPAI H5N8
2.3.4.4b viruses into the same region. LPAIV of European lineages of subtype H5 are maintained in
European metapopulations of aquatic wild birds; the HA of these viruses is distinctly different from those
of the Asian gs/GD-like ones (Olsen et al., 2006; Munster et al., 2007). The epidemiological data of the
French epizootic suggest spill-over infection of an LPAIV H5 precursor virus into waterfowl population in
south-west France, continuing unnoticed circulation of this virus over prolonged periods, de novo
generation of an HPAI phenotype, further secondary spread of this phenotype between duck holdings
and reassortment with at least two further LPAI viruses with disparate NA subtypes (Briand et al., 2017).
The same mechanism has also been at the basis of all European outbreaks of H7 HPAIV. There is
no indication of transboundary spread of these viruses from outside Europe, neither by migratory wild
birds nor by transmission chains within the poultry industries. None of the HPAIV of subtype H7 that
arose and circulated for some time outside Europe (e.g. H7N7 in Mexico, H7N3 in Canada, H7N7 in
Pakistan) found its way into European wild bird or poultry populations.
Apart from migratory wild birds, of course, further potential ways of introduction of HPAIV into
Europe exist. These include import of infected game and captive birds or poultry and contaminated
avian products, feed and other fomites. HPAI H5N1 viruses, for example, have been detected in
smuggled wild birds from Asia (Van Borm et al., 2005; OIE WAHID, 2013). In addition, contaminated
clothing and shoes of airline passengers from endemically infected regions must be considered as a
possible source of introduction although no cases linked to this route were identiﬁed so far. Spread
within or between EU MSs may also be related to co-owned premises and heavy trading activities in
different MSs (Hungary/UK, 2007). In addition, slaughtering and marketing of healthy ducks
asymptomatically infected by HPAIV H5N1 had caused clinically overt HPAI outbreaks in backyard
chicken holdings in Germany after offal from frozen duck carcasses had illegally been fed to
scavenging chickens (Harder et al., 2009).
3.1.2. LPAI detections in Europe and other continents
There is longstanding and ample scientiﬁc evidence that metapopulations of wild birds, especially
species in the orders Anseriformes and Charadriiformes, constitute a natural reservoir of all known
subtypes of avian-associated inﬂuenza A viruses which are maintained in low pathogenic forms (Yoon
et al., 2014; Lang et al., 2016).
There are seasonal ﬂuctuations in the overall prevalence of AIV in aquatic wild bird populations
associated with population turnover rates and migration. For as yet unknown reasons, the relative
prevalence of certain subtypes in these populations shows gross variations from year to year (Wille
et al., 2013; Latorre-Margalef et al., 2014). It is without doubt that transmission of H5 and H7 viruses
from such reservoirs is at the basis of the index cases of notiﬁable LPAIV outbreaks in poultry.
Domestic waterfowl appears to be fully permissive for wild bird-derived H5 and H7 LPAIV; infection is
usually productive but clinical signs are not induced although this can be modulated by the presence of
other (opportunistic) co-infections (Jourdain et al., 2010). Chickens, in contrast, seem not to be fully
permissive for these viruses and cycles of adaptation may be required to achieve fully productive
replication which, likewise, does not induce clinical signs that are easily perceived (Pillai et al., 2010a,
b). So, a chain of transmission (and adaptation) events from wild birds to domestic waterfowl to
gallinaceous poultry has been proposed to explain the occurrence of LPAIV H5 or H7 viruses in
domestic chickens and turkeys; turkeys as well as quails seem to have a very high susceptibility to
LPAIV of various origins and have been proposed as intermediate or bridging hosts between
Anseriformes and gallinaceous species (Wan and Perez, 2006; Pillai et al., 2010a; Thontiravong et al.,
2012; Pantin-Jackwood et al., 2014). Due to the lack of conspicuous clinical signs, these infections can
only be diagnosed by means of serological and/or virological laboratory tools. So, detection of such
infections in Europe is directly related to the intensity of speciﬁc surveillance measures. This may
explain, at least in part, the highly variable frequency of notiﬁable LPAI in different European countries
over the last decade: the Netherlands and Italy have reported the highest frequency of LPAI H5 or H7
infections but also run the most intensive H5- and H7-speciﬁc surveillance programmes (see annual
reports on AI surveillance of the EU-CRL (APHA, 2015)). The structure of the poultry production
systems may also inﬂuence the frequency of notiﬁable LPAI infections by modulating the likelihood
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 26 EFSA Journal 2017;15(10):4991
of direct and indirect contacts between LPAIV-infected aquatic wild birds, their environment and
domestic waterfowl. Countries with high contingents of free-range waterfowl production are likely to
experience (and detect) higher infection rates as is evident, e.g. for outdoor duck grazing holdings in
western France or foie gras production in Bulgaria (Cappelle et al., 2014; APHA, 2015; Marinova-
Petkova et al., 2016).
The vast majority of LPAIV H5 or H7 outbreaks in Europe has affected only single holdings and only
few cases with further secondary spread among poultry have been reported: an LPAIV H5N3 outbreak
reported from Germany in late 2008 ﬁnally affected 29 turkey holdings (Mughini-Gras et al., 2014);
transmission was brought to a stop only in early 2009 following culling of affected ﬂocks and the
implementation of restocking restrictions. Following the identiﬁcation of an outbreak caused by an H5N2
virus in an industrial turkey ﬂock in northern Italy in late August 2012, strengthened monitoring activities
resulted in the detection of seven additional LP H5N2 outbreaks in both industrial and rural poultry
sectors of three distinct Italian regions, with the last outbreak notiﬁed in October 2012 (SCoFCAH,
2012). Prolonged unnoticed spread and circulation of LPAIV H5 among waterfowl in south-western
France, probably since 2013, had ﬁnally culminated in the generation of HPAI H5 strains in 2015 that did
not induce overt clinical symptoms in ducks but caused fatal infections in chickens (Anonymous, 2016).
With respect to zoonotic propensities of low pathogenic H5 and H7 AIV, few data are available.
These few studies point towards higher zoonotic risks for LPAIV H7 due to increased afﬁnity of some
isolates to mammalian/human-like receptors. However, only single and sporadic cases of human LPAIV
H7 infection have been reported until 2013. In that year, a new LPAIV H7N9 emerged in China as a
reassortant of H7 and LPAI H9N2-G1-like viruses. These viruses proved to be highly zoonotic and
continue to cause, in annual cycles, clusters of human cases that were conﬁned to China with few
cases in travellers from China to other countries. A high case-fatality ratio was noticed although the
virus was apathogenic in poultry including chickens. This has severely hampered efforts to unravel and
drain an avian reservoir of these viruses. Human cases continue to occur until to date. Exposure to
presumably infected poultry is the main route of infection while no sustained human-to-human
transmission chains have been observed (Su et al., 2017). So far, these viruses remained largely
conﬁned to China and detection in feral20 and wild birds was on sporadic occasions only. Meanwhile
the emergence of a highly pathogenic phenotype of Chinese H7N9 has been detected, and these
viruses have already caused three human cases of infection (Kang et al., 2017). It is difﬁcult to assess
risks of incursions into Europe of these viruses through migrating wild birds due to the absence of
prevalence data in avian reservoir host populations.
The same H9N2 G1-like viruses which donated genome segments to the highly zoonotic Chinese
H7N9 reassortants also expressed discrete zoonotic propensities themselves which have led, so far, to a
limited number (n = 32, world-wide) of mild clinical human cases only. Mutations in the HA receptor
binding region of these viruses conferred a higher afﬁnity to human-like sialic acid receptors. Infections
with LPAI H9N2 G1-like viruses are extremely widespread in poultry in most Asian, Middle East and
North African countries where they cause substantial economic damage. Detection in wild bird
populations of G1-like viruses has also been repeatedly reported. LPAI H9N2 viruses are also prevalent in
European wild bird populations but these viruses are only distantly related to the G1 lineage and do not
bear mutations that induce receptor binding shifting. G1-like viruses have not been detected in poultry in
Europe. An introduction to Europe of G1-like H9N2 either via migrating wild birds along routes described
for the HPAIV H5N1 of clade 2.3.2.1c or via poultry or poultry products does not seem unlikely.
3.2. HPAI introduction via migratory and residential wild birds (TOR 1)
3.2.1. Risk pathways
Clades
Based on the mapping of HPAI outbreaks during the last 5 years (see Section 3.1.1), an assessment
was performed to determine the probability of H5 HPAIV introduction into the EU and subsequently into
a poultry holding via wild birds. HPAIVs from the clades 2.3.2.1c, 2.2.1.x and 2.3.4.4 are differentiated
as these viruses have different characteristics that may affect their risk of introduction.
20 The word feral is often used for birds of likely captive origin having established viable (but often non-migratory) populations in
the wild, such as, for example some Greylag geese in the Netherlands, or Wood duck in the UK.
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Entry routes
For the sake of the current risk analysis, wild bird species present in the EU have been divided in
two main groups of animals: water birds (ducks, geese, swans, grebes, etc.) and non-water birds
(raptors, song birds, waders, gulls, terns, storks, cranes, etc.) according to their general behaviour,
habitat preference and known susceptibility to AIV. Although waders are water birds, they are in this
opinion included in the non-water birds group because their behaviour is different from that of
Anatidae, in particular towards contact rates to poultry farm premises (Caron et al., 2017). More
information is provided in Tables B.1 and B.2 (Appendix B). Within each group, subgroups of birds
referring to the average common bird behaviour (e.g. habitat preferred) have been identiﬁed.
Given the ﬂyways of migratory water birds (see for instance Scott and Rose (1996) and data
received as per procurement, coordinated by Linnaeus University (SE) and Erasmus Medical Centre
(NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, unpublished (the
Consortium report Waldenstr€om et al., 2017)), four entry routes where migratory wild birds would
cross the EU border were considered (Figure 2):
• the NE route, via the EU border with Russia and Belarus, where migratory birds generally
enter the EU during the autumn migration (and to a limited extent during cold spells in winter)
along the East Atlantic ﬂyway. HPAIV expected to be introduced via this area belong mainly to
the 2.3.4.4 clade (Adlhoch et al., 2014; Bouwstra et al., 2015; Harder et al., 2015; Marchenko
et al., 2015; Saito et al., 2015; Verhagen et al., 2015). A particular emphasis was given to this
route, as it was considered to be the main migration corridor for European migratory birds
breeding in Russia;
• the eastern route (E), via the EU border with Ukraine, Moldova, Black Sea, Turkey until the
southern border of Turkey. Here too, migratory birds generally enter the EU during autumn
migration, although large-scale movements from countries further to the east may also occur
during cold spells. HPAIV so far detected in birds from this route mainly belong to the 2.3.2.1c
clade (Marinova-Petkova et al., 2012; Alkhamis et al., 2013), often originating from Central
Asia (Bi et al., 2015, 2016; Naguib et al., 2015; Marchenko et al., 2016; Tosh et al., 2016;
Ghafouri et al., 2017);
• the southern route (S), via the EU border from the southern border of Turkey to the northern
border of Portugal. Entry via this route is, as opposed to the above, mostly occurring during
spring, as birds migrate back from their African wintering grounds. Virus clades considered to
enter via the southern route belong to clades 2.2.1.2 (which is endemic to Egypt) and 2.3.2.1c
(which is prevalent in sub-Saharan West African countries, that also comprise major water bird
winter quarters) (Arafa et al., 2015; Kammon et al., 2015; Monne et al., 2015); following the
occurrence of viruses of clade 2.3.4.4b since winter 2016 in various African countries, these
viruses must be included here as well;
• the NW route, used by wild birds migrating from or across Greenland to the EU, entering the
EU between the northern border of Portugal and the northern border of Russia. Only a very
small proportion of migrating water birds actually enters the British Isles during autumn–winter
migration following this route. HPAIV present in North America could enter the EU via this
route (Saito et al., 2015; Bevins et al., 2016; Claes et al., 2016; Kaplan et al., 2016; Krauss
et al., 2016; Lee et al., 2016).
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For each entry route and clade, three models were set up describing, respectively, the:
• probability of HPAIV entry into the EU;
• development of HPAIV prevalence in the wild bird reservoir on EU territory;
• probability of HPAIV entry into a poultry holding without biosecurity measures on EU territory.
Figure 3 depicts the essential structures of the set-up, which is shortly described in the paragraphs
that follow.
The sections below describe the probability of HPAI introduction into the EU and subsequently into
a poultry holding without biosecurity, for the different wild bird entry routes and H5 HPAI viral clades.
Figure 2: Map of the borders where migratory wild birds enter the EU via the four entry routes
considered in this opinion
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3.2.2. NE route – clade 2.3.4.4
HPAIV clade 2.3.4.4 entry into the EU via the NE route
A mathematical model (see detailed description in Appendix C) was developed to quantitatively
estimate the risk under the scenario where water birds infected with HPAIV clade 2.3.4.4 would enter
the EU via the NE route during autumn migration. In essence, the probability of HPAI entry is a
function of the number of migratory birds entering the EU in a migration season and the HPAI
prevalence in this population. Based on the observation that detections of HPAI cases in wild non-
water birds are rare (e.g. EU report on AI surveillance, 2014; APHA, 2015)), in the model only
migratory water birds were considered as a source of HPAI introduction in the model.21 The total
number of migratory water birds entering the EU during a migration season was estimated by experts
as an uncertainty distribution (mean 36,660,070 with standard deviation 11,140,680). The duration of
the autumn migration period was estimated based on published data as 125 days (see Section D.1.1,
Appendix D). Experts estimated the proportion of HPAIV clade 2.3.4.4 infected migratory water birds
at the moment they cross the EU border (see Section D.1.2). All the parameter values used in the
model are provided in Table C.6 of Appendix C.
The model outcome suggests, with a probability of 1 (median of the uncertainty distribution), that
at least one migratory water bird infected with HPAIV clade 2.3.4.4 enters the EU via the NE route
(see Figure 1, Appendix E). This assessment has been performed based on data that were available on
HPAIV clade 2.3.4.4 until March 2016. The HPAI H5N8 detections in migratory water birds during the
2016–2017 winter are in line with what was predicted by the model.
HPAIV clade 2.3.4.4 prevalence in the wild bird reservoir
Once in the EU, infected migratory water birds could transfer HPAIV to the wild bird reservoir
(Figure 4). All migratory non-water birds are assumed not yet being infected (susceptible) when they
enter the EU since only very low numbers of non-water birds found positive for HPAI clade 2.3.4.4 in
2014. All residential wild birds are assumed to be susceptible to HPAIV infection at the start of the
EU 
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HPAI-infected 
water birds
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non-water birds
Probability that at least one HPAI-infected migratory bird enters the EU 
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Bold lines, quantitative assessment; thin lines, qualitative assessment.
Figure 3: Proposed entry pathways of HPAI viruses belonging to clades 2.3.2.1c, 2.2.1.2 and 2.3.4.4
into the EU via migratory wild birds
21 The lack of consideration of the migratory non-water birds as a vehicle of HPAI introduction (Figure 4) was assessed as a
source of uncertainty potentially affecting the outcome of the model.
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migration season, reﬂecting what is seen as a worst-case scenario. Virus transfer among wild birds
depends on their densities in the area where infected migratory water birds land. No data are available
on the density of migratory and residential wild birds covering the whole EU territory. Wetland
densities are sometimes used as a proxy for wild bird densities ((e.g. Empres Watch, September 2016,
Volume 36 FAO EMPRES watch, 2016)), but expert elicitation made clear that this does not reﬂect the
real situation because wild bird densities are also dependent on other characteristics such as food
availability and surrounding vegetation (EFSA, 2016a). Also, inner coastal areas have seasonally high
densities of wild migrating water birds, e.g. between the Danish islands. Therefore, a virtual contact
area was considered in the model where the virus is transferred via infected excretions (including
faeces, respiratory excretions, etc.), hence leading to virus ampliﬁcation in the wild bird reservoir
(Figure 4). Four scenarios were considered with respect to the proportion of migratory and resident
wild birds and the proportion of water and non-water birds out of the total population of wild birds in
the virtual area (Table 5).
The contact of a wild bird with an infected excretion could occur in wetlands or while foraging in
surrounding terrestrial habitats. A random pattern is assumed for the release of infected excretions
and for the contact of wild birds with excretions because wild birds move randomly and can defecate
frequently. Water birds were considered more likely to get infected through other water bird excretions
than by non-water bird excretions because they live in the same ecological niches (Kear, 2005). The
quantity of excretions is not considered as its effect on the probability of contact with excretions was
assumed to be negligible compared with that of sharing the same habitat preferences with other
(potentially infected) individuals. Conversely, the number of infected excretions is assumed to be
directly proportional to the number of birds shedding the virus. The model also assumes that wild birds
can become infected via contact with virus persisting for 13 days22 in excretions present in the
environment. Once infected, birds shed the virus, subsequently they either die or become resistant for
the rest of the simulated season. Based on available evidence, the model considered that once a wild
bird becomes infected, it can transmit the virus to another susceptible wild bird from the next day
onwards. More details on the model simulating AIV dynamics in the wild bird population can be found
in Section C.3 of Appendix C.
Table 5: Four scenarios are considered with respect to proportion of migratory and resident wild
birds and proportion of water and non-water birds out of the total population
Scenario
% migratory vs
% resident wild birds
% water birds vs
% non-water birds
Representing a virtual contact area
1 90% vs 10% 90% vs 10% Close to migration corridors and in a region
with high presence of water bodies
2 90% vs 10% 10% vs 90% Close to migration corridors and in a region
with low presence of water bodies
3 10% vs 90% 90% vs 10% Far from migration corridors and in a region
with high presence of water bodies
4 10% vs 90% 10% vs 90% Far from migration corridors and in a region
with a low presence of water bodies
22 Viral persistence for 13 days in the environment is an approximation from published data on viral perseverance (see
Section D.1.9, Appendix D). Analysis in an earlier version of the model indicated that extending virus persistence to 60 days
increased the number of infected birds whereas the kinetics of the epidemic remained identical.
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The model outcomes suggest that entry of HPAIV-infected water birds into the EU only leads to an
epidemic in the wild bird reservoir when the number of susceptible wild water birds is above a critical
number.23
When the number of water birds is high (scenarios 1 and 3), this will result in an increase of
virus prevalence within the wild bird reservoir after the entry of infected wild water birds but only for
total population sizes of 100,000 or 10,000. In scenario 1, due to the high number of migrating water
birds arriving daily, prevalence of infected water birds increases a few days after entry. When 648
susceptible water birds enter daily (i.e. when the total population size at the end of the migratory
season reaches 100,000 wild birds), the prevalence increases after 2 days and reaches a plateau
around day 25 of the migration season (median 0.002, 95th percentile24 0.029 at the end of the
migration season i.e. day 125) (see Figure 5: scenario 1, population capacity 100,000 birds). The lower
the number of susceptible water birds entering daily, the later the prevalence starts to increase: when
the number of susceptible water birds entering daily is reduced to 65,25 the virus prevalence in the wild
bird population will decrease until day 13 when the critical number of wild birds is reached. Then, the
virus prevalence increases gradually in the wild bird reservoir until the end of the migration season
(median 0.000, 95th percentile 0.020 at day 125) (see Figure 5: scenario 1, population capacity 10,000
birds). In scenario 3, due to the high number of resident water birds, virus prevalence immediately
increases within the wild bird reservoir after the entry of infected wild water birds (95th percentile 0.020
at day 125) (see Figure 5: scenario 3, population capacity 100,000 birds). Having sufﬁcient susceptible
resident wild birds but lowering the number of infected wild water birds entering, results in lower
maximum prevalence levels in the wild bird reservoir (95th percentile 0.004 at day 125) (see Figure 5:
scenario 3, population capacity 10,000 birds). It was not possible26 to use the model generated for this
opinion to simulate whether and how long the virus could be perpetuated in the wild bird population.
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reservoir in a virtual contact 
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Water birds
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Residential*
Non-water birds
Migratory* 
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Release of HPAI- 
infected excretion in 
poultry holding (1 km 
around holding) 
Probability HPAI 
infection of poultry 
holding without 
biosecurity measures 
HPAI-infected 
migratory water birds 
entering the EU 
The white ﬁelds represent components of the model based on real ﬁeld situations, whereas the green ﬁelds
represent components based on theoretical scenarios.
*Four scenarios are considered with respect to proportion of migratory/resident wild birds and proportion of water/
non-water birds (see Table 5).
Figure 4: Proposed entry pathways of HPAI viruses from migratory water birds into a poultry holding
23 Under the model conditions and assumptions, the critical number is around 1,700 for 95% quantile. While for median the
critical number is around 11,000. Extrapolation of this value to the real world is difﬁcult given the high uncertainty.
24 For each simulated prevalence distribution, the 95% simulation quantile from the right tail of the distribution is considered as
a worst case: any particular sample from this distribution have 5% chance of being greater than this value.
25 Total population size at the end of the migratory season is 10,000 wild birds.
26 Due to the assumptions taken into account (see Appendix C). For instance, introduction of juveniles was not considered.
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During the 2016–2017 outbreaks, when a high incidence of infection was detected in wild bird
populations and signiﬁcant contamination of the environment occurred, virus-positive wild birds have
been reported even 10 months after the ﬁrst events (EFSA, ECDC, EURL, 2017).
Reducing the number of water birds in the wild population (scenarios 2 and 4), will lead
to an epizootic in the residential wild bird population only when considerable numbers of susceptible
water birds enter (see Figure 5, scenario 2)27 or considerable numbers of susceptible water birds are
resident (see Figure 5, scenario 4).28
Simulating entry of infected wild water birds in the middle of the migration season (day 60)
suggests immediate onset of an epizootic in the wild bird reservoir as the critical number of susceptible
water birds is already available (see Figure E.2, Appendix E). The HPAI prevalence in wild water birds
at the end of the migration season is similar to the level obtained when infected wild birds arrive
already in the beginning of the migration season (comparison Figure 5 with Figure E.2).
It has to be noted that very low HPAI clade 2.3.4.4 prevalence levels in wild water birds are
obtained in all simulated scenarios.
Probability of HPAIV clade 2.3.4.4 entry into poultry holdings without biosecurity
measures
HPAI-infected migratory water birds entering the EU and/or HPAI-infected birds from the wild bird
reservoir around a poultry holding could release infectious excretions in and/or around the poultry
houses of a holding (Figure 4). Any mechanism of virus transfer from an infectious excretion in and/or
around the poultry houses to the animals is considered because our understanding of these processes
is not sufﬁcient to further differentiate these. A study performed in the Netherlands showed a
signiﬁcant lower relative risk of LPAIV introduction into poultry holdings when the distance to wild
waterfowl areas and medium size waterways was greater than 250 m (with slight further reduction in
Figure 5: Modelled HPAI clade 2.3.4.4 worst-case prevalence (95th percentile) in wild water birds
(piWB) after entry of infected wild water birds at day 1 of the migration season. Different
population sizes (10–100,000) and scenarios 1–4 are presented. Scenario 1: 90% water
birds, 90% migratory birds; scenario 2: 10% water birds, 90% migratory birds; scenario 3:
90% water birds, 10% migratory birds; scenario 4: 10% water birds, 10% migratory birds
27 Reaching the critical number of susceptible residential birds after entry of susceptible migratory birds for around 10 days
(population capacity 100,000 birds; median 0.000, 95th percentile 0.023 at day 125; see Figure 5, scenario 2).
28 The presence of 9,000 susceptible resident water birds (population capacity 100,000 birds; median 0.000, 95th percentile
0.005 at day 125; see Figure 5, scenario 4).
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risk with increasing distances) (Bouwstra et al., 2017). In the model, therefore, the environment within
an area with a radius of 1 km around a poultry holding (= 3.14 km2 surface) is considered crucial to
spark an initial poultry infection following passive (i.e. via fomites) transfer of virus. The release of
infected excretions within the area around the poultry holding is deﬁned as a function of the number
of wild birds landing and their HPAI prevalence (see details in Section C.4 of Appendix C). Finally, the
probability of a poultry holding to become infected is dependent on the level of biosecurity measures
implemented (extrapolation of data on the relation between LPAI infection and biosecurity; e.g. Parker
et al., 2012). To assess the worst-case scenario, a poultry holding without biosecurity measures
implemented is considered, having outdoor housing (the place where poultry is kept is surrounded by
fences but there is no horizontal protection to prevent access of wild birds), the presence of domestic
waterfowl and of gallinaceous poultry, and presence of a water body on the premises accessible to
both domestic waterfowl and wild birds. The effect of implementing biosecurity measures on the
probability of a poultry holding becoming infected with AIV is described in section further below.
The evolution of the daily probability of a holding without biosecurity to become HPAI clade
2.3.4.4 infected during the migratory season (see Figure E.4, Appendix E) follows the kinetics of virus
prevalence in wild water birds (Figure 5). HPAI clade 2.3.4.4 prevalence in wild non-water birds (see
Figure E.3, Appendix E) is more than 10-fold lower compared with prevalence in water birds. A
sensitivity analysis conﬁrmed that mainly prevalence of migratory infected water birds (pi_MWB) drives
the probability of a holding to become infected (see Figure E.5, Appendix E). This reﬂects the original
assumption that only water birds can bring the virus into the EU.
The model suggests that a poultry holding without biosecurity could become infected29 with HPAIV
clade 2.3.4.4 when the wild bird reservoir consists of more than 1,000 birds (consisting of 90%
migratory birds, 90% water birds; scenario 1). The median seasonal probability of poultry holdings
without biosecurity becoming HPAIV clade 2.3.4.4 infected is 0 and 2 (94 and 407, 95th percentile) per
1,000 holdings when considering wild bird populations of 10,000 and 100,000 birds, respectively
(Figure 6). The daily and seasonal probability of a poultry holding without biosecurity to become
infected are lower in scenarios 2–4 compared with scenario 1 (see Table E.1, Appendix E).
Furthermore, it should be noted that the risk period can be longer than a migration season of 125
days as considered here in the model. In the HPAI H5N8 2016/2017 outbreak, infected wild birds were
found during more than 10 months (EFSA, ECDC, EURL, 2017).
It can be concluded that the HPAIV prevalence in water birds as well as the size and composition of the
wild bird reservoir are determining the probability of a holding to become infected. It should be noted
that comparing the scenarios gives useful insights whereas the speciﬁc numerical outcomes
of the model should be considered with caution given all the assumptions of the model.
Figure 6: Seasonal probability (median (lower bar) – 95th percentile (upper bar)) of a poultry holding
without biosecurity becoming infected with HPAIV clade 2.3.4.4 via wild birds over the
entire migratory season, when this holding is located in an area where 10–105 wild birds
are present (consisting of 90% migratory birds, 90% water birds; scenario 1)
29 Looking at the 95th percentile, less than 1/1,000 holdings without biosecurity would become infected by HPAI H5N8 clade
2.3.4.4 when the wild bird reservoir contains 1,000 wild birds (in scenario 1) (see Table E.1, Appendix E).
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Reducing probability of HPAIV clade 2.3.4.4 entry into poultry holdings by implementing
biosecurity measures
The text above describes the probability of poultry holdings becoming infected by HPAIV clade
2.3.4.4 when no biosecurity measures are implemented on the premises. An EKE was performed to
estimate the fold reduction of HPAIV entry when implementing measures to attain increasing levels of
biosecurity. Very few quantitative data on the effect of biosecurity measure related to prevention of
AIV incursions are published (Ssematimba et al., 2013; Millman et al., 2017). More systematic research
has been addressed to bacterial infections such as Salmonella or Campylobacter (e.g. Newell et al.,
2011) but due to the distinct features of AIV and bacteria these data were deemed not convertible.
The experts took the median probability value of a worst-case poultry holding (no biosecurity) as the
benchmark value (two holdings infected out of 1,000) and estimated the fold reduction of the holding
probability to become infected when stepwise implementing biosecurity measures and considering
exposure to 100 wild birds. The outcome of the expert elicitation suggests that preventing access of
poultry to waterbodies on the premises could result in a threefold reduction in HPAIV entry probability.
Combining this measure with conﬁning poultry to indoor housing was estimated to further reduce the
HPAI entry probability twofold. If in addition, routine (daily average practised) biosecurity30 or high
biosecurity31 (as practised in nucleus or breeding herds) would be applied, the estimated fold
reduction of HPAI entry was around 4 and 44, respectively.
The estimated effect of biosecurity measures was considered to be independent of the virus
characteristics. Therefore, the results are relevant for HPAI and LPAI viruses. Based on these values,
the implementation and maintenance of carefully selected and adapted biosecurity measures are key
in the protection of poultry holdings from AIV incursions (Figure 7).
3.2.3. NE route – clades 2.2.1.2 and 2.3.2.1c
The mathematical model was also used to assess entry of HPAI clades 2.2.1.2 and 2.3.2.1c,
changing the values of parameters that were considered to be different from HPAI clade 2.3.4.4 (see
Table C.7, Appendix C).
Entry into the EU
Experts estimated that the number of HPAI clade 2.3.2.1c infected wild water birds at the moment
they cross the EU border is very similar to that of HPAI clade 2.3.4.4 infected water birds (median of
100 and 114 out of 1,000,000 birds, respectively), whereas this number is estimated to be much lower
for HPAI clade 2.2.1.2 infected water birds (median of 8 out of 1,000,000 birds).
For clade 2.3.2.1c, the model outcome suggests similar probability that at least one infected
migratory water bird enters the EU via the NE route as for HPAIV clade 2.3.4.4. For clade 2.2.1.2, the
6-fold 
reducon 
Worst-case poultry holding 
(no biosecurity) 
Prevent poultry access to 
water bodies
AND indoor poultry 
AND roune (daily 
pracce) biosecurity 
AND high biosecurity  
(e.g. breeding ﬂock) 
3-fold reducon 
2-fold reducon
4-fold reducon 44-fold reducon 
264-fold 
reducon 
24-fold 
reducon 
Figure 7: Based on median value of probability that holdings will become infected with HPAI clade
2.3.4.4 given the exposure to 100 infected wild bird, fold reductions were calculated for
increasing level of biosecurity
30 For instance, disinfection of boots, changing clothes, washing hands, etc.
31 For instance, rigorous implementation of showering in, complete exclusion of wild birds to feed, bedding and animal
by-products, separation of houses, etc.
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probability that at least one infected migratory water bird enters the EU via the NE route is similar as
for HPAIV clade 2.3.4.4 (median probability 100%) but the number of infected water birds entering is
more than 10-fold lower.32
Entry into holding
Most parameters related to HPAI ampliﬁcation in the wild bird reservoir are the same for the three
clades, whereas available scientiﬁc evidence suggests differences on the prevalence of infected wild
birds and shedding period. The sensitivity analysis of the model indicated that the prevalence value
inﬂuences the seasonal probability of holdings becoming infected, whereas the duration of the
shedding is less inﬂuential (Figure E.5, Appendix E). The differences in prevalence between the three
clades for birds entering via the NE route are described in the paragraph above.
HPAIV H5N1 persistence in seawater has been noted as an additional possible route of further
spread. Prolonged retention of viral infectivity was explicitly noticed for brackish seawater with lower
salinity such as present in some parts of the Baltic Sea (Domanska-Blicharz et al., 2010; Willeberg
et al., 2010; Perez et al., 2011; Alkhamis et al., 2012). So dispersion of AIV, e.g. from avian faecal
droppings, in shallow seawater may contribute to viral spread, at least locally. In contrast, tidal
currents may cause huge dilution effects that counteract regional and even local spread.
Outcomes of the model suggest that the relative ranking of the seasonal probability of holdings
becoming infected with one of the three clades during a migratory season is similar to their
prevalence.
For HPAIV clade 2.3.2.1c, the median seasonal probability of poultry holdings without biosecurity
becoming infected is between six- and three-fold smaller33 than for HPAIV clade 2.3.4.4 for scenario 1.
The seasonal probability of a poultry holding without biosecurity to become infected is lower in
scenarios 2, 3 and 4 compared with scenario 1.
For HPAIV clade 2.2.1.2, the median seasonal probability of poultry holdings without biosecurity
becoming infected is 10-fold smaller34 than for HPAIV clade 2.3.4.4 for scenario 1. The seasonal
probability of a poultry holding without biosecurity to become infected is negligible35 in scenarios 2, 3
and 4.
3.2.4. E route – clades 2.3.4.4, 2.2.1.2 and 2.3.2.1c
The assessment of the probability that HPAI enters the EU by migratory wild birds entering the EU
via the E, S or NW route has been carried out by analysing the differences with respect to HPAI clade
2.3.4.4 entry via the NE route (which is used as a benchmark, see Figure E.1). The outcome is the
identiﬁcation of a possible fold change using the terminology deﬁned in Section 2.2.
Entry into the EU
The eastern route comprises a sector reaching from Ukrainian/Moldavian borders with the EU
across the Black Sea until the southern border of Turkey. Migrating wild birds or birds driven by cold
spells out of Central Asia are expected to enter the EU territory via this route.
Using the above-described benchmark of clade 2.3.4.4 entry via the NE entry route (see
Section 3.2.2), potential sources of uncertainties related to the extrapolation of the benchmark
probability of entry from NE to other entry routes are described with respect to the different viral
clades of HPAIV H5. In principle, water birds entering the EU via either the NE or E routes are
originating from the same breeding grounds scattered across Arctic and Palaearctic Siberia. These
populations are believed to be at heightened risk of direct or indirect exposure to HPAIV of subtype H5
of Asian origin during migration. Although this has not been speciﬁcally studied, there is no reason to
believe that autumn migration length and dates via the E route would be different that from the NE
route. Introduction of HPAIV H5 via the E routes is, however, not necessarily restricted to the
(autumn) migration season but might as well be triggered by sudden cold spells. Rapid regional
relocation in an east-to-west direction of local water bird populations to escape cold spells that renders
surface waters inaccessible for feeding have been shown to be associated with outbreaks of HPAIV
32 Median numbers of 4080, 3525 and 300 for the HPAIV clades 2.3.4.4, 2.3.2.1c and 2.2.1.2, respectively.
33 Median 0, 95th percentile 15 and 170 infected per 1,000 holdings considering wild bird populations of 10,000 and 100,000
birds, respectively.
34 Median 0, 95th percentile 0 and 53 infected per 1,000 holdings considering wild bird populations of 10,000 and 100,000 birds,
respectively.
35 95th percentile 0 considering wild bird populations of 100,000 birds for scenarios 2, 3 and 4.
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H5N1 clade 2.2 in 2005–2006 in the EU (Ottaviani et al., 2010; Reperant et al., 2010). Cold spells in
Europe often occur later in the winter (e.g. in January or February) but these can also occur earlier
(for instance in December). It should be taken into account that the estimated population size of
water birds in the Black Sea area is larger than the NE one in several species.36 For example, the
estimation is 500,000 common teal (Anas crecca) in north-west Europe compared with 1,000,000
individuals in the population comprising western Siberia, NE Europe the Black Sea and Mediterranean
areas (Wetlands International, 2017b37). Similar ﬁgures for common pochard (Aythya ferina) are
250,000 and a range from 570,000 to 630,000, respectively.
Besides the number of migratory wild birds entering the EU via the E route, the probability of entry
of HPAIV into the EU is also dependent on the virus prevalence in the migratory wild bird population.
For clade 2.3.4.4, there are a few (two as of 12 January 2017) reports of infected wild birds at the
EU border with Ukraine and Moldova, although it should be noted that the surveillance intensity is low
in this area. It is assumed that the prevalence of infected migrating wild birds would be similar
compared with the NE route but has a higher uncertainty. So far, there is no evidence that HPAI clade
2.3.4.4 has been introduced into the EU via the E route in 2014 (Lycett et al., 2016). The introduction
pathways for the 2016 outbreaks of HPAI 2.3.4.4 are still under investigation. Taken together, it can be
concluded that the probability of HPAIV clade 2.3.4.4 entering the EU via the E route is slightly lower
(between 1.5- and 3-fold) compared with entry of such viruses via the NE route.
For HPAIV clade 2.2.1.2, there are no recent reports of infected wild birds close to the EU border
with Ukraine, Moldova and Turkey, although it should be noted that the surveillance intensity is low in
this area. In fact, 2.2.1.2 viruses have remained endemic in Egypt with few incursions into Israel and
Libya; elsewhere viral descendants of the former clade 2.2 are no longer extant. In conclusion, it is
expected that the probability of HPAIV clade 2.2.1.2 entering the EU via the E route is much lower
(between 10- and 1000-fold) compared with HPAIV 2.3.4.4 entry via the NE route.
For HPAIV clade 2.3.2.1c, there are various reports of infected wild birds (and poultry) in Central
Asia (see Figure 1 in Section 3.1.1). Entrance of such viruses into the EU via the E route likely
occurred for instance in March 2010 (Bulgaria and Romania) (Reid et al., 2011; Marinova-Petkova
et al., 2012). These could have been the result of classical migration or deviated migration due to a
cold spell. It is hence concluded that the probability of HPAI clade 2.3.2.1c entering the EU via the E
route is likely to be similar compared with HPAI 2.3.4.4 entry via the NE route.
3.2.5. S route – clades 2.3.4.4, 2.2.1.2 and 2.3.2.1c
Entry into the EU
The southern route concerns all wild birds with migrations originating south of Turkey, i.e. the
Middle East and Africa.
Entry via this route is considered to occur during spring migration as birds ﬂy back from wintering
grounds in Africa. For a given species, the spring migratory season is often contracted compared with
the more diffuse autumn migration (see for instance Guillemain et al., 2006 for common teal).
Comparison of the number of migratory birds entering the EU via the S route in comparison to the
NE route is not easy. However, it is considered that the birds wintering in Africa are mostly breeding
north-east of the EU (mainly in the Russian Federation; Scott and Rose, 1996), so that birds entering
in spring via the S route would be a fraction of those that entered via the NE route the previous
autumn. Given that water birds have high mortality rates during autumn and winter, especially in
juveniles (Guillemain et al., 2010, 2013), it was therefore considered that the number of birds entering
the EU via the S route during spring would be approximately 50–75% of these entering the EU via the
NE route.
An introduction of HPAIV into the EU via the S route would probably be restricted to the spring
migration period since this is the only period when wild birds enter from the south. There is a
generally higher prevalence of AIV infection in wild water birds in sub-Saharan Africa gradually
increased from the autumn to the end of the winter, as the migrants reached these wintering grounds,
to reach the highest values from January to March when spring migration commences (Gaidet et al.,
2012).
Besides the number of migratory wild birds entering the EU via the S route, the probability of entry
into the EU is also dependent on the virus prevalence in the migratory wild bird population.
36 Water bird population estimates retrieved from www.wpe.wetlands.org on 10 January 2017.
37 Retrieved from www.wpe.wetlands.org on 18 April 2017.
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For HPAIV clade 2.3.4.4, the ﬁrst virus detections in wild birds in Africa and the Middle East have
been reported in 2016–2017 (e.g. Egypt, Israel, Tunisia, Uganda). Additionally, these viruses were
detected in free-ranging poultry in Nigeria and Cameroon. However, surveillance is limited in wild birds
in northern Africa and the Middle East. Taken together, the probability of HPAIV clade 2.3.4.4 entering
the EU via the S route is much lower compared with HPAIV 2.3.4.4 entry via the NE route.
For HPAIV clade 2.2.1.2, there are detections reported in wild birds in Egypt as well as in poultry in
Egypt and its directly neighbouring countries such as Libya, Palestinian Territories (see Figure 1 in
Section 3.1.1). The rare detections of clade 2.2.1.2 virus in wild birds might be due to inefﬁcient spill-
over from poultry to migratory wild birds. This could be due to a lack of contact, although there are
some important wintering grounds and likely migratory stopovers in the area, e.g. along the Nile Valley
in Egypt (e.g. Scott and Rose, 1996). In conclusion, it is estimated that the probability of HPAIV clade
2.2.1.2 entering the EU via the S route is lower (between 3- and 10-fold38) compared with HPAIV
2.3.4.4 entry via the NE route.
For HPAIV clade 2.3.2.1c, poultry outbreaks have been reported in multiple sub-Saharan West
African countries (see Section 3.1.1 and Figure 1). Moreover, the virus is present in several countries
of the Middle Eastern region such as Lebanon, Iraq and Iran. So far, 2.3.2.1c viruses have not been
transmitted from sub-Saharan Africa into Egypt or other northern African countries. Therefore, the
probability of HPAIV clade 2.3.2.1c entering the EU via the S route is considered lower (between 1.5-
fold and 3-fold) compared with HPAIV 2.3.4.4 entry via the NE route.
3.2.6. NW route – clades 2.3.4.4, 2.2.1.2 and 2.3.2.1c
Entry into the EU
There are data suggesting migration of Anatidae and Charadriiformes species from Palaearctic NE
America via Greenland and Iceland to the United Kingdom, Ireland and other NW EU areas (Scott and
Rose, 1996; Guillemain and Elmberg, 2014).
The length of the migration season is assumed to be similar for the NW and NE route, although
there are no data to underpin this hypothesis.
Within the metapopulation of all AIV subtypes, two geographically restricted clusters can be
distinguished genetically: an American and a Eurasian one. This observation points towards prolonged
and efﬁcient separation of the reservoir replication pools of these groups. In fact, wild bird migration
between the American continent and Asia or Europe is limited and poses an active barrier to
intermingling of the respective virus groups. Nevertheless, ornithological data accumulate which
indicate occasional transcontinental bird migration, in particular via the Bering Strait (Peters et al.,
2012). Accordingly, interhemispheric reassortants of AIV have been detected repeatedly (Dugan et al.,
2008; Kishida et al., 2008; Fries et al., 2013). These also include HPAIV of clade 2.3.4.4 that were
introduced from Asia to North America in autumn 2014 by migrating wild birds, although most likely
through the Bering Strait (Lycett et al., 2016). Reassortment with indigenous North American LPAI
viruses yielded HPAIV H5N1 and H5N2 viruses, the latter of which became widespread in poultry in the
USA in 2015 (Bevins et al., 2016; Claes et al., 2016; Lee et al., 2016). A natural translocation of
‘Americanised’ HPAIV of clade 2.3.4.4 would depend on complex transmission routes which involve
relay-like virus transmission between wild bird populations resident in America and breeding in
Palaearctic NE America to geese and wader populations that breed in the same area but migrate via
Greenland and Iceland into Western Europe in autumn. Virus transfer via this complex route is
assumed to be a rare event.
Besides the number of migratory wild birds entering the EU via the NW route, the probability of
entry of HPAIV into the EU is also dependent on the virus prevalence in the migratory wild bird
population. HPAIV of clade 2.3.4.4 has been leaking into North America since autumn 2014 across the
Bering Strait along the Paciﬁc ﬂyway in a southerly direction (Lee et al., 2015). In late winter of 2015,
reversed virus dispersal in a northerly direction along the Rocky Mountain and Central Mississippi
ﬂyways was recorded (Saito et al., 2015; Bevins et al., 2016). Substantial numbers of poultry holdings
along these ﬂyways were found to be infected, although a large proportion of poultry cases were
apparently due to secondary virus spread within the poultry industry (USDA APHIS VS, 2015).
Detection ceased in summer of 2015 and a solitary redetection of HPAIV 2.3.4.4 was reported in
September 2016 in a mallard from Alaska (OIE, 2016b). Taken together, the probability of HPAIV clade
2.3.4.4 entering the EU by wild birds via the NW route is much lower (between 10- and 1,000-fold)
38 Uncertainty distribution extreme percentiles.
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compared with HPAIV 2.3.4.4 entry via the NE route. Viruses of clades 2.2.1.2 and 2.3.2.1c have
never been reported in North America (Figure 1, Section 3.1.1), hence the probability that they enter
the EU via the NW route is extremely low (more than 1,000-fold lower) compared with HPAIV clade
2.3.4.4 entry via the NE route.
3.2.7. Overview of seasonal probability of holdings without biosecurity becoming
infected for all routes and clades
The relative ranking of the seasonal probability of holdings without biosecurity becoming infected
with one of the three clades during a migratory season is similar to the relative ranking of the
probability that these viruses enter the EU by wild birds via a given migration route since both
probabilities are proportional to the number of infected wild birds entering the EU.
An overview of the seasonal probability of holdings without biosecurity is provided in Table 6. The
outcomes for the NE route are obtained via modelling (see Sections 3.2.2 and 3.2.3). For the E, S and
NW routes, the probability is estimated using HPAIV clade 2.3.4.4 (NE route) as the benchmark and
applying an uncertainty factor. The scientiﬁc evidence underpinning these estimates is provided in
Sections 3.2.4–3.2.6. This assessment has been performed in January 2017 and should be updated
when new epidemiological information becomes available.
3.3. LPAI introduction via migratory and/or residential wild birds
3.3.1. LPAI introduction into the EU by migratory wild birds (TOR 5)
There is a continuum of LPAI subtype H5 and H7 viruses which is maintained in the Eurasian
metapopulation of aquatic wild birds in an endemic manner (Munster et al., 2007). These viruses are
regularly detected at ﬂuctuating prevalences in wild birds in many European countries. Peak
prevalences are usually seen during autumn migration.
Zoonotic properties for these viruses have, so far, only been described for several H7 LPAIV lineages
which have caused mild ophthalmological or respiratory symptoms in people (Abdelwhab et al., 2014).
Compared with viruses of the highly zoonotic LPAIV H7N9 lineage of Chinese origin, European origin H7
viruses appear to have grossly reduced zoonotic propensities (Kalthoff et al., 2014a). Representatives of
the highly zoonotic Chinese H7N9 LPAIV lineages have to date not been detected in wild birds outside
China. The reservoirs of these viruses in China have not deﬁnitively been unravelled, so it remains
extremely difﬁcult to assess risks of a translocation by wild birds to outside China (Wang et al., 2013,
2014; Jones et al., 2014; Zhao et al., 2014; Lam et al., 2015; Chen et al., 2016).
In addition to LPAIV of subtype H5 and H7, the H9N2 viruses must also be considered with respect
to zoonotic risks. Asian origin H9N2 viruses of the G1 lineages have been shown to sporadically infect
humans and other mammals including swine (Butt et al., 2010; Yu et al., 2011). Mutations in the HA of
these H9N2 viruses have been associated with a shift of the receptor binding afﬁnity towards alpha-2,6
sialic acid residues which explains at least in part their increased zoonotic propensity (Wan et al.,
2008; Imai and Kawaoka, 2012; Srinivasan et al., 2013; Li et al., 2014). In addition, G1-like H9N2
viruses are frequently implicated as donators of internal gene segments in reassortments with H7 and
H5 subtype viruses (Pu et al., 2015). The Chinese H7N9 zoonotic virus lineage carries six internal
Table 6: Seasonal probability of poultry holdings without biosecurity becoming infected with HPAIV,
following entry of infected migratory water birds via the NE, E, S or NW route
Clade NE route(a) E route(c) S route(d) NW route(e)
2.3.4.4 Benchmark(a) Slightly lower Much lower Much lower
2.2.1.2 Much lower(b) Much lower Lower Extremely low
2.3.2.1c Similar(b) Similar Lower Extremely low
Similar, up to 1.5-fold higher or lower than the benchmark value; slightly lower, between 1.5- and 3-fold lower than the
benchmark value; Lower, between 3- and 10-fold lower than the benchmark value; much lower, between 10- and 1,000-fold
lower than the benchmark value; extremely low, more than 1,000-fold lower than the benchmark value.
(a): Based on model outcome, described in Section 3.2.2, and used as benchmark.
(b): Based on model outcome, described in Section 3.2.3.
(c): Based on expert judgement, described in Section 3.2.4.
(d): Based on expert judgement, described in Section 3.2.5.
(e): Based on expert judgement, described in Section 3.2.6.
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segments derived from genotype S of G1-like H9N2 viruses (Gu et al., 2014). During the last decade,
G1-like H9N2 viruses have established endemic status in poultry populations in many Asian countries
as well as in the Middle East and North African regions. Infection of poultry in these regions is
extremely wide spread and frequent. The prevalence of G1-like H9N2 infections in Eurasian wild birds
in Far East and Central Asia is not known. The vast majority of circulating viral load of these viruses is
associated with poultry, and wild birds are considered not to play an important role in their
epidemiology.
In wild birds in Europe, viruses of this G1-like lineage have not been detected although H9N2
infection is endemic within these populations as well; H9N2 viruses circulating in European wild bird
populations constitute a separate phylogenetic lineage that is also distinguished from G1-like viruses by
their apparent lack of zoonotic potential (Lindh et al., 2014; Muzyka et al., 2016). Although present
endemically in European wild bird populations, sporadic outbreaks of non-G1 H9N2 infections in
poultry are reported only occasionally from several European countries. An exception occurred in
turkey populations in Germany, where the non-G1-like H9N2 infections circulated over several years
and also caused infections in Poland through transboundary transport of infected pullets (Smietanka
et al., 2014). Once established in poultry populations, non-G1 H9N2 viruses can cause substantial
economic losses due to signiﬁcant morbidity of to 20% especially in young turkeys. These viruses may
pose a challenge to control since H9N2 infections are not in the list of notiﬁable or reportable diseases
in poultry and, hence, all measures of control remain at the disposal of the stockman.
Given that LPAIVs are endemic in the EU wild bird population, its introduction into the EU was not
simulated with the current model. As described in Section D.1.3 (Appendix D), LPAI viruses of
subtypes H5 and H7 are detected annually with seasonal variations in wild bird metapopulations in
Europe. According to the EURL reports of the wild bird monitoring programmes of MSs, the data
assembled by the Consortium of this working group and published data (Section D.1.3, Appendix D),
the highest annual occurrences in Anseriformes wild birds are detected during autumn, but a scattered
presence, especially of subtype H7 viruses, has also been described in spring.
3.3.2. LPAI introduction into a poultry holding from the wild bird reservoir
(TOR 4 and TOR 5)
For the simulations of LPAIV entry into a poultry holding via wild birds, scenarios are selected to
analyse the effect of H5, H7 and H9 LPAIV prevalence in the wild bird population (since this parameter
had a large effect on the outcome of the HPAI model) and the effect of protective immunity (since this
is an important biological factor in infectivity). LPAIV and HPAIV may infect and be transmitted by the
same wild bird species, hence the same classiﬁcation of wild birds into water birds and non-water birds
is used in both models (Tables B.1 and B.2, Appendix B). Experimental infections with LPAIV have
shown that a transient, low-level antibody response can be generated, which may be sufﬁcient to
provide partial protection against reinfection with viruses of the same subtype; it is less likely that the
induced humoral response confers protection against heterologous reinfections (Fouchier and Munster,
2009). Yet, frequent reinfections of mallards with viruses of the same subtype have also been reported
(Globig et al., 2013; Wille et al., 2014).
The LPAIV prevalence in Anseriformes wild bird populations is highly dependent on the time of the
year and the geographical location (see Section D.1.3, Appendix D). Data from virus detection,
isolation and characterisation were used from areas where LPAIV prevalence in wild birds was
assessed over several years (Latorre-Margalef et al., 2014; data received as per procurement,
coordinated by Linnaeus University (SE), Erasmus Medical Centre (NL) OC/EFSA/ALPHA2015/01
supplemented with NP/EFSA/ALPHA/2015/04, unpublished (Consortium report Waldenstr€om et al.,
2017) to determine three values reﬂecting the most likely prevalence in many MSs (0.002), the most
likely prevalence in northern MSs (0.02) and an extreme prevalence in northern MSs (0.06). These
three prevalence values are considered to reﬂect low, moderate and high exposure scenarios that have
been observed within the EU (Table 5).
The model was ﬁrst used for a complete na€ıve wild bird population. The effect of immunity on the
LPAI dynamics in the wild bird population and subsequently on the probability of LPAIV introduction
into a poultry holding was assessed by running an additional simulation with prevalence 0.02 and with
half of the wild bird population being immune.
For the LPAI model, the two highest wild bird population capacities (10,000 and 100,000 wild birds)
are used as in the HPAI model, facilitating comparison of the model outcomes. As for the population
composition, this was deﬁned as 90% entering (10% resident) wild birds and 90% water birds (10%
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non-water birds) since it was the highest risk scenario for HPAI. In fact, these conditions reﬂect the
autumn period. The different scenarios analysed with the model are presented in Table 7. All
parameters used in the LPAI model are provided in Table C.8 (Appendix C).
When the prevalence of infected entering water birds is high (0.06, see scenario 1 in
Figure 8), an immediate onset of the epidemic and a rapid increase in the prevalence of infected water
birds is observed during the ﬁrst 10 days. When an average of 39 susceptible water birds enter daily,
the prevalence immediately increases and reaches a maximum around day 10 (median 0.013, 95th
percentile 0.017) and then decreases to 0.003 (95th percentile 0.007) at the end of the considered
period (i.e. day 125) (see Figure 8: scenario 1, population capacity 100,000 birds). Reducing the
prevalence of infected water birds entering the new foraging area (0.02 in scenario 2 and
0.002 in scenario 4), will lead to an epidemic in the residential wild bird population only when
considerable numbers of (infected) water birds are present (which is the case in scenario 2 but barely
the case in scenario 4 – because prevalence is low). For scenario 2, and with a population capacity
100,000, a maximum prevalence level of 0.004 (95th percentile 0.007) is reached in water birds at day
13, followed by a decrease of prevalence to 0.001 (95th percentile 0.004) at day 125. For scenario 4,
LPAIV will only be maintained at a low level when a large wild bird population is present (100,000
birds).
Simulating 50% of the wild bird population being immune (scenario 3) when the
prevalence of entering infected water birds is 0.02 (same as in scenario 2), this leads to a similar
prevalence pattern in time as when the total population was considered na€ıve. This can be explained
by: (1) if 50% of the population is immune and R0 > 2, major outbreaks are still possible (Anderson
and May, 1991) and (2) initially the population is only small, but it increases during the migratory
season.
When compared with HPAI (see Figure 5 in Section 3.2.2), it can be concluded that LPAIV can
reach similar maximum prevalence levels. However, sometimes after an initial peak, LPAIV levels are
maintained at a lower level than HPAI in large populations of wild birds (100,000 birds). The model
outcomes suggest that immunity in half of the birds (as occurs during autumn) does not really
inﬂuence the LPAI spread in a wild bird population. The explanations here are the same as mentioned
for HPAI above.
Table 7: Scenarios analysed using the LPAIV model
Prevalence Scenario Population size
Proportion
entering wild
birds(a)
Proportion
water
birds(b)
Proportion
na€ıve
birds(c)
0.06 (high exposure) 1 10,000, 100,000 0.9 0.9 1.0
0.02 (moderate exposure) 2 10,000, 100,000 0.9 0.9 1.0
3 10.000, 100,000 0.9 0.9 0.5
0.002 (low exposure) 4 10,000, 100,000 0.9 0.9 1.0
(a): Proportion of wild birds entering the local area in relation to the (non-entering) wild birds already present in this area.
(b): Proportion of water birds (as opposed to non-water birds) in the wild bird population.
(c): Proportion of wild birds without protective immune response.
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Probability of LPAI entry into poultry holdings without biosecurity measures
The evolution of the daily probability of a holding without biosecurity becoming LPAI infected
during a period of 125 days (see Figure E.9, Appendix E) follows the kinetics of virus prevalence in
wild water birds (Figure 8). LPAI prevalence in wild non-water birds (see Figure E.8, Appendix E) is
more than 10-fold lower compared with prevalence in water birds.
The model suggests that a poultry holding without biosecurity could become infected with LPAI
when the wild bird reservoir consists of 90% migratory birds and 90% water birds (scenario 1). The
median probability of poultry holdings without biosecurity becoming LPAI infected over the season
(125 days) is 9 and 12 (796 and 863, 95th percentile) per 10,000 holdings when considering wild bird
populations of 10,000 and 100,000 birds, respectively (Figure 9). The daily and seasonal probability of
a poultry holding without biosecurity to become infected are lower in scenarios 2, 3 and 4 when
compared with scenario 1 (see Table E.2, Appendix E). The relative effect of implementing biosecurity
on lowering the probability of LPAIV entry into a holding is similar to that which has been described for
HPAIV (see end of Section 3.2.2).
It can be concluded that the LPAIV prevalence in water birds entering a forage area determine the
probability of a holding becoming infected. In comparison to HPAI, the seasonal probability is fourfold
lower for the 100,000 population capacity and similar for the 10,000 population capacity. This is in line
with the observed lower probability of LPAI than HPAI outbreaks in poultry holdings.
It should be noted that comparing the scenarios gives useful insights, whereas the
speciﬁc numerical outcomes of the model should be considered with caution given all the
assumptions utilised in model.
Figure 8: Modelled LPAI 95th percentile prevalence in wild water birds (piWB) after entry of infected
wild water birds at day 1 of the migration season. Different population sizes (10,000 and
100,000) and scenarios 1–4 are presented. Scenario 1: 0.06 prevalence in infected entering
water birds; scenario 2: 0.02 prevalence in infected entering water birds; scenario 3: 0.02
prevalence in entering infected water birds and 50% immune population; scenario 4: 0.002
prevalence in infected entering water birds
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3.4. HPAI and LPAI introduction via non-wild bird pathways (TOR 1,
TOR 3 and TOR 5)
A qualitative risk assessment has been performed for 10 pathways regarding HPAI and LPAI
introduction (other than wild birds) into poultry holdings of MS in two scenarios: (i) third country trade
and (ii) intra-EU movements (see Section 2.3). The following terms were used to describe the
probability of HPAI and/or LPAI introduction into a commercial poultry holding via a given commodity:
negligible (indistinguishable from 0), extreme unlikely (up to 1%), very unlikely (from 1% up to 2%),
unlikely (from 2% up to 10%) and non-negligible (from 10% up to 100%) (see Section 2.3).
Several steps are required to delineate risks along the trade pathways. The country of origin for
third country trade should be considered. For live birds, hatching eggs and day-old chicks, there is a
limited list of approved countries, under Commission Regulation (EC) No 798/200839 Part 1 of Annex I.
For certain countries, only regions are approved. If a disease event occurs, the Annex is adapted to
regionalise for disease-free areas. All such decisions are made through the Standing Committee on
Plants, Animals, Food and Feed (PAFF) meetings and are agreed with MSs. For other products, such as
fresh or frozen meat, again the country list is limited, whereas for treated or processed products the
list of approved countries is much broader as these commodities are considered a lower risk.
For imports from third countries, the commodity in many circumstances will be certiﬁed, which can
include AI surveillance programmes for poultry and testing requirements and quarantine for captive
birds (Regulation (EU) No 139/201340). Animal Health Certiﬁcates for imports from third countries into
the EU have requirements for the country of origin, the disease-free status of the premises or region,
a veterinary check prior to travel and checks on arrival to the EU. For live birds which are moving with
the owners into the Community, and therefore classiﬁed as pets, there are requirements for one of
several options involving either 30-day isolation and negative tests for H5N1 before movement or
quarantine on arrival. Veterinary checks are required (Commission Decision 2007/25/EC41). All live
animals must enter through a live animal border inspection post (BIP) and all products through a
product BIP where additional checks on documents, identity and physical checks take place. At this
stage, additional testing may be required if there are issues with the checks. Ofﬁcial veterinarians will
be responsible for these checks. Once the commodity has entered the EU, it may move to another MS;
for products, these are now in free circulation and no further checks are made unless there are food
Figure 9: Seasonal probability (median (square) – 95th percentile (upper bar)) of a poultry holding
without biosecurity becoming infected with LPAI via wild birds over the entire considered
period (125 days), when this holding is located in an area where 10,000–105 na€ıve wild
birds are present (consisting of 90% entering birds, 90% water birds; scenario 1)
39 Commission Regulation (EC) No 798/2008 of 8 August 2008 laying down a list of third countries, territories, zones or
compartments from which poultry and poultry products may be imported into and transit through the Community and the
veterinary certiﬁcation requirements. OJ L 226, 23.8.2008, p. 1–94.
40 Commission Implementing Regulation (EU) No 139/2013 of 7 January 2013 laying down animal health conditions for imports
of certain birds into the Union and the quarantine conditions thereof. OJ L 47, 20.2.2013, p. 1–17.
41 Commission Decision 2007/25/EC of 22 December 2006 as regards certain protection measures in relation to highly pathogenic
avian inﬂuenza and movements of pet birds accompanying their owners into the Community. OJ L 8, 13.1.2007, p. 29–34.
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safety issues. At the place of destination, further checks may be made on live animals if there are
concerns raised about the country or region of origin after the consignment was dispatched.
For intra-EU movements, the health certiﬁcate requirements are less stringent as the overall disease
status of the MSs is considered to be high and the onus is on the consignor to ‘never knowingly consign a
commodity which could present a risk for disease spread’. Nevertheless, a veterinary inspection is still
required before movement. The MS of destination may consider (with a risk assessment) the need for
further checks at the destination, if there are concerns about undisclosed disease when the consignment
was certiﬁed. The rationale behind this procedure is that there is transparency on the MSs’ disease
statuses; harmonised disease control measures are implemented if there is an outbreak that restrict
movements of commodities from the infected holdings and from holdings in established protection and
surveillance zones.
For intra-EU movements of pet birds, no veterinary checks or owner self-certiﬁcation are required.
The owner of ‘birds other than poultry’ excluding pet birds must self-certify the birds are free of
disease (Articles 4 and 7 of Council Directive 92/65/EEC42), whereas, due to the risk of psittacosis, a
commercial document signed by the competent veterinary authority is necessary for movements of
psittacines only. Certain products, such as poultry semen, are not covered by harmonised certiﬁcates,
but instead national rules may be used.
Speciﬁc pathogen-free (SPF) eggs are not taken into account here, as they are considered, by their
very nature, to be pathogen-free and to enter speciﬁed approved bodies, such as laboratories or
research establishments.
The main outcomes of the qualitative risk assessment are described in the sections below and
Table 8, whereas the detailed assessment and the available scientiﬁc evidence is provided in
Appendix F (see overview Table F.6).
Table 8: Probability of HPAI and LPAI introduction into a commercial poultry holding via non-wild
bird pathways, separating third country trade and intra-EU movements (for brevity, some
categories have been grouped; relevant explanation of the probability scores is reported in
Appendix F and summarised in Sections 3.4.1–3.4.10)
Pathway
Third country trade Intra-EU movements
HPAI LPAI HPAI LPAI
Live birds, including
birds as pets, bird of
prey, pigeons or
others
Extreme unlikely Very unlikely
Live poultry (poultry
for breeding or
production (> 72 h
old); day-old chicks and
hatching eggs)
Extreme unlikely (live poultry
and day-old chicks); very unlikely
(hatching eggs)
Unlikely Unlikely (hatching eggs);
Non-negligible (live poultry
and day-old chicks)
Meat and eggs for
human consumption
Very unlikely Not relevant (meat);
Very unlikely (eggs)
Very unlikely Not relevant (meat);
Very unlikely (eggs)
Semen Non-negligible Not relevant Non-negligible Not relevant
Feathers, skin and
down
Extreme unlikely Not relevant Very unlikely Not relevant
Feed Extreme unlikely (non-negligible(a))
Bedding Extreme unlikely (non-negligible(a))
Manure Not relevant Non-negligible
Pharmaceuticals Extreme unlikely
Other animal
by-products
Extreme unlikely Not relevant Extreme
unlikely
Not relevant
(a): When the commodity is stored in way that wild birds can have access to it.
42 Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the
Community of animals, semen, ova and embryos not subject to animal health requirements laid down in speciﬁc Community
rules referred to in Annex A (I) to Directive 90/425/EEC. OJ L 268, 14.9.1992, p. 54–72.
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3.4.1. Live birds
This covers the captive birds such as Passeriformes, birds of prey, Psittacines, peacocks, swans,
wild ducks, wild geese, snipe, woodcocks, grouse, birds as pets, racing pigeons (not for consumption)
and zoo birds (i.e. originating in an approved body, institute or centre).
The overall risk of introduction of infection into a commercial poultry farm is considered extreme
unlikely for third country trade because birds must be tested for AI and must enter quarantine.
For intra-EU movements, the risk level is higher than for third country imports and was assessed as
very unlikely which accounts for the lack of pre-movement testing and quarantine, the increased
volume of trade, but recognising that poultry will generally not be exposed.
For birds traded between approved bodies, institutes or centres, under Council Directive 92/65/EEC,
there are requirements on the centres to have in place surveillance programmes for listed diseases,
which include avian inﬂuenza. Therefore, the movement between approved premises are an even
lower risk. For birds from registered holdings, there are no requirements for surveillance programmes,
but there must be no reports of disease at the holding for the 30 days prior to consigning the birds.
A large proportion of the trade volume will be racing pigeons which are not raised for human
consumption. Currently, available evidence suggests that pigeons appear to be less susceptible to
infection than many other species of birds and are ineffective propagators and disseminators of virus
(Kaleta et al., 2007; Werner et al., 2007; EFSA, 2008; Abolnik, 2014). Exceptions occur as cases of
natural infections have been reported from countries with endemic HPAIV H5N1 status (Mansour et al.,
2014) and in the 2016/2017 epizootic a few wild and farmed pigeons have tested positive; however,
these may be considered spill-over infections in areas where there are high levels of environmental
contamination. The role of wild pigeons in onward transmission of avian inﬂuenza is not considered
important in the overall epidemiology of disease, according to historical information gathered over the
last 10 years or so (see Section F.4, Appendix F). Globally, pigeons are rarely found to be infected
during either epizootics or in endemic areas where H5 and H7 viruses circulate, hence they do not play
an important role in the spread of AIV. Nevertheless, experimental infection of pigeons with H5 and H7
viruses is possible (see Table F.2, Appendix F). Council Directive 92/65/EEC allows the movement of
captive birds including racing pigeons, to another MS provided they originate in a holding free of AI for
the previous 30 days and show no signs of disease on the day of travel. An owner declaration to such
an effect is required. Once birds are released for racing, they will generally return to their home loft
quickly and usually will not stray on to poultry farms and only land en route to drink.
3.4.2. Live poultry
This regards breeding, production birds, hatching eggs and day-old chicks of all poultry types
(gallinaceous poultry, Anseriformes, ratites, gamebirds). For brevity, not all additional conditions, such
as surveillance programmes and any premovement testing are speciﬁcally mentioned in the following
text and the reader is recommended to view the appropriate legislation. However, the requirements
have been taken account of in the accompanying risk tables in Appendix F.
According to the EU legislation (Directive 2009/158/EC43), these commodities (or their parent
ﬂocks) should come from approved establishments before moving: a residency period of 12 weeks in
an approved establishment (certiﬁed according to Regulation (EC) No 798/2008) is required before
being imported from third countries, the residency period is of 6 weeks in the case of intra-EU
movements. Approved breeding establishments are under ofﬁcial control and are required to have in
place early detection, notiﬁcation, heightened biosecurity and to take part in active serosurveillance
programmes. The legislation also requires that breeding establishments are neither directly under
disease control restrictions for notiﬁable disease nor in a region under such restrictions.
For third country imports, day-old chicks and live poultry must be kept separately from other
poultry present on arrival. They are then either observed for 6 weeks and, if disease is suspected,
subjected to clinical examination and testing, or they are kept for 3 weeks and undergo testing. For
hatching eggs, these must be hatched separately, or if this is not possible, the whole batch must then
be considered as one epidemiological unit for which control measures must be applied. (Annex VIII of
Regulation (EC) No 798/2008). These post-movement requirements do not apply after intra-EU
movement to another MS.
43 Council Directive 2009/158/EC of 30 November 2009 on animal health conditions governing intra-Community trade in, and
imports from third countries of, poultry and hatching eggs. OJ L 343, 22.12.2009, p. 74–113.
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For third countries trade of these commodities, the overall risk is considered very unlikely for
hatching eggs and extremely unlikely for live birds. The difference in the risk level is due to very high
numbers of hatching eggs in comparison to the numbers of live poultry and therefore takes account of
the aggregated risk score, as opposed to the risk level for a single consignment. However, as the eggs
will be in a designated hatchery the risk of exposure to other poultry should be mitigated.
For intra-EU movements, however, there are varying risk levels, which reﬂects the high volume of
trade, possible mixing of batches and lack of pre-movement testing requirements. LPAIV incursion is of
more concern because with the HPAI strains the required veterinary inspection should detect any
clinical signs. Therefore, for the movement of day-old chicks or live poultry, from a region where LPAIV
is suspected to be present, the probability of AIV infection transfer was considered non-negligible, but
unlikely for HPAI. Regular testing of the (parent) ﬂock should be considered in such regions. Hatching
eggs are less of a concern for LPAI because they will not be infected (unlikely), and they should be
disinfected in accordance with Article 8(1) of Directive 2009/158/EC and in line with Chapter 6.4 of the
OIE code, such that the eggs are cleaned and sanitised as soon as possible after collection with an
approved sanitising agent and all crates and packing materials should be new or sanitised.
Nevertheless, fomite contamination (egg shells, crates, etc.) cannot be entirely discounted, through
recontamination or incorrect sanitation procedures.
3.4.3. Meat and eggs for human consumption
This section refers to fresh, frozen, non-processed meat and table eggs for human consumption.
The limited list of approved third countries, the certiﬁcate requirements and the swill feeding ban in
the EU limits the probability of incursion of HPAIV through these pathways for exposure of commercial
poultry and these are considered very unlikely probability pathways.
For intra-EU movements, given the veterinary inspection processes in slaughter houses and the
likely clinical signs in parent ﬂocks (which may at least include reduced egg production observed in
Anseriformes for HPAI) as well as the swill feeding ban, again the probability of HPAI incursion is
considered very unlikely, but it should be noted that there are very high volumes of these commodities
and therefore reducing the exposure of commercial poultry is the most important rate limiting step.
For LPAI, as birds are rarely viraemic, meat or table eggs would not contain high levels of virus and
therefore these pathways are not considered relevant for meat, while for table eggs it is the fomite
risk which leads to a probability of very unlikely. Such commodities are also considered a negligible risk
for public health, as food safety rules should ensure no sick animal enters the food chain and provided
products are cooked according to food hygiene rules.
3.4.4. Semen
Semen for the artiﬁcial insemination of turkeys is commonly used in the EU. There is scientiﬁc
literature on the infection of turkeys after being artiﬁcially inseminated and this was considered an
important route for transmission of pandemic inﬂuenza A (H1N1) into turkeys (Pantin-Jackwood et al.,
2010). There are no harmonised rules for this commodity, and therefore, there are no trade statistics.
For bilateral international trade, MSs should apply the requirements of the OIE code – that the donor
stags are disease-free and no disease has been reported in the past 21 days. However, the lack of
data on the volumes used and the lack of trade rules means that the risk of this pathway for HPAI
cannot be rejected, hence the risk might be considered non-negligible, given the level of uncertainty.
It is important to emphasise that the probability of ‘non-negligible’ is between 10% and 100%, hence
the uncertainty.
This pathway is considered not relevant for the introduction of LPAI, as there is no viraemia
associated with infection.
3.4.5. Feathers, skin and down
According to Commission Regulation (EU) No 142/2011, the importation into and the transit through
the EU of untreated feathers and parts of feathers and down is prohibited. Treatments comprise
physical and/or chemical processes ensuring complete viral inactivation. For imports of treated feathers,
parts of feathers and down, no health certiﬁcate is required. For LPAI, these commodities may be
contaminated rather than infected, therefore these pathways are not considered relevant. There is an
anomaly with the trade code. According to the Vet Checks Decision (2007/275/EC) EX 0505 is described
as ‘Skins and other parts of birds, with their feathers or down, feathers and parts of feathers (whether
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or not with trimmed edges) and down, not further worked than cleaned, disinfected or treated for
preservation; powder and waste of feathers or parts of feathers’. Therefore, it is considered that
feathers and parts of feathers and down have been treated by ‘another method’ but not undergone a
full steam treatment. This is why, once imported, these products have to go to an approved
establishment in the EU for further treatment. Therefore they may appear in the trade database as
‘raw’ as they have not been fully processed or if ‘other’ is a viable option under the Combined
Nomenclature (CN) codes (Council Regulation (EEC) No 2658/8744). The risk of HPAIV introduction into
commercial poultry holdings via treated skin, feathers and down is therefore considered extreme
unlikely for imports from third countries, whereas when transported between MSs, when treatment is
not required, it is considered very unlikely taking into account the high volume.
3.4.6. Feed containing poultry products and other feed such as processed grain
Poultry products used as feed should not be fed to poultry themselves, except for poultry tallow. In
the EU, there is an intraspecies recycling ban on feeding of processed animal protein (PAP), such as
poultry blood meal. It is allowed to feed other treated blood products that are not PAP and also
poultry tallow back to poultry. Poultry blood products can be fed to pigs/ﬁsh but not ruminants. Poultry
PAP cannot be used for other livestock feed except for aquaculture. World-wide, poultry by-products
(offal), as an offshoot of broiler production, may be processed for animal feed but the process itself
reduces the pH to prevent bacterial and viral development. Whole poultry meal and processed poultry
meal may all be used as feed and therefore these products could be diverted to poultry feed by
mistake. In general, this is considered extremely unlikely to be a suitable pathway for incursion of AI
into commercial poultry. Feed speciﬁcally for poultry, if commercially produced, is processed as part of
pelleting manufacture, and again, it is extremely unlikely this would be a suitable pathway for disease
incursion. However, the product itself could be exposed to virus-infected wild birds or virus-
contaminated environment while being transported or on arrival when stored, therefore in these
circumstances this pathway is considered non-negligible. However, it is considered as part of the
general wild bird indirect exposure pathways, which highlights the importance of biosecurity around
storing feed away from possible contamination. In summary, therefore, the probability of AIV survival
in feed is extreme unlikely but feed might become contaminated during storage, hence the risk level is
given in parentheses in Table 8.
3.4.7. Bedding
Hay and straw must only enter the EU from third countries with a commercial document; however,
there are no consignments notiﬁed in the UN ComTrade database from third countries. For intra-EU
movements, large volumes of such a commodity are moved in the EU. In general, the risk of
introduction of AIV via this pathways is considered extreme unlikely, however, similarly to the feed
pathway, if contamination occurs at time of harvest, during transport or storage, through contact with
infected wild birds or contaminated vermin and because of the intended exposure to poultry, this
pathway is scored as non-negligible, with some uncertainty based on the time since harvest and the
transport conditions which may affect viral perseverance. Contamination of imported bedding with wild
bird faeces cannot currently be eliminated as a potential pathway and this possible risk score is given
in parentheses in the relevant section of Table 8.
3.4.8. Manure
In an outbreak situation, manure cannot be removed from poultry holdings and spread in the
protection and surveillance zone except for transport for treatment and storage following under control
of competent authority. These prohibitions also apply in zones that reach into a neighbouring MS.
According to Commission Regulation (EU) No 142/2011, the importation into and the transit through
the EU of unprocessed manure is prohibited; therefore, this pathway is not relevant in the case of
Third Countries trade. However, within the EU, the competent authorities of two MSs which share a
common border may authorise the dispatch of manure between farms located in border regions of
those two MSs subject to appropriate conditions for the control of any possible risks to public or
animal health, such as obligations for the operators concerned to keep appropriate records, which are
44 Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs
Tariff. OJ L 256, 7.9.1987, p. 1–675.
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laid down in a bilateral agreement. In outbreak situations, the information in these records should be
used for tracing the infection. The product itself consists of a mixture of bird manure, poultry feed,
sawdust and bedding material that accumulates at the bottom of or on manure conveyor belts in
poultry sheds and therefore can potentially include dead poultry. If not treated or pelleted, it can
contain high levels of virus if taken from an infected poultry farm, and should always be stacked to
reduce viral load (Directive 2005/94/EC on AI control), in accordance with disease control measures.
Therefore, for manure originating in holdings with HPAI-infected galliforme species it would be
expected that the disease would have been conﬁrmed and all manure treated. For manure originating
from holdings with HPAI in Anseriformes species or LPAI in any poultry species, it is possible that
disease would not be detected, and therefore, this is considered a non-negligible pathway taking also
into account reduced virus perseverance in manure. In terms of exposure directly to commercial
poultry, it cannot be discounted as a potential pathway if the manure is spread near a poultry farm or
if there is access to wild waterfowl.
3.4.9. Pharmaceuticals
Vaccines for notiﬁable avian inﬂuenza are rarely used in the EU, mostly because of the trade
implications for products from vaccinated poultry, but also because of the costs associated with
application of vaccines to individual birds and surveillance costs. They must comply with Directive
2001/82/EC and Regulation (EC) No 726/2004 (Article 52 of AI Directive). Vaccination requires explicit
approval of vaccination plan by the European Commission on applications by MSs. All registered
vaccines must be notiﬁed to the European Commission and each MS must submit plans for approval
indicating vaccine to be used and keep records of birds vaccinated (captive birds in zoos and
collections or in special circumstances, some poultry). Only one vaccine for avian inﬂuenza is approved
for use in the EU: the Nobilis Inﬂuenza H5N2 for use in chickens. It is an inactivated vaccine
manufactured in the EU. Nevertheless, other live vaccines for use in poultry (e.g. against Newcastle
Disease virus) are often produced in eggs (SPF eggs) and contamination could occur, but is thought
improbable given the controls in place with Good Manufacturing Practices with pharmaceutical
companies and veterinary medicine authorities. Therefore, this is considered an extreme unlikely
pathway, but all authorised vaccines are assessed for quality, safety and efﬁcacy. As part of the quality
assessment, the applicant has to provide information on any potential extraneous agents and there is
a monograph which outlines which agents to test for and ensure that there is no risk. Also, if material
(s) of animal origin is used during production of the vaccine then information has to be provided and a
transmissible spongiform encephalopathy (TSE) risk assessment performed. If they are live vaccines
that have been attenuated in some way, the potential to revert to virulence is assessed based on the
safety data provided. Any concerns on safety such that a product could revert to a virulent state would
be noted and taken into account when determining the beneﬁt/risk of the product, and whether an
authorisation is given. The ﬁnal product tests in place should give assurance that there is no
contamination, but in case it does, there are steps in place to manage the risk from such events. The
tests that are performed on authorised live/inactivated vaccines reassures that there is no risk of
extraneous agents, and these tests include one for inﬂuenza A.
Finished medicinal products, such as vaccines, are not covered by veterinary legislation for import
and therefore there are no import data available. Intermediate products derived from Category 3
material and intended for technical uses in medical devices, in vitro diagnostics, laboratory reagents
and cosmetics are included (See Commission Decision 2007/275/EC) but these products are not
considered a risk of introducing avian inﬂuenza to poultry as they are destined for laboratories.
3.4.10. Other animal by-products (ABPs)
There are many other products of poultry origin (such as processed meat, processed parts of birds
including feathers, skin, feet, casings, blood), but they were discounted as not being a signiﬁcant pathway
(and scored as extremely unlikely for HPAI and not relevant for LPAI) as they were either for treatment,
processing (e.g. for pet food) or for human consumption. ABP rules (Regulations (EC) No 1069/200945
and (EC) No 142/2011) about the disposal of categories 1 and 2 waste means high-risk material will be
rendered. Category 3 ABPs are also considered a very low risk category for AIV transmission.
45 Regulation (EC) No 1069/2009 of the European Parliament and of the Council of 21 October 2009 laying down health rules as
regards animal by-products and derived products not intended for human consumption and repealing Regulation (EC) No
1774/2002. OJ L 300, 14.11.2009, p. 1–33.
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Unprocessed pet food such as dog chews made of poultry meat or frozen day-old chicks are frequently
traded and imported, with health certiﬁcation. Both represent an extremely unlikely pathway for the
introduction of HPAIV (and not relevant for LPAIV) into commercial poultry.
3.4.11. Illegal introduction
For any of the commodities mentioned, illegal introduction is theoretically possible but very difﬁcult
to quantify. Illegal consignments of captive birds or hatching eggs from captive birds are picked up at
the EU border on occasion, but the number which are not identiﬁed are ipso facto, unknown (EFSA,
2008) and there have been three recorded occasions of such birds testing positive for H5N1 HPAI.
Birds of prey have been implicated in a case of illegal introduction into the EU at Brussels airport in
2005 (Van Borm et al., 2005). In the UK in 2006, an African Grey parrot was tested positive for H5N1
HPAI while in quarantine. In 2013, a mixed consignment of psittacines and Passeriformes were illegally
introduced into Austria and stopped at Vienna Airport. Of the nearly 100 birds of this consignment, 60
were alive and of the dead birds, four tested positive for H5N1 HPAI. Poultry meat (fresh or frozen)
and table eggs are frequently intercepted in passenger luggage (information from UK Border Force
seizures). However, if even those may be expected to be infected with a higher likelihood than their
parallel legal commodities, the volumes involved are far lower.
3.5. HPAI and LPAI transmission and spread (TOR 6)
3.5.1. Transmission between birds in a poultry population
The transmission parameters of LPAI infections and HPAI infections are shown in Tables G.1 and
G.2 (Appendix G). In chicken, the estimates of the basic reproduction ratios, R0, (the average number
of secondary infections caused by one infectious bird) for LPAI and HPAI are similar, ranging from 0.8
to 9.1 and 1.6 to 10.7, respectively.46 However, due to high mortality, the average infectious period of
HPAI is considerably shorter than that of LPAI, resulting in much quicker transmission as indicated by
infection rate parameters, (b, the average number of secondary cases caused by one infectious
individual per day) that is 0.76–4.5 for HPAI and 0.1–0.91 for LPAI. One should bear in mind that the
variation of these parameters among LPAI and HPAI viruses is large, hampering a universal conclusion.
However, van der Goot et al. (2003) showed that for an H5N2 subtype including a speciﬁc HPAI isolate
and its LPAI precursor, both R0 and b were lower for LPAI than for HPAI (Van der Goot et al., 2003).
So overall, it can be concluded HPAI viruses are transmitted much quicker in chicken populations than
LPAI viruses. Although virus strain is a likely determinant of transmissibility, differences between
studies and the wide conﬁdence intervals of the estimates of transmission parameters do not allow
deﬁnitive conclusions. Moreover, successful adaptation to the host species studied likely inﬂuences
transmission.
For turkeys, less information is available than for chicken, however, the trend appears like that of
chicken. Also, for ducks, the information is limited, although it points towards higher transmission
parameters of LPAI viruses in ducks than in chickens. Additionally, the tables show high values of both
R0 and b for HPAI H5N1 in ducks, whereas the value for R0 for H5N8 virus in ducks reported is quite
moderate, but this reﬂects only a single publication. Although differences between isolates have been
observed, results from Pillai et al. (2010a,b) indicate that a poultry derived isolate transmits better
between chickens than a wild bird-derived isolate (Pillai et al., 2010a). Wild bird isolates transmit
better among turkeys and ducks than among chickens. The latter reﬂects the higher susceptibility of
turkey compared with chickens to LPAI and probably the species jump is less of a hurdle from wild
birds to domestic ducks than from wild birds to chicken.
3.5.2. Transmission between ﬂocks within a farm
No information is available in the published scientiﬁc literature on transmission parameters of avian
inﬂuenza viruses between ﬂocks within a farm. In the Netherlands, during the 2014 H5N8 outbreaks,
only a single poultry house was found affected in each of the ﬁve affected farms, although up to ﬁve
poultry houses were present on the individual farms (Stegeman et al., 2015). Nevertheless, this only
suggests that early warning was effective and the farms were depopulated before the virus was
transferred to other poultry houses on the premises. Similar observations have been made in the
46 Including both experimental and ﬁeld data.
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turkey holding in Germany which had been affected ﬁrst during the 2014/2015 epizootic (Conraths
et al., 2016), while in the UK, on the infected duck holding, there were six sheds across two sites and
birds tested positive in three sheds on one site, with only mild clinical signs reported; therefore,
delaying the early detection and resulting in spread between the three sheds (APHA, 2014). The other
site had been previously depopulated and the carcasses were recalled as a precautionary measure.
Regarding LPAI, there is no information available.
3.5.3. Spread between farms
Interpreting AI spread between farms is difﬁcult because transmission parameters have only been
quantiﬁed during large epidemics, which creates bias in the reported data (Table G.3, Appendix G).
Information suggests similar reproduction numbers for LPAI epidemics than for HPAI epidemics and a
picture reﬂecting a lower infection rate parameter in the ﬁrst compared with the latter. However, to
enable a valid estimate of the overall spreading potential of HPAI and LPAI also the minor outbreaks,
those outbreaks affecting only one or a few holdings, should be considered. This is hampered by quick
depopulation of HPAI outbreaks (resulting from early warning because of the clear clinical
manifestation of the disease) and limited surveillance for LPAI (many outbreaks will be missed). In
addition, stamping out was applied during the HPAI outbreaks, whereas this was not applied during
documented LPAI epidemics before 2006. Consequently, transmission potential of LPAI will be
overestimated based on the published information, whereas it will be underestimated for HPAI. Kernel
estimations in the Netherlands, however, suggest a much higher potential for HPAI to spread than for
LPAI. Moreover, in a poultry-dense region in the Netherlands most between herd spread was attributed
to proximity to an infected holding and approximately 20% of the outbreaks could be attributed to
wind-borne spread (Ssematimba et al. 2013; Ypma et al., 2013). In addition, professional contacts by
visitors, feed trucks, egg collection trucks and vehicles from the rendering company proved a
signiﬁcant risk for transmission.
3.5.4. One health perspective
Human infection with AIV is mainly due to close contact with infected birds, their infectious
excretions or carcasses. Although most of the human cases identiﬁed were due to zoonotic
transmission of HPAI viruses from infected birds, the term highly pathogenic is only referring to the
pathogenicity of the virus in poultry and not related to disease severity in humans. In Europe, people
with the highest exposure are often professionals involved in identiﬁcation, analysis, culling and
destroying of infected animals as well as cleaning and disinfection of contaminated houses and
equipment. For instance, during the H7N7 outbreak in the Netherlands (2003), the virus was detected
from 89 patients: 86 humans who handled affected poultry and in three of their family members
(Fouchier et al., 2004). However, also wild bird ringers and other occupational groups with contact to
infected live or dead (wild) birds might be at increased risk of infection with avian inﬂuenza viruses.
Data on AI outbreaks, in particular on poultry holdings, need to be shared between-animal and human
health risk assessors since these data are required to assess the risk of transmission between holdings,
the exposure of humans to AIV and the possibility of virus to jump species and infect humans (De
Nardi et al., 2014). This information is also needed for risk managers to develop public health
recommendations on personal protection measures, monitoring and follow up, antiviral pre- or post-
exposure prophylaxis administration or vaccination of directly exposed persons. The occurrence of
avian inﬂuenza outbreaks needs also to be communicated with local practitioners and hospitals to raise
awareness for the initiation of testing and ruling out of avian inﬂuenza infection of exposed people
with respiratory symptoms or conjunctivitis.
Conversely, people returning from avian inﬂuenza affected countries in Asia should avoid entering
poultry holdings when having respiratory symptoms or, in general, within a 10- to 14-day period after
returning, the maximum estimated incubation period of avian inﬂuenza.
3.6. Mutation from LPAI to HPAI (TOR 7)
The HA protein is a major determinant of pathogenicity for subtypes H5 and H7 in avian hosts
(Bottcher-Friebertshauser et al., 2014). Differences in the number of basic amino acids in the
endoproteolytic CS of this protein distinguish low from highly pathogenic phenotypes. The presence of
multiple basic amino acids in the CS is strongly correlated with an increase of virulence of avian
inﬂuenza viruses of the H5 and H7 subtypes in gallinaceous hosts.
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3.6.1. Current understanding of the mechanism
Endoproteolytic processing of the HA is pivotal to render progeny virions infective. As AIV do not
encode a protease of their own, they depend on utilising host proteases. The CS of HPAI viruses of
subtypes H5 and H7 is accessible and cleavable by subtilisin-like proteases (Steinhauer, 1999; Kido
et al., 2012). The amino acid consensus motif of subtilisin-accessible CSs is –R–X–R/K–R–G, where ‘X’
stands for any amino acid except proline (P). In contrast, the CS of LPAI viruses is not accessible or
cleavable by subtilisin-like proteases. Instead, only trypsin-like proteases have been shown to process
this site, which harbours the common motif –X–X–R–G. Trypsin-like proteases are located in the
respiratory and gut-associated epithelia of the avian host. This conﬁnes productive replication of LPAIV
to these tissues and restricts replication locally. In contrast, subtilisin-like proteases are expressed by
virtually all cells of the avian host. Therefore, HPAIV replication is enabled in a systemic manner giving
rise to massive tissue damage provoking severe clinical symptoms that ultimately may lead to the
death of the infected host (Franҫa and Brown, 2014).
It has repeatedly been shown in vitro, and there is also evidence in vivo, that HPAI phenotypes can
arise de novo from LPAIV precursor viruses by mutations in the HA CS sequence (Munster et al.,
2005). In the simplest cases, two nucleotide substitutions were sufﬁcient to induce non-synonymous
mutations that generated a subtilisin-like from a trypsin-like CS motif. More often, insertional mutations
of untemplated adenosine and guanosine nucleotides at this site had caused the change in the CS
motif. It is believed that a slippage mechanism of the viral polymerase complex is at the basis of this
process as it increases the frequency of nucleotide insertion and then the acquisition of additional
codons to generate the polybasic CS. The presence of consecutive adenine residues and a stem-loop
structure, in the viral RNA region encoding the HA CS motif of inﬂuenza viruses of the H5 subtype,
have been experimentally demonstrated to play a crucial role in inducing the viral polymerase slippage
and then the acquisition of the multiple insertions required to create a polybasic CS (Nao et al., 2017).
Non-homologous recombination resulting in the insertion of a foreign nucleotide sequence into the HA
CS has been described as an additional, third mechanism for generating HPAI phenotypes. In these
(rarer) cases, all of them restricted to American viruses of the H7 subtype, small fragments of the viral
matrix gene or the viral nucleoprotein gene or the host 28S RNA were translocated by unknown
mechanisms into the CS site (Suarez et al., 2004; Pasick et al., 2005; Maurer-Stroh et al., 2013).
However, there are viral strains in which the HA CS amino acid sequence and the pheno/pathotype
did not match in the predicted way (Londt et al., 2007). Discordant results between the molecular
classiﬁcation, derived by sequencing of the HA CS, and virulence for experimentally infected chickens
have been observed in few AIVs of the H5 and H7 subtype. Two good examples for the H5 subtype
are the A/chicken/PA/1/83 (H5N2) and the A/chicken/Texas/298313/04 (H5N2) viruses. Although these
viruses contained multiple basic amino acids at the HA cleavage site that would be consistent with the
classiﬁcation as highly pathogenic AIVs, they were not virulent for experimentally inoculated chickens.
Conversely, a Chilean H7N3 HPAIV which arose by intersegmental recombination displayed basic amino
acid residues only at positions -1, -4 and -6 (PKTCSPLSRCRETR-G) (Suarez et al., 2004) but clinically
classiﬁed as HPAI.
In addition, there is experimental evidence demonstrating that the insertion of a multiple basic HA
cleavage site may not be sufﬁcient to transform all LPAIV into HPAIV, not even in H5 and H7
backgrounds (e.g. Stech et al., 2009). This indicates that virulence is inﬂuenced by further viral
determinants either in the HA (Abdelwhab and Abdel-Moneim, 2015) or beyond (Stech et al., 2015).
However, the mechanisms driving the different mutations in the ﬁeld and the reasons why HA CS
changes are restricted to the H5 and H7 subtypes remain obscure. Experimentally, the presence of a
polybasic HA cleavage site, even in non-H5/H7 HA can support a highly pathogenic phenotype in the
appropriate viral background (Veits et al., 2012). Therefore, the restriction of natural HPAIVs to certain
viruses of the subtypes H5 and H7 subtypes is likely to be a result of their unique predisposition to
acquire a polybasic HA cleavage site (Nao et al., 2017).
3.6.2. Factors that inﬂuence LPAI to HPAI mutation
Emergence of HPAI viruses in the ﬁeld appears to be a rare event. Between January 2006 and June
2016 in Europe, only nine primary HPAI outbreaks caused by viruses that had likely arisen de novo
from LPAI precursors, were reported against a number of 274 primary and secondary outbreaks of
LPAI of the H5 and H7 subtypes that had been ofﬁcially reported in the same period. Based on the
data collected from 43 HPAI outbreaks identiﬁed over 56 years from a variety of host species at a
global level and on the results of the molecular and phylogenetic characterisation of LP/HP viruses of
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the H5 and H7 subtypes, a qualitative assessment was performed to determine whether viral,
environmental and host species-speciﬁc aspects might inﬂuence LP-to-HP mutation rates. The main
outcomes are described below and the tables along with result of phylogenetic analyses are available
in Appendix H. The risk of transition from LPAIV to HPAIV is difﬁcult to assess as it depends on a large
variety of interconnected elements which comprise an unknown predisposing ‘optimal’ viral gene
constellation and a combination of host- and environmental-speciﬁc factors.
Intrinsic factors
By intrinsic factors, we refer to all the genotypic and phenotypic attributes of a virus strain that
may determine whether it has the potential to evolve from LPAI precursor to HPAI type. The
identiﬁcation of the intrinsic factors associated with the potential of a LPAI virus to evolve into a HPAI
genotype/phenotype is challenging, as it is presently restricted by the current scientiﬁc knowledge of
which exact molecular determinants are necessary for the evolution of HPAI from LPAI precursors and
by the limited awareness of the steps by which the genetic changes for HPAI emergence occur. The
most relevant intrinsic risk factor known to inﬂuence the ability of a virus to switch from a LPAI
precursor to a HPAI phenotype is its HA subtype, as to date only the H5 and H7 subtypes seem to be
prone to the incorporation of multiple basic amino acids. Of the 43 primary HPAI outbreaks that
occurred world-wide between 1959 and 2017, 15 were caused by the H5 subtype and 28 by the H7
subtype combined with different neuraminidase subtypes (see Table 1 provided by the Consortium:
Richard et al., 2017). More speciﬁcally, the HP H5 viruses were in combination with the N2 (n = 8
outbreaks), N1 (n = 4 outbreaks), N3 (n = 1 outbreak), N8 (n = 1 outbreak) and N9 (n = 1 outbreak)
subtypes. Most of the HP H7 outbreaks were combined with the N7 (n = 13 outbreaks) and N3 (n = 9
outbreaks) while combination with N1, N8, N9 and N2 subtypes seemed to be related to more unique
epidemic events. Although a different NA combination frequency has been identiﬁed, the existence of
a certain degree of association between the geographic distribution of the outbreaks and the NA
subtype (e.g. HPAI H7N7 in Europe versus H7N3 in the Americas), the lack of comprehensive
information of the NA subtype of the LPAI H5 and H7 viruses cocirculating in the regions affected by
the HP outbreaks and the scarcity of experimental evidence of the role of the HA/NA balance in the
evolution of the AI pathogenicity prevent the identiﬁcation of the NA subtype as a potential risk factor.
The LPAI precursor virus was known and available for analysis for 10 out of 41 (10/41) HP primary
outbreaks described in poultry. Comparison of the genetic changes between HPAI viruses and LPAI
precursors was carried out to evaluate whether it is possible to identify speciﬁc molecular traits that
can increase the risk of transition from LPAI to HPAI genotype/phenotype. As well, the results of the
in vitro and in vivo experiments carried out to assess the molecular changes and phenotypic markers
associated with a switch from low to highly pathogenicity in avian inﬂuenza viruses were analysed with
the same purpose (Tables 1, 2 and 3; by the Consortium: Richard et al., 2017). The main conclusion
that can be reached following these analyses is that except for the multibasic amino acids in the CS,
genetic changes for the evolution of HP viruses from LP precursor vary in type and number (from 9 to
68 substitutions/whole genome) according to the virus pair. Aside from changes at the cleavage site of
HA, mutations mainly occurred in the HA in positions adjacent or apart from the CS, including the
receptor binding site, and in the polymerase genes. M1, M2 and NEP genes turned out to be
the components with the lowest number of substitutions, so suggesting a possible marginal role in the
pathogenicity evolution of the AI pairs compared here. In the few cases in which the LPAI precursor
was known, the duration of the known circulation time of the precursor LPAI varied and ranged from
10 days to 24 months, meaning that the LP/HP switch is an unpredictable evolutionary process.
As the HA gene is the major determinant of pathogenicity in AI viruses, the last potential intrinsic
risk factor investigated was the phylogenetic relatedness of HA sequences of HP and LP viruses. 3,705
sequences of the HA gene segment of HP and LP avian inﬂuenza viruses of the H5 and H7 subtypes
were retrieved from GISAID (GISAID, 2017). Based on global phylogenetic clustering of avian inﬂuenza
viruses (Krauss et al., 2007), the downloaded sequences were divided into four distinct data sets,
namely H5 Eurasia–Africa–Oceania, H5 Americas, H7 Eurasia–Africa–Oceania and H7 Americas which
were then phylogenetically analysed to evaluate whether pathogenicity classes would correlate with
phylogenetic clustering among the AI HA genes. Phylogenetic analyses indicated that the HA genes of
HPAI H5 and H7 viruses identiﬁed over 114 years (1902–2017) from a variety of host species in
Eurasia, Africa, Australia, and North and South America do not share the same common ancestors but
fall within distinct genetic clusters with LPAI viruses identiﬁed from both domestic and wild birds
(Figures H.1–H.4, Appendix H). This suggests that the inference of phylogenetic relationships between
LPAI and HPAI cannot be used to predict whether a virus has the potential to evolve from a LPAI
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precursor to a HPAI type (Figures H.1–H.4), as it seems that HPAI viruses can emerge from genetic
clusters with a distinct evolutionary history. Three monophyletic groups of LPAI viruses (deﬁned by
long branches and posterior probabilities higher than 90) that so far never evolved into a highly
pathogenic phenotype were recognised in both the H5 and H7 phylogenetic trees: groups E5-C1, A5-C,
and A7-C1 (Figures H.1–H.4, Tables H.1–H.4). In particular, group E5-C1 contains 165 H5 viruses,
collected from 1993 to 2011 in Europe and Asia, shows only three spill overs in poultry according to
the genetic sequences available (Figure H.1, Table H.1); group A5-C consists of 338 H5 viruses, which
circulated between 2000 and 2014 in the Americas and caused only few poultry infections (8 cases)
(Figure H.2, Table H.2); group A7-C1 includes 310 H7 subtype American viruses, which spread in
poultry and wild birds in North America for 12 years (1994–2006), mainly in the State of New York
(73%) (Figure H.4, Table H.4). Based on the genetic data available, two out of the four clusters
(groups E5-C1, A5-C), entirely composed of LPAI viruses, have been mostly identiﬁed in wild birds (96–
97%) and have been only sporadically reported in poultry species. Differently the group A7-C1, despite
its extensive circulation in poultry species (68%), never switched to the HPAI form. Interestingly, the
existence of an additional monophyletic group (E7-B2) in the H7 Eurasia–Africa–Oceania phylogeny
which had been circulating for 8 years in poultry, wild birds and humans without showing the evolution
to an HP genotype needs to be highlighted. This group includes 867 low pathogenic avian viruses
which between 1999 and 2017 had only circulated in Asia (Figure H.3, Table H.3), as well, this group
also contains the zoonotic LPAI H7N9 viruses which have been circulating in China since 2013 (Su
et al., 2017). In February 2017, the emergence of HPAI H7N9 viruses was observed within this cluster,
which once again demonstrates that it is not possible to predict the risk of pathogenicity evolution
from the phylogenetic clustering. Therefore, more scientiﬁc evidence and comprehensive genetic data
from LP and HP H5 and H7 outbreaks are needed to ascertain the risk of evolution towards an HP type
for these speciﬁc LPAI clusters.
Extrinsic factors
The extrinsic factors include host species-speciﬁc and environmental aspects. This assessment has
identiﬁed a signiﬁcant gap in knowledge of the contribution of environmental and host-related items in
the emergence of HPAI viruses. So far, no transition of LPAIV to HPAIV has been clearly attributed to
any speciﬁc aspect, such as host species, host immune status, holding type, poultry density and
holding management. The role of these factors and their interaction is unclear and it seems that even
minute permutations can lead to chaotic and unpredictable effects on virus pathogenicity evolution.
First, the role of host-speciﬁc aspects was investigated. Information from 42 HPAI outbreaks
revealed that chickens and turkeys were the species in which initial detection of HPAI was most
frequently observed (81%). It is not clear whether the dominance of gallinaceous poultry in primary
cases is due to the fact that gallinaceous poultry regularly produce massive clinical signs while
waterfowl more often develop a delayed and milder course of disease; this would render HPAIV cases
in gallinaceous poultry more prone to detection by syndromic surveillance. In South Africa, H5N2 HPAI
outbreaks involving only farmed ostriches were also reported. During one of these (H5N2 in 2006) a
LPAI virus was isolated from ostriches but only after the initial detection of HPAI. As well, in 1996 in a
geese commercial holding in the Chinese province of Guangdong two different H5N1 pathotypes were
recognised, suggesting that even this species might have been involved in the pathogenicity evolution
of an avirulent virus (Abdelwhab et al., 2013). Multiple other domestic bird species other than the
three described have been affected in secondary outbreaks: duck, guinea fowl, Chukar partridge, emu,
pigeon, pheasant and quail. Viruses of the H5 or H7 subtype isolated from wild birds are almost
invariably LPAI in poultry. With the exception of a large die-off of terns in South Africa which had
occurred in 1961 (Becker, 1966) and from which A/tern/South Africa/61 (H5N3) was isolated and of a
molecular-based identiﬁcation of an HPAI H5N2 virus in healthy wild birds in Nigeria in 2007 (Gaidet
et al., 2008), HPAI virus isolations from wild birds have been associated to contacts with infected
poultry, usually as a result of surveillance of birds trapped or found dead in infected poultry holdings.
More speciﬁcally, the species in which the switch from LPAI to HPAI had occurred was known only in
10 out 42 outbreaks, and chickens turned out to be the most widely affected group (no of outbreaks
8) followed by turkeys (no of outbreaks 2).
For the age of the animals, LPAI to HPAI switch or primary outbreaks were detected in breeders,
broilers, laying hens, in meat and breeder turkeys. Although it has been shown that younger animals
are the most susceptible to HPAI infections, which could give a selective advantage to HPAI over LPAI,
there is no information from the ﬁeld suggesting that a LPAI/HPAI switch occurs preferentially in
younger animals. During one outbreak (Canada H7N3 2004), LPAI virus was isolated from older ﬂocks
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 53 EFSA Journal 2017;15(10):4991
(52 weeks of age) 10 days before HPAI was isolated from younger ﬂocks (24 weeks of age) (Pasick
et al., 2007). On the other hand, all the ﬁve European H7 HPAI outbreaks which have occurred since
2009 have involved layer hens; in four out of ﬁve cases this poultry category has been identiﬁed as the
one where transition of LPAI viruses to HPAI phenotypes occurred.
Initial HPAI outbreaks were recorded in industrial, free-range and backyard holdings. There was
therefore no correlation between the size of the holding or the poultry density and the emergence of
HPAI viruses. However, an in-depth analysis of the 10 outbreaks for which the species involved in the
LPAI to HPAI switch was known revealed that all the holdings except for one (South Africa H5N2 in
ostriches) were characterised by a high poultry density in the affected holding. In addition, there was
a strong positive correlation between the number of subsequent outbreaks and the poultry industry
density in the affected geographic area (i.e. Italy in 1999–2000; Capua and Marangon, 2000), the
Netherlands in 2003 (de Jong et al., 2009)). Therefore, poultry holding density should be considered a
major contributing factor for the appearance of HPAI epidemics with a large effect.
The involvement of wild birds in these outbreaks was often unknown. During the H7N7 outbreak
which hit the UK in 1979, wild birds were observed to be feeding on holdings due to the harsh winter
conditions (Alexander and Spackman, 1981). In the H7N7 outbreak in 1985 in Australia, free-living
starlings also were affected, likely as a result of a spill-over of the virus from poultry (Barr et al.,
1986). In the H5N2 outbreak in South Africa, wild birds were observed to accumulate at ostrich
holdings around watering troughs and feeders (Abolnik et al., 2009). Epidemiological data and the
characteristics of the virus detected during the Italian HP H7N7 avian inﬂuenza epidemic in 2013
showed that the introduction in the ﬁrst affected layer holding was due to contacts between free-
range hens and wild waterfowl (Bonfanti et al., 2014). In the H5N1 outbreaks which had started in
1996 and soon spread world-wide, the long-distance spread of the virus from Asia westwards after a
spill-over of the virus from poultry (Keawcharoen et al., 2008) was ascribed to wild birds. A similar
mechanism was found to occur in the H5N8 outbreaks in 2014 and 2016 (Lycett et al., 2016).
As free-range and outdoors holdings are known to be more exposed to the risk of AIV introduction
through wild birds and considering that any introduction of H5 or H7 LPAI viruses could, according to
the presently available data, result in a pathogenicity transition, these types of poultry holdings could
be considered at a higher risk of being involved in HPAI transition events. As a matter of fact, in four
out of the ﬁve H7 HPAI outbreaks which have occurred in Europe since 2009, the poultry holdings
initially involved had outdoor access.
Mechanisms by which HPAI variants that emerged from LPAI precursors successfully compete with,
gain ground and ﬁnally prevail in populations infected with the LPAIV precursor remain elusive. Faster
transmission of HPAIV as indicated by increased infection rate parameters, (b, the average number of
secondary cases caused by one infectious individual per day) may play a role (see Section 3.5.1).
3.7. HPAI and LPAI surveillance
3.7.1. Surveillance components
The surveillance system for AI in the EU consists of three mandatory components: (1) passive
poultry surveillance, (2) active poultry serosurveillance and (3) passive wild bird surveillance. In
addition, three voluntary components can be implemented: (1) testing to exclude (TTE)47 notiﬁable
avian disease, (2) poultry production parameter monitoring and (3) active wild bird surveillance. A
description of the surveillance system is provided in Section I.1 (Appendix I). The text below describes
the results of the analysis of the current serosurveillance in gallinaceous and anseriforme poultry, and
HPAI surveillance in wild birds.
47 TTE is a surveillance component designed to complement existing passive notiﬁable surveillance. It allows a PVS to send
samples to either private or public laboratories to exclude the presence of notiﬁable avian disease without notifying at the
competent authority. This can only be done where the PVS does not formally suspect notiﬁable disease otherwise the
conventional passive notiﬁable cascade must be carried out. It should also be used with caution when the risk of avian
inﬂuenza incursion into poultry premises is high, for example during an HPAI epizootic in that country or in contiguous
countries. More information is provided in Section I.1.2.
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3.7.2. Current HPAI serosurveillance in gallinaceous and Anseriformes poultry
3.7.2.1. Gallinaceous poultry
In gallinaceous birds, the value of serosurveillance to detect HPAI is extremely low. The very high
mortality associated with HPAI in chickens and turkeys is quickly noticed by the poultry keeper and will
almost always result in quick detection by passive surveillance (notiﬁcation). In addition, most birds die
before developing detectable antibodies due to the high case fatality rate. The acute nature of the
disease also limits the utility of production parameters, such as drop in feed consumption, water
consumption or egg production, for syndromic surveillance. A steep rise of mortality is by far the most
prominent sign that is obvious to farmers and veterinarians. Compulsory notiﬁcation in situations when
more than 2% of the birds on a farm die within two days has been implemented previously
(Commission Decision 2005/734/EC). However, in large farms with multiple poultry houses, this
threshold is likely too high (e.g. on a 100.000 chicken farm the threshold would be 2,000 dead birds)
and a legislative threshold might prevent poultry keepers from reporting before the threshold is
reached. Establishing the threshold per house may be more effective, although compliance is more
difﬁcult to control. The effectiveness of TTE has not been properly evaluated, however, it is considered
useful in areas at risk of HPAI incursion. It should not be used when there is HPAI suspicion, or when
HPAI has already been introduced into the area. In the latter case, TTE could lead to a delay in
diagnosis as the laboratories will test samples from suspected holdings with higher priority.
3.7.2.2. Anseriforme poultry
Duck and geese holdings are present across most of the EU although the density varies a lot
(Figure I.1, Appendix I). HPAI incursion into dense areas of anseriforme poultry production is a threat
as these species are related to the migratory waterfowl. This genetic similarity may mean that any
HPAIV adapted to these migratory waterfowl is likely to be efﬁcient in its transmission to anseriforme
poultry. In addition, this adaptation may also lead to infection with a limited clinical response hindering
detection through passive surveillance. If disease remains undetected, it may spread to contiguous
holdings via direct movement of live birds, indirect spread through personnel, machinery or equipment
or via other fomites. This may be accentuated by farming practices that cause signiﬁcant movement of
poultry populations as with duck gavage feeding, where mixing of infected ﬂocks with other
susceptible poultry populations might occur.
These farming practices are likely to have played an important role in the French H5 episode in
2015/2016 which showed signiﬁcant undetected spread of HPAI in duck populations in the south-west
of the country. Initial detection of HPAI was in a chicken farm where it was associated with signiﬁcant
mortality before other outbreaks were detected in ducks, geese and guinea fowl. The level of spread
(over 80 premises infected with HPAI) found after further investigations suggested that the original
infection was unlikely a recent exposure. In the 2016/2017 H5 (clade 2.3.4.4b) HPAI epizootic, this
same population was again infected alongside similar populations in Hungary and Bulgaria using similar
farming practices.
The 2016/2017 H5 HPAI (clade 2.3.4.4b) epizootic was associated with clear clinical signs and high
mortality in most affected holdings, in contrast to the 2014/2015 H5 HPAI (clade 2.3.4.4a) and the
French 2015/2016 H5 HPAI epizootics. As a result, there were high numbers of detections made by
passive surveillance in anseriforme and game bird holdings during the 2016/2017 HPAI epizootic
(Figure 10; see also EFSA scientiﬁc report 2017b).
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Serological Surveillance
MSs carry out serological surveillance on a proportion of their poultry population according to EU
legislation and the surveillance programme that they submit to the European Commission.
Serosurveillance does not only detect prior exposure to HPAI viruses, but also to H5 and H7 LPAI
viruses. The submitted programme can be risk-based based on poultry demographics, proximity to
waterbodies, production type/biosecurity level, trade, timing of sampling and reactive sampling (see
Section I.1.4, Appendix I). Sampling carried out on ducks and geese between 2014 and 2016 can be
found in Figure 11, while sampling carried out on game birds (both gallinaceous and anseriforme) over
the same time period can be found in Figure 12.
Figure 10: HPAI virus detected in Anseriformes and game birds during the 2016/2017 H5 HPAI (clade
2.3.4.4b) epizootic
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Figure 11: Active serological surveillance in duck and geese holdings samples between 2014 and 2016
Figure 12: Active serological surveillance in game bird holdings samples between 2014 and 2016
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 57 EFSA Journal 2017;15(10):4991
The majority of sampling carried out is representative of the underlying demographics. Risk-based
surveillance is useful as it targets ﬂocks where the risk of AI introduction is considered to be most
likely, although its application varies with regards to their application of the risk factors and how they
are weighted. The scientiﬁc evidence about individual risk factors is limited regarding what factors are
important and is mostly not quantitative in nature. Quantitative information is mostly restricted to
speciﬁc situations in single MS, which is often not available or applicable to other MSs and the EU
level. Therefore, availability of speciﬁc advice as to the quantitative weighting of risk factors in
particular countries is very limited. The lack of quantitative weighting information also hampers the
comparison of surveillance results between MSs. Reporting quantitative information on the weighting
factors used by MSs in relation to the available scientiﬁc evidence is needed to better understand how
risk-based surveillance is implemented and will subsequently help to improve the risk-based approach
and comparison between MSs.
Serological Surveillance Positives
Results of the active annual serological surveillance programme from 2014 to 2016 show that
anseriforme poultry have more often been found AI seropositive (HI test) than gallinaceous poultry,
with farmed anseriforme game birds particularly affected. See Table 9 for a complete breakdown of
serological survey results across the EU.
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Table 9: Active serological surveillance of AI (number of holdings) in the EU by poultry category (data reported to EURL)
Category species
Category
type
2014 2015 2016 Total Proportion
positive
(2014–2016)Sampled Positive Sampled Positive Sampled Positive Sampled Positive
Fattening ducks A 619 14 971 26 999 22 2,589 62 2.4%
Fattening geese A 333 2 498 7 459 8 1,290 17 1.3%
Duck breeders A 252 7 330 6 632 74 1,214 87 7.2%
Farmed game birds (waterfowl) A 234 0 342 11 196 69 772 80 10.4%
Geese breeders A 208 10 296 23 265 19 769 52 6.8%
Farmed game birds (gallinaceous) A* 992 0 930 14 896 15 2,818 29 1.0%
Chicken breeders G 3,145 2 5,702 6 2,661 7 11,508 15 0.1%
Laying hens G 3,888 3 3,747 8 3,480 7 11,115 18 0.2%
Backyard ﬂocks G 2,619 0 2,341 5 2,493 2 7,453 7 0.1%
Fattening turkeys G 2,254 0 2,443 16 2,144 12 6,841 28 0.4%
Free-range laying hens G 1,782 5 2,884 10 1,812 13 6,478 28 0.4%
Broilers (at heightened risk) G 1,045 0 1,238 1 1,193 0 3,476 1 0.0%
Turkey breeders G 181 0 215 4 232 1 628 5 0.8%
Free-range laying hens G 0 0 0 0 219 5 219 5 2.3%
Others O 1,278 3 1,343 19 942 12 3,563 34 1.0%
Ratites O 141 1 195 2 138 4 474 7 1.5%
Category type: (A: Anseriforme poultry, G: Gallinaceous poultry, O: Others).
A*: While this category explicitly states gallinaceous poultry, their method of husbandry and their close contact with wild birds may attenuate clinical signs and are therefore categorised as
anseriforme poultry.
Nb. Sampling is not uniform across all EU MSs, MSs can choose to use either representative or risk-based sampling under EU legislation.
Samples were tested using the hemagglutination-inhibition (HI) assay in accordance with the Diagnostic Manual for avian inﬂuenza, which lays down the procedures for conﬁrmation and
differential diagnosis of avian inﬂuenza (Commission Decision 2006/437/EC).
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The distribution of game bird holdings, which can include both anseriforme and gallinaceous
poultry, across the EU can be found in Figure I.2 (Appendix). Gallinaceous game birds may not always
show high mortality and present clinical signs typical for HPAI in gallinaceous poultry (e.g. chickens
and turkeys). The reason is that they are generally kept in close contact with wild birds and
consequent exposure to LPAIV present in these populations. The resulting immune response may, in
some cases, attenuate clinical disease manifestation of HPAI in the holding.
From the above, it can be concluded that for Anseriformes, notiﬁcation based on passive
surveillance is less effective than for gallinaceous birds, and that serosurveillance in Anseriformes could
be an effective complementary method to passive notiﬁable disease surveillance to detect HPAI,
provided adequate follow up of positive ﬁndings. In the absence of such follow-up, HPAIV circulation
among Anseriformes can be prolonged as was shown in France 2015/2016 (Annex A). In addition to
serosurveillance, regularly testing of anseriform birds that died during the production period (bucket
sampling) for the presence of virus might prove useful to detect HPAI. Pooling of such samples for
polymerase chain reaction (PCR)-directed diagnosis may be useful. Although, HPAI may not induce
clear clinical signs in anseriform birds, in combination with other infections present on the farm it
might result in dead birds.
3.7.3. Analysis of the current HPAI surveillance in wild birds
Passive wild bird surveillance includes dead birds being reported to the veterinary authorities that
are subsequently tested for HPAI virus. The intensity of reporting (e.g. numbers of birds found dead)
differs between MSs or even between regions in a MS.48 The effectiveness of passive surveillance
highly depends on the mortality associated with HPAI in wild birds, which has differed considerably
between the outbreaks in Europe. During the HPAI H5N1 epizootic in 2005/2006, passive surveillance
clearly demonstrated virus spread in the wild bird population as considerable numbers of dead birds
were found H5N1 infected (Bragstad et al., 2007). The 2014/2015 HPAI H5 (clade 2.3.4.4a) epizootic
presented itself, however, without noticeable mortality in wild birds. The 2016/2017 H5N8 (clade
2.3.4.4b) epizootic was associated with large numbers of birds found dead in many different regions
and including many different species. Based on the wild bird HPAI ﬁndings during these epizootics, a
predictive risk map was created using a logistic regression model analysing the relationship between
reported wild bird events and environmental factors (Figure 13; see Section 2.7).
In total, here have been 2,961 birds reported to be positive (on a total of 158,361 tested via
passive surveillance) with HPAI between 2006 and April 2017 (Table 10), including 2,099 (70.9%)
during the H5 H5Nx HPAI (clade 2.3.4.4b) epizootic in 2016–April 2017. From 2006 to April 2017,
HPAIV was detected in 1.9% of the birds submitted to the NRLs as part of passive surveillance for
avian inﬂuenza in the EU.
Active surveillance of clinically healthy wild birds was a legislative requirement for MSs from 2006 to
2010. Since June 2010, there is no longer an EU legislative requirement for MSs to test clinically
healthy wild birds. Early positive ﬁndings in the 2014/15 HPAI H5 (clade 2.3.4.4a) epizootic resulted
from active surveillance, although the absolute number was very low in comparison to the number of
tested samples (3/5194 birds were found positive for H5 HPAI through active surveillance under the
EU surveillance programme between October and December 2014). LPAIV surveillance in the
Netherlands demonstrated a disconnect between wild bird ﬁndings and ﬁndings in poultry (Verhagen
et al., 2017). Overall, in active surveillance, 94 birds have been reported positive with HPAI between
2006 and April 2017 (Table 11), 50 of these were during the H5 H5Nx HPAI epizootic in 2016–2017. In
relation to the number of submitted samples, this corresponds to an HPAI positive proportion of
0.03% of all submitted samples.
To increase the efﬁciency of active surveillance, the sampling strategy should be guided by better
knowledge of the epidemiology of HPAI in wild birds. This would require an in depth analysis of the
dynamics in space and time of the HPAI wild bird data, including affected species, indicated above. In
addition, it is recommended to implement targeted active surveillance at epidemiologically important
sites where bird populations are studied intensively. There is a need to combine an HPAI test result
with information of the bird sourcing the sample (e.g. place in the wild bird contact network), as this
will allow virus dynamics in wild bird populations to be better understood, which is essential to
designing more efﬁcient active wild bird surveillance programmes. Serological surveillance could play a
48 For instance, during the 2016/2017 epidemic, some MSs stopped reporting the number of wild birds found dead within an
area where an infected wild bird was detected and hence considered affected.
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valuable role in informing which wild bird species are more likely to be infected and shed HPAI, and
even particular clades of H5 HPAI virus. Instead of active wild bird surveillance across the EU (as done
in the past), a few priority locations within the EU could be identiﬁed (e.g. based on Figure 13) to
implement targeted wild bird surveillance combining active virology tests (swabbing) with enhanced
passive surveillance. The latter could for instance be done by lowering thresholds that MSs (e.g. the
UK) have in place to ensure that laboratories are not ﬂooded with samples or by implementing
additional patrols to increase the likelihood of ﬁnding dead wild birds (as done by France during winter
2016/2017). Targeting efforts at a few priority locations may detect the presence of circulating AIV,
when infection prevalence and sample sizes are sufﬁcient, when these do not cause massive mortality
among these birds. It would be useful to implement such a targeted approach in the EU (near the
borders) and at global level, making the results available to the international community. Such a
strategy should be well coordinated since it should combine research objectives with fast reporting of
positive ﬁndings, allowing risk managers to increase preparedness.
Figure 13: Relative risk map of predicted highly pathogenic avian inﬂuenza (HPAI) H5 occurrences in
wild birds in Europe based on wild bird events reported in Europe between 2005 and
2017, and using the methodology as described in Si et al., 2010 (see Section 2.7)
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Table 10: Results of active wild bird surveillance January 2006–April 2017
Country
Total
sampled
Negative
HPAI
(% of
sampled)
ALL LPAI
(% of
sampled)
H5
LPAI
H7
LPAI
Notiﬁable
LPAI (% of
sampled)
Non-
notiﬁable
LPAI
Unknown
pathotype
(% of sampled)
Austria 5,598 5,396 2 (0.04) 45 (0.80) 34 10 44 (0.79) 1 138 (2.47)
Belgium 32,891 31,473 0 (0.00) 378 (1.15) 20 13 33 (0.10) 345 897 (2.73)
Bulgaria 538 533 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 5 (0.93)
Cyprus 606 602 0 (0.00) 4 (0.66) 0 0 0 (0.00) 4 0 (0.00)
Czech Republic 2,156 1,977 0 (0.00) 179 (8.30) 16 0 16 (0.74) 163 0 (0.00)
Denmark 16,032 15,475 1 (0.01) 468 (2.92) 81 18 99 (0.62) 369 75 (0.47)
Estonia 505 503 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 2 (0.40)
Finland 1,113 1,037 4 (0.36) 61 (5.48) 1 1 2 (0.18) 59 6 (0.54)
France 10,715 9,369 0 (0.00) 428 (3.99) 100 18 118 (1.10) 310 514 (4.80)
Germany 83,610 82,267 43 (0.05) 168 (0.20) 95 6 101 (1.12) 67 749 (0.90)
Greece 1,782 1,778 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 4 (0.22)
Hungary 11,766 11,715 0 (0.00) 51 (0.43) 19 0 19 (0.16) 32 0 (0.00)
Ireland 1,146 1,125 0 (0.00) 4 (0.35) 2 0 2 (0.17) 2 12 (1.05)
Italy 19,862 19,418 0 (0.00) 107 (0.54) 14 11 25 (0.13) 82 204 (1.03)
Latvia 2,797 2,645 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 133 (4.76)
Lithuania 2,497 2,301 0 (0.00) 108 (4.33) 0 2 2 (0.08) 106 88 (3.52)
Luxembourg 832 832 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Malta 8 8 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Netherlands 57,431 53,353 0 (0.00) 2,778 (4.84) 57 21 78 (0.14) 2,700 1,229 (2.14)
Poland 9,330 9,239 34 (0.36) 22 (0.24) 4 0 4 (0.04) 18 35 (0.38)
Portugal 4,262 4,238 0 (0.00) 24 (0.56) 13 3 16 (0.38) 8 0 (0.00)
Romania 4,297 4,297 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Slovakia 557 551 2 (0.36) 4 (0.72) 0 2 2 (0.36) 2 0 (0.00)
Slovenia 1,405 1,351 0 (0.00) 7 (0.05) 1 0 1 (0.07) 6 47 (3.35)
Spain 30,239 30,153 0 (0.00) 24 (0.08) 4 9 13 (0.04) 11 29 (0.10)
Sweden 12,332 11,848 8 (0.06) 270 (2.19) 136 7 143 (1.16) 127 206 (1.67)
Switzerland 416 413 0 3 0 0 0 3 0
United Kingdom 16,612 16,453 0 (0.00) 21 (0.13) 17 0 17 (0.10) 4 89 (0.54)
Total 331,335 320350 94 (0.03) 5,154 (1.56) 614 121 735 (0.22) 4,419 4,462 (1.35)
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Table 11: Results of passive wild bird surveillance January 2006–April 2017
Country
Total
sampled
Negative
HPAI
(% of
sampled)
ALL LPAI
(% of
sampled)
H5 LPAI H7 LPAI
Notiﬁable
LPAI (% of
sampled)
Non-
Notiﬁable
LPAI
Unknown
pathotype
(% of sampled)
Austria 7,709 7283 284 (3.68) 9 (0.12) 3 1 4 (0.05 5 131 (1.70
Belgium 1,863 1,769 6 (0.32) 45 (2.42) 1 0 1 (0.05) 44 43 (2.31)
Bulgaria 530 507 22 (4.15) 0 (0.00) 0 0 0 (0.00) 0 1 (0.19)
Croatia 197 178 18 (9.14) 1 (0.51) 0 0 0 (0.00) 1 0 (0.00)
Cyprus 1,499 1,481 0 (0.00) 18 (1.20) 0 0 0 (0.00) 18 0 (0.00)
Czech Republic 3,905 3,831 66 (1.69) 4 (0.10) 0 1 1 (0.03 3 0 (0.00)
Denmark 2,090 1,952 44 (2.11) 7 (0.33 0 1 1 (0.05) 6 20 (0.96)
Estonia 125 125 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Finland 1,324 936 17 (1.28) 3 (0.23) 0 0 0 (0.00) 3 368 (27.79)
France 6,308 5,934 145 (2.30) 88 (1.40) 12 7 19 (0.30) 69 77 (1.22)
Germany 57,031 54,846 1,485 (2.60) 33 (0.06) 22 2 24 (0.04) 9 563 (0.99)
Greece 1,559 1,543 12 (0.77) 0 (0.00) 0 0 0 (0.00) 0 4 (0.26)
Hungary 9,320 9,223 37 (0.40) 21 (0.23) 3 0 3 (0.03) 18 2 (0.02)
Ireland 1,957 1,862 12 (0.61) 0 (0.00) 0 0 0 (0.00) 0 5 (0.26)
Italy 12,099 12,036 25 (0.21) 16 (0.13) 0 1 1 (0.01) 15 12 (0.10
Latvia 198 194 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Lithuania 976 961 13 (1.33) 1 (0.10) 0 0 0 (0.00) 1 1 (0.10)
Luxembourg 544 543 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 1 (0.18)
Malta 19 19 0 (0.00) 0 (0.00) 0 0 0 (0.00) 0 0 (0.00)
Netherlands 11,862 11,821 13 (0.11) 20 (0.17) 1 0 1 (0.01) 19 7 (0.06)
Poland 1,779 1,631 143 (8.04) 2 (0.11) 0 2 2 (0.11) 0 2 (0.11)
Portugal 2,566 2,559 1 (0.04) 5 (0.19) 0 0 0 (0.00) 5 0 (0.00)
Romania 2,082 1,900 177 (8.50) 2 (0.10) 2 0 2 (0.10) 0 3 (0.14)
Slovakia 2,396 2,309 82 (3.42) 4 (0.17) 0 0 0 (0.00) 4 1 (0.04)
Slovenia 2,417 2,175 217 (8.98) 2 (0.08) 1 1 2 (0.08) 0 22 (0.91)
Spain 7,112 7,052 3 (0.04) 20 (0.28) 6 1 7 (0.10) 13 16 (0.22)
Sweden 3,133 2,985 113 (3.61) 8 (0.26) 4 0 4 (0.13) 4 7 (0.22)
Switzerland 466 347 10 (2.15) 0 (0.00) 0 0 0 (0.00) 0 109 (23.39)
United Kingdom 15,295 15,195 16 (0.10) 3 (0.02) 2 0 2 (0.01) 1 69 (0.45)
Total 158,361 153,197 2,961 (1.87) 312 (0.20) 57 17 74 (0.05) 238 1,464 (0.92)
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3.7.4. Analysis of the current H5 and H7 LPAI surveillance in poultry
Current H5 and H7 LPAI serosurveillance, when conducted as representative rather than risk-based
sampling, has been designed to detect serological evidence of LPAIV in a country or region when the
percentage of seropositive farms is at 5% or higher (with 95% conﬁdence in some poultry types and
99% conﬁdence in others) (Commission Decision 2010/367/EU). Consequently, in combination with H5
and H7 LPAI outbreak reports, it provides a year to year snapshot of the regional/national LPAI
situation, can demonstrate LPAIV farm seroprevalence to be below 5% and would detect major
changes in LPAIV trends across years. Comparisons of the positive ﬁndings between MSs are limited
because of differences in the national surveillance programmes (such as variation in: sampling frame
strata, random or non-random selection of holdings to sample within strata, temporal variation in
sampling, and ambiguities in reporting of denominator population data) (Gonzales et al., 2010). Some
countries test more than the EU requirements, resulting in a higher likelihood of ﬁnding seropositives
(e.g., IT, NL). In addition, legislation allows a risk-based implementation of surveillance, which was
implemented by 10 MS49 in 2014 (APHA, 2015). The chosen risk-based approaches differ between
countries (e.g. some may emphasise free-range chickens, others waterfowl) and the weighting of the
risk factors lacks underlying quantitative evidence, resulting in limited value in making comparisons of
surveillance results.
It can be argued that LPAI surveillance provided advance warning of H5 LPAIV circulation in French
duck ﬂocks over several years (Annex A). Although LPAI surveillance can show major changes in LPAIV
prevalence over the year or indicate the LPAIV level at regional level, it is not effective for ‘early
warning’ of LPAIV infections at the holding level or detection before mutation to HPAI takes place. The
reasons are that according to the legislation (1) only a sample of farms is tested, (2) a relatively small
number of birds within a ﬂock is tested, (3) tested farms are tested only once in a year and (4) the
assay tests for antibodies that are only detectable when most virus shedding of the bird has been
taken place (Gonzales et al., 2014). Consequently, at the time of seropositive detection, most virus
production in a ﬂock has already taken place. The latter is supported by the observation that upon a
seropositive ﬁnding, when samples are collected for virus detection, a minority of the farms turns out
positive in PCR. Even in the Netherlands where all farms are tested and free-range farms even four
times a year, most attempts fail to detect virus in seropositive farms. Also in cases where egg yolk is
used to detect antibodies in a continuous ﬂow, infected farms will on average be detected after the
peak of virus production has taken place (Gonzales et al., 2014). Only a detection strategy based on
adequate real time monitoring of production parameters (Gonzales et al., 2012a,b) or notiﬁcation of
mild clinical disease would have the potential for early detection of individual outbreaks. Nevertheless,
because a drop in production and mild disease may be caused by many diseases other than LPAI, the
speciﬁcity of such a system would be very low, resulting in many false alarms. In addition, in domestic
waterfowl a drop in production parameters may be absent upon LPAI infection.
It is highly likely that most LPAIV outbreaks in the EU are not detected because of the small
proportion of farms that are tested using active surveillance and the low sensitivity of passive
surveillance due to the mild clinical signs. From the reasoning above, it can be concluded that it is not
possible to design a surveillance programme for early detection of individual LPAI outbreaks that is
practically feasible. LPAIV outbreaks often do not result in secondary spread, as was for example
demonstrated for laying hens in the Netherlands (Gonzales et al., 2014); infection fades out without
any control measure being implemented. Nevertheless, LPAIV infections may result in secondary
spread, as was shown in turkeys in Italy (Comin et al. 2012) and Germany (personal communication
T. Harder, September 2017), ducks in France, and laying hens in poultry dense regions (Gonzales
et al., 2014). In those situations, major LPAI epidemics can arise, associated with continued virus
replication with a continued risk of virus mutation to HPAIV. Consequently, a surveillance programme
focussing on detecting clusters of connected LPAI outbreaks would be essential to curtail further LPAIV
spread. Although such a surveillance strategy does not guarantee detection before LPAIV has mutated
to HPAIV (see Section 3.6), the French HPAI epidemic in 2015/16 (Annex A) and the Italian H7N1
1999/2000 epidemic (Capua et al., 2003) have shown that continued LPAIV spread can eventually
result in a HPAI epidemic. Because the effectiveness of detecting clusters of LPAIV outbreaks depends
on the spread of LPAIV between farms, no single design surveillance programme can be developed for
the whole of the EU. A risk-based approach is required that at least takes into account poultry species,
production type and density of poultry ﬂocks. Therefore, there is a need to collect robust data on
49 BE, BG, DE, FI, FR, IT, LI, the NL, RO, the UK.
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poultry populations across the EU. Based on, for example, the available control measures, this would
enable development of the design prevalence (maximum number of LPAI-infected farms before
detection in a region). Once this number is determined and the number of farms in the region is clear,
the number of herds to be sampled can be determined. However, in case of positive ﬁndings, follow-up
is necessary to ﬁnd out whether this is an individual seropositive farm or a cluster of positive farms. AI
surveillance planning and follow up should be based on the local situation but reporting should allow
analysis and comparison across MSs.
To optimise detection of circulating AI viruses in the EU, the following improvements of annual
surveillance are suggested:
• Focus testing on Anseriformes as they have a much higher risk of AI introduction and
serosurveillance might in addition to LPAIV detect circulation of HPAI viruses that do not evoke
clear clinical signs in Anseriformes. Testing should be done at least once a year during a
production stage where subsequent virus testing of the same ﬂock is still possible;
• Holdings repeatedly positive (consecutive years) should apply a strict holding-speciﬁc
biosecurity plan to reduce the risk of virus introduction and transmission and also should apply
bucket sampling during the production rounds until they are again negative;
• During high-risk periods (AI in the region), bucket sampling should be applied on holdings with
Anseriformes;
• Collect robust data on populations (numbers of holdings/birds per species/production type and
their location);
• Harmonise the interpretation of deﬁnitions (e.g. risk factors, data variables) to improve
reporting and subsequent analysis;
• Make annual reporting of results more user-friendly;
• Reporting of quantitative data regarding the used risk-based approach would facilitate analysis
of the results and to make progress on developing the methodology.
3.8. Early detection of HPAI (TOR 2)
Early detection of HPAI in gallinaceous species relies on notiﬁcation of clinical suspicion. For
Anseriformes species, the sensitivity of ‘notifying clinical suspicions’ as a mechanism for early detection
might be low for some HPAIV lineages. Subclinically infected domestic Anseriformes have a higher
likelihood of continued spreading of HPAIV when compared with clinically infected gallinaceous birds.
As a consequence, expanding early detection of HPAI in Anseriformes using serological surveillance
and bucket sampling may help to timely detect and curtail HPAI in Anseriformes. More information is
provided in Section 3.7 since early detection is related to surveillance.
3.9. Biosecurity to prevent HPAI and LPAI entry and spread (TOR 2,4)
This chapter gives overall recommendations on biosecurity measures, however holding-speciﬁc
guidance is very important since every holding is unique and might require speciﬁc adaptation of
otherwise generic rules. Identifying the weak biosecurity points of a holding is essential as these
determine in a chain of measures the overall biosecurity level of a holding. Advising personnel how to
strengthen biosecurity in practice and generating awareness on the importance of sustained
implementation will result in augmented biosecurity.
Commercial chicken production with only indoor housing
The most feasible, sustainable and efﬁcient measure to reduce the risk of AI entry into indoor
commercial chicken holdings is preventing wild bird access to poultry, in particular by making the
housing wild bird proof (Figure J.2, Appendix J). Protection against faecal droppings from ﬂying wild
birds is also an additional measure, in particular faecal dropping that rinses from the roof or are
washed down after rainfall and enters the house through the ventilation or drain inlets. Other
measures with a high feasibility and sustainability are separation of waterfowl from other poultry
species and providing potable drinking water instead of untreated surface water. Clearly, these
measures can be achieved with a single one-off investment, and further on require limited efforts to
sustain. The implementation of a hygiene lock (a separate distinct secondary doorway with a hygiene
barrier for entry of people and equipment) for each poultry house, restricting access to the birds and
biosecurity training for staff have the second, third and fourth highest rank for effectiveness to prevent
AIV entry, respectively, although their feasibility and sustainability are scored lower. This suggests that
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adapting (routine) human behaviour is important to reducing the risk of virus entry into a poultry
holding, although it is difﬁcult to sustain raised awareness and alertness over a long period. However,
it should be noted that biosecurity has is also relevant to other hazards in addition to AIV and hence
should be implemented in routine practices where possible. In particular biosecurity training was
considered very useful as it will teach people to understand the main risks, which is a ﬁrst step
towards effective risk mitigation. It is recommended that professional staff on poultry holdings attend
general biosecurity trainings but also that they receive holding-speciﬁc biosecurity advice, ideally from
an expert (e.g. veterinarian) familiar with the particular holding to explain the practical implementation
in the daily working environment. The 2016–2017 epidemics increased the awareness of professional
staff across the EU of the risk of AIV entry whereas knowledge on the risk of AIV spread via fomites
and equipment seems to be limited still.
The highest ranked measures to prevent spread of the virus are to contain poultry and fomites (i.e.
those that were in contact with poultry) during transport, cleaning and disinfection of equipment,
biosecurity training, cleaning and disinfection of transport vehicles, and use of a hygiene lock for each
poultry house. When deﬁning a biosecurity plan for a holding, biosecurity measures reducing the
contact rate with AIV should be combined with measures reducing the virus quantities. These
measures should also be implemented in disease-free time to prevent unnoticed AIV spread, in
particular in Anseriformes ﬂocks.
Commercial chicken production with outdoor access
The outcome of the ranking exercise indicated that restricting access and providing biosecurity
training are the most feasible, sustainable and efﬁcient measures to reduce the risk of AI entry and
spread in commercial holdings where chickens have access to outdoor areas (Figure J.3, Appendix J).
A hygiene lock for each production unit has the highest rank for preventing AIV entry and the second
highest rank for preventing spread, but its feasibility and sustainability are ranked considerably lower.
All experts agreed that the effectiveness of biosecurity measures is in general much lower when
poultry have outdoor access compared with indoor only housing. Therefore, in high-risk periods, the
ﬁrst recommendation is to restrict outdoor access as much as possible. In case it is not possible to
conﬁne all domestic birds, it is recommended to reduce the size of the outdoor area. Increasing
poultry density in the remaining area is one way to make the environment less attractive to wild birds.
Preventing direct contact between wild birds and poultry is also considered highly effective to reduce
the risk of AIV entry. The use of netting50 is considered useful by experts and feasible as it is already
implemented for instance in fruit orchards. Installing horizontal protection (e.g. a roof or canvas) is
also useful, certainly in part of the outdoor area (i.e. where feed and water are provided if this cannot
be performed indoors). Making the area around the holding (where possible) unattractive to wild birds
prevents against roosting and nesting nearby. Furthermore, grass on the holding must be kept cut
(wild birds eat grass seeds, forage in long grass) and fallen fruit should be removed around the
holding. Placing ﬂashing or rotating lights or using acoustic devices at the entry points will deter wild
birds from entering, but rotation is needed since wild birds will quickly get used to these. Anseriformes
should be strictly separated from Galliformes.
Commercial production of turkeys and Anseriformes
Ranking the biosecurity measures for commercial turkey or Anseriformes production would have a
similar outcome as that described above for chickens. A few points related particularly to biosecurity in
keeping turkeys and ducks are explained below.
As already described in the Statement on AI (EFSA, 2017a), turkey holdings may be at higher risk
than chicken farms for AI introductions because of the constant need for introduction of clean bedding
during the production cycle of turkeys and their high ventilation requirement (Mendes et al., 2013).
The most critical point is the way bedding material is brought in. Especially in regions with high
numbers of wild birds (e.g. geese and ducks) or due to an attractiveness of the holding for gulls and
crows, the premises of the holdings and the area in front of the poultry house may be highly
contaminated with potentially infectious faecal material of wild birds. Contact of poultry with this
material, e.g. through vehicle wheels of lifters/tractors, must be prevented. Several solutions to
improve biosecurity here are conceivable including to roll out a canvas cover outside before bringing
50 The diameter (e.g. 25 mm) should be selected to prevent access of local and migrating wild water birds. Netting could be
opened and closed depending on the risk, as performed in fruit production sector. Song birds might sit on the nets but experts
indicate that this is not likely for most water birds (which have the highest risk to excrete AIV).
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the bedding in, and to store this cover afterwards. It is recommended to store bedding as much as
possible in the same building where the turkeys are kept (or as close as possible to it) to reduce the
risk of introducing wild bird faecal material from the outside into the poultry house. A practical solution
used in several MS is building a wall of straw or otherwise packaged bedding material in the poultry
house at the beginning of the production cycle and breaking this gradually down when new bedding is
provided to the birds. There are also a few turkey holdings with a closed production system in the EU
using a pipe-ﬁlling system to distribute bedding.51 The disadvantage of such system is the high
amount of dust produced while bringing bedding in, as this can increase the incidence of respiratory
problems on birds. New bedding materials with a higher absorption capacity have also been explored
(e.g. straw pellets, wood shavings, chopped straw). In addition, bedding storage, if kept separately
from the turkey houses, must be proofed from wild birds, rodents and predators. It is virtually
impossible to disinfect/decontaminate bedding material to which wild birds have had access.
Many turkey fattening facilities use natural ventilation with an open rooftop or tunnel; these
systems require that all air inlets (e.g. chimneys) are wild bird proof. Changing to mechanical
ventilation systems in controlled housing environments might help to reduce the risk for airborne AI
introduction, although it should be combined with strict implementation of other biosecurity measures
since there have also been AI outbreaks reported in holdings with controlled housing environments.
There is ample practical information available in the public domain on ventilation systems that can be
used in turkey production (ZDG, 2013; AviagenTurkeys, 2015). It should be mentioned that currently
the importance of aerogenic transmission of AIV between holdings is not clear.
Due to the different fattening cycles of female (15–16 weeks) and male (21 weeks) turkeys, ‘brood
and move’ routines are in place at holdings where both sexes are reared together. Loading of female
turkeys during the ﬁnal growing period of males inevitably leads to intense contact to loading crews
and processing plant trucks and creates a high risk of AIV introduction. Reduction of such risks would
require separate fattening of female and male turkeys; otherwise highest biosecurity rules for loading
crews and trucks would have to be implemented. These would focus on difﬁcult-to-handle very high
hygiene standard including use of disinfected crates and containers, disinfecting trucks at the entrance,
shower in and shower out for all visitors, farm clothing and farm boots, etc.
Artiﬁcial insemination is common practice on turkey breeding farms and performed on a weekly
basis. Most of the breeding companies in the EU house male and female turkeys on the same farm. If
artiﬁcial insemination is carried out by staff employed on the holding and movement from farm to farm
is excluded, risks of introduction of AIV are considered to be low. However, odd cases of transmission
of human inﬂuenza to turkeys through contaminated instruments have been reported (Pantin-
Jackwood et al., 2010). Replenishing breeding stock from outside, of course, demands highest
biosecurity measures including quarantine management of newly introduced stock.
Conﬁnement of breeding ducks and in particular geese is difﬁcult due to their physiological need to
access water pools and daylight,52 although many systems are entirely indoor, with water periodically
provided in ‘troughs’. A key problem in current duck production is the high demand for clean bedding
(as for turkeys) and the movement of the birds from rearing to production and ﬁnally to fattening/
moulting houses.53 Using a plastic tunnel and having a concrete ﬂoor between houses at the same
holding, when disinfected prior to movement, could reduce the risk of contact with wild bird faecal
droppings. However, often, ducks are moved between holdings (even at large scale between different
MS) during the production cycle (i.e. from large pre-fattening ﬂocks to many small fattening ﬂocks and
again to collection places before slaughter), which bears a high risk for AIV spread. Transport of day-
old ducks happens in closed vehicles, which are in most cases suited to be disinfected. However, large
vehicles need large disinfectant tanks, which often can be ﬁxed only on the outside of the vehicle what
could cause challenges is wintertime. Collecting reusable material (e.g. plastic boxes/cages) on a round
trip with more holdings on the way could be a high risk activity. These materials should to be collected
on the way back, when the vehicle is empty. Vehicles transporting live birds other than day-old birds
are opened. If the birds’ craw is not empty at the time of loading, faeces may be scattered off. Vehicle
cleaning and disinfection after live bird transport (liver ducks/geese for fattening, reared turkey for
fattening, pre-reared breeders) is a bigger task than an average holding supplied with disinfectant
51 Dussau-distribution composed of a straw bale shredder system standing outside and a pipe-ﬁlling system inside the turkey
house.
52 This need is included in welfare regulations of several countries.
53 For instance, in Barbari duck production in Hungary, there are three laying cycles in a lifetime, interrupted twice by 14 weeks
of moulting (in the ﬁrst round 25–30 weeks, in the second 22 weeks and in the third 19 weeks of production). The total life
cycle lasts around 3 years, the rearing period included. (info provided by Anna Luca Vecsei, 18 August 2017).
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tools can handle. General lorry wash stations often do not serve live animal transport vehicles. These
vehicles and their boxes are properly washed and disinfected at the slaughterhouses and at the home
garage, however regular checks are important to maintain high quality. Establishment of supervised
regional live animal truck wash stations would be useful.
In Hungary, depending on the duck species, natural or artiﬁcial insemination is used. Introducing
new males to breeder ﬂocks happens in pekin duck holdings. However, it is difﬁcult to ﬁnd available
males. When there is no direct epizootic threat present, nor the Hungarian authority, nor the Food
Business Operators require AI tests prior to the transport of the new males, although precautions are
taken (e.g. quarantine requirements) to avoid Pasteurella multocida infection. The animal keepers are
motivated to be careful in AI peacetimes as well. Artiﬁcial insemination is used in the Hungarian
mulard duck industry, and now in increasing number also at goose breeder holdings. The sperm
producing males are often kept in the same holding, sometimes in the same building, in cages,
separated from the females. Operating all in-all out system is not realistic, given that different age
group males are needed to be reared to maintain the continuous sperm supply.
Non-commercial (backyard) poultry production with outdoor access
For backyard holdings, biosecurity training has been assigned the highest overall rank when
considering feasibility, sustainability and effectiveness to reduce AIV entry (Figure J.4, Appendix J).
Preventing direct and indirect contacts between domestic and wild birds was identiﬁed as most
efﬁcient to prevent entry but has a lower rank for feasibility and sustainability. Protection against faecal
droppings from ﬂying wild birds would also be efﬁcient to prevent virus entry, although it has very low
feasibility and sustainability. This low feasibility is mainly due to the cultural practice of keeping poultry
in completely free-range conditions on the family property in several MSs. It is recommended to
conﬁne and at least limit the outdoor access area of domestic birds in high-risk periods (see above).
Restricting access is considered effective to reduce the risk of AIV entry and spread. Health monitoring
and appropriate carcass disposal are speciﬁcally effective to reduce the risk of virus spread.
In some MSs, poultry dealers (people buying poultry from different breeding facilities, keeping the
animals at their own facility and distributing them subsequently to people within the area) are the
main distributors of domestic birds to backyards. Such distribution networks have been identiﬁed for
severe risk of introduction and spread of AIV and hence strict biosecurity measures have to be
implemented. It is recommended that poultry dealers buy birds only from sources that can provide a
health certiﬁcate and ensure traceability of the birds (at least at batch level). Pre-ordering of ﬁxed
numbers of poultry should be encouraged to ensure that no unsold poultry returns to the distributor’s
premises. The poultry dealers should receive a biosecurity training including how to clean and disinfect
crates and vehicles and how to recognise clinical signs, which should facilitate early detection of AI
cases. A veterinarian should assist the poultry dealer in the supervision of the ﬂocks and provide
biosecurity advice. Mixing of gallinaceous and Anseriformes birds should not occur.
Small-scale commercial holdings
Small backyard holdings that directly sell poultry or poultry products in the local area, e.g. to their
neighbours, may have increased contact rates at their premises if selling is performed at the farm.
However, it is likely that it involves only people that do not rear poultry themselves. Hence, the risks of
incursion and spread of AIV are considered low. Small-scale commercial holdings which also market
products through local retailing shops that collect poultry or poultry products from more than one
holding in the area, may have higher risks for AIV entry and spread as a result of increasing numbers
of contacts and linked production lines. The highest risk commodity is live poultry. Selling only
slaughtered poultry should be encouraged, and public awareness should be increased concerning the
prevention of access of backyard chickens to uncooked offal from purchased poultry carcasses (Harder
et al., 2009).
Within small-scale commercial holdings, the same biosecurity measures should be applied as in
larger commercial holdings. There should be physical separation between the area where farming
activities take place and the vending area. Cleaning and disinfection of the vending area should be
strictly implemented.
Hunting and use of decoy birds
The effect of hunting on the risk of AIV spread depends on the type and location of shooting. In
general, shooting may increase local movement rates of game birds and cause increased (indirect)
contacts between wildlife and poultry on farming premises, trigger migration or increase the contact
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rate between potentially infected and non-infected wildlife (Cox and Afton, 1997; Vaananen, 2001).
Therefore, any type of shooting or any other activity disturbing wild birds (e.g. walking dogs, water
sports, etc.) within zones where HPAIV has been detected in wild birds might increase the risk of virus
spread. Galliformes and Anseriformes that are raised for shooting (game birds, usually mallards)
should be batch-tested before release as they could carry AIV without showing clinical signs (Vittecoq
et al. 2012). Risk-based testing of game birds, in particular Anseriformes, could be implemented before
trading to reduce the probability of unnoticed AIV spread. EU legislation is already in place for intra-EU
trade in game birds (Commission Decision 2006/605/EC), stating that birds younger than one month
should be tested by virology (20 cloacal and 20 tracheal swabs) during the week before dispatch to
other MSs, plus health examination during the 24 h before dispatch. This is considered a safe practice
and it is recommended to implement virological testing of swabs before game bird release in the wild
within the country of rearing.
The use of live decoys for duck hunting will lead to AIV spread when the decoys are infected
during the hunt and then bring the virus back to captive ﬂocks at the hunter’s place of residence
(other decoys, backyard poultry ﬂocks or professional poultry premises). It may therefore be
appropriate to ban decoy transport in HPAI-infected or high-risk areas during AIV outbreaks. Under
some circumstances, live decoys could still be used for hunting in AIV-infected zones if they are kept
on the hunting site at all times, since it is the transport that is the main problem.
At all times, carrying of hunted wildfowl, defeathering, gutting and butchering of carcasses are
activities associated with a high risk of contact to, and dispersal of, AIV if the hunted bird is infected.
Soiling of shoes and clothes, transport boxes and vehicles (car boot) is likely. Therefore, poultry
farmers and workers on poultry farms attending wild bird hunting should seriously consider whether
such activities might not pose difﬁculties in controlling risk for their holdings. In any case, hunters
must strictly observe biosecurity measures to ensure that exposure of poultry to any of the items
mentioned above is prevented. Hunting bans could be considered when separation of hunting and
poultry rearing activities cannot be applied rigorously during high-risk periods.
Biosecurity measures that could be applied in a zoo
Zoos with avian species on display pose a particular problem to prevention and control, including
biosecurity measures:
• often mixed species are shown outside in areas mimicking natural habitats;
• feeding in the open may be provided in a way to display the birds to visitors;
• described habitats and feeding measures will attract wild birds which may have unhindered
contact with zoo birds;
• zoo birds often have substantial ﬁnancial value or are important to maintain genetic diversity in
breeding and restocking programmes which may interfere with culling measures.
Practices of keeping birds in zoos, on the contrary, may also have advantages in terms of raising
biosecurity:
• exotic species may require year-round indoor rearing;
• smaller aviaries already provide access limitation for wild birds which may easily be further
enforced (e.g. with impenetrable rooﬁng);
• often stables are available for wintering the birds from open habitats;
• animal keepers usually are experienced and more compliant in observing biosecurity measures.
Very few preventive measures are at hand that can be applied in zoos without interfering with the
display of the birds. Vaccination is only possible following permission by the European Commission and
the usefulness of the licensed vaccines may be questioned. Also, AIV-antibody-positive birds (H5, H7)
will no longer be eligible for exchange breeding programmes outside the EU.
Therefore, most of the reinforced biosecurity measures applied to avian collections at zoos have
been applied after an outbreak of notiﬁable AI had been diagnosed (Globig et al., 2016). EU legislation
grants exemption from culling of affected avian collections under deﬁned conditions (laid down in
Article 13 of Directive 2005/94/EC derogations from culling for certain holdings). These essentially
include a risk assessment by the competent veterinary authority indicating that keeping the collection
or only culling part of it will not further increase risks of incursion to neighbouring poultry holdings or
spill-back infection to wild birds. Speciﬁc measures taken by affected zoos comprised:
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• dividing the avian population into smaller epidemiological units;
• conﬁning all birds indoors with separate housing for small epidemiological units;
• assigning separate staff to each of the epidemiological units;
• prohibit sharing of staff, feed, bedding, machinery and equipment between the different
epidemiological units;
• discouraging/scaring off further visits of (aquatic) wild birds by
– draining open water bodies or
– horizontal screening of larger water bodies with warning tape
– conﬁne all feeding in the zoo indoors including the animals in the children’s’ area.
Closing the zoo for the public for a number of days has been instrumental to install all measures.
Re-opening is possible when all of the avian collection has been appropriately dealt with. Prolonged
access restriction of the public to larger halls/spheres where zoo birds move unrestrained may be
considered.
Improving knowledge on biosecurity
There are very limited data on the effect of biosecurity measures in preventing AIV entry and
spread. Therefore, the text above describes the outcome of expert opinions. Performing case–control
studies during outbreaks and collecting data via questionnaires are considered potentially very useful
to improve our knowledge. Questionnaires carried out by independent organisations (e.g.
universities,54 poultry associations55) often get answers that better reﬂect reality when compared with
questionnaires carried out by the authorities. Providing feedback to farmers on the outcomes of the
questionnaires will help them to improve their biosecurity implementation. It is recommended to look
at biosecurity with a broader context, beyond AI, to assure motivation for poultry farmers also outside
the AI high-risk periods.
3.10. Establishment of a control & monitoring area and risk zones
(TOR 2)
The protection measures in relation to HPAIV ﬁndings in wild birds were assessed based on the HPAI
H5N8 2016/2017 outbreak (EFSA, 2016a). In this chapter, additional scientiﬁc guidance is provided on
zoning around wild bird cases or poultry outbreaks and on exit strategy to lift protection measures.
3.10.1. Reconsider zoning
Restriction zoning around wild bird cases (Commission Decision 2006/563/EC) is no longer
constructive when several cases are diagnosed within a short time frame in the same region (see
EFSA, 2016a). Depending on the prevailing host species affected, a larger and possibly even
transnational area of heightened alertness should be implemented instead. In this area, intensiﬁed
passive monitoring would be required to gather data on the actual incidence of infection in wild bird
populations. This may require speciﬁc input from ornithologists. Data would inform authorities on the
grading and duration of reinforced biosecurity measures for poultry holdings.
Meticulous management of restriction zoning around infected poultry holdings (Commission
Decision 2006/415/EC56) remains pivotal to prevent secondary spread which is the greatest threat to
commercial poultry production systems. Descriptions of zones and measures should be easily
graspable for people directly affected (local language) but need to be conceivable for MS as well, in
particular when crossing MS boundaries. Further thoughts are required to control outbreaks with
strains of stronger zoonotic propensities than the H5 HPAI 2.3.4.4a and b clades. The animal health
aspects would not change but protection of humans would be critical and could be based on the ECDC
toolkit.57 Such strains with increased zoonotic potential currently circulate in Egypt (clade 2.2.1.2),
South-East Asia (H5N6, clade 2.3.4.4c) and China (H7N9). In the light of previous experience, human
infections must be expected should these strains reach the EU and spread through the same channels
54 For example ‘Biocheck poultry’ http://www.biocheck.ugent.be/v4/about/poultry/ which is available in several languages
(Biocheck (Ghent University), 2017).
55 Hygi€enescan AVINED.
56 Commission Decision 2006/415/EC of 14 June 2006 concerning certain protection measures in relation to highly pathogenic
avian inﬂuenza of the subtype H5N1 in poultry in the Community and repealing Decision 2006/135/EC. OJ L 164, 16.6.2006,
p. 51–60.
57 https://ecdc.europa.eu/en/publications-data/toolkit-investigation-cases-avian-influenza-humans, last accessed on 27 August 2017.
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as in 2016/2017. In particular, poultry farmers and workers such as catching crews would be at highest
risk before the incursion has been detected. In addition, after declaration of the outbreak, personnel
on duty collecting and disposing dead wild birds as well as culling crews are exposed to the virus.
Maintenance of reinforced biosecurity and wearing of enhanced personal protection equipment58 is
problematic when culling large poultry holdings with heavy poultry individuals (turkey fatteners
> 14 weeks, breeding geese). In cases where human-to-human transmission of highly zoonotic strains
cannot fully be excluded, quarantine measures may be extended to farmers and workers. These
additional measures would grossly delay actions and gradually deplete the pool of available staff that is
off service during quarantine periods.
3.10.2. Exit strategy to lift protection measures
To date, there are two main risk factors identiﬁed for the incursion of notiﬁable AI into poultry
holdings:
• primary introduction by direct or indirect contact via infected wild birds;
• secondary spread between poultry holdings.
The grading and duration of protection measures should be related to the infection pressure
through both of these pathways. So, knowledge on the incidence (i.e. the number of new infections/
time unit) of infections along these pathways is required.
Secondary spread between poultry holdings at national level often has a local or regional restriction
element. Therefore, a regional scaling and adaptation of protection measures may be justiﬁed. The
situation is more complicated when assessing risks of spread through wild bird populations. These are
much more volatile than poultry populations and, if migrating species are involved, may affect a much
wider geographic range and therefore will require supranational assessment. In addition, data on the
incidence are much more difﬁcult to collect.
EU and national legislation require risk assessments to justify actions of the competent veterinary
authorities, especially if exemptions from or lifting of actions are demanded. Often regional and even
local authorities are responsible for carrying out such assessment which is conceivable as it is the local
authorities that should have the most thorough knowledge of the local conditions. However, such
assessments can be heavily inﬂuenced by factors widely exceeding local geographic restrictions, be
they transnational trading activities or wild bird migration. The principal basis for any risk assessment
in terms of deﬁning exit scenarios would ideally be the quantiﬁcation of the viral load in the
‘environment’ (combined poultry holdings and wild bird populations as well virus contamination of the
environment) as a proxy of the risk of incursion/spread. Such data, however, cannot be measured
directly. They have to be extrapolated considering various criteria such as:
• an epidemic curve (requires continuous, intensiﬁed passive surveillance of wild bird
populations), i.e. knowledge on the dynamic of the epizootic;
• knowledge on regional wild bird and poultry population structures and densities;
• knowledge on regional intensity and structures of poultry trading activities.
Expertise and a harmonised and structured approach of collating and interpreting such data on an
EU but at least on a national level59 would aid in terms of transparency of the decisions taken.
Naturally, this process would require epidemiological, ornithological and virological data integration by
expert groups. In addition, stakeholder expertise might be required as well. So, such processes can
probably not be compressed into simple and harmonised algorithms and decision trees.
4. Conclusions
Mapping of HPAI and LPAI outbreaks during the last 5 years (TOR 5)
• In the last decade, several clades of HPAIV H5 and members of the Eurasian lineage of HPAIV
H7 have been detected in Europe. The majority of recent HPAI outbreaks on EU territory are
of an epidemic, sporadic character. HPAIV H5 affected poultry and wild birds, whereas HPAIV
H7 was only found in poultry.
58 For more information, see Adlhoch et al. (2016).
59 It is noted that Directive 2005/94/EC requires that Member States have established expert groups in their contingency plans.
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• Distinct HPAI clades of goose/Guangdong-like H5 subtype viruses are endemic/present in
poultry populations in several subcontinental regions outside the EU, e.g. South-East and
possibly Central Asia, China, Egypt, West Africa. Some of the H5 virus clades circulating in
these areas bear zoonotic potential and may cause lethal disease in humans.
• None of the HPAI viruses recently detected in the EU revealed signiﬁcant zoonotic potential.
However highly zoonotic HPAIV are circulating in Asia (H7N9, H5N6 and H5N1) and in Egypt
(H5N1) that may be introduced to Europe.
• H5 and H7 LPAI viruses are endemic in the European wild bird population.
• Potentially zoonotic LPAI viruses of subtype H9N2 (G1 lineage) are enzootic in poultry in many
parts of Asia, the Middle East and Northern Africa. Although not detected so far in Europe,
introduction is possible.
HPAI introduction via migratory and residential wild birds (TOR 1)
• Outbreaks of HPAI H5 in poultry were initiated by primary incursions of infected migratory wild
birds into Europe, but intrinsic generation from a LPAI precursor virus and secondary spread
between poultry holdings has been observed as well.
• Four different geographical routes for the entry of wild birds into the EU have been deﬁned.
According to results obtained from the epizootic model generated in this opinion, the north-
eastern and eastern routes have been associated with a high risk of H5 HPAIV-infected wild
birds entering the EU. No H5 HPAIV incursion has been observed so far from the southern and
north-western routes.
• Upon introduction of HPAIV into a wild bird population of sufﬁcient size within the EU,
ampliﬁcation and further wild bird-associated geographical spread of the virus may take place.
• An association was identiﬁed between the HPAIV occurrence in wild birds and the likelihood of
infection of poultry holdings, which is supported by the association between detections in wild
birds and poultry in the ﬁeld.
• According to expert opinion, prevention of access of poultry to water bodies could result in an
estimated threefold reduction in HPAI entry probability. Combining this biosecurity measure
with conﬁning poultry to indoor housing was estimated to further reduce the HPAI entry
probability twofold, and adding routine or high biosecurity would result in a further estimated
reduction of 4- and 44-fold, respectively.
• The estimated impact of biosecurity measures was considered independent of the HPAI virus
characteristics.
LPAI introduction via migratory and/or residential wild birds (TOR 4 and TOR 5)
• For LPAIV, endemically infected wild bird populations play an important role as a source of
primary incursions, but secondary spread by undiagnosed infected poultry ﬂocks must be
considered as well.
• According to results obtained from the epizootic model generated in this opinion, LPAIV can
reach similar maximum prevalence levels in wild bird populations when compared with HPAIV.
• At the same prevalence in the wild bird reservoir, the risk of LPAIV infection of a poultry
holding was estimated to be lower than that of HPAIV.
• The impact of implementing biosecurity on lowering the probability of LPAIV entry into a
holding is considered similar to that of HPAIV.
HPAI and LPAI introduction via non-wild bird pathways (TOR 1, TOR 3 and TOR 5)
• The risk of HPAIV and LPAIV introduction into the EU through non-wild bird pathways is
estimated to be lower compared with the wild bird pathway.
• The only non-wild bird pathways that were considered to have a non-negligible risk of HPAI
introduction are intra-EU movements and Third country trade of semen, intra-EU movements
of manure originating from holdings with Anseriformes species.
• The only non-wild bird pathways that were considered to have a non-negligible risk of LPAI
introduction are intra-EU movements of live poultry and day-old chicks, intra-EU movements of
manure originating from holdings with any species.
• Introduction of AI into a poultry holding via feed and bedding is considered non-negligible
when accessible by wild birds during storage or any point during the transport route.
• Pigeons are rarely found to be infected during either epizootics or in endemic areas where H5
and H7 viruses circulate, hence they do not play an important role in the spread of AIV.
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 72 EFSA Journal 2017;15(10):4991
• Illegal introductions of HPAIV-infected commodities (e.g. birds of prey, pet birds, unprocessed
poultry meat) have been detected at the EU border.
HPAI and LPAI transmission and spread (TOR 6)
• The transmission rate between animals within a ﬂock is assessed to be higher for HPAI viruses
than LPAI viruses.
• Quantitative information on between-ﬂock transmission on farms is lacking.
• Spread of HPAI viruses between farms is highly likely in the absence of control measures. In
most cases, LPAIV remain restricted to a single farm, although horizontal spread has been
observed in several occasions.
Mutation from LPAI to HPAI (TOR 7)
• In very few cases, it could be proven that HPAI outbreaks were caused by intrinsic mutation of
LPAIV to HPAIV and since 2005 the secondary spread of such HPAI viruses in the EU was
limited except for one event which has led to recurrent HPAIV outbreaks in a single region of
France.
• No speciﬁc factors related to host species, environmental conditions or viral lineage were
identiﬁed and likewise no molecular markers that would be useful predictors of increased risk
of a speciﬁc LPAIV to mutate to an HPAI phenotype were recognised. However, emergence of
HPAI viruses from LPAI precursors in Europe seems to have occurred more frequently for LPAI
viruses of the H7 subtype.
• Current knowledge does not allow a prediction as to if, and when, LPAI will mutate to HPAI.
HPAI and LPAI surveillance (TOR 2, TOR 4 and TOR 8)
• Introduction of HPAIV in gallinaceous poultry populations inevitably results in severe clinical
disease and high mortality, whereas the clinical manifestation and mortality in anseriform
poultry depends on the phenotypic characteristics of a HPAI virus.
• Passive surveillance through notiﬁcation of suspicious clinical signs/mortality is the most
effective method for early detection of HPAI outbreaks in gallinaceous poultry.
• For effective surveillance in anseriform poultry, passive surveillance through notiﬁcation of
suspicious clinical signs/mortality needs to be accompanied by serological surveillance and/or a
virological surveillance programme of birds found dead (bucket sampling).
• Risk-based surveillance is useful as it targets ﬂocks where AI introduction is considered to be
higher, although there is limited quantitative (EU-wide) evidence to weight the risk factors.
• Reporting of risk-based surveillance approaches are not currently detailed enough to allow
robust analysis and comparison of the results.
• There is currently a lack of data on non-affected holdings and houses within the affected
regions, which is required in order to establish the magnitudes of risk of infection for the
various potential risk factors, such as location, holding- and ﬂock sizes, biosecurity measures,
etc.
• Current LPAI serological surveillance programme is useful to detect major changes in regional
LPAI occurrence and does result in the detection of active H5 or H7 infection in a minority
(around 20%) of follow-ups conducted.
• The serological surveillance is unﬁt for early warning of LPAI outbreaks at the individual
holding level. Serosurveillance could be effective in detecting clusters of LPAIV-infected
holdings.
• Early warning of LPAI at individual holding outbreak level is practically not possible given that
the clinical signs are not speciﬁc and seroconversion comes too late.
• Passive surveillance is an appropriate method for HPAI surveillance in wild birds if the HPAIV
infections are associated with mortality.
• Active wild bird surveillance has a very low efﬁciency in detecting HPAI.
• When HPAIV has been detected in poultry within a given geographical area active wild bird
surveillance could play a role in detecting HPAIV infections in wild birds that are not associated
with mortality as a possible source of virus introduction.
• A relative risk map of predicted H5 HPAIV occurrences in wild birds in Europe has been
generated based on the wild bird events reported between 2005 and 2017, which could
contribute to identiﬁcation of priority locations in the EU where targeted active wild bird
surveillance could be implemented during wild bird migration periods.
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Early detection of HPAI (TOR 2)
• Recognition and reporting of suspicion, sampling, testing and reporting of results should be
done in a timely manner.
• For gallinaceous species, early detection of HPAI relies on notiﬁcation of clinical suspicion.
• For Anseriformes species, the sensitivity of ‘notifying clinical suspicions’ as a mechanism for
early detection can be low for some HPAIV lineages.
• Subclinically infected domestic Anseriformes have a higher likelihood of continued spreading
HPAIV when compared with clinically infected gallinaceous poultry.
Biosecurity to prevent HPAI and LPAI entry and spread (TOR 2 and TOR 4)
• Biosecurity measures were found to play a key role in preventing AI spread from wild birds to
poultry. Human diligence is pivotal to select, implement and maintain effective biosecurity measures.
• While certain general biosecurity principles universally apply to poultry holdings, unique
features for each holding need to be considered for optimised protection.
• According to expert opinion, the most feasible, sustainable and efﬁcient measure to reduce the
risk of AI entry in indoor poultry holdings is to prevent direct and indirect wild bird contact.
Other measures with a high feasibility and sustainability are separation of waterfowl from other
poultry species, provision of potable drinking water instead of surface water, the
implementation of a hygiene lock for each poultry house, and biosecurity training of staff.
• According to expert opinion, the highest ranked measures to prevent secondary spread of the
virus are to contain poultry and fomites (i.e. materials that were in contact with poultry) during
transport, cleaning and disinfection of equipment, biosecurity training, cleaning and disinfection
of transport vehicles, and the use of a hygiene lock for each poultry house.
• Outdoor poultry holdings bear an increased risk of AI incursions and the applicable biosecurity
measures are more limited.
• According to expert opinion, restricting access to persons and providing biosecurity training are
the most feasible, sustainable and efﬁcient measures to reduce the risk of AI entry and spread
in commercial holdings where poultry has access to outdoor areas.
• According to expert opinion, for backyard holdings, biosecurity training has been assigned the
highest overall rank to prevent AI entry and spread.
• The risk of AIV introduction and spread will remain high in production processes when
movement of animals, restricting access throughout the whole production cycle and/or contact
with wild birds is not reduced.
Establishment of a control & monitoring area and risk zones (TOR 2)
• There is no scientiﬁc evidence to guide the sizes of a control and monitoring zone upon ﬁnding
HPAIV in wild birds because it depends on the dynamics of the epizootic and the affected bird
species.
• Establishing small-sized (e.g. few km) restriction zones may be instrumental to be able to
implement increased surveillance activities in poultry in this zone which has been shown to be
effective to identify further cases.
• In the progression of a wild bird epizootic, establishing wider zones, rather than a succession
of small, restricted zones may be more appropriate.
• Informing poultry keepers on the detection of HPAIV in wild birds in the region will increase
their awareness of the risk of virus introduction into their holding.
• Protection of persons becomes crucial in case of outbreaks with HPAIV having increased
zoonotic potential.
5. Recommendations
Mapping of HPAI and LPAI outbreaks during the last 5 years (TOR 5)
• A close observation of the global AI-related epidemiology is recommended to inform
competent authorities and guide strategic preventive measures. This may include collaborative
wild bird surveillance programmes with third countries in Eastern Europe and Central Asia.
• Establishing a harmonised data collection system, integrating outbreak notiﬁcation data, wild bird
ﬁndings and epidemiological parameters, will aid in providing timely epidemiological analysis.
• Limiting data conﬁdentiality claims will facilitate data exchange between MSs.
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HPAI introduction via migratory and residential wild birds (TOR 1)
• To reduce the probability of AI introduction in poultry having outdoor access, it is
recommended to provide for holding capacity to separate wild birds and poultry during high-
risk periods.
• To reduce the probability of AI introduction in poultry, it is recommended to discourage (new)
poultry rearing in areas with a high density of wild Anseriforme populations.
• To reduce the spread of AI between holdings, it is recommended to limit transport and mixing
of birds from different origins during the production cycle.
HPAI and LPAI introduction via non-wild bird pathways (TOR 1, TOR 3 and TOR 5)
• It is recommended to perform studies on virus perseverance in semen and faeces/manure
(unprocessed, storage, composting, effect of cleaning and disinfection procedures).
• It is recommended that MSs trading poultry semen report their national rules (based on OIE
recommendations) and an estimate of the volumes traded so that a risk-based approach can
be developed to assess the risk of AI introduction and spread via semen.
HPAI and LPAI transmission and spread (TOR 6)
• It is recommended to perform epidemiological studies to assess the effect of risk factors
inﬂuencing between-ﬂock and between-farm spread. Collection of standardised epidemiological
data at the EU level from the holdings (e.g. location) and their houses (e.g. affected or not,
number of susceptible birds, population structure) would be required on an ongoing basis.
Mutation from LPAI to HPAI (TOR 7)
• Besides epidemiological data, it is also recommended to standardise and improve collection of
virological information across the EU from LP and HP outbreaks such as HA/NA subtype and
viral genetic sequences to increase our ability to assess the role of speciﬁc viral, environmental
and host factors on the pathogenicity evolution.
• It is recommended to perform research applying a holistic approach and investigating the
broader inﬂuenza genetic spectrum, as well as the contribution of environmental and host-
related aspects in the emergence of HPAI viruses.
HPAI and LPAI surveillance (TOR 2, TOR 4 and TOR 8)
• Member States should focus their annual serological surveillance programme in Anseriformes
and game bird populations where those populations exist.
• Serosurveillance should aim at detecting clusters of LPAIV-infected farms in order to identify
those LPAI events with continuous between farm spread.
• Epidemiological follow-up of serological positives should be carried out at positive holdings to
determine if there is clustering of AI-infected holdings in space and/or time regardless of
whether the seropositive birds are still at the holding or whether active virus infection has been
detected. If the group (i.e. epidemiological unit such as shed or ﬂock) of poultry that tested
positive on serology are not available for PCR testing, then any other poultry (in particular
seronegative birds) still remaining on that holding should be tested.
• It is recommended to quantify the weighting of the risk factors used to design risk-based
surveillance across EU to facilitate analysis of the results and to compare results of MSs.
• Targeted active wild bird surveillance through virology tests (swabbing) combined with
enhanced passive surveillance at a few priority regions in the EU may detect, if infection
prevalence and sample sizes are sufﬁcient, the presence of circulating AIV when these do not
cause massive mortality among these birds.
Early detection of HPAI (TOR 2)
• Virological testing of dead anseriforme poultry collected in holdings on a daily/weekly base (i.e.
bucket sampling) is recommended during outbreak and other high-risk periods. Pooling of such
samples for PCR-directed diagnosis may be useful.
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Biosecurity to prevent HPAI and LPAI entry and spread (TOR 2 and TOR 4)
• Restrict wild bird access to poultry and open water bodies need to be avoided on the premises.
• Use hygiene locks and restrict access of people to poultry houses. Limit contacts with other
poultry holdings (fomite, material, workers).
• It is recommended that professional staff of poultry holdings attend general biosecurity
trainings but also receive holding-speciﬁc biosecurity advice ideally from an expert (e.g.
veterinarian) familiar with the particular holding.
• Hobby keepers should receive information to achieve a minimal understanding of biosecurity to
prevent entry and/or spread of AIV in their backyards and during markets and/or shows.
• It is recommended to conﬁne and at least limit the outdoor access area of domestic birds in
high-risk periods (see above).
• If poultry cannot be conﬁned during high-risk periods, it is recommended to prevent direct
contact between wild birds and poultry by reducing the size of the outdoor area and/or by
using netting. Feed and water should be provided under a roof or a horizontal fabric.
• Biosecurity training and improved control of catching crews and other ‘mobile’ staff (e.g.
insemination teams) may be useful to limit indirect spread of HP and LPAIV during large-scale
operations in commercialised poultry holdings.
• Game bird hunting activities must be fully separated from rearing poultry.
• Game birds should be tested for AI before release.
• Online biosecurity questionnaires could be used by farmers to check their current biosecurity
level and subsequently to improve it based on the received feedback.
Establishment of a control & monitoring area and risk zones (TOR 2)
• Upon detection of HPAIV in wild birds, it is recommended that control and in particular
monitoring areas are established based on the ecological habitat and ﬂight distance of the
affected bird species.
• During an epizootic of HPAIV in wild birds, it is recommended to test samples from new
species and non-previously reported areas. Testing in reported areas can be restricted to check
viral presence in relation to an exit strategy.
• Sharing data and expertise at national and EU level on exit strategies would aid in terms of
harmonised and structured approaches as well as interpretation of available data. Collaboration
between authorities and stakeholders is crucial.
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Glossary and Abbreviations
Categories of wild
birds
Water or non-water birds (see tables in Appendix B)
Entering wild birds Wild birds entering the local area considered in the model
Foraging area An area with a surface of 4 ha used by wild birds for foraging (it includes any
land cover except water/wetland, artiﬁcial, and woodland)
Formal EKE EKE following the steps: initiation, pre-elicitation (deﬁnition of the elicitation
protocol), elicitation and detailed reporting (see details in Appendix B.8 of the
Uncertainty Guidance; EFSA, 2016a)
Hatching eggs Eggs for incubation laid by poultry
Infected bird Bird in which AIV is detectable
Migratory wild bird Wild bird living at least part of the year outside the EU
Poultry Fowl, turkeys, guinea fowl, ducks, geese, quails, pigeons, pheasants,
partridges and ratites (ostriches, emus, etc.) reared or kept in captivity for
breeding, re-stocking or the production of meat or eggs for consumption
Poultry holding In the model, a poultry holding is considered to consist of the poultry houses
and the surroundings within a radius of 1 km (=3.14 km2 surface)
Resident wild bird Wild bird living within the EU during the whole year
Semi-formal EKE EKE following minimal requirements of: predeﬁned question and expert board,
fully documented (see details in Appendix B.8 of the Uncertainty Guidance;
EFSA, 2016a)
Virtual contact area A virtual contact area is deﬁned as an area of about 4 ha in size in which wild
birds forage (see more details in Section C.5.2, Appendix C)
Wild bird reservoir Migratory and residential wild birds available in an area
Worst-case poultry
holding
A poultry holding with outdoor housing (the place where poultry is kept is
surrounded by fences but there is no horizontal protection to prevent access of
wild birds), the presence of domestic waterfowl and the presence of a water
body accessible to domestic waterfowl and wild birds on the poultry holding
ABP animal by-product
ADNS Animal Disease Notiﬁcation System
AI avian inﬂuenza
AIV avian inﬂuenza virus
BIP border inspection post
CN Combined Nomenclature
CS cleavage site
dpi days post-infection
ECDC European Centre for Disease Prevention and Control
EID50 median egg infectious dose
EKE Expert knowledge elicitation
EMPRES Emergency Prevention System for Animal Health
FAO Food and Agriculture Organization of the United Nations
gs/GD original goose/Guangdong
HA haemagglutinin
HPAI highly pathogenic avian inﬂuenza
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IVPI intravenous pathogenicity index
LPAI low pathogenic avian inﬂuenza
MC Monte Carlo
MNWB migratory non-water birds
MS Member State
MWB migratory water birds
NPLE non-pasteurised liquid egg
OIE World Organization for Animal Health
PAP processed animal protein
PCR polymerase chain reaction
PFU plaque-forming units
PVS private veterinary services
RBS risk-based surveillance
RNW residential non-water birds
RWB residential water birds
SIR susceptible-infective-recovered
SPG speciﬁc pathogen-free
TCID50 median tissue culture infectious dose
TOR Terms of Reference
TSE transmissible spongiform encephalopathy
TTE testing to exclude
WG Working Group
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Appendix A – Reported HPAI and LPAI outbreaks in the last 5 years
The tables in this appendix are based on the EMPRES-I database (FAO/EMPRES-i, 2014c).
A.1. HPAI outbreaks in domestic and wild bird species
Table A.1: Reported HPAI outbreaks in domestic birds in the different continents from January
2010 to June 2017 (FAO/EMPRES-i, 2014b)
Region Subtype
Year
Total
2010 2011 2012 2013 2014 2015 2016 2017
Africa H5N1 443 376 100 93 364 706 455 199 2,736
H5N2 46 5 2 2 55
H5N8 1 80 81
H7N1 1 1
HPAI(e) 1 1
Total 444 422 106 95 364 706 458 279 2,874
Americas H5 1 1
H5N1 1 1
H5N2 12 227 239
H5N8 1 3 4
H7N3 44 64 1 2 30 1 142
H7N9 2 2
Total 44 64 15 233 30 3 389
Asia H5 2 1 3 1 7
H5N1(a) 1,328 1516 444 392 406 259 312 162 4,819
H5N2(b) 6 1 10 564 47 122 750
H5N3 1 26 27
H5N6(c) 1 36 129 131 385 682
H5N8(d) 44 510 43 126 723
H7N9 25 25
HPAI(e) 1 2 2 5
Total 1,330 1,518 450 394 500 1,489 535 822 7,038
Europe H5 8 4 12
H5N1 2 2 14 8 2 28
H5N2 30 6 3 39
H5N5 6 6
H5N6 1 1
H5N8 10 3 373 746 1,132
H5N9 21 4 25
H7N7 6 2 3 11
Total 2 6 12 70 402 762 1,254
Oceania H5 1 1
H7N2 2 2
H7N7 1 1
Total 1 1 2 4
Total 1,777 1,940 601 561 891 2,498 1,425 1,866 11,559
(a): In 2015, the serotypes H5N1 and H5N2 were reported for one outbreak and subtypes H5N1 and H5N6 were reported for
another outbreak; in 2016, one outbreak involved both domestic and in wild birds species.
(b): In 2015, the subtypes H5N2 and H5N1 were reported for one outbreak the serotypes H5N2 and H5N6 were reported for
another outbreak.
(c): In 2015, the subtypes H5N6 and H5N1 were reported in four outbreaks; the subtypes H5N6, H5N1 and H5N2 were reported
in two outbreaks; the subtypes H5N6 and H5N2 were reported in ﬁve outbreaks; the subtypes H5N6 and H5N8 were
reported in one outbreak.
(d): In 2015, the subtypes H5N8, H5N1 and H5N6 were reported for one outbreak; in 2017, one outbreak involved both
domestic and wild birds species.
(e): Unspeciﬁed.
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A.2. LPAI outbreaks in domestic and wild bird species
Table A.2: Reported HPAI outbreaks in wild birds in the different continents from January 2010 to
June 2017 (FAO/EMPRES-i, 2014b)
Region Subtype
Year
Total
2010 2011 2012 2013 2014 2015 2016 2017
Africa H5N1 4 4
H5N8 2 5 7
H7N1 1 1
Total 7 5 12
Americas H5 7 7
H5N1 2 2
H5N2 1 35 1 1 38
H5N8 20 20
H7N3 2 1 3
Total 2 1 65 1 1 70
Asia H5 1 1
H5N1(a) 13 67 26 5 2 7 2 2 124
H5N2 2 1 3
H5N6 3 9 170 182
H5N8(b) 30 4 15 24 73
HPAI 2 1 1 4
Total 13 69 26 5 33 17 27 197 387
Europe H5 1 1 7 9
H5N1 4 2 10 16
H5N5 4 7 11
H5N8 3 2 289 670 964
H5N9 3 3
H7 1 1
Total 4 2 1 4 12 294 687 1,004
Total 17 69 30 6 38 94 329 890 1,473
(a): In 2016, one outbreak involved both domestic and in wild birds species.
(b): In 2017, one outbreak involved both domestic and wild birds species.
Table A.3: Reported LPAI outbreaks in domestic birds in the different continents from January 2010
to June 2017 (FAO/EMPRES-i, 2014a)
Region Subtype
Year
Total
2010 2011 2012 2013 2014 2015 2016 2017
Africa H5 1 1
H5N2 3 17 12 31 16 3 82
H7 1 2 3
H7N1 2 12 1 15
H7N2 2 2
H7N7 10 3 13
H9 7 7
H9N2 15 50 15 3 4 11 1 99
Total 22 55 54 20 36 29 6 222
Americas H5 3 3
H5N1 1 1
H5N2 1 4 1 1 7
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Region Subtype
Year
Total
2010 2011 2012 2013 2014 2015 2016 2017
H5N8 1 1
H7 1 1
H7N3 1 1 1 3
H7N6 2 2
H7N7 1 1
H7N8 9 9
H7N9 9 9
LPAI 1 2 3
Total 1 2 1 2 7 14 13 40
Asia H5 1 1 2
H5N2 4 2 9 8 1 22 5 9 60
H5N3 1 1
H5N6 1 1 2
H7 1 1 2
H7N2 1 1 1 3
H7N3 2 1 3
H7N6 1 1
H7N7 6 6
H7N9 161 356 81 19 125 742
H9N2 255 636 124 151 19 1 1 1,187
LPAI 1 1
Total 268 641 133 322 380 104 26 136 2,010
Europe H5 7 1 1 1 10
H5N1 6 3 17 8 34
H5N2 1 4 4 9 11 4 33
H5N3 2 3 7 10 22
H5N8 2 2
H5N9 5 1 6
H7 2 2 1 1 1 7
H7N1 1 1 2 1 1 6
H7N3 1 1
H7N7 21 1 3 4 29
H7N9 1 1
LPAI 5 1 6
Total 4 27 12 18 10 19 43 24 157
Oceania H5 1 1
H5N3 1 1
Total 1 1 2
Total 273 692 201 396 412 166 112 179 2,431
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Appendix B – Composition of water and non-water birds
Wild bird species present in the EU have been grouped in two main groups of animals: water birds
(ducks, geese, swans, grebes, etc.) and non-water birds (raptors, song birds, waders, gulls, terns,
storks, cranes, etc.) according to their general behaviour, habitat preference and known susceptibility
to AIV.
B.1. Water birds
B.2. Non-water birds
Although waders are water birds, they are in this opinion included in the non-water birds group
because their behaviour is different from that of Anatidae, in particular, towards the use of poultry
farm premises (Caron et al., 2017).
Population of non-water birds
A representative population of 10,000 non-water birds within Europe would be composed of various
groups of species. In an earlier stage of this work, it was estimated by working group experts with
ornithological background that a typical breakdown of species would be as follows (Table B.3):
Table B.1: List of species according to the subgroup, the order and family they belong to in the
water birds group
Sub-category Order Family
Dabbling ducks Anseriformes Anatidae
Diving ducks
Shelducks
Seaducks
Geese
Swans
Mergansers
Grebes Podicipediformes Podicipedidae
Coot and other Rallidae Gruiformes Rallidae
Cormorants Suliformes Phalacrocoracidae
Pelicans, Herons, Spoonbills, Ibises Pelecaniformes Pelecanidae, Ardeidae, Threskiornithidae
Table B.2: List of species according to the sub-group, the order and family they belong to in the
non-water birds group
Sub-category Order Family
Raptors Falconiformes Falconidae
Accipitriformes Accipitridae, Pandionidae
Strigiformes Stigidae, Tytonidae
Song birds Passeriformes Aegithalidae, Alaudidae, Bombycillidae, Certhiidae, Cinclidae, Corvidae,
Emberizidae, Estrildidae, Fringillidae, Hirundinidae, Laniidae,
Motacillidae, Muscicapidae, Oriolidae, Paridae, Ploceidae, Prunellidae,
Remizidae, Sittidae, Sturnidae, Sylviidae, Troglodytidae, etc.
Columbiformes Columbidea
Waders Charadriiformes Charadiidea, Scolopaciea, Recurvirostridae, etc.
Gulls–Terns–Storks–
Cranes
Charadriiformes Laridae
Ciconiiformes Ciconiidae
Gruiformes Gruidae
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Table B.3: Composition of a population of 10,000 non-water birds
Group of non-water birds species Number Percentage%
Songbirds 9,350 93.50
Gulls-Storks-Cranes 500 5.00
Waders 100 1.00
Raptors 50 0.50
Total 10,000 100.00
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Appendix C – Model description
For the sake of clarity, the description of the theoretical model (Sections C.1–C.4) is provided
separately from model parameterisation (Section C.5). The model setting is based on evidence and
expert knowledge and has a level of generality. Therefore, in principle, it might be applied any time
assumptions are realistically met, whilst the way parameters are estimated is speciﬁc for the current
assessment.
C.1. Model setting
The structure of the model reﬂects the circumstantial scientiﬁc evidence available and knowledge of
the involved experts. Some assumptions though have been introduced in order to keep an acceptable
balance between realism and level of complexity.
Most of the data available to estimate parameters of the model suffered from limitations in terms of
representativeness of the target population and different types of bias. These limitations represent
sources of uncertainty that have been expressed for each input parameter in the model in the form of
uncertainty probability distributions. Available data have been used to support an expert judgement
process (EFSA, 2016a). In addition to the possible ﬂaws affecting inputs to the model, other potential
uncertainties related to model structural aspects (e.g. assumptions on the mechanism underpinning
the dynamic of AI infection in wild bird population) have been identiﬁed. All these sources of
uncertainty, that are not inherent to the evidence, could not be addressed directly as input to the
model. Their potential impact has been taken into consideration when analysing model outputs and
assessed quantitatively whenever possible.
The main objective of the model is to describe the entrance of AI viruses into Europe through
migratory wild birds, the possible dynamic of AI in both migratory and resident wild bird populations,
and to assess the risk of transmission from wild birds to poultry during one migration season. In
particular, HPAIV clade 2.3.4.4 entry via the NE entry route during the 2016–2017 migration60 was
modelled (see Sections C.5 and C.6) as well as entry of LPAIV (see Sections C.5 and C.7).
The contributions of the various wild bird species to the probability of introduction and infection
were considered to differ substantially, so ideally separate assessments were sought for. In general,
there was a lack of comprehensive data on the course of AI infections at individual wild bird species
level. Therefore, only two broad categories of wild birds, water birds and non-water birds (see
Tables B.1 and B.2 in Appendix B), were formed and considered as reﬂecting major differences in
behaviour, habitat preference, susceptibility to infection and contact frequency with poultry.
During the migration season, migratory water birds and non-water birds enter the EU via one of
the entry routes (see Section 3.2.1) and mix with resident wild birds. Several studies on the
movements, spatio-temporal size and distribution of wild bird populations have been published mostly
based on ringing data (e.g. Scott and Rose 1996; Wetlands International, 2017a), but these studies
are limited to a few bird species or restricted to a few geographic areas. A European comprehensive
overview is lacking. Therefore, a model of a generalised local wild bird population is considered
representing those birds associated with the same feeding area or the preferred habitat (here called
the ‘virtual contact area’).
The model allows to estimate the probability of AIV introduction via migratory birds and then to
describe the AI dynamics in a local wild bird population. To this scope, for HPAI, different population
scenarios are used (see Table 1, Section 3.2.1) based on alternative size (total number of birds) and
composition (share of water versus non-water and migratory versus non-migratory birds) of the bird
population associated with a virtual contact area (see deﬁnition in Section C.5.2). Bird population size
is regulated through a carrying capacity, the maximum size of wild bird population that can be present
in the virtual contact area. For each scenario size (i.e. carrying capacity value), population composition
in the model was altered by assuming comparable shares of residential versus migratory birds and
water versus non-water birds. Only for LPAI, three different initial prevalence levels were considered
(0.2%, 2% and 6%) one of which combined with two proportions of na€ıve population (0.5 and 1) (see
Table 3, Section 3.3.2).
Based on the observation that detection of AI cases in wild non-water birds is rare (e.g. EU annual
report on AI surveillance (APHA, 2015)), it was decided to consider only water birds as a potential
source of AI introduction in the EU via wild birds. The model describes the mechanism of AI
transmission among wild birds via contact with any contaminated matrix (e.g. faeces on feeding
60 The modelling was done before the onset of the 2016–2017 HPAI outbreaks.
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grounds, cloacal and oropharyngeal excretions, contaminated water, scavenging on carcasses of birds
that succumbed to AI, etc.). These infection sources (hereafter named infectious excretions) are
assumed to be the route of transmission, embedding also the effect of direct bird-to-bird contacts. The
model only considers defecation of wild birds when they reside on land or in water, since the
proportion of defecation when ﬂying is considered to be small. The possible impact of defecation
during ﬂight is included in the uncertainty analysis.
The susceptible-infective-recovered (SIR) theory is used to describe the transmission of the
infection among the two wild bird groups, water and non-water birds, interpreting the transition
between S and I as the transmission rate b, whose expected value is expressed here as the probability
that a bird gets infected in a day. The latter is estimated combining probability of a susceptible bird of
getting in contact with infectious excretions with probability of acquiring the infection given the contact
occurs. Considering the assumption that infectious excretions are the only route of infection, a new
compartment (named G in the model) was added to the traditional SIR model in order to capture the
persistence of the excretion infectivity beyond the infectivity of the bird. This enables the possibilities
that virus can be transmitted to susceptible wild birds without the presence of infectious birds in the
deﬁned area. The transition between I and G is regulated by the shedding period, whilst that from G
to S is ruled by the duration of the persistence of the excretions in the environment (see
Section D.1.9).
The model describes the dynamics of the epidemic in the wild bird reservoir and allows calculating
the prevalence of infected wild birds for each day during the migratory season for both the water and
the non-water wild bird populations. The infection might subsequently be transmitted to poultry via
any possible route, for instance direct and indirect wild bird–poultry interaction, movement of people,
vehicles, machinery, etc., acting as fomites. Transmission by any of these routes implies the presence
of excretions of at least one infectious wild bird in the poultry holding. The number of wild birds, both
water and non-water birds, that can enter into the holding area daily (and subsequently produce
excretions) was estimated by experts. The number of infected wild birds was then derived from the
estimated number of wild birds circulating in the area and the prevalence calculated with the model.
Based on evidence, it was considered that the level of biosecurity in a poultry holding would affect
the risk of an AI incursion given the number of infected birds entering the poultry holding (e.g. Parker
et al., 2012). Therefore, that probability was estimated separately for a holding without biosecurity
measures and for four scenarios reﬂecting stepwise increased implementation of biosecurity measures
(see Section 3.9) aiming at preventing the introduction of the virus into the holding’s poultry
population.
As presented in Figure C.1, the model provides an estimate for the:
• Entry assessment: probability of HPAI introduction across the EU boundaries via wild birds;
• AI dynamics in the EU wild bird reservoir: HPAI or LPAI prevalence in wild bird
populations during the migratory season;
• Exposure assessment and poultry holding incursion: probability of HPAI or LPAI
infection of poultry holdings due to the exposure to infected wild birds.
For each of these outcomes, details are provided in the Sections C.2–C.4.
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Two main sources of uncertainty have been addressed in the model: those inherent to the evidence
used as an input and the ones due to the setting of the model and the assumptions done. It must be
acknowledged indeed that choices made for the structure of the model and related assumptions reﬂect
different needs including balance between complexity and realism. Hence, they can introduce
uncertainty in the results. Uncertainty related to the evidence has been addressed expressing model
parameters as uncertainty probability distribution and combining these using simulations with MC
algorithm. The approach taken to analyse the second type of uncertainties varies depending on the
level of realism of the assumption, the expected impact on the outcome and the feasibility of
quantifying it, as indicated in the Tables C.1–C.3 reported under the uncertainty analysis of each model
outcome.
C.2. Entry assessment
C.2.1. Assumptions
For the sake of simplicity and considering, the limitations in the available data, the following
assumptions have been made in the ‘entry assessment’ component of the model:
1) The entrance of migratory wild birds into the EU during a migratory season was modelled with
a constant rate.
2) Only migratory water birds are a potential source of AIV introduction in the EU.
C.2.2. Description
It is assumed that a proportion of migratory water birds crossing the EU border daily, is infected
with a prevalence of infection pMWB described by an uncertainty distribution. The latter distribution is
assumed not to change over the migratory season.
The probability of HPAI introduction in the EU (ProbE) is expressed as the probability that at least
one infected water bird enters the EU during the migratory season:
ProbE ¼ 1 ð1 pMWBÞTMWB
TMWB ¼ Number of Migratory water birds entering EU in a migratory season
Figure C.1: Schematic overview of the model inputs, components and outputs
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pMWB ¼ AI Prevalence in migratory water birds at the time they enter EU
LPAI is considered endemic within the EU, hence this compartment of the model is not applicable.
C.2.3. Uncertainty analysis
As described previously, two types of uncertainties were addressed:
• the one expressing limitations in the knowledge of the model inputs;
• the one expressing the impact of assumptions of the assessment and the model on the
outcome.
Uncertainty related to the evidence used to estimate the two parameters in the model – total
number of migratory water birds and AI prevalence – has been expressed using probability
distributions estimated via a process of Expert Knowledge Elicitation (EKE) (Table C.1). Then
uncertainty distributions have been combined using Monte Carlo (MC) simulations.
The approach taken to analyse the second type of uncertainties varies depending on the level of
realism of the assumption, the expected impact on the outcome and the feasibility of quantifying it as
indicated in the table below.
The impact of the only uncertainty related to assumptions that was considered needed to assess
quantitatively was estimated via a semi-formal EKE and reported in Appendix E (model outputs).
C.3. AI dynamics in the wild bird reservoir
C.3.1. Assumptions
For the sake of simplicity and considering the limitations in the available data, the following
assumptions have been made in the ‘AI dynamics’ compartment of the model:
3) For HPAI, the dynamic of the transmission of the virus among wild birds during the
autumn migratory season is investigated.
4) For LPAI, the dynamic of the transmission of the virus among wild birds is investigated
during period having the length of the autumn migratory season.
5) For HPAI, only migratory water birds are a potential source of AIV introduction in the EU.
6) For LPAI, only water birds are a potential source of AIV introduction into a free local area.
7) For HPAI, the entrance of susceptible migratory wild birds into the EU during the migration
season was modelled with a constant rate.
8) For LPAI, the entrance of susceptible wild birds in the local area during the investigated
period was modelled with a constant rate.
9) For HPAI, the entrance of migratory infected birds occurs in a single occasion during the
migratory season.
10) For LPAI, the entrance of infected birds can occur in several occasions during the
considered period.
11) The prevalence of HPAIV-infected migratory wild birds at the time they cross the EU border
is assumed to be constant during the migration season. The experts could not identify
reliable information in order to model the variability of the prevalence across the migration
season.
12) The prevalence of LPAIV-infected water birds entering the local area is assumed to be
constant during the considered period.
Table C.1: Expected impact of assumptions on the ‘entry assessment’ compartment of the model
on the model outcome
Assumption Expected impact Explanation
Only migratory water
birds are potential
source of AI
introduction in the
EU via wild birds
Assessed quantitatively using
EKE on model outcome
The uncertainty distribution is very much
concentrated (uncertainty is limited). Considering
also the migratory non-water birds would squeeze,
the distribution even more towards 1 further
decreasing the uncertainty
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13) The distribution of birds by day of infectivity is uniform at the time they cross the EU
border (for HPAI) or they enter the local area (for LPAI). The experts could not identify
reliable information in order to model the distribution differently.
14) Once a wild bird got infected, it becomes able to transmit infection to a susceptible bird via
its excretions from the following day onwards.
15) The quantity of virus excreted does not differ among ‘categories of wild birds’ (water birds
(WB) versus non-water birds (NWB)).
16) Contact with excretions is assumed to be the only route of infection, although it can
happen in different ways. Bird-to-bird direct contact is considered to be implicitly covered
by contact with excretions and is therefore not separately treated.
17) The probability of a wild bird to get infected is assumed not to depend on the time spent
during a given day in a virtual contact area.
18) The probability of getting in contact with infectious excretions is assumed to be higher
within the same category of birds (WB with WB and NWB with NWB) and lower between
categories (WB with NWB and NWB with WB). The rationale for this is that birds of the
same category share habitats and feeding area longer or to a greater extent than birds
from different categories.
19) Infectivity of the excretions in the environment is assumed to be maintained for a number of
days after release, also beyond recovery of the infected bird. During the persistence period, the
level of infectivity of the excretions is assumed to be constant, which is considered to reﬂect a
worst-case scenario given the availability of evidence that infectivity normally decreases
(although the kinetics vary between different matrices and environmental conditions).
20) The number of infectious excretions is assumed to be directly proportional to the number
of birds shedding the virus (infected) plus the number of infected birds that are no longer
infectious but whose excretions are still infectious;
21) AI infection confers immunity to birds once birds recover from the disease.
22) All NWBs are susceptible when they enter the EU (HPAI) or a local free area (LPAI). The
inﬂuence of heterologous immunity and previous exposure is not considered unless explicitly
stated.
23) All residential (HPAI) or locally present (LPAI) wild birds (both WBs and NWBs) are
susceptible to the infection prior to arrival of infected water birds; the inﬂuence of
heterologous immunity and previous exposure is not considered unless explicitly stated.
24) All wild birds visit virtual contact areas daily during the migration season.
25) A random pattern is assumed for the release of the infected excretions in the virtual
contact area and for the contact of birds with them; the quantity of excretions has not
been considered for the different categories of birds.
26) For both HPAI and LPAI, baseline wild bird mortality (including natural mortality plus
hunting) occurring during the migration season is not considered in the model since its
impact has been assessed considering a worst-case scenario analysis and came out to be
negligible on the ampliﬁcation dynamic. Hence, the size of the wild bird population in each
scenario ﬂuctuates within the carrying capacity only on the basis of the daily arrival of wild
birds and, only for HPAI, for the mortality due to AI infection. Hatch rate is ignored given
the period of the year considered for the reference scenario (fall-winter season).
C.3.2. Description
Contact with infected excretions is considered the only route of AI transmission. The AI dynamic in
wild bird population is described within virtual contact areas visited daily by wild birds. These are
places where the contact with infected excretions can take place. Different wild bird population
scenarios in a virtual contact area have been simulated based on different carrying capacities (i.e.
maximum number of birds that would aggregate in the area) and various compositions for the
proportion of migratory birds (pM) and water birds (pWB) (see Table 1, Section 3.2.2). For the sake of
simplicity, the index related to the type of scenario is omitted throughout the formulas reported below.
In the virtual contact area and for each simulated population, daily arrival of susceptible migratory
wild birds over the migration season is described using a constant arrival rate. HPAI is considered to
be an epizootic event in the virtual contact area and therefore the entrance of migratory infected birds
is described to occur in a single occasion during the migratory season. The same epizootic model was
used to simulate LPAIV entry in free local areas.
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 104 EFSA Journal 2017;15(10):4991
The number of infected migratory water birds carrying HPAIV and entering in Europa in one single
occasion is given by:
IMWB ¼ MWB pMWB
where:
MWB is the number of migratory water birds arriving in a virtual contact area during the whole
migratory season.
IMWB is the number of infected migratory water birds arriving in a virtual contact area during the whole
migratory season.
Consequently, the number of susceptible migratory water birds (SMWBt) and non-water birds (SMWBt)
entering a virtual contact area at time t (in days) during the migration season via one of the entry
routes is assumed to be constant in t and, respectively:
SMWBðtÞ ¼ MWB  ð1 pMWBÞ=MSLength
SMNWB(t) ¼ MNWB/MSLength
where:
MWB ¼ N pM  pWB
MNWB ¼ N pM  ð1 pWBÞ
N = maxbirds capacity of the theoretical area
pM = percentage of migratory birds
pWB = percentage of water birds
MNWB = number of migratory non water birds arriving in a virtual contact area during the whole
migratory season.
The size of these population subgroups depends on the maximum population capacity N and the
percentages pM and pWB considered in each scenario. In order to explore the potential inﬂuence of
population size in the virtual contact area, two different times of entrance of infected migratory water
birds were considered: at the beginning (day 1) and in the middle (day 60) of the migration season.
For the LPAI model, it is considered that introduction of LPAIV into a free local area within the EU
can occur via infected water birds entering the area. These birds are further referred to as ‘entering
birds’ since they can be migratory birds arriving from countries outside the EU or birds previously
resident in neighbouring areas and locally moving to the virtual area under consideration.
Different wild bird population scenarios in a virtual local area have been simulated based on
different carrying capacities (i.e. maximum number of birds that can land in the area), three initial AI
prevalence levels (0.2%, 2% and 6%) and different proportions of na€ıve birds (reﬂected in two initial
proportions of susceptible birds (0.5 and 1)) (see Table 5, Section 3.2.2). The wild bird population
composition was kept ﬁxed as for the proportion of entering/present wild birds (0.9/0.1) and water/
non-water birds (0.9/0.1) since this was considered the worst-case scenario.
In the virtual local area and for each simulated population, daily arrival of entering wild birds over
the considered period is described using a constant arrival rate and the entrance of infected birds is
described to occur in several occasions during the considered period.
The total number of infected entering water birds carrying LPAIV and entering the virtual local area
during the considered period is given by:
IEWB ¼ EWB pEWB
For each day of the considered period, the number of entering LPAI-infected birds is simulated with
a multinomial distribution, allocating IEWB infected water birds in 125 days. Consequently, the number
of susceptible water birds (EWBt) and non-water birds (ENWBt) entering a virtual local area at time t (in
days) during the considered period is assumed to be constant in t and, respectively:
SEWBðtÞ ¼ EWB pnv  ð1 pEWBÞ=PLength
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 105 EFSA Journal 2017;15(10):4991
SENWB(t) ¼ ENWB pnv=PLength
where:
EWB ¼ N pE  pWB
ENWB ¼ N pE  ð1 pWBÞ
pnv ¼ initial proportion of na€ıve birds
N = maxbirds capacity of the theoretical area
PLength = length in days of the considered period
pE = percentage of birds entering local area from EU-infected areas or from outside the EU.
Finally, the number of immune water birds (EWBt) and non-water birds (ENWBt) entering a virtual local
area at time t (in days) during the considered period is assumed to be constant in t and, respectively:
REWBðtÞ ¼ EWB ð1 pnvÞ  ð1 pEWBÞ=PLength
RENWB(t) ¼ ENWB ð1 pnvÞ=PLength
Given the assumptions above, it was considered that the model best describing AIV dynamic in the
wild bird reservoir in the virtual contact area is a SIR model. However a new compartment (named G)
was added to the traditional SIR model in order to capture the persistence of the excretion infectivity
beyond the infectivity of the bird. The transition between S (Susceptible) and I (Infected) is assumed
to occur at transition rate b, whose expected value is expressed as the product of the probability of
contact of wild birds with infected excretions and probability of a wild bird to get infected given a
contact with infected excretions.
The probability for a WB or a NWB of getting in contact with infected excretions shed by WB and
NWB in a virtual contact area is expressed as a non-linear function of the total infected excretions
released in a virtual area and still infective at time t. It is assumed that infectivity of excretions can
persist up to an approximated maximum of 13 days (see Section D.1.9). Therefore, at time t, birds
can be infected not only by virus shed in the same day but also by virus persisting in the environment
in the following 13 days. The release of excretions is assumed to occur randomly in space and with a
frequency and amount that is the same for the two categories of birds. Therefore, each day, the
number of infected birds is assumed to be a proxy of the virus newly excreted (I) while the number of
birds recovered from infection, but whose excretions are still infective, is a proxy of the excretions in
the persistence period beyond bird infectivity (G). The level of infectivity of the excretions is assumed
to be constant over the period of persistence. Although not corresponding to reality, this last
assumption is more likely to underestimate the probability of infection because infectivity is likely to
decrease over time
ProbðcontactWBÞ ¼ 1 ebWB;WBðIWBþGWBÞbNWB;WBðINWBþGNWBÞ
ProbðcontactNWBÞ ¼ 1 ebWB;NWBðIWBþGWBÞbNWB;NWBðINWBþGNWBÞ
where WB, WB; NWB, WB; NWB, NWB; and WB, NWB indicate the possible bird-to-excretion contact
types via excretions (ﬁrst acronym indicates the source of infection, the second one the infection
recipient) and:
IWB = number of infected WB
INWB = number of infected NWB
GWB = number of WB already recovered whose excretions are still infectious
GNWB = number of NWB already recovered whose excretions are still infectious.
The probability of infection, respectively, for a WB and a NWB is expressed as the product of the
conditional probability that a susceptible WB or NWB becomes infected given a contact with infectious
excretions and the probability of a contact as deﬁned above:
ProbInfWB ¼ C1HP;LP  ProbðInfWBjcontactÞ  ProbðcontactWBÞ
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ProbInfNWB ¼ C1HP;LP  ProbðInfNWBjcontactÞ  ProbðcontactNWBÞ
where
C1HP;LP ¼ reduction coefﬁcient for the probability that a susceptible wild bird becomes infected given
a contact with excretions containing LPAI infectious virus with respect to HPAI-infected excretion.
The reduction coefﬁcient is equal to 1 for HPAI model, while for LPAI model, it describes the factor
of decrease of the probability that a susceptible wild bird becomes infected given a contact with
excretions containing LPAI infectious virus with respect to the same probability calculated for a
susceptible wild bird coming in contact with HPAI-infected excretion.
The transition between I (Infected) and G (recovered with infected excretions) is regulated by the
rate of recovery (inverse of the shedding period). Move from compartment G to R (Recovered) is ruled
by the rate of persistence (inverse of persistence duration).
From day t = 1 onwards, the daily change in the size of the four populations of Susceptible (S),
Infected (I), Recovered with infected excretions (G) and Recovered with non-infected excretions (R) is
described by the following differential equations:
a) for WBs:
dSWB
dt
¼ ðProbInfWBÞ  SWB(t)þMWB(t)
dIWB
dt
¼ ðProbInfWBÞ  SWB(t)þ 1A(t) IMWB ðrWB þmdWBÞ  IWB(t)
dGWB
dt
¼ rWB  IWB(t) s GWB(t)
dRWB
dt
¼ s GWB(t)þ RMWB(t)
ProbInfWB ¼ 0 t\tk
ProbInfWB t tk

tk ¼ first day of arrival of infected migratory birds
mdWB ¼ mortality rate in WB due to AI
rWB ¼ rate of recovery in WB (inverse of shedding period)
s ¼ rate at which excretions become not infected (inverse of persistance duration)
GWB ¼ recovered WB with excretions still infective
1A(t) ¼
1; t 2 A
0; t not 2 A

is the indicator function of the subset A of days t in which infected
migratory birds arrive
For HPAI, the proportion of na€ıve birds is pnv = 100%. For LPAI, the same formulas apply replacing
SMWB(t) with SEWB(t) and RMWB(t) with REWB(t).
b) for NWBs:
dSNWB
dt
¼ ProbInfNWB  SNWB(t)þ SMNWB(t)
dINWB
dt
¼ ðProbInfNWBÞ  SNWB(t) ðrNWB þmdNWBÞ  INWB(t)
dGNWB
dt
¼ rNWB  INWBðtÞ  s GNWB(t)
dRNWB
dt
¼ s GNWB(t)þ RMNWB(t)
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ProbInfNWB ¼ 0 t\tk
ProbInfNWB t tk

tk ¼ first day of arrival of infected migratory birds
mdNWB ¼ mortality rate in NWB due to AI
rNWB ¼ rate of recovery in NWB (inverse of shedding period)
s ¼ rate at which excretions become not infected (inverse of persistance period)
GNWB ¼ recovered NWB with excretions still infectious
For HPAI, the proportion of na€ıve birds is pnv = 100%. For LPAI, the same formulas apply replacing
SMNWB(t) with SENWB(t) and RMNWB(t) with RENWB(t). For each day of the migration season, the
SIR model allows calculating the prevalence of infected wild birds (both for WBs and NWBs). The
starting values are:
a) for WBs:
SNWBð0Þ ¼ RWB ðpnvÞ
INWBð0Þ ¼ 0
GNWBð0Þ ¼ 0
RNWBð0Þ ¼ RWB ð1 pnvÞ
where RWB = N 9 (1  pM) 9 pWB is the number of residential water birds present in a virtual contact
area over the migratory season (for HPAI) or the considered period (for LPAI).
b) for NWBs:
SNWBð0Þ ¼ RNWB ðpnvÞ
INWBð0Þ ¼ 0
GNWBð0Þ ¼ 0
RNWBð0Þ ¼ RNWB ð1 pnvÞ
where RNWB = N 9 (1  pM) 9 (1  pWB) is the number of residential non water birds present in a
virtual contact area over the migratory season (for HPAI) or the considered period (for LPAI).
The prevalence of infected WBs at day t = k is given by:
pk;WB ¼ It;WB
RWB ðpnvÞ þ
Pk
t¼1 SMWBt 
Pk
t¼1 DWBt
where:
IWB;t ¼ solution of differential equation for IWB at time t
DWBd are WB dead due to AI disease given by:
DWBt ¼ mdWB  IWB;t
The prevalence of infected NWBs at day d = k is given by:
pt;NWB ¼ It;NWBNWBt ¼
It;NWB
RNWB ðpnvÞ þ
Pk
t¼1 SMNWBt 
Pk
t¼1 DNWBt
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where
INWB;t ¼ solution of differential equation for INWB at time t
DNWBd is the number of NWB dead by AI disease given by:
DNWBt ¼ mdNWB  INWB;t
C.3.3. Uncertainty analysis
Two types of uncertainty have been addressed in the model:
• Uncertainty on the evidence used to estimate the parameters in the model.
• Uncertainty related to the assumptions made in the model and in the overall assessment.
Uncertainty related to model parameters has been expressed using probability distributions
estimated via EKE (Table C.2). Then, these uncertainty distributions have been combined in the model
using MC simulations.
The approach taken to analyse the uncertainties related to the assumptions made in the ‘AI
dynamics’ compartment of the model varies depending on the level of realism of the assumption, the
expected impact on the outcome and the feasibility of quantifying it as indicated in the table below.
Table C.2: Expected impact of assumptions on the ‘AI dynamics’ compartment of the model on the
model outcome
Assumption Expected impact Explanation
The entrance of migratory susceptible
wild birds into the EU during migration
season is modelled with a constant rate
Negligible impact 1) The composition of the migratory wild birds
does not affect the output
2) Different species arriving at different time
covering all the migration period
Once birds land in the virtual area they
stay there for the whole season (125
days duration)
Negligible impact Birds will stay long enough in the area to allow
transfer of the virus. Prolonging their stay has
limited impact
Entry of infected migratory WB in the
EU is clustered on one day
Assessed quantitatively Worst-case scenario
The distribution of birds by day of
infectivity is uniform at the time they
cross the EU border
Most realistic
(negligible impact)
No evidence for a link between infection and
host ﬁtness
Once a wild bird got infected, it
becomes able to transmit infection to a
susceptible bird via its excretions from
the next day
Most realistic
(negligible impact)
Based on experimental data (Keawcharoen
et al., 2008)
Random pattern assumed for the
release of the infected excretions and
for the contact birds-excretions
Most realistic
(negligible impact)
From data defecation rate, every 5 min, and
they move randomly (e.g. about 7 min in
Durant et al. 2006)
Contact with excretions is the only route
of infection.
Most realistic
(negligible impact)
Direct and indirect transmission of virus occurs
via excretions
Groups of wild bird species are assumed
to forage in a similar surface of the
virtual contact area during a given day
Most realistic
(negligible impact)
The probability of a wild bird to get in contact
with contaminated excretions was estimated
for groups of wild bird species with different
behaviours
Probability of getting in contact with
infected excretions excreted by birds
from the same category is higher
Most realistic
(negligible impact)
Birds of the same category share the same
ecological niches which has only partial overlap
with the other category
Quantity of excretion is not considered
to differ between the different
categories of birds
Negligible impact Sharing the same ecological niches for birds of
the same category has a much higher
inﬂuence on the probability of contact
compared to the quantity excreted
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It was not needed to estimate the combined impact of the uncertainties related to the assumptions
since they were considered either reﬂecting the worst-case scenario or expected to have a negligible
impact on the model/assessment outcome.
C.4. AI introduction into a poultry holding
C.4.1. Assumptions
For the sake of simplicity and considering the limitations in the available data, the following
assumptions have been made in the ‘poultry introduction’ compartment of the model:
27) The presence of excretions in the holding premises is assumed to initiate infection
(covering both ‘direct’ and ‘indirect’ virus transfer).
28) The probability of infection of a poultry holding is assumed to be a function of the
holding’s biosecurity level and of the number of infected wild birds landing daily into the
holding area. The transfer of infectious excretions from wild birds to poultry can happen
via any mechanism.
29) No overlap was assumed among virtual contact areas and holding premises.
30) Defecation by wild birds occurs on land or in water but not during ﬂight.
C.4.2. Description
The model describes the probability that a poultry holding with a speciﬁed level of biosecurity
becomes AI infected via wild birds. Since the WBs and NWBs are assumed to have a different
Assumption Expected impact Explanation
Infectivity of the excretions in the
environment is assumed to be
maintained for a number of days after
release. During the persistence period
level of infectivity of the excretions is
assumed to be constant.
Worst-case scenario Evidence indicate a decrease of infectivity
(Nazir et al., 2010)
Number of infected excretions is
assumed to be directly proportional to
the number of birds shedding the virus
(infected) plus number of birds that
recovered from infection but whose
excretions are still infectious
Negligible impact Sharing the same ecological niches for birds of
the same category has a much higher
inﬂuence on the probability of contact
compared to the quantity excreted
AI infection confers immunity to birds
once birds recover from the disease
Negligible impact Quantity of virus excreted by a bird re-infected
with the same clade in a migration season is
considered negligible to inﬂuence the outcome
of the model; low prevalence low probability of
reinfection
All migratory non-water birds are
susceptible when they enter the EU
Most realistic
(negligible impact)
Categories were set up also on the probability
they bring in the infection; evidence: very few
non water birds found infected with HPAI
2.3.4.4 clade
All residential wild birds (both water
birds and non-water birds) are
susceptible to the infection at the start
of the migration season; the inﬂuence
of heterologous immunity and previous
exposure is not considered
Worst-case scenario Immunity would reduce viral ampliﬁcation
Population dynamics of wild birds do not
include baseline wild bird mortality
Worst-case scenario Including baseline mortality will decrease the
size of the susceptible population. Analysis of
the impact on the outcome of the model was
negligible
Population dynamics of wild birds do not
consider hatch
Most realistic
(negligible impact)
Hatching does not occur during the migration
or winter seasons
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propensity of landing into a poultry holding (1 km radius area), the probability is computed separately
for the two groups of birds.
The probability of infection of a poultry holding located in the proximity of a virtual contact area is
assumed to be a function of the holding’s biosecurity level and of the number of infected wild birds
landing daily into the holding area and releasing infectious excretions. Four different biosecurity levels
have been considered (see Figure 7, Section 3.2.2). Based on expert judgement (see Section D.4), the
relationship between the probability of infection of a poultry holding and the number of infected wild
birds is deﬁned as a non-linear function, with different regression coefﬁcients at different levels of
biosecurity.
Therefore, the probability that any biosecurity bn-type poultry holding becomes infected via wild
birds on day t is given by:
ProbðPHbninfÞ ¼ 1 eðC
2
HP;LPbWB;bnIint;WBþC2HP;LPbNWB;bnIint;NWBÞ
where:
Iint;WB ¼ pt;WB WBin n. infected WB entering a poultry holding with biosecurity bn in day t
Iint;NWB ¼ pt;NWB  NWBin n. infected NWB entering a poultry holding with biosecurity bn in day t
WBin ¼ number WB entering a poultry holding daily
NWBin ¼ number NWB entering a poultry holding daily
bn ¼ b0, b1, b2, b3, b4 ¼ biosecurity levels (see definition aboveÞ
bbn ¼ incidence rate ðindex for WB and NWB omittedÞ
ProbðPHb0 infÞ ProbðPHb1 infÞ ProbðPHb2 infÞ ProbðPHb3 infÞ ProbðPHb4 infÞ
C2HP;LP ¼ reduction coefﬁcient for the probability for a worst-case holding to get the infection given
the presence of LPAI-infected wild bird with respect to HPAI-infected wild bird.
The reduction coefﬁcient is equal to 1 for HPAI model, while for LPAI model it describes the factor
of decrease of the probability that a worst-case holding becomes infected given the presence of LPAI-
infected wild bird with respect to the same probability calculated for a worst-case holding coming in
contact with HPAI-infected wild bird.
The probability that any biosecurity bn-type poultry holding becomes infected via wild
birds during the whole migration season (named as seasonal probability in the main text) is given by:
ProbseasonðPHbn infÞ ¼
X125
t¼1
ProbtðInfbnÞ  f½1 Probt1ðInfbnÞ. . .. . .. . .½1 Prob1ðInfbnÞg
C.4.3. Uncertainty analysis
Uncertainties related to the evidence used to estimate the parameters in the model, has been
expressed using probability distributions estimated via EKE (Table C.3). Then, uncertainty distributions
have been combined using MC simulations.
The approach taken to analyse the second type of uncertainties varies depending on the level of
realism of the assumption, the expected impact on the outcome and the feasibility of quantifying it as
indicated in Table C.3 below.
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The impact of the only uncertainty related to assumptions that was considered needed to assess
quantitatively was estimated via a semi-formal EKE and reported in Appendix E (model outputs).
C.5. Model parameterisation
This section reports the methods used to estimate model parameters. It reﬂects the structure of
the model that is arranged in three compartments: entry assessment, AI ampliﬁcation in the wild bird
reservoir, AI introduction into a poultry holding.
Existing data were available for few parameters of them, which were later kept constant in the
model. Most of the parameters entering the model were estimated by experts either via semi-formal or
formal EKE. As output of the EKE process, an estimate of quartiles plus lower and upper bounds of the
uncertainty distribution for the elicited parameter was provided by the experts, ﬁrst individually and
then collectively after a discussion ﬁnalised by reaching a consensus.
Those values were subsequently used to identify – among a set of reasonable parametric
distributions – the one best ﬁtting the elicited quantiles (based on the minimisation of the squared
distance from theoretical quantiles) and to estimate its parameters. All the analyses were performed
using statistical software R, package rriskDistributions and a modiﬁed version of package SHELF 2.01
(O’Hagan, 2016).
The list of parameters used in the simulation model, together with their estimated uncertainty
distributions is provided in Sections C.6, C.7, D.2 and D.3.
C.5.1. Entry assessment
The prevalence of HPAI (clade 2.3.4.4, 2.3.2.1c or 2.2.1.x) infection in WB at the entry point into
the EU and the number of MWB entering the EU in a migration season, were estimated by an EKE
process and described by an uncertainty probability distribution.
C.5.2. AI dynamics in the wild bird reservoir
Virtual contact area
For the scope of this assessment, a virtual contact area is deﬁned as an area of about 4 ha in size
in which wild birds forage. It is assumed to include either the ﬁrst of the following items or a
combination of the ﬁrst item with one of the following two:
1) a foraging area with a surface of 4 ha where wild birds are supposed to gather in order to
feed on grass/crops/shrubland (foraging area). These areas are assumed to have any cover
but water/wetland, artiﬁcial cover, bareland or woodland;
Table C.3: Expected impact of assumptions on the ‘poultry introduction’ compartment of the model
on the model outcome
Assumption Expected impact Explanation
Probability of infection of a poultry
holding is assumed to be a function of
the holding’s biosecurity level
Most realistic
(negligible impact)
Extrapolation from data for LPAI
Probability of infection of a poultry
holding is assumed to be a function of
the number of infected wild birds
landing daily into the holding area
Most realistic
(negligible impact)
Regional origin of the virus (e.g. no HPAI
clade 2.3.4.4. of America origin was found
in EU holdings)
No overlap among virtual contact
areas and holding premises was
considered
Assessed quantitatively The number of wild water birds on the
holding will increase, which could shift the
distribution on the probability to introduce
the virus to the right
Contact with excretions is assumed to
be the only route of infection
Most realistic
(negligible impact)
The deﬁnition of excretions is very broad,
covering both direct and indirect virus
transfer
Defecation by wild birds occurs on
land or in water but not during ﬂight
Most realistic
(negligible impact)
Many wild birds species spent much more
time on land/water during a day compared
to their ﬂight time. Defecation mainly occurs
directly after feeding
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 112 EFSA Journal 2017;15(10):4991
2) water/wetland area;
3) any NWB typical habitat other than foraging areas (i.e. woodland, shrubland).
Virus transfer between wild birds visiting the virtual contact area is possible even if they are not
present at the same moment, for instance via exposure to contaminated faeces.
Probability of contact
The probability of contact with infected excretions is estimated separately for WB and NWB,
according to the following bird-to-bird contact types: 1. WB, WB; 2. NWB, WB; 3. NWB, NWB; 4. WB,
NWB (where the ﬁrst acronym indicates the source of infection, the second one the infection recipient)
deﬁned as follows:
1) Contact WB, WB: Contact of WBs with virus shed by other WBs occurring in a theoretical
area deﬁned as a foraging area and/or wetland/water area;
2) Contact NWB, NWB: Contact of NWBs with virus shed by other NWBs occurring in a
theoretical area deﬁned as a foraging area and or any other NWB typical habitat (i.e.
woodland, shrubland);
3) Contact WB, NWB: Contact between NWB and virus shed by WB occurring in a theoretical
area deﬁned as a foraging area;
4) Contact NWB, WB: Contact between WB and virus shed by NWB occurring in a theoretical
area deﬁned as a foraging area.
The probabilities of contact related to the various bird-to-bird contact types have been elicited by
experts, in the form of uncertainty distributions (see Section D.1.4), taking into account the following
considerations. As for transmission occurring via water (only for WBs), dilution by the volume of the
water body, possible currents and sedimentation to the ground would grossly reduce the virus density
but the virus may persists longer in the water61 compared to on the soil. Therefore, as a general rule
agreed in the expert group, the immediate probability to get into contact with infected excretions in
the water, given the number of infected birds, was considered lower than the analogous probability of
contact occurring on the soil in the foraging areas, but it was considered to last longer in time in the
water compartment. The two probabilities have not been estimated separately.
Habitats other than water and foraging areas were considered as places where contact with
infected excretions could also take place, but only for NWBs. Within the group of experts estimating
this parameter uncertainty distribution, it was agreed that the probability of contact would be lower in
such places compared to the foraging areas. The two probabilities thought have not been estimated
separately.
Experts were asked to estimate the uncertainty for different levels of exposure to infected
excretions, namely virus shed by 1, 10 and 100 birds for each quantile of the uncertainty distribution.
A non-linear regression model provided the best ﬁt for each quantile separately for WB and NWB
for each bird-to-excretion contact type:
ProbðcontactNWB;WBÞ ¼ 1 ebNWB;WBINWB
ProbðcontactWB;WBÞ ¼ 1 ebWB;WBIWB
ProbðcontactNWB;NWBÞ ¼ 1 ebNWB;NWBINWB
ProbðcontactWB;NWBÞ ¼ 1 ebWB;NWBIWB
For HPAI, the initial conditions used to run the SIR model, assuming that all infected migratory WBs
enter EU the ﬁrst day of the migratory season, for a theoretical area and a population scenario are
given below:
• Number of infected at time 1 for:
– WBs is I1,WB = MWB 9 pMWB
– NWBs is I1,NWB = 0
61 Waterbodies have in general relative constant, low temperatures, which tend to prolong the survival of the virus, and
desiccation of the virus cannot occur in water, as it can happen on the ground.
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• Number of susceptible at time 1 for:
– WBs is S1,WB = MWB1 + RWB
– NWBs is S1,NWB = MNWB1 + RNWB
Where RWB and RNWB indicate residential WB and NWB.
All susceptible birds can potentially get in contact with infected excretions
• Number of recovered for both WB and NWB is:
R1;WB ¼ R1;NWB ¼ 0
Meaning that there are no recovered birds at the start of the migration season.
Similar initial conditions are used for LPAI, where MWB/MNWB are replaced by EWB/ENWB.
Model scenarios for HPAI
Different scenarios in terms of size (10–100,000 birds) and composition of wild bird populations are
considered in each virtual contact area in order to assess AI infection ampliﬁcation in the wild bird
reservoir. Population composition in the scenario was altered by assuming different proportions of
migratory birds (pM) and water birds (pWB). The scenarios represent extreme situations, identiﬁed by
10% and 90% of migratory/resident and water/non-water birds in the wild bird reservoir (see Table 1,
Section 3.2.2).
The total number of migratory WBs entering the virtual contact area during the migration season is
given by the population size multiplied by the proportion of migratory birds and the proportion of WBs.
Similar calculations are done for NWBs (see example Table C.4).
Model scenarios for LPAI
For the LPAI simulations, scenarios are selected to analyse the effect of virus prevalence in the wild
bird population (since this parameter had a large impact on the outcome of the HPAI model) and the
effect of protective immunity (since this an important biological question). A description is provided in
Section 3.3.2.
Table C.4: Population size and different wild bird composition for the considered scenarios given a
population size of 100,000 wild birds. The number of migratory water birds (MWB),
migratory non-water birds (MNWB), residential water birds (RWB) and residential non-
water birds (RNW) are calculated applying the proportions of migratory birds (pM) and
water birds (pWB) to the population size
Scenario Population size pM pWB RWB RNWB MWB MNWB
1 100,000 0.9 0.9 9,000 1,000 81,000 9,000
2 100,000 0.9 0.1 1,000 9,000 9,000 81,000
3 100,000 0.1 0.9 81,000 9,000 9,000 1,000
4 100,000 0.1 0.1 9,000 81,000 1,000 9,000
Table C.5: Population size, wild bird composition, prevalence of infected entering water bird and
proportion of na€ıve wild population for the considered scenarios given a population size
of 100,000 wild birds. The number of migratory water birds (MWB), migratory non-
water birds (MNWB), residential water birds (RWB) and residential non-water birds
(RNW) are calculated applying the proportions of migratory birds (pM)and water birds
(pWB) to the population size
Scenario Population size pM pWB RWB RNWB MWB MNWB pEWB pnv
1 100,000 0.9 0.9 9,000 1,000 81,000 9,000 6% 1
2 100,000 0.9 0.9 9,000 1,000 81,000 9,000 2% 1
3 100,000 0.9 0.9 9,000 1,000 81,000 9,000 2% 0.5
4 100,000 0.9 0.9 9,000 1,000 81,000 9,000 0.2% 1
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C.5.3. AI introduction into a poultry holding
Poultry holding area
For the purpose of this assessment, the poultry holding is determined by a 1 km radius circle from
the centre of the holding and has a surface of 3.14 km2. Infected excretions released by wild birds
within the poultry holding area may enter into a production unit via any means (e.g. boots, car
wheels, etc.).
Probability of infection
Under the assumption that there is a non-linear relationship between the probability that a poultry
holding becomes infected and the number of infected birds landing in the holding premises, the
approach previously adopted to estimate the probability of a contact with infected matrices was also
used here. Parameters expressing the probability of infection were estimated given the presence of 1,
10 and 100 infected birds in the poultry holding area.
Parameter estimates for the probability of infection given exposure to infected excretions of WB
and NWB are given Sections D.1.13 and D.1.14, for HPAI and LPAI, respectively.
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C.6. Variables used to model HPAI
The model described above was also used to assess entry of HPAI clades 2.3.4.4, 2.3.2.1c and 2.2.1.2 into the EU via the NE route. Only the parameters
‘number of infected water birds entering the EU’ and ‘the infectious period for WBs and NWBs’ and ‘mortality rate due to the disease for WBs and NWBs’
were considered to be different between the clades. The estimated values for all parameters used in the model are provided in Tables C.7 (clade 2.3.4.4)
and C.8 (clades 2.3.2.1c and 2.2.1.2).
Table C.6: List of variables used in the HPAI clade 2.3.4.4 simulation model with description, type of EKE performed, type of distribution ﬁtted and
relative parameter estimates
Parameter Description Source
Uncertainty
distribution
shape
U distr par1 U distr par2 U distr par3 U distr par4 More info
MSLength Length (in days) of the
fall–winter migration
season for wild birds
entering the EU
through the north-east
border
Semi-formal
EKE
Constant 125 NA NA NA Section D.1.1
pMWB Number of HPAI clade
2.3.4.4 infected water
birds at the moment
they cross the EU
border out of 106
Formal EKE Weibull Scale = 0.48 Shape = 237.75 NA NA Section D.1.2
Prob(contactNWB,NWB) Probability that a non-
water bird comes in
contact with HPAI
clade 2.3.4.4 infectious
excretions of non-
water birds
Semi-formal
EKE
Beta a = 0.72 b = 69.84 NA NA Section D.1.4
Prob(contactNWB,WB) Probability that a
water bird comes in
contact with HPAI
clade 2.3.4.4 infectious
excretions non-water
birds
Semi-formal
EKE
Beta a = 0.55 b = 74.55 NA NA Section D.1.4
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Parameter Description Source
Uncertainty
distribution
shape
U distr par1 U distr par2 U distr par3 U distr par4 More info
Prob(contactWB,NWB) Probability that a non-
water bird comes in
contact with HPAI
clade 2.3.4.4 infectious
excretions non-water
birds
Semi-formal
EKE
Beta a = 0.56 b = 45.26 NA NA Section D.1.4
Prob(contactWB,WB) Probability that a
water bird comes in
contact with HPAI
clade 2.3.4.4 infectious
excretions water birds
Semi-formal
EKE
Beta a = 0.56 b = 35.64 NA NA Section D.1.4
1/rNWB Reciprocal of the
duration in days of the
HPAI clade 2.3.4.4
shedding period in
non-water birds
Semi-formal
EKE
Tnorm Mean = 4.14 SD = 4.3 Lower
bound = 0.15
Upper
bound = 17.28
Section D.1.5
1/rWB Reciprocal of the
duration in days of the
HPAI clade 2.3.4.4
shedding period in
water birds
Semi-formal
EKE
Weibull Scale = 1.87 Shape = 5.96 NA NA Section D.1.5
mdNWB Mortality rate in non-
water birds due to
HPAI clade 2.3.4.4
disease
Literature Constant 0.75 NA NA NA Section D.1.7
mdWB Mortality rate in water
birds due to HPAI
clade 2.3.4.4 disease
Literature Constant 0.07 NA NA NA Section D.1.7
Preservation AIV preservation in the
environment
Literature Constant 13 Section D.1.9
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Parameter Description Source
Uncertainty
distribution
shape
U distr par1 U distr par2 U distr par3 U distr par4 More info
Prob(InfNWB | contact) Probability that a
susceptible non-water
bird becomes infected
with HPAI clade
2.3.4.4 given a contact
with excretions
containing infectious
virus in a forage area
Semi-formal
EKE
Beta a = 0.78 b = 1596.73 NA NA Section D.1.10
Prob(InfWB | contact) Probability that a
susceptible water bird
becomes infected with
HPAI clade 2.3.4.4
given a contact with
excretions containing
infectious virus in a
forage area
Semi-formal
EKE
Beta a = 0.74 b = 235.89 NA NA Section D.1.10
NWBini Number of non-water
birds landing into a
holding
Formal lnorm Mean = 6.75 SD = 1.05 NA NA Section D.1.12
WBini Number of water birds
landing into a holding
Formal Weibull Scale = 0.46 Shape = 111.36 NA NA Section D.1.12
bb0 Regression coefﬁcient
for the probability for
a worst-case holding
to get the HPAI clade
2.3.4.4 infection given
the presence of HPAI-
infected wild bird
Formal beta a = 0.38 b = 561.41 NA NA Section D1.13
TMWB Total number of
Migratory WB entering
EU during migration
season
Selected
scenarios
Tnorm Mean = 53403.94 SD = 70370.43 Lower bound
= 1,6826.33
Upper bound
= 5,5632.39
Section C.5.2
Model scenarios
NA, not applicable.
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Table C.7: List of variables used in the HPAI clades 2.3.2.1c and 2.2.1.2 simulation model (which are different compared to the HPAI clade 2.3.4.4
variables, see Table C.6) with description, type of EKE performed, type of distribution ﬁtted and relative parameter estimates
Parameter Description Source
Uncertainty
distribution
shape
U distr
par1
U distr
par2
U distr
par3
U distr
par4
More
info
pMWB Number of HPAI clade 2.3.2.1c infected HPAIV water birds at the
moment they cross the EU border out of 106
Semi-
formal EKE
Weibull 0.53 191.45 NA NA Table D.1
Number of HPAI clade 2.2.1.2 infected HPAIV water birds at the
moment they cross the EU border out of 106
Semi-
formal EKE
Weibull 0.62 14.67 NA NA Table D.1
1/rNWB Reciprocal of the duration in days of the HPAI clades 2.3.2.1c and
2.2.1.2 shedding period in non-water birds
Semi-
formal EKE
tnorm 17.02 10.22 0.1 10.37 Table D.1
1/rWB Reciprocal of the duration in days of the HPAI clades 2.3.2.1c and
2.2.1.2 shedding period in water birds
Semi-
formal EKE
Weibull 1.45 4.93 NA NA Table D.1
mdNWB Mortality rate in non-water birds due to HPAI clade 2.3.2.1c disease Literature Constant 1 NA NA NA Table D.2
Mortality rate in non-water birds due to HPAI clade 2.2.1.2 disease Literature Constant 0.79 NA NA NA Table D.2
mdWB Mortality rate in water birds due to HPAI clade 2.3.2.1c disease Literature Constant 0.63 NA NA NA Table D.2
Mortality rate in non-water birds due to HPAI clade 2.2.1.2 disease Literature Constant 0.79 NA NA NA Table D.2
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C.7. Variables used to model LPAI
Table C.8: List of variables used in the LPAI simulation model
Parameter Description Source
Uncertainty
distribution
shape
U distr par1 U distr par2 U distr par3 U distr par4 More info
MSLength Length (in days) of the fall–
winter migration season for
wild birds entering the EU
through the north-east
border
Semi-formal
EKE
Constant 125 NA NA NA Table D.1
Prob(contactNWB,NWB) Probability that a water bird
comes in contact with LPAI
infectious excretions
Semi-formal
EKE
Beta a = 0.72 b = 69.84 NA NA Section D.1.4
Prob(contactNWB,WB) Probability that a non-water
bird comes in contact with
LPAI infectious excretions
Semi-formal
EKE
Beta a = 0.55 b = 74.55 NA NA Section D.1.4
Prob(contactWB,NWB) Semi-formal
EKE
beta a = 0.56 b = 45.26 NA NA Section D.1.4
Prob(contactWB,WB) Semi-formal
EKE
beta a = 0.56 b = 35.64 NA NA Section D.1.4
1/rNWB Reciprocal of the duration in
days of the LPAI shedding
period in non-water birds
Semi-formal
EKE
tnorm b = 2.69 Lower
bound = 0.97
Upper
bound = 16.85
Section D.1.6
1/rWB Reciprocal of the duration in
days of the LPAI shedding
period in water birds
Semi-formal
EKE
tnorm a = 5.06 b = 3.61 Lower
bound = 1.87
Upper
bound = 25.13
Section D.1.6
mdNWB Mortality rate in non-water
birds due to LPAI disease
Literature Constant 0.0025 NA NA NA Section D.1.8
mdWB Mortality rate in water birds
due to LPAI disease
Literature Constant 0.001 NA NA NA Section D.1.8
Prob(InfNWB | contact) Probability that a susceptible
non-water bird becomes
infected with LPAI given a
contact with excretions
containing infectious virus in
a forage area
Semi-formal
EKE
beta a = 0.78 b = 1596.73 NA NA Section D.1.10
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Parameter Description Source
Uncertainty
distribution
shape
U distr par1 U distr par2 U distr par3 U distr par4 More info
Prob(InfWB | contact) Probability that a susceptible
water bird becomes infected
with LPAI given a contact
with excretions containing
infectious virus in a forage
area
Semi-formal
EKE
beta a = 0.74 b = 235.89 NA NA Section D.1.10
NWBini Number of non-water birds
landing into a holding
Formal EKE lnorm Mean = 6.75 SD = 1.05 NA NA Table D.1
WBini Number of water birds
landing into a holding
Formal EKE Weibull Scale = 0.46 Shape = 111.36 NA NA Table D.1
bb0 Regression coefﬁcient for the
probability for a worst-case
holding to get the LPAI
infection given the presence
of LPAI-infected wild bird
Formal EKE beta a = 0.39 b = 615.11 NA NA Table D.1
Preservation Virus preservation Literature Constant 13 NA NA NA Section D.1.3
C1HP;LP Reduction coefﬁcient for the
probability that a susceptible
water bird becomes infected
given a contact with
excretions containing LPAI
infectious virus with respect
to HPAI-infected excretion
Formal EKE 0.01 0.03 0.05 0.1 0.5 Section D.3
C2HP;LP Reduction coefﬁcient for the
probability for a worst-case
holding to get the infection
given the presence of LPAI-
infected wild bird with
respect to HPAI-infected
wild bird
Formal EKE 0 0.08 0.1 0.3 1 Section D.3
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Appendix D – Model input values
D.1. Identiﬁed scientiﬁc evidence
D.1.1. Length of the fall–winter migration season
It was determined as 125 days (e.g. mid-August to mid-December), reﬂecting the average fall–
winter migratory season in terms of duration and weather conditions based on the fall–winter
migratory seasons which occurred since fall 2005 until the end of winter 2015 (Kear, 2005).
For the LPAI model, also a period of 125 days was used but without specifying when it occurs
during the year. Keeping the length of the time period for the LPAI and HPAI the same facilitates
comparison of the model outcomes. However, as LPAI viruses can circulate throughout the year in the
wild bird population (data received as per procurement, coordinated by Linnaeus University (SE),
Erasmus Medical Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04,
unpublished), the 125-day period considered in the LPAI model can occur at any time point during a
year. Using scenarios with different prevalences reﬂects periods in the year with high/medium/low
prevalence (see Section 3.3.1).
D.1.2. Number of HPAIV clade 2.3.4.4 infected water birds
Data were used from 2014 to 2015 since the estimation of this parameter has been done in March
2016.
Data sources are (i) the European Commission database on wild birds and (ii) the NewFluBird
database maintained at the Friedrich Loefﬂer Institute (DE) (Duncan et al., 2017a).
Virus clade 2.3.4.4 (H5N8) has been detected in the EU in wild birds in the year 2014 for the ﬁrst
time. In total, 37,080 wild birds of around 200 species were sampled in 2014 and 2015, and among
those 10 animals were found as HPAIV H5N8 infected in 2014 and 2015.
The number and the proportion of sampled and positive wild birds belonging to the different group
of species is reported in Table D.1.
D.1.3. Prevalence of LPAIV in water birds
There is a high variation in (H5, H7 and H9) LPAIV prevalence between different seasons and in
geographical location within the EU since the prevalence is inﬂuenced by many factors like wild bird
population composition, weather and climate, vegetation structure, etc. (Perez-Ramirez et al., 2012;
Lambrecht et al., 2016).
LPAIV have been detected in more than 100 wild bird species but Anseriformes (particularly ducks,
geese and swans) and Charadriiformes (particularly gulls, terns and waders) appear to constitute the
most relevant species in LPAIV dynamics (Fouchier and Munster, 2009). These wild bird orders are, in
this scientiﬁc opinion, included in the water and non-water bird groups, respectively. Dabbling ducks of
the Anas genus has been found to be the more frequently infected with LPAIV than other birds
(Krauss et al., 2004; Munster et al., 2007; Parmley et al., 2008; Busquets et al., 2010b). This is likely
Table D.1: Total number and percentage of sampled and H5N8 infected wild birds in EU in 2014
and 2015 by group of species and according to the surveillance stream
Group of species
Number of sampled wild birds
(% of sampled wild birds)
Number of H5N8
infected wild birds
Passive
surveillance
Active
surveillance
Passive
surveillance
Active
surveillance
Waterbirds 1,548 (34.9) 27,180 (83.2) 1 8
Songbirds 1,416 (32.0) 2,806 (8.6) – –
Other 636 (14.4) 388 (1.2) – –
Raptors 552 (12.5) 50 (0.2) – –
Gulls–Storks–Cranes 263 (5.9) 2,206 (6.8) – 1
Waders 16 (0.1) 19 (0.1) – –
Total 4,431 (100) 32,649 (100) 1 9
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linked with habitat preference and foraging behaviour (ﬁltering surface water) that facilitate faecal–oral
virus transmission. A seasonal pattern in AIV prevalence in mallards has been reported, with peaks in
summer and autumn (Swieton et al., 2017).
A lot of data were collected on LPAIV prevalence in water birds to prepare for the formal EKE to
elicit this parameter (e.g. data received as per procurement, coordinated by Linnaeus University (SE),
Erasmus Medical Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04,
unpublished) and experts identiﬁed additional studies (Barral et al., 2008; Lebarbenchon, 2008;
Busquets et al., 2010b; Perez-Ramirez et al., 2010, 2012; Jurado-Tarifa et al., 2014; Swieton et al.,
2017). Although the availability of a large data set, it was not possible to elicit an average prevalence
across the EU given the variability of LPAIV prevalence in time and space.
Surveillance studies, mainly targeting mallards, indicated an annual peak in late summer and early
autumn due to an increased susceptible population, followed by low infection during winter and a
small increase during spring (Latorre-Margalef et al., 2014). In mute swans, higher numbers of
antibody-positive birds are found in summer and winter (e.g. Lambrecht et al., 2016).
The H5+H7+H9 LPAIV prevalence as used for the model was based on mallards sampled at Ottenby
in southern Sweden during fall migration, period August–December 2002–2015. The estimated weekly
H5+H7+H9 LPAIV prevalence was estimated at 2.0%, and maximum weekly H5+H7+H9 LPAIV
prevalence was estimated at 5.9%. The minimum H5+H7+H9 LPAIV prevalence value was estimated
based on mallards sampled at the same site but in the spring. To estimate the H5+H7+H9 LPAIV
prevalence, LPAIV general prevalence was extracted from weekly prevalence data as provided by
Jonas Waldenstr€om (data received as per procurement, Linnaeus University (SE), Erasmus Medical
Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, unpublished) and
LPAIV subtype distribution from mallards sampled at the same sample site was extracted from Table 1
in Latorre-Margalef et al. (2014).
D.1.4. Probability contact between wild birds and infectious excretions
The quantity of faeces excreted by water birds in one day largely varies between species and can
be up to 75 g fresh weight per individual. A forage area of 4 ha is considered in the model and the
surface of the forage area covered by excretions spread by 1, 10 or 100 infected water birds can vary
from 50 to 500 m2. The experts took the following assumptions into account when estimating the
variable: the faeces (virus) is dropped randomly in the foraging area, increasing the number of birds in
a foraging area increases the surface covered by excretions and birds walk randomly in the foraging
area.
D.1.5. Shedding period of HPAIV
Table D.2: HPAI H5N8 virus detection in oropharyngeal (O) or cloacal (C) swabs of different water
bird species after experimental infection via the intranasal route (positive/total number
of birds)
Species Swab 2 dpi 3 dpi 5 dpi 7 dpi 9 dpi 11 dpi Study
Muscovy duck O 4/4 4/4 4/4 3/4 2/4 A
C 4/4 4/4 4/4 3/4 1/4 A
Mallard O 4/4 4/4 0/4 0/2 B
C 1/4 3/4 0/4 0/2 B
Baikal teal O 1/2 0/1 0/1 0/1 0/1 C
C 1/2 0/1 0/1 0/1 0/1 C
Domestic duck O See ﬁgure A of study C C
C See ﬁgure B of study C C
Study A: strain A/Baikal teal/Korea/K14-E016/2014 (Lee et al., 2016).
Study B: A/duck/Jiangsu/k1203/2010 (Zhao et al., 2013).
Study C: A/broilerduck/Kr/buan2/2014 (Kang et al., 2015).
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D.1.6. Shedding period of LPAIV
Analysis of HPAI and LPAI transmission based on reported outbreaks, indicate a longer infectious
period for LPAI than for HPAI (Comin et al., 2011; Saenz et al., 2012). Henaux and Samuel (2011)
reported longer median virus shedding times for LPAI-infected ducks (10–11.5 days in oral and cloacal
swabs) than HPAI-infected ducks (5 days) and geese (7.5) days (Henaux and Samuel, 2011). The
authors used LPAI data from studies published between 1978 and 1987. The tables below provides
data on H5, H7 and H9 LPAIV shedding following inoculation as reported in more recent studies.
Table D.3: HPAI H5N8 virus detection in oropharyngeal (O) or cloacal (C) swabs of different non-
water bird species after experimental infection via the intranasal route (positive/total
number of birds)
Species Swab 2 dpi 5 dpi 7 dpi 9 dpi 11 dpi Study
Layer chicken O 8/8 6/6 NR NR NR A
C 7/8 6/6 1/1 NR NR A
Korean native chicken O 2/5 2/5 1/3 1/2 1/2 A
C 2/5 1/3 1/3 0/2 1/2 A
Quail O 4/4 NR NR NR NR A
C 4/4 NR NR NR NR A
NR: not reported.
Study A: strain A/Baikal teal/Korea/K14-E016/2014 (Lee et al., 2016).
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 124 EFSA Journal 2017;15(10):4991
Table D.4: H5, H7 or H9 LPAIV detection in oropharyngeal (O), cloacal (C) or faecal (F) swabs of different water bird species after experimental infection
(positive/total number of birds)
Species LPAIV Route Swab 2 dpi 3 dpi 5 dpi 7 dpi 9 dpi 11 dpi 14 dpi Reference
Mallard H5N2 A/mallard/MN/3555779/0 IN O 5/5 5/5 1/5 0/5 0/5 0/5 0/5 Franca et al. (2012)
C 4/5 4/5 5/5 4/5 2/5 0/5 0/5
IT O 5/5 5/5 1/5 0/5 0/5 0/5 0/5
C 5/5 4/5 5/5 5/5 0/5 0/5 0/5
IO O 5/5 5/5 4/5 2/5 0/5 0/5 0/5
C 5/5 5/5 5/5 2/5 1/5 0/5 0/5
IC O 5/5 4/5 0/5 0/5 0/5 0/5 0/5
C 5/5 5/5 5/5 3/5 0/5 0/5 0/5
II O 5/5 3/5 4/5 0/5 0/5 0/5 0/5
C 5/5 5/5 5/5 5/5 2/5 0/5 0/5
Mallard H7N7
A/mallard/Sweden/7206/2004
IE C 6/6 6/6 6/6 6/6 6/6 5/6 2/6 Jourdain et al. (2010)
F 6/6 6/6 6/6 4/6 4/6 4/6 3/6
Pekin ducks H7N2
A/chicken/NJ/15086-3/1994
ICh O + + + + + + + Spackman et al. (2010)
C + + + + + – –
H7N2
A/turkey/NY/4450-4/1994
ICh O + + + + + – –
C + + + + + + +
H7N2
A/chicken/NY/3112-1/1995
ICh O + + + + + – –
C + + + + + + +
H7N3
A/chicken/NY/12273-11/1999
ICh O + + + + + + +
C + + + + + + +
H7N2
A/chicken/NY/30749-3/2000
ICh O + + + + + – –
C + + + + + – –
H7N2
A/guinea hen/MA/148081-11/2002
ICh O + + + + + – –
C + + + + – – +
H7N2
A/chicken/PA/9801289/1998
ICh O + + + + – – –
C + + – – – – –
H7N2
A/turkey/VA/SEP-67/2002
ICh O + + + + + – –
C + – – – – – –
H7N2
A/chicken/MD/MinhMa/2004
ICh O + + + + + – –
C + – – + – – –
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Species LPAIV Route Swab 2 dpi 3 dpi 5 dpi 7 dpi 9 dpi 11 dpi 14 dpi Reference
H7N8
A/mallard/OH/421/1987
ICh O + + – – – – –
C – – + + + + +
H7N3
A/pintail/MN/423/1999
ICh O + + + + + + +
C + + + + + + +
H7N9
A/ruddy turnstone/DE/1538/2000
ICh O + + + + + + +
C + – + + + + +
Mallard H5N2
A/mallard/MN/355779/00
ICh O 2/5 5/5 4/5 ND 0/5 ND 0/5 Costa et al. (2011)
C 2/5 5/5 5/5 ND 3/5 ND 1/5
H7N3
A/mallard/MN/182761/98
ICh O 1/5 1/5 0/5 ND 0/5 ND 0/5
C 0/5 0/5 0/5 ND 0/5 ND 0/5
Redhead duck H5N2
A/mallard/MN/355779/00
ICh O 5/5 5/5 2/5 ND 3/5 ND 0/5
C 2/5 2/5 2/5 ND 2/5 ND 1/5
H7N3
A/mallard/MN/182761/98
ICh O 4/5 3/5 0/5 ND 1/5 ND 0/5
C 0/5 0/5 0/5 ND 0/5 ND 0/5
Wood duck H5N2
A/mallard/MN/355779/00
ICh O 3/5 3/5 2/5 ND 0/5 ND 0/5
C 0/5 0/5 0/5 ND 0/5 ND 0/5
H7N3
A/mallard/MN/182761/98
ICh O 2/5 2/5 0/5 ND 0/5 ND 0/5
C 1/5 0/5 0/5 ND 0/5 ND 0/5
Mallard H5N2
A/mallard/MN/346250/00
OINO O 3/4 0/4 3/4 0/4 ND ND ND Achenbach and Bowen (2011)
C 3/4 3/4 3/4 0/4 ND ND ND
Contact O 1/4 3/4 2/4 0/4 ND ND ND
C 0/4 4/4 4/4 0/4 ND ND ND
H7N3
A/Ruddy turnstone/ReedsBeachNJ/00
OINO O 3/4 4/4 4/4 0/4 ND ND ND
C 4/4 4/4 3/4 0/4 ND ND ND
Contact O 4/4 4/4 4/4 0/4 ND ND ND
C 4/4 4/4 3/4 1/4 ND ND ND
IN: intranasal; IT: intratracheal; IO: intraocular; IC: intracloacal; II: intraingluvial; IE: intra-oesophagus; ICh: intrachoanal; ND: non-determined; OINO: orally, intranasally and ocularly; +: mean
log10 virus shed titres of 13–15 birds > 0.25; –: mean log10 virus shed titres of 13–15 birds < 0.25.
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Table D.5: H5, H7 or H9 LPAIV detection in oropharyngeal (O) or cloacal (C) swabs of different non-water bird species after experimental infection
(positive/total number of birds)
Species LPAIV Route Swab 2 dpi 3 dpi 5 dpi 7 dpi 9 dpi 11 dpi 14 dpi Reference
Laughing gull H5N2
A/mallard/MN/355779/00
ICh O 5 5 4 ND 2 ND 0 Costa et al. (2011)
C 3 4 5 ND 1 ND 0
H7N3
A/mallard/MN/182761/98
ICh O 2 2 0 ND 0 ND 0
C 0 0 0 ND 0 ND 0
Gyr-saker hybrid falcon H7N2
A/Anas plathyrhynchos/Spain/1877/2009
Feed O + + + + + – ND Bertran et al. (2012)
NC O + + + + + + ND
Finches H9N2
A/environment/Bangladesh/9306/2010
ON O 4/5 ND 3/5 ND 0/5 ND ND Lenny et al. (2015)
Parakeets H9N2
A/environment/Bangladesh/9306/2010
ON O 5/5 ND 4/5 ND 0/5 ND ND
Feed: feeding; NC: nasochoanal; ICh: intrachoanal; ND: non-determined; ON: oculonasally; +: inverted Ct value < 35; –: inverted Ct value > 35.
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D.1.7. Mortality rate HPAIV in wild birds
The AI consortium extracted data from 30 studies (Duncan et al., 2017a) and overviews are
provided in Tables D.6 and D.7. Only studies where birds have been experimentally infected were
considered (n = 22). The mortality rate has been computed as the average of the ratio by study
between the number of birds died because of the infection, and the number of birds experimentally
inoculated. The minimum and the maximum are provided for completeness. Please bear in mind that
values provided in the two tables below are from studies that differ in terms of inoculation dose,
species inoculated, number of animals inoculated, general setting, etc.
For clade 2.2.1, one of the three studied included for computing the estimates was performed on
pigeons. Due to the well-documented low mortality caused by the infection with HPAI virus in pigeons,
this study was excluded from the estimates.
D.1.8. Mortality rate LPAIV in wild birds
Infection with LPAIV generally causes no major clinical signs in wild birds. The Tables D.7 and D.8
below give an overview of the reported morbidity and mortality reported in water and non-water birds,
respectively, following inoculation with H5, H7 or H9 LPAIV.
Table D.6: Mortality rate in water birds and non-water birds by clade based on data extracted from
the scientiﬁc literature by the AI consortium (Duncan et al., 2017a)
Viral clade and group
of wild bird species
Average
mortality
rate
Min.
mortality
rate
Max.
mortality
rate
No. of birds
inoculated in the
studies
No. of
experimental
studies
2.2.1 0.79 0.125 1 91 10
Non-water bids 0.79 0.71 0.88 23 2
Water birds 0.79 0.12 1 68 8
2.3.2.1 0.66 0 1 189 26
Non-water bids 1 1 1 8 2
Water birds 0.63 0 1 181 24
2.3.4.4 0.16 0 1 62 15
Non-water bids 0.75 0.5 1 8 2
Water birds 0.07 0 0.5 54 13
Grand total 0.54 0 1 342 51
Table D.7: Morbidity and mortality in water birds following experimental infection with H5, H7 or
H9 LPAIV
Species HN-type Dose (EID50 and TCID50) Route
Morbidity/
mortality
Reference
Pekin duck H5N3 3.3–1.6 9 105/L air AER No Kuiken (2013)
H5N2 1 9 105 NAS or ORA No
H2N2 1 9 107 ORA or REC No
Mallard H5N2 1 9 107 EID50 ORA and TRA No
H5N2 1 9 108.7 EID50 OES No
H5N1 1.25 9 105 EID50 IV No
H5N1 1.1 9 106 EID50 IV No
H4N6 and
H5N2
1 9 106 EID50 OCU, NAS and
PHA
No
H7N7 1 9 108.7 EID50 OES No
H5N9 1.5 9 106 PFU OES and PHA No
H3N8 and
H5N2
1 9 105–1 9 106 EID50 NAS No
Comm.
Layer type
duck
H5N2 1 9 107.2 EID50 NAS No
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D.1.9. AIV preservation
Although there is evidence that the AI virus can persist in the environment for a period of up to
several weeks and even months depending on the matrix and the environmental conditions
(Stallknecht and Brown, 2009; Nazir et al., 2010, 2011; Wood et al., 2010; EFSA, 2016a), a persistence
of 13 days was used as an approximation in the model. The approximation includes that the infectivity
is kept constant which does not reﬂect the observed gradual decay but compensates for the shortened
period.
D.1.10. Probability wild bird infection given contact with HPAIV-
infectious excretions
Table D.9 provides information on the virus concentration in oral and cloacal swabs of falcons
infected with HPAI H5N1 under experimental conditions.
D.1.11. Probability wild bird infection given contact with LPAIV-
infectious excretions
In wild birds, LPAIV is thought to preferentially infect cells lining the intestinal tract, leading to virus
shedding mainly via faeces (Fouchier and Munster, 2009). Transmission via the faecal–oral route is
considered the primary mode of LPAIV transmission in many bird species, although transmission via
respiratory secretions may also be relevant for particular land-based bird species (Ellstrom et al., 2008).
Achenbach and Bowen (2011) describe transmission of LPAIV H7N3 from inoculated mallards to
chickens, red-winged blackbirds and other mallards that were co-housed (Achenbach and Bowen,
2011). In a similar experiment, LPAIV H5N2 was only transmitted from mallards to chickens and
mallards via direct or indirect transmission, but not to red-winged blackbirds.
Species HN-type Dose (EID50 and TCID50) Route
Morbidity/
mortality
Reference
Cherry
Valley dom.
Duck
H5N1 1 9 108 EID50 NAS No
Pekin duck H5N1 106 EID50 (23 days
old pekin duck)
ED and NAS No Ferreira et al. (2010)
Mule duck H7N1 106 EID50 (7-day-old
mule duck)
AER: aerosol; IV: intravenous; NAS: intranasal; OCU: supraocular; OES: intra-oesophageal; ORA: intraoral; PHA: intrapharyngeal;
REC: intrarectal; TRA: intratracheal; ED: eye drop; EID50: median egg infectious dose; TCID50: median tissue culture infectious
dose; PFU: plaque-forming units; n.a., not appropriate.
Table D.8: Morbidity and mortality in non-water birds following experimental infection with H7
LPAIV
Species HN-type
Dose
(EID50/mL)
Route
Morbidity/
mortality
Reference
Captive-reared
gyr-saker hybrid
falcon
H7N2 106 Nasochoanal
and by natural
feeding
No Bertran et al. (2012)
Table D.9: HPAIV shedding of non-water birds following experimental inoculation
Species HPAIV Route Swab
Virus
concentration
Test
method
Reference
Gyr-saker
hybrid
falcon
H5N1
A/Great crested grebe/
Basque Country/
06.03249/2006)
Feed O  26 (inverted
Ct value)
RT-PCR Bertran et al. (2012)
NC O  28 (inverted
Ct value)
RT-PCR
Feed: feeding; NC: nasochoanal.
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Lenny et al. (2015) reported that ﬁnches and parakeets inoculated with H9N2 subsequently
excreted the virus but were not able to infect na€ıve birds of the same species that were kept in the
same cage (Lenny et al., 2015).
Tables D.10 and D.11 give an overview of the reported virus concentration shed by water and non-
water birds following inoculation with H5, H7 or H9 LPAIV.
Table D.10: LPAIV shedding of water birds following experimental inoculation
Species LPAIV Route Swab
Virus
concentrationA
Reference
Mallard H7N7
A/mallard/Sweden/7206/2004
IE C  21 (inverted
Ct value)
Jourdain et al. (2010)
F  15 (inverted
Ct value)
Mallard H5N2
A/mallard/MN/3555779/0
IN O  4.5 EID50/mL Franca et al. (2012)
C  4.9 EID50/mL
IT O  3.5 EID50/mL
C  4.9 EID50/mL
IO O  4.4 EID50/mL
C  6.5 EID50/mL
IC O  3.8 EID50/mL
C  6.2 EID50/mL
II O  4.2 EID50/mL
C  6.5 EID50/mL
Pekin ducks H7N2
A/chicken/NJ/15086-3/1994
ICh O  2.5 EID50/mL Spackman et al., 2010
C  3.0 EID50/mL
H7N2
A/turkey/NY/4450-4/1994
ICh O  3.8 EID50/mL
C  3.8 EID50/mL
H7N2
A/chicken/NY/3112-1/1995
ICh O  2.5 EID50/mL
C  2.5 EID50/mL
H7N3
A/chicken/NY/12273-11/1999
ICh O  2.1 EID50/mL
C  3.0 EID50/mL
H7N2
A/chicken/NY/30749-3/2000
ICh O  3.5 EID50/mL
C  1.8 EID50/mL mL
H7N2
A/guinea hen/MA/148081-11/
2002
ICh O  4.0 EID50/mL
C  1.5 EID50/mL
H7N2
A/chicken/PA/9801289/1998
ICh O  2.0 EID50/mL
C  1.5 EID50/mL
H7N2
A/turkey/VA/SEP-67/2002
ICh O  3.8 EID50/mL
C  0.3 EID50/mL
H7N2
A/chicken/MD/MinhMa/2004
ICh O  2.8 EID50/mL
C  1.6 EID50/mL
H7N8
A/mallard/OH/421/1987
ICh O  1.9 EID50/mL
C  0.9 EID50/mL
H7N3
A/pintail/MN/423/1999
ICh O  4.1 EID50/mL
C  4.2 EID50/mL
H7N9
A/ruddy turnstone/DE/1538/
2000
ICh O  3.5 EID50/mL
C  5.0 EID50/mL
Mallard H5N2
A/mallard/MN/346250/00
OINO O 2.3 EID50/mL Achenbach and
Bowen (2011)C 5.9 EID50/mL
Contact O 1.9 EID50/mL
C 4.6 EID50/mL
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 130 EFSA Journal 2017;15(10):4991
D.1.12. Number of wild birds landing into a holding
The probability for wild birds to land in a poultry holding is affected by several factors, such as the
land use and ecological environment around the holding, the species-speciﬁc behaviour, attractiveness
of the area (e.g. food availability), altitude of the holding, etc. (Busani et al., 2009; Mughini-Gras et al.,
2014). Tables D.12 and D.13 give an overview of water and non-water birds observed in immediate
barn area of poultry holdings in Canada (Burns et al., 2012).
Species LPAIV Route Swab
Virus
concentrationA
Reference
H7N3
A/Ruddy turnstone/
ReedsBeachNJ/00
OINO O 3.3 EID50/mL
C 4.4 EID50/mL
Contact O 2.9 EID50/mL
C 6.5 EID50/mL
IN: intranasal; IT: intratracheal; IO: intraocular; IC: intracloacal; II: intraingluvial; IE: intra-oesophagus; O: oral; C: cloacal; F: fecal.
A: mean value at day with highest virus excretion detected via RT-PCR.
Table D.11: LPAIV shedding of non-water birds following experimental inoculation
Species LPAIV Route Swab
Virus
concentration
Test
method
Reference
Gyr-saker
hybrid falcon
H7N2
A/Anas
plathyrhynchos/
Spain/1877/2009
Feed O  24 (inverted
Ct value)
RT-PCR Bertran et al. (2012)
NC O  22 (inverted
Ct value)
RT-PCR
Feed: feeding; NC: nasochoanal.
Table D.12: Water birds observed in immediate barn area of poultry holdings in Canada (Burns
et al., 2012)
Sub-category Order
Species (Number of birds
in immediate barn area)
Dabbling ducks Anseriformes Mallard (6)
Geese Canada goose (11)
Swans Trumpeter swan (4)
Pelicans, Herons, Spoonbills, Ibises Pelecaniformes Great blue heron (6)
Table D.13: Non-water birds observed in immediate barn area of poultry holdings in Canada (Burns
et al., 2012)
Sub-category Order Species (Number of birds in immediate barn area)
Raptors Falconiformes Peregrine falcon (3),American kestrel (5)
Accipitriformes Red-tailed hawk (10), Bald eagle (9)
Song birds Passeriformes European starling (144), North-western crow (45), American robin (33),
House ﬁnch (26), House sparrow (58), White crowned sparrow (25),
Dark-eyed junco (27), Song sparrow (18), Savannah sparrow (28),
Golden-crowned sparrow (8), Spotted towhee (8), American goldﬁnch
(17), Black-capped chickadee (14), Brewers blackbird (4), Yellow-rumped
warbler (5), American pipit (5), Red-winged blackbird (28), Barn swallow
(10), Chestnut-backed chickadee (4), Bewick’s wren (3), Brown-headed
cowbird (10), Pine siskin (3), Townsend’s solitaire (3), Stellar’s jay (1),
Horned lark (48), Common grackle (13), American crow (14), Blue jay (7),
Chipping sparrow (8), Northern cardinal (7), Gray catbird (2), Yellow
warbler (2)
Columbiformes Rock dove (35), Mourning dove (10)
Waders Charadriiformes Glaucous-winged gull (14), Ring-billed gull (2), Killdeer (18)
Gulls-Terns-
Storks-Cranes
Charadriiformes Mew gull (3)
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D.1.13. Regression coefﬁcient probability HPAIV infection worst-case
holding
The concentration of HPAI H5N8 virus excreted by a water bird in one standard day- excretion is
for 5 days, high loads are excreted for only 2 days. Peak titres are 1,000,000 TCID50/gr faeces (0.5
day); average titres over 5 days per gr faeces are 1,000. The infective dose by groups of birds was
250–1,000 TCID50 (for domestic waterfowl) and 5,000–20,000 TCID50 (for gallinaceous poultry) (Kim
et al., 2014; Li et al., 2014; Kanehira et al., 2015; Kang et al., 2015; Lee et al., 2016; Sun et al., 2016).
Further scientiﬁc evidence is provided in the systematic literature review performed by the AI
consortium, identifying and synthesising the evidence on risk factors of HPAI and LPAI introductions into
European poultry holdings (data received as per procurement, Linnaeus University (SE), Erasmus Medical
Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, Gonzales et al., 2017).
D.1.14. Regression coefﬁcient probability LPAIV infection worst-case
holding
The concentration of LPAIVs shed by mallards and falcons experimentally infected with LPAI H5N2
and H7N2, respectively, is given in Table D.14. Further scientiﬁc evidence is provided in the systematic
literature review performed by the AI consortium, identifying and synthesising the evidence on risk
factors of HPAI and LPAI introductions into European poultry holdings (Duncan et al., 2017b).
D.1.15. Migratory wild birds entering the EU during a migratory season
There is a lack of information on the number of migratory wild water birds entering the EU via the
NE route during a migratory season, covering the bird species listed in Section B.1 (Appendix B).
There is also large variation expected between years. Therefore, it was decided to select theoretical
scenarios reﬂecting different real world conditions (see Section C.5.2, Appendix C).
Table D.14: LPAI virus excretion of wild birds following experimental infection
Species Dose Route HN-type
Virus excretion
(Peak titres expressed
in log10 EID50/mL or
TCID50/g of tissue)
Reference
Mallards IN, IT and IO:
106 EID50/0.1 mL;
IC and II:
106 EID50/1 mL
IN, IT, IO,
IC
and II
H5N2 OP: 2.5–4.8
EID50/mL;
CL: 3.0–7.0
EID50/mL
Franca et al. (2012)
Captive-reared
gyr-saker
hybrid falcon
106 EID50/mL Nasochoanal
and natural
feeding
routes
H7N2 103.2–107.2
TCID50/g
of tissue
Bertran et al. (2012)
IN: intranasal; IT: intratracheal, IO: intraocular, IC: intracloacal; II: intraingluvial; EID50: median egg infectious dose;
TCID50: median tissue culture infectious dose.
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D.2. Estimates for the HPAI model
Tables D.15, D.16 and D.17 show the collection of estimates for the HPAI model parameters.
Table D.15: Estimates for HPAI provided in the EKEs by working group members or event participants
Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
MNWB Total number of
migratory non-
water birds
entering the EU
during fall–
winter migratory
season through
the north-east
border
Total number of
migratory non-water birds
entering the EU during
fall–winter migratory
season through the
north-east border.
Number of birds in 1,000
units
2.3.4.4 175,000 390,000 515,000 590,000 700,000 Semi-formal
EKE
Mslength Length (in days)
of the fall–winter
migratory
season for wild
birds entering
the EU through
the north-east
border
Average over last 100
year of length in days of
the fall–winter migratory
season for wild bird of
the water bird group
entering in EU through
north-east border
2.3.4.4 125 Data
MWB Total number of
migratory water
birds entering
the EU during
fall–winter
migratory
season through
the north-east
border
Total number of
migratory water birds
entering the EU during
fall–winter migratory
season through the
north-east border.
Number of birds in 1,000
units
2.3.4.4 17,500 26,500 37,250 46,500 55,000 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
NWBin Number of non-
water birds
landing into a
holding
Estimate the average
number, over 2016–2017
fall–winter migratory
season (5 months
duration), of non-water
birds (migratory and/or
residential) that will land
on any holding surface of
a ‘worst-case’ poultry
holding per day
2.3.4.4 200 400 750 2,000 10,000 Workshop
Prob
(contactNWB,NWB)
1
Probability that a
non-water bird
comes in contact
with the
excretions of 1
infected non-
water bird in a
foraging area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 1
infected non-water bird in
a foraging area (see
deﬁnition above) and in
other potential area in a
standard day (number
out of 10,000). Think of
the various groups of
birds separately (i.e.
raptors, songbirds,
waders, gulls–storks–
cranes) and then sum
them up
2.3.4.4 2 14.5 175 350 1,750 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob
(contactNWB,NWB)
10
Probability that a
non-water bird
comes in contact
with the
excretions of 10
infected non-
water bird in a
foraging area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 10
infected non-water bird in
a foraging area (see
deﬁnition above) and in
other potential area in a
standard day (number out
of 10,000). Think of the
various groups of birds
separately (i.e. raptors,
songbirds, waders, gulls–
storks–cranes) and then
sum them up
2.3.4.4 17.5 130 1,500 2,700 7,000 Semi-formal
EKE
Prob
(contactNWB,
NWB)
100
Probability that a
non-water bird
comes in contact
with the
excretions of
100 infected
non-water bird
in a foraging
area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds that
might come in contact
with the excretions
shedded by 100 infected
non-water bird in a
foraging area (see
deﬁnition above) and in
other potential area in a
standard day (number out
of 10,000). Think of the
various groups of birds
separately (i.e. raptors,
songbirds, waders, gulls–
storks–cranes) and then
sum them up
2.3.4.4 150 1,450 5,498.5 6,249 9,500 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob
(contactNWB,WB)
1
Probability that a
water bird
comes in contact
with the
excretions of 1
infected non-
water bird in a
foraging area
Think of a standard
population of 10,000
water birds. Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 1
infected non-water bird in
a foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000)
2.3.4.4 1 10 51 210 600 Semi-formal
EKE
Prob
(contactNWB,WB)
10
Probability that a
water bird
comes in contact
with the
excretions of 10
infected non-
water bird in a
foraging area
Think of a standard
population of 10,000
water birds. Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 10
infected non-water bird in
a foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000)
2.3.4.4 7.5 65 485 1,475 4,000 Semi-formal
EKE
Prob
(contactNWB,WB)
100
Probability that a
water bird
comes in contact
with the
excretions of
100 infected
non-water bird
in a foraging
area
Think of a standard
population of 10,000
water birds. Indicate the
number of these birds
that might come in
contact with the
excretions shedded by
100 infected non-water
bird in a foraging area
(see deﬁnition above) in a
standard day (number
out of 10,000)
2.3.4.4 75 525 3,475 5,749 8,500 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob
(contactWB,NWB)
1
Probability that a
non-water bird
comes in contact
with the
excretions of 1
infected water
bird in a
foraging area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 1
infected water bird in a
foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000). Think of
the various groups of
birds separately (i.e.
raptors, songbirds,
waders, gulls–storks–
cranes) and then sum
them up
2.3.4.4 3 16 112.5 275 900 Semi-formal
EKE
Prob
(contactWB,NWB)
10
Probability that a
non-water bird
comes in contact
with the
excretions of 10
infected water
bird in a
foraging area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds
that might come in
contact with the
excretions shedded by 10
infected water bird in a
foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000). Think of
the various groups of
birds separately (i.e.
raptors, songbirds,
waders, gulls–storks–
cranes) and then sum
them up
2.3.4.4 30 160 1,125 2,750 8,999.5 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob
(contactWB,NWB)
100
Probability that a
water bird
comes in contact
with the
excretions of
100 infected
water bird in a
foraging area
Think of a standard
population of 10,000 non-
water birds (see
deﬁnition above).
Indicate the number of
these birds that might
come in contact with the
excretions shedded by
100 infected water bird in
a foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000). Think of
the various groups of
birds separately (i.e.
raptors, songbirds,
waders, gulls–storks–
cranes) and then sum
them up
2.3.4.4 100 1,000 5,998.5 6,499 7,499.5 Semi-formal
EKE
g_MWB Prevalence of
infected HPAIV
water birds at
the moment
they cross the
EU border
Think of a population of
1,000,000 migratory
water birds crossing the
EU north-east border
during the 2016/2017 fall
–winter migration season.
Estimate the number of
these birds that will be
HPAI H5N8 infected at
the time they cross the
north-east EU border
2.3.2.1c 0 15 100 500 1,000 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
g_MWB Prevalence of
infected HPAIV
water birds at
the moment
they cross the
EU border
Think of a population of
1,000,000 migratory
water birds crossing the
EU north-east border
during the 2016/2017 fall
–winter migration season.
Estimate the number of
these birds that will be
HPAI H5N8 infected at
the time they cross the
north-east EU border
2.2.1.2 0 2 8 25 200 Semi-formal
EKE
Prob
(contactWB,WB)
1
Probability that a
water bird
comes in contact
with the
excretions of 1
infected water
bird in a
foraging area
Think of a population of
10,000 water birds.
Indicate the number of
these birds that might
come in contact with the
excretions shedded by 1
infected water bird in a
foraging area (see
deﬁnition above) or in a
water body in a standard
day (number out of
10,000)
2.3.4.4 1.5 19.5 150 400 1,500 Semi-formal
EKE
ShedWB Duration in days
of the shedding
period in water
birds
Total number of days a
HPAI-infected water bird
will shed infectious virus
2.3.2.1c 0 2 4 6 14 Semi-formal
EKE
ShedWB Duration in days
of the shedding
period in water
birds
Total number of days a
HPAI-infected water bird
will shed infectious virus
2.2.1.2 0 2 4 6 14 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob
(contactWB,WB)
10
Probability that a
water bird
comes in contact
with the
excretions of 10
infected water
bird in a
foraging area
Think of a population of
10,000 water birds.
Indicate the number of
these birds that might
come in contact with the
excretions shedded by 10
infected water bird in a
foraging area (see
deﬁnition above) or in a
water body in a standard
day (number out of
10,000)
2.3.4.4 12 170 1,450 3,500 6,499.5 Semi-formal
EKE
ShedNWB Duration in days
of the shedding
period in non-
water birds
Total number of days a
HPAI-infected non-water
bird will shed the
infectious virus
2.3.2.1c 0 1 3 5 10 Semi-formal
EKE
ShedNWB Duration in days
of the shedding
period in non-
water birds
Total number of days a
HPAI-infected non-water
bird will shed the
infectious virus
2.2.1.2 0 1 3 5 10 Semi-formal
EKE
Prob
(contactWB,WB)
100
Probability that a
water bird
comes in contact
with the
excretions of
100 infected
water bird in a
foraging area
Think of a population of
10,000 water birds.
Indicate the number of
these birds that might
come in contact with the
excretions shedded by
100 infected water bird in
a foraging area (see
deﬁnition above) or in a
water body in a standard
day (number out of
10,000)
2.3.4.4 112.5 1,275 6,498.5 7,249 7,499.5 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
p_MWB Prevalence of
infected HPAIV
water birds at
the moment
they cross the
EU border
Think of a population of
1,000,000 migratory
water birds crossing the
EU north-east border
during the 2016/2017 fall
–winter migration season.
Estimate the number of
these birds that will be
HPAI H5N8 infected at
the time they cross the
north-east EU border
2.3.4.4 0 16.94 114.42 463.67 5,000 Formal
EKE
Prob(PHb0 inf)
1 Probability for a
worst-case
holding to get
the infection
given the
presence of 1
HPAI-infected
wild bird
Think of 10,000 worst-
case poultry holdings (see
deﬁnition above). Given
exposure of the holding
to 1 H5N8 infected wild
bird, estimate the number
of worst-case poultry
holdings that will get
infected in one day
2.3.4.4 0 0.58 4.03 18.84 5,000 Formal
EKE
Prob(PHb0 inf)
10 Probability for a
worst-case
holding to get
the infection
given the
presence of 10
HPAI-infected
wild bird
Think of 10,000 worst-
case poultry holdings (see
deﬁnition above). Given
exposure of the holding
to 10 H5N8 infected wild
bird, estimate the number
of worst-case poultry
holdings that will get
infected in one day
2.3.4.4 0 5.19 23.78 112.99 5,000 Formal
EKE
Prob(PHb0 inf)
100 Probability for a
worst-case
holding to get
the infection
given the
presence of 100
HPAI-infected
wild bird
Think of 10,000 worst-
case poultry holdings (see
deﬁnition above). Given
exposure of the holding
to 100 H5N8 infected wild
bird, estimate the number
of worst-case poultry
holdings that will get
infected in one day
2.3.4.4 0 43.17 183.44 854.36 5,000 Formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob(PHb1 inf) Probability for a
holding to get
the infection
given the
presence of 100
HPAI-infected
wild bird if
access by wild
birds to the
water bodies
was prevented
Consider the scenario
described in Q21c and
take the median number
of worst-case poultry
holdings you estimated as
a starting point for this
question. If access by
poultry (including
waterfowl) to the water
bodies was prevented in
these poultry holdings,
what would be the
number of such poultry
holdings that will get
infected in one day
2.3.4.4 0 16.94 61.31 190.15 5,000 Formal
EKE
Prob(PHb2 inf) Probability for a
holding to get
the infection
given the
presence of 100
HPAI-infected
wild bird if in
addition access
of poultry to any
outdoor area
were prevented
Consider the scenario
described in Q22 and
take the median number
of poultry holdings you
estimated as a starting
point for this question. If
access by poultry
(including waterfowl) to
the water bodies AND
access of poultry to any
outdoor area were
prevented in these
poultry holdings, what
would be the number of
such poultry holdings that
will get infected in one
day
2.3.4.4 0 7.21 29.38 110.54 5,000 Formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob(PHb3 inf) Probability for a
holding to get
the infection
given the
presence of 100
HPAI-infected
wild bird if in
addition routine
(daily average
practiced)
biosecurity
measures were
applied
(disinfection of
boots, changing
clothes, washing
hands)
Consider the scenario
described in Q23 and
take the median number
of poultry holdings you
estimated as a starting
point for this question. If
access by poultry
(including waterfowl) to
the water bodies AND
access of poultry to any
outdoor area were
prevented AND routine
(daily average practiced,
e.g. on a layer/fattening
holding) biosecurity
measures were applied
(e.g. disinfection of
boots, changing clothes,
washing hands, standard
ﬁltering provisions) in
these poultry holdings,
what would be the
number of such poultry
holdings that will get
infected in one day
2.3.4.4 0 2.39 7.75 28.21 5,000 Formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
Prob(PHb4 inf) Probability for a
holding to get
the infection
given the
presence of 100
HPAI-infected
wild bird if in
addition high
biosecurity
measures were
applied (as
practised in
nucleus or
breeding herds)
(rigorous
implementation
of showering in,
complete
exclusion of wild
birds to feed,
bedding and
animal by-
products,
separation of
houses)
Consider the scenario
described in Q23 and
take the median number
of poultry holdings you
estimated as a starting
point for this question. If
access by poultry
(including waterfowl) to
the water bodies AND
access of poultry to any
outdoor area were
prevented AND high
biosecurity measures
were applied (as
practised in nucleus or
breeding holding) (e.g.
rigorous implementation
of showering in; complete
exclusion of wild birds to
feed, bedding and animal
by-products; separation
of houses) in these
poultry holdings, what
would be the number of
such poultry holdings that
will get infected in one
day
2.3.4.4 0 0.0026 0.6694 6.6169 5,000 Formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
ProbInf_NWB|
contact
Probability that a
susceptible non-
water bird
becomes
infected given a
contact with
excretions
containing
infectious virus
in a forage area
Think of a standard
population of 10,000 non-
water birds (see deﬁnition
above). Indicate the
number of these birds
that might become
infected, provided they
get in contact with
excretions containing
infectious virus in a
foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000). Think of
the various groups of
birds separately (i.e.
raptors, songbirds,
waders, gulls–storks–
cranes) and then sum
them up
2.3.4.4 0 0.0001 0.000325 0.00065 0.0125 Semi-formal
EKE
ProbInf_WB|
contact
Probability that a
susceptible
water bird
becomes
infected given a
contact with
excretions
containing
infectious virus
in a forage area
Think of a population of
10,000 water birds.
Indicate the number of
these birds that might
become infected,
provided they get in
contact with excretions
containing infectious virus
in a foraging area (see
deﬁnition above) in a
standard day (number
out of 10,000)
2.3.4.4 0.000025 0.00055 0.002125 0.004 0.025 Semi-formal
EKE
ShedNWB Duration in days
of the shedding
period in non-
water birds
Total number of days a
HPAI-infected non-water
bird will shed the
infectious virus
2.3.4.4 0 2.7 5 7.6 14 Semi-formal
EKE
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Variable Description Question description Clade LB Q1 Median Q3 UB
Estimate
done by
ShedWB Duration in days
of the shedding
period in water
birds
Total number of days a
HPAI-infected water bird
will shed infectious virus
2.3.4.4 0 3 5 7 14 Semi-formal
EKE
WBin Number of water
birds landing
into a holding
Estimate the average
number, over 2016–2017
fall–winter migratory
season (5 months
duration), of water birds
(migratory and/or
residential) that will land
on any holding surface of
a worst-case poultry
holding
2.3.4.4 0.1 5.5 50 300 1,000 Formal
EKE
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Table D.16: Regression coefﬁcient estimates for probability of contact with infected excretion for each bird-to excretion contact type
Route of infection
Uncertainty distribution
centile probability
Correlation between
empirical and predicted
Beta estimate
From NWB to WB 0.01 0.9999944 7.53E-05
0.25 0.9998164 5.41E-04
0.5 0.999827 4.28E-03
0.75 0.9939367 8.89E-03
0.99 0.9963089 4.84E-02
From WB to WB 0.01 0.999985 1.13E-04
0.25 0.9996709 1.37E-03
0.5 0.9976682 1.08E-02
0.75 0.9546119 1.69E-02
0.99 0.9802862 1.09E-01
From NWB to NWB 0.01 0.9998891 1.51E-04
0.25 0.999852 1.56E-03
0.5 0.9913423 8.32E-03
0.75 0.9606092 1.11E-02
0.99 0.9981449 1.26E-01
From WB to NWB 0.01 0.979903 1.03E-04
0.25 0.9985441 1.06E-03
0.5 0.9991636 9.30E-03
0.75 0.9637193 1.20E-02
0.99 0.9939418 1.92E-01
Table D.17: Regression coefﬁcient estimates for probability of wild bird to poultry holding contact
Bird-to-bird contact type
Uncertainty distribution
centile probability
Correlation between
empirical and predicted
Beta estimate
From wild bird to poultry holding 0.25 0.9998668 4.335122e-05
0.5 0.9998462 1.857073e-04
0.75 0.9998513 8.960164e-04
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D.3. Estimates for the LPAI model
Estimates from the HPAI model were used also in the LPAI model for the following variables: Prob(contactNWB,NWB), Prob(contactNWB,WB),
Prob(contactWB,NWB), Prob(contactWB,WB), NWB
in
i , WB
in
i (Tabe D.18).
Table D.18: Estimates for LPAI provided in the EKEs by working group members or event participants
Variable Description LB Q1 Median Q3 UB Estimate done by
MSLength Length (in days) of AIV transmission period
considered in the LPAI model
Fixed to 125 days (same as for HPAI) Arbitrary
1/rNWB Reciprocal of the duration in days of the LPAI
shedding period in non-water birds
1 3 4 6 14 Semi-formal EKE
1/rWB Reciprocal of the duration in days of the LPAI
shedding period in water birds
2 4 6 8 21 Semi-formal EKE
mdNWB Mortality rate in non-water birds due to LPAI
disease
0.0025 0.0025 0.0025 0.0025 0.0025 Literature
mdWB Mortality rate in water birds due to LPAI
disease
0.001 0.001 0.001 0.001 0.001 Literature
Prob(InfNWB|contact) Probability that a susceptible non-water bird
becomes infected with LPAI given a contact
with excretions containing infectious virus in a
forage area
0 0.0001 0.000325 0.00065 0.0125 Semi-formal EKE
Prob(InfWB|contact) Probability that a susceptible water bird
becomes infected with LPAI given a contact
with excretions containing infectious virus in a
forage area
0.000025 0.00055 0.002125 0.004 0.025 Semi-formal EKE
NWBini Number of non-water birds landing into a
holding
Estimate from HPAI was used
WBini Number of water birds landing into a holding Estimate from HPAI was used
C1HP;LP Reduction coefﬁcient for the probability that a
susceptible water bird becomes infected given
a contact with excretions containing LPAI
infectious virus with respect to HPAI-infected
excretion
0.01 0.03 0.05 0.1 0.5 Formal EKE
C2HP;LP Reduction coefﬁcient for the probability for a
worst-case holding to get the infection given
the presence of LPAI-infected wild bird with
respect to HPAI-infected wild bird
0 0.08 0.1 0.3 1 Formal EKE
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D.4. Estimates for biosecurity impact in the HPAI and LPAI model
The main output of the EKE considered is the probability of a poultry holding to get infected due to exposure of the holding to 100 H5N8 infected wild
birds when implementing stepwise biosecurity measures.
Distributions are obtained from the formal EKE procedure, in particular, the experts had been asked to estimate the number of poultry holdings that will
get infected in 1 day, given exposure of the holding to 100 H5N8 infected wild birds and given a speciﬁc level of biosecurity. The range estimated by the
expert was taken ﬁxed for all the four biosecurity steps considered.
For each scenario considered, the linear pool distribution was obtained averaging with equal weight all the best ﬁtting expert’s distributions. Then, the
median and the quantiles of the ﬁtted distribution were calculated and used, together with range, in order to ﬁt a theoretical distribution. The median and
quantiles calculation implies an approximation of the linear pool distribution: the goodness of the approximation can be measured with the value of the area
under the curve, which should be theoretically equals to 1. The goodness of the approximation decreases when the range is much bigger than the
interquartile range, indeed the area under the curve moves from 0.9636 (related to worst case of biosecurity) to 0.7544 (related to the highest level of
biosecurity). In Table D.19, the ﬁtted distribution together with the estimated parameters are reported.
Table D.19: Characteristics for the elicited distributions
Biosecurity level Description of biosecurity level Distribution k j
1 Effect preventing access of domestic poultry to water bodies Weibull 0.64 112.33
2 Effect indoor housing Weibull 0.57 60.01
3 Effect implementation routine biosecurity Weibull 0.62 15.74
4 Effect implementation high biosecurity Weibull 0.2 2.12
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Appendix E – Model outputs
E.1. HPAI clade 2.3.4.4
E.1.1. Entry assessment
E.1.2. Ampliﬁcation in the wild bird reservoir
Figure E.1: Probability of clade 2.3.4.4 HPAIV introduction into the EU via migratory wild birds
Figure E.2: Modelled HPAI clade 2.3.4.4 prevalence (95th percentile) in wild water birds (piWB) after
entry of infected wild water birds at day 60 of the migration season. Different population
capacities (10–100,000) and scenarios (1–4, see deﬁnition in Table 5 in Section 3.2.2) are
presented
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E.1.3. Introduction into poultry holding
Figure E.3: Modelled HPAI clade 2.3.4.4 prevalence (95th percentile) in wild non-water birds after entry
of infected wild water birds at day 1 of the migration season. Different population capacities
(10–100,000) and scenarios (1–4, see deﬁnition in Table 5 in Section 3.2.2) are presented
Figure E.4: Daily probability (95th percentile) of a poultry holding without biosecurity to become
infected with HPAI clade 2.3.4.4 after entry of infected wild birds at day 1 of the
migration season. Different population sizes (10–100,000) and scenarios (1–4, see
deﬁnition in Table 1) are presented
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pi_MWB, prevalence of migratory infected water birds; ProbH_b0, probability that a poultry holding is infected
due to the presence of infected wild birds; ShedWB, shedding period for water birds; ShedNWB, shedding period
for non-water birds; WG_in, number of water birds present in the holding premise; NWB_in, number of non-
water birds present in the holding premise.
Figure E.5: Sensitivity analysis on the seasonal probability that a poultry holding without biosecurity
becomes infected after entry of infected wild birds at day 1 of the migration season, for
the four scenarios (as deﬁned in Table 5 in Section 3.2.2). A wild bird population capacity
of 100,000 birds is considered
Table E.1: Daily and seasonal probability that a poultry holding without biosecurity could become
infected after entry of infected wild birds at day 1 of the migration season. Different
population sizes (ranging from 100,000 to 100) and scenarios (1–4, see deﬁnition in
Table 5 in Section 3.2.2) are presented
Scenario
Population
capacity
Daily probability at day 125 Seasonal probability
Median 95th percentile Median 95th percentile
1 100,000 0.0000347 0.004827 0.00227 0.406861
10,000 0 0.001743 0 0.094249
1,000 0 0.00000145 0 0.000827
100 0 0 0 0
2 100,000 0 0.002918 0 0.156423
10,000 0 0.00000485 0 0.000778
1,000 0 0 0 0
3 100,000 0 0.002867 0 0.298166
10,000 0 0.0000422 0 0.002877
1,000 0 0 0 0
4 100,000 0 0.000128 0 0.011515
10,000 0 0 0 0
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E.2. HPAI clades 2.2.1.2 and 2.3.2.1c
E.2.1. Introduction into poultry holding
Figure E.6: Probability of a poultry holding without implementing biosecurity becoming infected with
HPAIV clade 2.2.1.2 via wild birds over the entire migratory season, when this holding is
located in an area where 10–105 wild birds are present (consisting of 90% migratory
birds, 90% water birds; scenario 1)
Figure E.7: Probability of a poultry holding without implementing biosecurity becoming infected with
HPAIV clade 2.3.2.1c via wild birds over the entire migratory season, when this holding is
located in an area where 10–105 wild birds are present (consisting of 90% migratory
birds, 90% water birds; scenario 1)
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E.3. LPAI
E.3.1. Ampliﬁcation in the wild bird reservoir
Figure E.8: Modelled LPAI 95th percentile prevalence in wild non-water birds. Different population
capacities (10,000 and 100,000) and scenarios (1–4, see deﬁnition in Table 7 in
Section 3.3.2) are presented
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E.3.2. Introduction into poultry holding
Figure E.9: Daily probability (95th percentile) of a poultry holding without biosecurity to become
infected with LPAI after entry of infected wild birds. Different population sizes
(10–100,000) and scenarios (1–4, see deﬁnition in Table 7 in Section 3.3.2) are
presented
Figure E.10: Sensitivity analysis on the seasonal probability that a poultry holding without biosecurity
becomes LPAI infected after entry of infected wild birds. A wild bird population capacity
of 100,000 and a prevalence of infected entering water birds of 0.6% birds are
considered
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Table E.2: Daily and seasonal probability that a poultry holding without biosecurity could become
infected after entry of LPAI-infected wild birds. Different population sizes (ranging from
100,000 to 10,000) and scenarios (1–4, see deﬁnition in Table 7 in Section 3.3.2) are
presented
Scenario
Population
capacity
Daily probability at day 125 Seasonal probability
Median 95th percentile Median 95th percentile
1 100,000 7.56E-06 0.000358 0.001286 0.086275
10,000 5.45E-06 0.000361 0.000975 0.07956
2 100,000 3.80E-06 0.000202 0.000563 0.033405
10,000 2.78E-06 0.000175 0.000385 0.028812
3 100,000 2.78E-06 0.000143 0.000464 0.031332
10,000 1.61E-06 0.000109 0.000256 0.022919
4 100,000 1.62E-06 0.000104 0.000155 0.009643
10,000 3.32E-07 2.55E-05 2.63E-05 0.003133
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Appendix F – AI introduction non-wild bird pathways
F.1. Deﬁnitions
The parameters that have been identiﬁed as relevant to qualitatively assess the risk of introduction
of AI via non-wild bird pathways are here listed together with the relevant deﬁnitions.
Import volume: amount of the commodity that is traded. Analyses are carried out separately for
imports from third countries and intra-EU movements.
For the current assessment, the trade volumes have been extracted from open access databases,
for 2014, 2015 and 2016 to look for the pattern in annual levels. These are presented in the sections
below. It should be noted that the main database for this, UN Comtrade (the United Nations
International Trade Statistics Database), will not be exact volumes as these reports are based on
Combined Nomenclature (CN) codes (Council Regulation (EEC) No 2658/8762). Nevertheless, it gives a
good approximation to the countries involved in trade and relative volumes. Section F.21 of this
Appendix provides further information on the different trade pathways and the third countries which
are approved for trade to the EU.
Probability of testing (according to EU legislation): likelihood that the commodity will be tested for AIV
presence during transport considering the procedures described in the current EU legislation.
Tests that can be used (according to EU legislation): list of methods that can be used according to the
Avian Inﬂuenza Diagnostic Manual (2006/437/EC) to test AIV presence in the given commodity.
Probability of virus detection (given AIV presence in commodity): likelihood that AIV will be detected in
the commodity when AIV is present, using the listed tests.
Probability of virus preservation during transport: likelihood that AIV infectivity is maintained after
transport/quarantine measures of a commodity that is considered contaminated or infected.
Probability of poultry exposure to the commodity: likelihood that poultry is in contact with the
commodity that is considered contaminated or infected (generally, this refers to commercial poultry
being fed on commercial feed).
Probability of AIV introduction into a commercial poultry holding via the commodity (small scale–large
scale): likelihood that a holding of kept birds (poultry or zoo) after contact with a commodity
considered infected becomes AIV infected. This parameter represents the overall result from the
assessment of the previous parameters.
Pathways and commodities:
The 10 pathways and the corresponding commodities other than wild birds that have been taken
into consideration in Section 3.4 as possible means of AIV introduction into a commercial poultry
holding are:
• Live birds: captive birds such as Passeriformes, birds of prey, Psittacines, peacocks, swans, wild
ducks, wild geese, snipe, woodcocks, grouse, birds as pets, racing pigeons (not for
consumption) and zoo birds (i.e. originating in an approved body, institute or centre)
• Live poultry: breeding, production birds, hatching eggs and day-old chicks of all poultry types
(gallinaceous poultry, Anseriformes, ratites, gamebirds)
• Meat and eggs for human consumption: meat, table eggs
• Semen
• Feathers, skin and down: raw feathers (with some treatment), treated skin feathers and down
• Feed
• Bedding
• Manure
• Pharmaceuticals (vaccines)
• Other animal by-products (bones, feet, casings, pet food (not livestock feed)).
62 Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs
Tariff. OJ L 256, 7.9.1987, p. 1–675.
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Deﬁnition of ‘commodity’: the means by which there is potential to introduce AIV into a commercial
poultry holding
For each commodity, the different parameters identiﬁed as relevant to qualitatively assess the risk
of introduction of AI via non-wild bird pathways have been evaluated and assessed for both HPAI and
LPAI in two scenarios: (i) Third country trade and (ii) Intra-EU movements, with a description of the
entry and exposure to poultry pathways, given the EU rules and requirements for trade.
Illegal introduction is brieﬂy described in the text but is not included in the qualitative assessment
due to a lack of data.
When there are no differences in the parameter assessments between HP and LP in the same
scenario, the results of the assessment of the commodity refer to AI in general (HPAI+LPAI). If there
are differences in the parameters (for example where testing for H5N1 HPAI only is required), then the
two pathogenic strains are assessed separately.
The volume of trade is important to consider for the aggregated risk which can increase the risk
level if there is a large volume. Certain commodities, such as meat, table eggs and hatching eggs are
less important for the spread of LPAI because infection in the parent ﬂock will not lead to infection in
the commodity.
For many commodities, such as live poultry, captive birds, hatching eggs and day-old chicks
entering the EU from third countries, there are only a limited number of countries which are approved
for trade. These countries are listed in Part1, Annex I of Commission Regulation (EC) No 798/2008,
where certiﬁcate requirements are listed.
F.2. Psittaciformes (CN code 010632)
This commodity covers all psittacine species. It includes, e.g. parrots, lovebirds, macaws and
parakeets. Birds must be bred in captivity and cannot be taken from the wild (Article 5 of Commission
Regulation (EU) No 139/2013 has replaced (EC) No 318/200763). It does not include pet birds.
F.2.1. Background info
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and
Psittaciformes (topic) for the period 2005–2015 (restricting to documents in English only). The
abstracts of three publications returned from this search string were screened and the extracted
information from the relevant papers is reported below. Also, the EMPRES-i database was consulted for
the period 1-1-2005 to 15-6-2015. Experts provided additional scientiﬁc evidence that was not
retrieved by the performed searches.
Reported AI cases in Psittaciformes since 2005
The scarcity of publications on avian inﬂuenza in Psittaciformes in the last 10 years indicates that
these birds are rarely reported to be infected. Consultation of the EMPRES-i database and screening of
the scientiﬁc literature identiﬁed only few reports. Hawkins et al. (2006) reported the isolation of a
LPAI H5N2 virus from a 3-month-old red-lored Amazon parrot (Amazona autumnalis autumnalis)
suffering from severe lethargy and probably illegally imported into the US (Hawkins et al., 2006).
Kaleta et al. (2007) has published a review on AIVs in birds of the order Psittaciformes, providing
an overview table on natural infections of AIVs in psittacine birds that were found dead upon arrival in
importing countries, in quarantine stations or in pet shops (period 1973–2006) (Kaleta et al., 2007).
In the UK in 2006, an African Grey parrot was tested positive for H5N1 HPAI while in quarantine. In
2013, a mixed consignment of psittacines and Passeriformes, were illegally introduced into Austria and
stopped at Vienna Airport. Of the ~ 100 birds, 60 were alive, and of the dead birds, 4 tested positive
for H5N1 HPAI (Bundesministerium f€ur Gesundheit, 2013).
Clinical signs of AI infections in Psittaciformes
Intranasal infection of chickens, ducks and turkeys with 0.2 mL of 106 EID50 of the LPAI H5N2 virus
isolated from the red-lored Amazon parrot (see above) did not cause any clinical signs, although it
could replicate to high titres in these birds and efﬁciently transmit to contact control cage mates (Pillai
et al., 2008). Parakeets were also shown to be susceptible to intranasal inoculation of LPAI H7N9 virus
(Jones et al., 2014). Virus was shed via the oropharyngeal route for 6 days but the birds remained
63 Commission Regulation (EC) No 318/2007 of 23 March 2007 laying down animal health conditions for imports of certain birds
into the Community and the quarantine conditions thereof. OJ L 84, 24.3.2007, p. 7–29.
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free of disease signs. Parakeets intranasally infected with 106 EID50 of a H9N2 strain showed sporadic
clinical signs (lethargy, hunched posture, laboured breathing) and shed virus oropharyngeally for
6 days, although in quantities 2–3 logs lower than chickens (Lenny et al., 2015).
Experimental infection of budgerigars (Melopsittacus undulatus) via the intranasal route with H5N1
HPAIV showed similar pathogenicity compared to chickens and quails (Isoda et al., 2006). Two out of
three strains induced severe nervous disorders in some animals and mortality in all birds by 5 days
post-inoculation. The third H5N1 strain used in this study was probably not able to infect any
budgerigar given the absence of seroconversion 14 days post-inoculation.
International trade and intra-EU transport
The OIE Terrestrial Code chapter 10.4 (OIE, 2010) describes the recommendations for importation
of live birds other than poultry. In essence, regardless of the avian inﬂuenza status of the country of
origin, an international veterinary certiﬁcate is required, attesting: (i) that the birds showed no clinical
sign of avian inﬂuenza infection at the day of shipment, (ii) that the birds were kept in isolation since
they were hatched or for at least 21 days prior to shipment and showed no clinical signs of avian
inﬂuenza, (iii) that a statistically valid sample of the bird consignment was tested to demonstrate
freedom from avian inﬂuenza infection and (iv) that the birds are transported in new or appropriately
sanitised containers.
EU rules (Commission Decision 2007/25/EC) are in place for the movement of pet birds (i.e
accompanied by their owner). Birds which are destined for special breeding programmes or for
Approved Bodies, Institutes or Centres or from registered bodies (Council Directive 92/65/EEC) into
and between Member States. There is a gap in the requirements for pet birds, in that the veterinary
certiﬁcate which covers the country of origin, the quarantine or testing requirements and an owner
attestation is required is only required for third country trade, and the country of origin can be one of
any on the OIE list. For intra-community trade, there is no such requirement for a veterinary
certiﬁcate. Therefore, there is a risk that such birds, if they have had contact with infected wild birds
or poultry while in the country of origin, could potentially be incubating avian inﬂuenza viruses.
However, these species are not generally considered to play a major role in transmission of such
viruses to other birds and particularly not poultry.
For other captive birds, Regulation (EC) No 139/2013 applies for non-poultry birds. There is some
debate over the deﬁnition of certain ‘poultry’ species which are not speciﬁcally used for production of
birds destined for the food chain. Therefore, it is possible some poultry type birds are being moved
under incorrect certiﬁcation. Nevertheless, such birds must originate in an approved premises and be
destined for an approved quarantine unit, accompanied by a health certiﬁcate and having already
undergone testing for avian inﬂuenza virus with negative results. Birds are placed in quarantine for
30 days on arrival.
Reported AI introductions linked to import of Psittaciformes
There have been no reported or known introductions of avian inﬂuenza to EU poultry ﬂocks through
the import of such birds. It is unlikely they would be in contact with poultry, and EU quarantine rules
assure the birds, in quarantine, would either not survive an HPAIV infection if they are susceptible, or
that testing would identify positive birds. In conclusion, it is considered extremely unlikely that
psittacine birds actively shedding infectious AIV would leave an EU quarantine unit. Thus, the risk that
AI outbreaks in EU poultry ﬂocks ensue via this pathway is considered negligible.
F.2.2. Third country trade – AI
• Import volume: 600–1,000 Psittaciformes; based on average annual trade over 3 years. Birds
should originate in registered or approved breeding establishments (see Directive 2009/158/EC).
CITES regulations may apply as well. Countries approved for the imports of such birds are those
listed in Part 1 of Annex I of Regulation (EC) No 798/2008. Australia, parts of Brazil, Canada,
Chile, Israel, New Zealand, Tunisia, USA as well as, Argentina and part of the Philippines (listed in
Annex I to Regulation (EC) No 139/2013) are authorised for imports, provided the authorities
have approved captive bird breeding establishments. Probability of testing (according to EU
legislation): All birds are subject to approved virus detection tests with negative results
7–14 days prior to the shipment. On arrival, birds are transported directly to an approved
quarantine facility where they remain for 30 days (Commission Implementing Regulation (EC) No
139/2013). During quarantine, and without use of sentinel birds, imported birds must be
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examined virologically (serological testing not being appropriate). Tracheal/oropharyngeal and/or
cloacal swabs (or faeces) must be taken from at least 60 birds or from all birds if the consignment
is less than 60 birds, during the ﬁrst 7 to 15 days of the quarantine. Therefore, the probability of
testing is non-negligible.
• Tests that can be used (according to EU legislation): Any AI test in accordance to diagnostic
manual can be used; all virological testing of samples taken during quarantine must be carried
out in ofﬁcial laboratories designated by the competent authority using diagnostic procedures
in accordance with the diagnostic manual for avian inﬂuenza. For virological examination,
pooling of samples up to a maximum of ﬁve samples of individual birds in one pool is allowed.
Faecal material must be pooled separately from other organ and tissue samples.
• Probability of virus detection (given AIV presence in commodity): The random sampling size is
chosen to guarantee detection of an infection at a prevalence of 5% with 95% conﬁdence. Any
clinical signs would be reported to the Competent Authorities and prompt further individual
sampling. It is considered non-negligible that virus will be detected, given the testing
requirements.
• Probability of virus preservation during transport: Thirty days in quarantine means even if the
birds had been infected in the period between testing in place of origin and time of shipment,
enough time should have elapsed to cover the incubation period (21 days according to the OIE
and Commission Regulation (EC) No 94/200564) and birds would either be detected as
‘infected’ or would have recovered, eliminated the virus and be seropositive. Therefore this is
considered extreme unlikely.
• Probability of poultry exposure to the commodity: Direct contact with commercial poultry is
considered extreme unlikely. Indirect contact with poultry type birds (e.g. in zoos or backyard
holdings) considered unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: Extreme unlikely.
F.2.3. Intra-EU movements- AI
• Trade volume: Between 150,000 and 200,000 individual animals per year. Birds must be
certiﬁed as originating in a holding where no signs or reports of AIV in the previous 30 days
have occurred. Holdings must be registered or approved. This does not include any birds
travelling as pets with their owners.
• Probability of testing (according to EU legislation): No testing required, therefore this
parameter is very unlikely.
• Tests that can be used (according to EU legislation): Not applicable (NA).
• Probability of virus detection (given AIV presence in commodity): NA.
• Probability of virus preservation during transport: if birds were infected and if they were
clinically well at the time of the transport, the birds could still be infective at the time of
movement into a MS given the short transport times. Therefore, under certain circumstances
this parameter can be scored as non-negligible.
• Probability of poultry exposure to the commodity: Direct contact to commercial poultry is
considered extreme unlikely. Indirect contact to poultry, for example on backyard premises is
considered unlikely. Contact with other kept birds: non-negligible.
• Probability AIV introduction into a poultry holding via the commodity: there are no reports of
EU origin psittacines from registered or approved breeding facilities becoming infected with
AIV, but given the uncertainty and the lack of testing requirements, this is considered very
unlikely.
F.3. Birds of prey (CN code 0101631)
This commodity covers all birds of prey species. CITES regulations may apply as well. Birds must be
bred in captivity and cannot be taken from the wild.
64 Commission Regulation (EC) No 92/2005 of 19 January 2005 implementing Regulation (EC) No 1774/2002 of the European
Parliament and of the Council as regards means of disposal or uses of animal by-products and amending its Annex VI as
regards biogas transformation and processing of rendered fats. OJ L 19, 21.1.2005, p. 27–33.
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F.3.1. Background info
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and prey or
falcon or owl or buzzard or hawk or harrier (topic) for the period 2005–2015 (restricting to documents
in English only). The abstracts of 21 publications were screened and experts provided additional
scientiﬁc evidence that was not retrieved by the performed searches. The extracted information from
the relevant papers is reported below and in Table F.1.
Ducatez et al. (2007) identiﬁed 48 dead or sick vultures in Burkina Faso of which at least 17 were
conﬁrmed to be HPAI positive. HPAI H5N1 viruses were isolated from vultures and affected poultry
farms in the same region and were phylogenetically similar. The authors mention that virus
transmission from poultry to vultures could have happened. The feeding behaviour of vultures could
also be involved in transmission within domestic poultry and/or transmission between poultry holdings,
although clear supporting scientiﬁc evidence is lacking.
Khan et al. (2009) reported an outbreak of HPAI H5N1 in Houbara bustards, which were introduced
into the Kingdom of Saudi Arabia for hunting purposes by falcons. Thirty-eight out of 41 bustards died
as well as 10 out of 16 falcons that came in contact with these birds. However, molecular analysis
indicated that there were two different HPAI H5N1 viruses cocirculating in the falconry and poultry
sectors in Saudi Arabia (Monne et al., 2008); therefore, there was no clear link between the birds of
prey and poultry outbreaks.
Shivakoti et al. (2010) found an emaciated mountain hawk-eagle in Japan from which they isolated
HPAI H5N1. Nine days later, on HPAI outbreak in poultry farms started. However, there are no clear
links between the infected hawk-eagle and the poultry farms.
Reid et al. (2011) reported HPAI H5N1 isolated from a common buzzard in Bulgaria (29 March
2010), with 99.9% similarity with the HA gene sequence of HPAI H5N1 (clade 2.3.2) isolates from an
outbreak in backyard chicken ﬂocks in Romania (13–29 March 2010).
Kohls et al. (2011) found AIV-RNA of subtypes H6, H9 or H13 in swabs of gulls (4.1%) and ducks
(3.8%) hunted by falconry birds such as Gyrfalcon and peregrine falcon during two successive hunting
seasons (2006–2008), whereas all 54 falconry birds were negative.
Bertran et al. (2012) successfully infected gyr-saker hybrid falcons with HPAI H5N1 or LPAI H7N2,
via the nasal choanal route or via ingestion of previously infected chicks.
van den Brand et al. (2015) detected H5N1-infected common buzzards (12/385) and peregrine
falcons (2/6) during an H5N1 outbreak in wild water birds in Germany (2006), whereas seven other
species were negative: Eurasian sparrow hawk (111), common kestrel (38), undetermined species of
buzzard (36), white-tailed sea eagle (19), undetermined species of raptor (12), northern goshawk
(10), red kite (3), rough-legged buzzard (3) and western marsh-harrier (1). The results suggested that
H5N1 outbreaks in wild water birds are more likely to lead to exposure to and mortality from H5N1 in
raptors such as common buzzards and peregrine falcons that hunt or scavenge medium-sized birds,
than in raptors that hunt small birds and do not scavenge such as Eurasian sparrow hawks and
common kestrels. The authors hypothesised that the raptors became infected by feeding on H5N1-
contaminated carcasses, as reported for gulls (Brown et al., 2006).
Naguib et al. (2015) reported an outbreak of HPAI H5N1 clade 2.3.2.1c in hunting falcons in Dubai.
Ip et al. (2015) reported presence of HPAIV H5N8 and reassortants thereof in wild bird species,
including birds of prey as well as in hunting falcons, in the U.S. in 2014.
During the H5N8 outbreak in 2015/6 in the EU also several cases of a large avian predator species,
White-tailed eagle, have been reported.
Clinical signs of AI infections in birds of prey
Table F.1: Clinical signs and/or cause of death of birds of prey reported in the scientiﬁc literature
(2005–2015)
Virus
type,
clade
Species Infection
Clinical signs and/or cause of
death
Reference
HPAI
H5N1, 2.2
Common buzzard,
peregrine falcon
Natural Encephalitis Van den
Brand et al. (2015)
HPAI
H5N1,
2.3.2
Common buzzard Natural No signs of infection Reid et al. (2011)
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International trade and intra-EU transport regarding birds of prey
EU rules are in place for the movement of pet birds (i.e. accompanied by their owner) (Commission
Decision 2007/25/EC) or birds which are destined for special breeding programmes or for Approved
Bodies (Council Directive 92/65/EEC) into the Union. There is a gap in the requirements for pet birds,
in that the veterinary certiﬁcate which covers the country of origin, the quarantine or testing
requirements and an owner attestation is only required for third country trade, and the country of
origin can be one of any on the OIE list. For intra-community trade, there is no such requirement for a
veterinary certiﬁcate. Therefore, there is a risk that such birds, if they have had contact with infected
wild birds or poultry while in the country of origin or if fed on contaminated poultry chicks, could
potentially be incubating avian inﬂuenza viruses; however, these species are not generally considered
to play a major role in transmission of such viruses to poultry, because the birds of prey would be
hunting and not having prolonged contact with live birds. This differs, of course, when such birds are
destined to join a zoological collection or falconry.
For other captive birds, Regulation (EU) No 139/2013 applies for imports from third countries of
non-poultry birds. Such birds must originate in an approved premises and be destined for an approved
quarantine unit, accompanied by a health certiﬁcate and having already undergone testing for avian
inﬂuenza virus with negative results. Birds are placed in quarantine for 30 days on arrival.
Virus
type,
clade
Species Infection
Clinical signs and/or cause of
death
Reference
HPAI
H5N1,
2.3.2.1.c
Gyr falcons and
hybrids of gyr and
peregrine falcons
Natural Signs of systemic disease Naguib et al. (2015)
HPAI H5N1 Vultures Natural Dyspnoea, neurological signs,
asthenia, locomotion problems,
diarrhoea, respiratory disorders,
prostration, rufﬂed feathers
Ducatez et al. (2007)
HPAI
H5N1, 2.2.
Gyr-Saker (Falco
rusticolus x Falco
cherrug) hybrid
falcons
Experimental One falcon died on 3 dpi, three
died on 4 dpi and one died on
5 dpi. Four had reduced food
intake starting from the day of
infection and three had a slightly
bloody tracheal exudate detectable
the day after exposure. One bird
died with no clinical signs
Lierz et al. (2007)
HPAI
H5N1, NS
Houbara bustards Natural Torticollis, paralysis of the leg and
imbalance, swollen head, nasal
discharge, greenish diarrhoea.
Within 4 days, 38 out of 41
bustards died
Khan et al. (2009)
HPAI
H5N1, NS
Falcons Natural Nervous signs and diarrhoea
HPAI
H5N1, NS
American kestrels Experimental Feather ﬂufﬁng, rhythmic side to
side head movements, ataxia,
head held at an angle, loss of
appetite, loss of balance and
motor control, tremors
Hall et al. (2009)
HPAI
H5N1, NS
Gyr-Saker
(F. rusticolus x
F. cherrug) hybrid
falcons
Experimental The infected falcons died or were
euthanised between 5 and 7 dpi
after showing acute severe
neurological signs
Bertran et al. (2012)
LPAI H7N2 Gyr-Saker
(F. rusticolus x
F. cherrug) hybrid
falcons
Experimental No clinical signs (although all
seroconverted)
Bertran et al. (2012)
dpi: days post-infection; NS, not speciﬁed.
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Reported AI introductions into poultry linked to import of birds of prey
There are no known reports of direct transmission of avian inﬂuenza viruses to poultry by imports
of birds of prey. They are generally considered to be spill-over hosts as a result of consuming infected
or contaminated birds themselves. Birds of prey, that were tested positive for HPAI, have been
implicated in a case of illegal introduction into the EU at Brussels airport in 2005 (Van Borm et al.,
2005).
F.3.2. Third country trade – AI
• Import volume: Fewer than 500 birds per annum.
• Probability of testing (according to EU legislation): All birds are subject to approved virus
detection tests with negative results 7–14 days prior to the shipment. On arrival, birds are
transported directly to an approved quarantine facility where they remain for 30 days
(Regulation (EU) No 139/2013). During quarantine, and without use of sentinel birds, imported
birds must be examined virologically (serological testing not being appropriate). Tracheal/
oropharyngeal and/or cloacal swabs (or faeces) must be taken from at least 60 birds or from
all birds if the consignment is less than 60 birds, during the ﬁrst 7–15 days of the quarantine.
Therefore, the probability of testing is non-negligible.
• Tests that can be used (according to EU legislation): Any AI test in accordance to diagnostic
manual can be used. All virological testing of samples taken during quarantine must be carried
out in ofﬁcial laboratories designated by the competent authority using diagnostic procedures
in accordance with the diagnostic manual for avian inﬂuenza. For virological examination,
pooling of samples up to a maximum of ﬁve samples of individual birds in one pool is allowed.
Faecal material must be pooled separately from other organ and tissue samples.
• Probability of virus detection (given AIV presence in commodity): The random sampling size is
chosen to guarantee detection of an infection at a prevalence of 5% with 95% conﬁdence. Any
clinical signs would be reported to the Competent Authorities and prompt further individual
sampling. Virus detection is considered non-negligible and allows for the small uncertainty that
other birds are present in the quarantine facility and in contact with infected birds and are not
tested or show no clinical signs.
• Probability of virus preservation during transport: Given the requirements for quarantine, this
level is considered to be extreme unlikely.
• Probability of poultry exposure to the commodity: Direct contact to commercial poultry
extreme unlikely. Indirect contact to poultry unlikely. Contact with other kept birds: non-
negligible. Captive birds should not be kept with commercial poultry in the EU. Poultry workers
should not keep captive birds at home and therefore poultry exposure is considered extreme
unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: Given the import
requirements for testing and quarantine and exposure to poultry overall this is considered
extreme unlikely.
F.3.3. Intra-EU movements – AI
• Import volume: Around 500–1,500 birds per annum. This does not include any birds travelling
as pets with their owners.
• Probability of testing (according to EU legislation): Very unlikely as there are no requirements
• Tests that can be used (according to EU legislation): NA
• Probability of virus detection (given AIV presence in commodity): NA
• Probability of virus preservation during transport: Non-negligible
• Probability of poultry exposure to the commodity: Extreme unlikely
• Probability of AIV introduction into a poultry holding via the commodity: Very unlikely to
account for the uncertainty around the lack of testing requirements.
F.4. Other birds (Traces code 010639)
This commodity covers bird consignments other than poultry, Psittaciformes, ratites or birds of prey
((but including for instance pigeons 01063910) and other birds, such as Passeriformes, peacocks,
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swans, wild ducks, wild geese, snipe, woodcocks, grouse, quails, pheasants and partridges). The
commodity is transported without the presence of the owner.
F.4.1. Background information
A literature search has been carried out in Web of Science using the string ‘Avian’ (title) and
(pigeon*) or (columb*), and ‘spread’ (topic) and ‘inﬂuenza’ (topic) from 2006 to onwards (without
restrictions the documents for language). Forty-one records resulted and after screening for relevance
of the abstracts and full-texts, nine articles were considered relevant as they contained test results of
pigeons or Columbiformes. Table F.2 summarises the evidence reported on the role of pigeons in AIV,
ampliﬁcation and/or shedding in eight papers. The ninth paper, Hernandez-Jover et al. (2015), is
considered separately because it is a quantitative risk assessment, which estimates the probability of
introduction of LPAIVs from wild birds into poultry exhibition ﬂocks in Australia, and the subsequent
spread to other poultry ﬂocks using scenario trees and Monte Carlo stochastic simulation modelling
(Hernandez-Jover et al., 2015). The authors reported that ‘the median probability of LPAI spread
through movement of birds in ﬂocks keeping waterfowl and turkeys was estimated by the authors to
be 0.28 (0.123–0.541) and 0.230 (0.104–0.421), respectively. A lower probability was estimated for
chicken (0.087; 0.027–0.202) and pigeon (0.0003; 3.0 9 105 to 0.0008) ﬂocks. The sensitivity
analysis indicates that the prevalence of LPAI in wild waterfowl and the probability of contact of
domestic birds with wild waterfowl are the most inﬂuential parameters on the probability of exposure,
while the probability of spread is mostly inﬂuenced by the probability of movement of birds and the
probability of the exhibitor detecting and reporting LPAI.’
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Table F.2: Results from experimentally infected pigeons
Al-Attar et al. (2008)
Virus subtype and sample collection: H9N2, 60 pigeons were captured from Nineveh province around Mosul
city (Iraq) in 2007
Virus ampliﬁcation: 81.5% and 50% of birds were positive in ELISA and HI tests, respectively
Virus shedding: not analysed
Brown et al. (2009)
Virus subtype and sample collection: HPAI H5N1, experimental infection of 20 wild-caught adult rock
pigeons (Columba livia)
Virus ampliﬁcation: A high virus concentration (106.1 EID50/0.1 mL) was required to produce infection (3/5) or
death (2/5)
Virus shedding: When infection did occur, the duration of viral shedding was brief and viral titres were low
(below detectable limit of the tissue culture titration assay (101.87 TCID50/mL)
Chang et al. (2014)
Virus subtype and sample collection: not subtype speciﬁc, H5 AI seroprevalence analysis (HI tests) in live
wild birds in Yunnan Province (China)
Virus ampliﬁcation: 2/2 samples from Columbiformes were seronegative
Virus shedding: not analysed
Hayashi et al. (2011)
Virus subtype and sample collection: HPAI H5N1, experimental infection (106 EID50) of groups of 8 pigeons
with two HPAI H5N1 viruses
Virus ampliﬁcation: Replication of both viruses has been detected, a survival experiment was not conclusive
since also control birds died
Virus shedding: Shedding of both viral strains was observed 5 days post-infection (3/3 or 1/3 birds with mean
titres 102.8 and 102.7 EID50/mL)
Kalthoff et al. (2014a,b)
Virus subtype and sample collection: LPAI H7N9 and H7N7, experimental infection (106 TCID50) of racing
pigeons
Virus ampliﬁcation: no clinical signs, antibodies detected in ELISA against NP and H7 (8/8), VN negative (8/8)
and HI was negative (6/8) or weakly positive (2/8, titre 2 or 4)
Virus shedding: very low RNA levels were detected in oropharyngeal and cloacal swabs (Cq values variation
26.2–34.2)
Klopﬂeisch et al. (2006)
Virus subtype and sample collection: HPAI H5N1, experimental infection (108 EID50) of 14 4-month-old
racing pigeons (Columbia livia f. domestica)
Virus ampliﬁcation: 3 birds died after disease associated with neurotropism whereas the remaining 9 pigeons
showed neither clinical signs nor gross or histological lesions although H5 seroconversion (titres ranging from
1:32 to 1:64 in HI test) indicated that they had been infected
Virus shedding: ﬁve SPF White Leghorn chickens were added to the aviary with the pigeons 48 h
postinoculation and none of these seroconverted at 19 days postinoculation (whereas inoculation of chickens
with the virus strain conﬁrmed their susceptibility to the virus)
Pantin-Jackwood et al. (2014)
Virus subtype and sample collection: LPAI H7N9, experimental infection (106 EID50) of 6- to 12-month-old
rock pigeons (Columbia livia domestica)
Virus ampliﬁcation: infection without clinical signs
Virus shedding: very low viral shedding (101.7–2.5 EID50/mL mean virus titre) at 2 and 4 days postinoculation
(5–7/11 and 1/8 birds, respectively), pigeons did not transmit the virus to direct contact pigeons
Shriner et al. (2016)
Virus subtype and sample collection: not subtype speciﬁc, H5 AI seroprevalence analysis (ELISA and HI
tests) in live wild birds captured around poultry farms during an acute HPAI H5N8 outbreak
Virus ampliﬁcation: 3/38 rock pigeons were suspected positive in ELISA but were below the detection level of
the HI test (< 1:8 titre)
Virus shedding: not analysed
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Natural infections of Passeriformes are interpreted as a consequence of spill-over infection from
infected poultry holdings (Han et al., 2012; Slusher et al., 2014); there are no reports of self-sustained
transmission chains in Passeriformes temporally and geographically independent of the presence of
HPAIV in poultry holdings. Special cases have involved small passerine species such as the muniahs in
Buddhist animal release rites in Hong Kong and elsewhere in South-East Asia (Gutierrez et al., 2011).
The role of some passerine species such as starlings, sparrows, and swallows acting as bridging hosts
between water bird habitats and poultry holdings has been debated controversially (Forrest et al.,
2010; Caron et al., 2015). Although some of these species were found to be susceptible in
experimental infection (e.g. Fujimoto et al., 2015), there are no reports that actually link naturally
infected passerines with incursions of HPAIV into poultry holdings. In this respect, members of the
Corvidae family comprising crows, jays and magpies should be mentioned here as they are also
passerine birds and have more frequently been found infected with HPAIV probably as a consequence
of scavenging on carcasses of other infected birds (e.g. Khan et al., 2014). It is an acknowledged data
gap for the role of bridging species in causing incursion of AI into poultry holdings.
F.4.2. Third country trade – AI
• Import volume: ~ 600–1,000 per annum birds other than poultry, Psittaciformes or birds of
prey.
• Probability of testing (according to EU legislation): non-negligible, as this is required for third
country imports.
• Tests that can be used (according to EU legislation): any AI test in accordance to OIE
diagnostic manual.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.4.3. Intra-EU movements – AI
• Import volume: 20,000–25,000 per annum of birds other than poultry, Psittaciformes or birds
of prey. The different species cannot be differentiated using the Comtrade database.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): NA.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely which
accounts for the lack of testing requirements.
F.5. Pet birds (consignment with presence of owner)
This commodity covers bird consignments other than poultry, Psittaciformes or birds of prey (but
including for instance pigeons and Passeriformes), that are transported with the presence of the owner
(no more than ﬁve birds per consignment). It is regulated by Commission Decision 2007/25/EC.
For intra-EU movements of pet birds, there are no rules, except for the number of birds which can
travel with each person. For third country imports into the EU, a veterinary certiﬁcate and owner
declaration are required, showing the country of origin and the period of quarantine or results of
testing for H5N1 by PCR or serology.. The two pathogenic strains are separated for the purpose of this
category because of different requirements for third country origin pets to have a (negative) test
certiﬁcate for H5N1.
F.5.1. Background information
The animal species included in this commodity are the same already described in the background
information of previous sections but the use of these animals is different. As pet birds, they would be
going directly to the owner’s household and would be extremely unlikely to be exposed to commercial
poultry.
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F.5.2. Third country trade – HPAI
• Import volume: no requirement to record as trade statistics – information may be available
from national statistics but given the parameter values it was not considered necessary to
collect these data.
• Probability of testing (according to EU legislation): non-negligible for H5N1.
• Tests that can be used (according to EU legislation): either PCR or serology, in accordance to
diagnostic manual.
• Probability of virus detection (given AIV presence in commodity): non-negligible only for H5N1.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.5.3. Intra-EU movements – HPAI
• Import volume: no requirement to record as Trade statistics – information may be available
from national statistics but given the parameter values it was not considered necessary to
collect these data.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very likely (other virus else
than H5N1).
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.5.4. Third country trade – LPAI
• Import volume: no requirement to record Trade statistics.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely which
accounts for the lack of testing required.
F.5.5. Intra-EU trade – LPAI
• Import volume: no requirement to record Trade statistics.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): n/a.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely, as only
self-certiﬁcation as disease free is required for intra-EU movements MSs.
F.6. Hatching eggs – Gallus gallus (Traces code 040711)
This commodity covers eggs for incubation, laid by Gallus gallus.
F.6.1. Background information (for Gallus gallus and other poultry species)
The information here reported considers also hatching eggs laid by other poultry species (described
in the following Section F.7).
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and hatching
(topic) for the period 2005–2015 (restricting to documents in English only). The abstract of 35
publications were screened and it was noticed that most were describing in-ovo vaccination studies. The
full text of a few relevant publications was screened and the extracted information is reported below.
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Vertical AI transmission and AI susceptibility of hatching poultry eggs
There is only limited proof of true vertical AI transmission. No AIVs were detected in the faecal
samples of newly hatched ducklings in two duck holdings where avian inﬂuenza virus was circulating
(Marinova-Petkova et al., 2016). Most LPAIV and virtually all HPAIV infections are lethal to the embryo
although the mean death times may differ (Cobb, 2011) and hatching of HPAI infected eggs has not
been convincingly documented. This does not exclude the presence of LPAIV and HPAIV in the egg
white and yolk or on the shell of embryonating eggs originating from infected layers. Scientiﬁc
evidence comes from unpublished studies cited by Swayne and Beck (2004), suggesting the presence
of HPAI H5N2 virus in 85% to 100% of eggs laid 3–4 days after experimental inoculation of poultry
with HPAI virus. In addition, H5N2 HPAI virus has been recovered from the yolk and albumen of eggs
from naturally infected chicken ﬂocks (Cappucci et al., 1985) and from experimentally infected hens
(Beard et al., 1984). Promkuntod et al. (2006) reported the detection of H5N1 in Japanese quail eggs.
It is not clear whether a viraemic stage of infection is required to deposit AIV inside an egg or whether
local infection of the oviduct would be sufﬁcient as well. Most LPAI and HPAI viruses cause shell
malformation, reduction or cessation, respectively, of egg production (e.g. Gonzales et al., 2012a,b),
and/or hatching (e.g. Cai et al., 2011), further limiting the potential for vertical transmission of AI
virus.
Newly hatched birds are more susceptible to infectious diseases than older birds because of an
immature immune system. On the other hand, embryos and hatchling may be speciﬁcally protected by
maternally derived AI-speciﬁc antibodies (for instance, if they were derived from layers repeatedly
vaccinated, (Abdelwhab et al., 2012)), although it seems that high maternal antibody-titres are
required to provide full clinical protection (De Vriese et al., 2010; Maas et al., 2011).
Cobb (2011) provides an overview on the spread of pathogens through trade in poultry hatching
eggs. Reference is made to chapter 6.4 of the OIE Terrestrial Animal Health Code (OIE, 2009)
describing hygiene and disease security procedures for poultry breeding ﬂocks and hatcheries. Similar
procedures are laid down in Council Directive 2009/158/EC Annex II.
International trade and intra-EU transport
The OIE Terrestrial Code chapter 10.4 (OIE, 2010) describes the recommendations for importation
of hatching eggs of poultry. In essence, the birds should have been derived from a ﬂock and kept in
an AI-free area (at least 21 days prior to the collection of the eggs) and should be transported in new
or appropriately sanitised containers.
Once an AI outbreak is suspected or conﬁrmed within the EU, no poultry may enter or leave the
affected holding or be transported within the protection zone without an authorisation from
the competent authority, observing appropriate biosecurity measures such as to minimise any risk of
the spread of avian inﬂuenza (Council Directive 2005/94/EC).
Legislation on imports of live poultry, day-old chicks and hatching eggs, table eggs, egg products,
and the meat of game birds and poultry is laid down in Commission Regulation (EC) No 798/2008.
This includes a list of approved countries for which there are certiﬁcates to allow the import of such
consignments. Some countries are regionalised, some have special additional measures. Hatching eggs
must similarly have originated from breeding ﬂocks free of notiﬁable AI and have been present in a
hatchery for 6 weeks prior to import. In the case of hatching eggs, the live poultry hatched from such
eggs must similarly be isolated for a period of 3 weeks. Testing is not required; as it is presumed that
infected eggs will not hatch or that the infected chicks will not survive.
For movements within the EU for live poultry, day-old chicks and hatching eggs, Directive
2009/158/EC applies.
Reported AI introductions linked to import of hatching poultry eggs
No reports were found. The import rules and expert scientiﬁc opinion on the hatchability of infected
eggs suggest this route is unlikely, although birds are not tested once hatched.
Nevertheless, the possible fomite transfer during transport should not be discounted. Particularly if
birds are less likely to show clinical signs and the birds are housed in a hatchery or rearing unit
together with other birds.
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F.6.2. Third country trade – AI
• Import volume: 25–30 million eggs per year.
• Probability of testing (according to EU legislation): extreme unlikely, but quarantine required
for 30 days during which time the hatchery must record hatchability and report any suspicion
of notiﬁable disease.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: extreme unlikely, given the quarantine
requirements.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely, which
accounts for the aggregated risk because of the volume of eggs which are transported and the
potential for fomite contamination.
F.6.3. Intra-EU movements – HPAI
• Import volume: 1.1 billion eggs per year.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: very unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding/hatchery via the commodity: unlikely,
which accounts for the volume and therefore the aggregated risk score. However, with the
HPAI strains the required veterinary inspection should detect any clinical signs.
F.6.4. Intra-EU movements – LPAI
• Import volume: 1.1 billion eggs per year.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): unlikely.
• Probability of virus preservation during transport: non-negligible for fomite transfer.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding/hatchery via the commodity: even taking into
account the fomite risk and the large volume of eggs, it was scored as unlikely because they will
not be infected, although fomite contamination (egg shells, crates, etc.) cannot be discounted.
F.7. Hatching eggs – other (Traces code 040719)
This commodity covers eggs for incubation, laid by poultry species other than Gallus gallus.
F.7.1. Background information
See Section F.6.1.
F.7.2. Third country trade – AI
• Import volume: 5 million of non-gallinaceous poultry; 200,000–300,000 for both game birds
and non-poultry.
• Probability of testing (according to EU legislation): extreme unlikely, but quarantine required
for 30 days.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: extreme unlikely, due to quarantine
requirements.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely which
accounts for the aggregated score of a large volume of trade.
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F.7.3. Intra-EU movements – AI
• Import volume: 120–170 million per annum of which 15 million non-poultry hatching eggs and
50 million for game birds hatching eggs.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: very unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: unlikely, which
accounts for the aggregated score of a large volume of trade.
F.8. Day-old-chickens (Traces code 010511 or 010512)
This commodity covers all Gallus gallus individuals less than 72 h old, not yet fed. It covers four
commodity codes, depending on grandparent, parent, layers or other breeding stock.
F.8.1. Background information (for chickens and other poultry species)
The information reported in this section considers also individuals less than 72 h old of other
poultry species.
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and ‘Day-old
poultry’ (topic) for the period 2005–2015 (restricting to documents in English only). The abstract of 61
publications were screened and it was noticed that most were describing studies vaccinating 1-day-old
poultry. The full text of a few relevant publications was screened and the extracted information is
reported below.
AI susceptibility day-old poultry
In general, day-old chickens are more susceptible to infectious diseases than older birds because of
an immature immune system. For instance, in newly hatched birds, the activation, phagocytosis and
bactericidal activities of heterophils and macrophages were shown to be age-dependent in that they
increase with age (Kodama et al., 1976; Wells et al., 1998; Kogut et al., 2002).
Yamamoto et al. (2007a,b) inoculated day-old call ducks with HPAI H5N1 and reported neurological
signs (drowsiness, ataxia and intermittent generalised seizure) and corneal opacity followed by
mortality between 3 and 7 days post-infection.
In the past, intracerebral injection of AI viruses in day-old chicks was performed to determine the
pathogenicity of the virus (e.g. Afzal et al., 2012). However, the intracerebral pathogenicity index is not
recommended any longer by the OIE (2015).
International trade and intra-EU transport
International trade and intra-EU transport rules reported for Sections F.6 and F.7 apply also to this
commodity.
Only a limited list of countries or regions is approved for the import into the EU of poultry
(breeding, production, day-old chicks (DOCs) and hatching eggs). DOCs must originate from a parent
ﬂock free of HPAI or vaccinated under a vaccination plan agreed by the European Commission; no
such plans are currently agreed. The parent ﬂock should have been present at premises free of HPAI
for 6 weeks and there should have been no other HPAI outbreaks in the surrounding 10 km for
30 days. Once the consignments are imported into the EU, the Regulation requires that the birds be
kept at the destination for a minimum of three weeks (not more than 2 months) with sampling and
(negative) testing for AI, during which time there is also monitoring for clinical signs. For intra-EU
movements, day-old chicks must originate from a hatchery where eggs come from ﬂocks in an
approved breeding establishment, have been held for 6 weeks and which are subject to a monthly
inspection and 72–h inspection or 72 premovement veterinary examination.
Small consignments of fewer than 20 units are not subject to the same requirements, but must
originate from ﬂocks which have been present in the EU since hatching or for at least 3 months, and
must show no clinical signs of disease.
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Reported AI introductions linked to import of day-old-poultry
The import conditions, requiring isolation and testing on arrival means this is an unlikely route for
introduction of AI into the EU poultry sector.
Nevertheless, the possible fomite transfer during transport should not be discounted, particularly if
birds are less likely to show clinical signs and the birds are kept in a hatchery or rearing unit together
with other birds. However, the quarantine requirements mean infected birds would show clinical signs
while in quarantine and therefore will not be placed on a poultry farm.
F.8.2. Third country trade – AI
• Import volume: 200,000–400,000 of birds per year.
• Probability of testing (according to EU legislation): non-negligible; quarantine required for
21 days and negative testing.
• Tests that can be used (according to EU legislation): according to the diagnostic manual.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.8.3. Intra-EU movements – HPAI
• Import volume: 500–700 million birds per year.
• Probability of testing (according to EU legislation): extreme unlikely – not required by the
legislation.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: very unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: unlikely to account for
the aggregated risk score and high volume of trade and because with the HPAI strains the
required veterinary inspection should detect any clinical signs.
F.8.4. Intra-EU movement – LPAI
• Import volume: 500–700 million birds per year.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: non-negligible.
F.9. Day-old-poultry (ducks or geese)
This commodity covers all ducks or geese less than 72 h old, not yet fed. The import rules are the
same as for day-old chicks from gallinaceous poultry.
F.9.1. Background information
See Section F.8.1.
F.9.2. Third country trade – AI
• Import volume: 50,000–200,000 birds per year.
• Probability of testing (according to EU legislation): non-negligible.
• Tests that can be used (according to EU legislation): according to the diagnostic manual.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
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F.9.3. Intra-EU movement – HPAI
• Import volume: 50–60 million birds per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): very unlikely.
• Probability of virus preservation during transport: very unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: unlikely.
F.9.4. Intra-EU movement – LPAI
• Import volume: 50–60 million birds per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: non-negligible.
F.10. Poultry weighing more than 185 g/more than 72 h old –
Gallus gallus (Traces code 010594)
This commodity covers all Gallus gallus individuals reared or kept in captivity for breeding or for
production, which are more than 185 g in weight/more than 72 h old (therefore not considered day
old chicks).
F.10.1. Background information (for Gallus gallus and other poultry
species)
The information reported in this section considers also individuals reared or kept in captivity for
breeding or production purposes.
The background information of this commodity is covered by the legislation (Council Directive 2009/
158/EC) which requires live poultry to enter quarantine on arrival in the EU and be tested (negative)
prior to leaving.
AI susceptibility of older poultry
Na€ıve birds from all poultry species are considered susceptible to AIV infection. At least for HPAIV
H5N1-infected ducks, several studies report an age-dependent evolution in AI susceptibility with the
presence of mortality and/or clinical signs in young animals and no/milder mortality and/or clinical
signs in older birds (Pantin-Jackwood and Swayne, 2007; Pantin-Jackwood et al., 2007; L€ondt et al.,
2010). This can be related to a variety of factors including the virus strain and host-speciﬁc factors
such as immune competence (Kothlow and Kaspers, 2008). Reemers et al. (2010) inoculated 1- and
4-week old chickens with H9N2 via the nasal route. The results suggest that the strength of virus-
induced host responses is affected by maturation of the (respiratory) immune system and may be a
key factor in age-dependent host responses to AI infection.
International trade and intra-EU transport
International trade and intra-EU transport rules reported for Sections F.6, F.7 and F.8 apply also to
this commodity.
For live poultry (breeding or production), the birds must originate in a territory free of HPAI and not
be vaccinated against HPAI, they must have been present at the premises for at least 3 months or
since hatching, the premises must be free of HPAI and not within 10 km of an outbreak of HPAI in the
past 30 days. Once the consignments of live poultry are imported into the EU, the Regulation requires
that the birds be kept at the destination for a minimum of three weeks with sampling and (negative)
testing for AI, during which time there is also monitoring for clinical signs.
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Reported AI introductions linked to import of older poultry
There are no reported AIV introductions to EU poultry holdings through the imports of breeding
poultry. The list of approved countries is limited and the birds must enter quarantine for 21 days prior
to entering a poultry holding.
Nevertheless, the possible fomite transfer during transport should not be discounted, particularly if
birds are less likely to show clinical signs and the birds are in hatchery or rearing unit with other birds.
F.10.2. Third country trade – AI
• Import volume: 800,000–1 million birds per annum.
• Probability of testing (according to EU legislation): non-negligible.
• Tests that can be used (according to EU legislation): any AI test in accordance to diagnostic
manual.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.10.3. Intra-EU movements – HPAI
• Import volume: 400–500 million birds per annum.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): birds should exhibit clinical
signs.
• Probability of virus preservation during transport: unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: unlikely because with
the HPAI strains the required veterinary inspection should detect any clinical signs.
F.10.4. Intra-EU movements – LPAI
• Import volume: 400–500 million birds per annum.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): clinical signs are unlikely to
be observed.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: non-negligible.
F.11. Poultry weighing more than 185 g – not Gallus gallus
(Traces code 010599 and 010633)
This commodity covers non-Gallus gallus species reared or kept in captivity for breeding ((e.g.
turkeys 01059930), guinea fowl (01059950), ducks (01059910), geese (01059920). Also, included are
the ratites, under CN code 010633).
F.11.1. Background information
Same as for Section F.10.1.
The background information of this commodity is covered by the legislation (2009/158/EC), which
requires live poultry to enter quarantine and be tested (negative) prior to leaving.
F.11.2. Third country trade – AI
• Import volume: < 200 birds per annum.
• Probability of testing (according to EU legislation): non-negligible.
• Tests that can be used (according to EU legislation): any AI test in accordance to diagnostic
manual.
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• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.11.3. Intra-EU movements – HPAI
• Import volume: 15–18 million birds per annum.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): birds should exhibit clinical signs
• Probability of virus preservation during transport: unlikely.
• Probability of poultry exposure to the commodity: non-negligible
• Probability of AIV introduction into a poultry holding via the commodity: unlikely because with
the HPAI strains the required veterinary inspection should detect any clinical signs.
F.11.4. Intra-EU movements – LPAI
• Import volume: 15–18 million birds per annum.
• Probability of testing (according to EU legislation): very unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): clinical signs are unlikely to
be observed.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: non-negligible.
F.12. Meat (Traces code 0207)
This commodity covers the raw meat of all poultry, fowls, turkeys, guinea fowls, ducks, geese,
quails, pigeons, pheasants and partridges reared or kept in captivity for the production of meat. Only
fresh and frozen meat is accounted for (cooked meat is not considered a relevant commodity for AIV
transmission; therefore, it has not been assessed).
F.12.1. Background information
This section provides scientiﬁc evidence relevant to assess the possible spread of HPAI via meat of
poultry. An analysis of the risk for a food-borne infection to humans is beyond this opinion. Pensaert
and Van Reeth (2010) did an analysis for the H1N1 virus and concluded that turkey meat infected with
this virus is not a food-borne threat. Harder et al. (2016) provided a review on the same topic related
to HPAIV H5N1.
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and meat
(topic) for the period 2005–2015. The abstract of 32 publications were screened and the full text of
relevant publications was screened. The extracted information is reported below.
AI detection in meat of poultry
HPAI infections induce systemic infections in poultry and virus can be identiﬁed in many tissues.
Many HPAI viruses are mainly dispersed in the neuronal and respiratory system, heart and pancreas
although virus can sometimes also be detected in muscle tissue (Swayne and Beck, 2005; Antarasena
et al., 2006; Toffan et al., 2008; L€ondt et al., 2010; Pasick et al., 2010; Kapczynski et al., 2013). Even if
muscle cells are not the primary permissive cell type, blood vessel endothelial cells in muscle tissue
might harbour infectious virus.
A few papers were found describing the presence of infectious virus in meat after an experimental
HPAI infection (see Table F.3). On the other hand, LPAI induces mainly localised respiratory and
gastrointestinal infections (Mo et al., 1997; Alexander, 2000; Swayne and Beck, 2005) and virus is not
to be expected to be disseminated systemically. Therefore, it is not surprising that no papers were
identiﬁed on the presence of LPAI in meat. Nevertheless, remnants of lung and kidney tissues in frozen
carcasses produced from LPAIV-infected poultry may still harbour infectious virus. However, Zepeda
and Salman (2007) performed a quantitative release assessment and reported that the probability of
LPAI introduction through chicken meat imports is ‘insigniﬁcant’.
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AI tenacity in meat of poultry
Ejaz et al. (2007) infected 10-weeks-old broiler chickens intranasally with LPAI H9N2. After
10 days post-inoculation, the animals were euthanised and their carcasses were cut into small pieces
and frozen at 20°C. At a weekly basis, samples were thawed and presence of the virus was
analysed through embryonated egg inoculation. Infectious virus was detected in bone marrow and
legs (until 6 weeks post-storage), neck and wings (until 4 weeks post-storage), and breast (until
2 weeks post-storage).
Nazir et al. (2011) spiked duck breast meat with H4N6, H5N1 and H6N8 LPAIVs and analysed the
residual infectivity on cell culture at regular intervals for a maximum of 24 weeks. A linear regression
model was used to analyse the data and to calculate the time required for 90% loss of virus infectivity
(T90 values). Incubation at 20°C resulted in T90 values of 3, 2 and 3 days for H4N6, H5N1 and H6N8
viruses, respectively, whereas incubation at 0°C resulted in T90 values of 40, 54 and 81 days for H4N6,
H5N1 and H6N8 viruses, respectively.
Beato et al. (2012) experimentally infected chickens, turkeys and ducks with HPAI H7N1 via the
oronasal route and collected pectoral muscles. The samples were stored at 4°C and infectious virus
was re-isolated in chicken, turkey and duck meat (kept at 4°C) for 135, 90 and 75 days, respectively.
AI inactivation from meat of poultry
Thomas and Swayne (2007) infected chickens via the intranasal route with HPAI H5N1 and
detected the virus in thigh and breast muscle samples. Thermal inactivation of the virus was
independent of the meat type. Cooking heavily contaminated meat (as tested in this study) requires
13.3 min and 21.9 s at 60°C and 70°C, respectively, to achieve an 11-log EID50 reduction of the H5N1
virus titre. These time periods are around two- and fourfold lower, respectively, than the minimum
time described in the USDA time-temperature guidelines to cook chicken meat for a 7-log reduction of
Salmonella.
Isbarn et al. (2007) performed a study suggesting that inactivation of HPAI H7N7 in a chicken meat
suspensions is more efﬁcient using a combination of temperature and high hydrostatic pressure
compared to using temperature only. The generated mathematical inactivation model predicts a virus
inactivation by 7 logs after 1 min exposure to 460 MPa and 15°C.
Thomas et al. (2008) analysed thermal inactivation of HPAI and LPAI H5N2 in meat spiked with the
virus and in meat from intranasally infected White Leghorn chickens. For HPAI, inactivation took longer
in meat from infected chickens than in spiked meat. Linear regression models predicted that the
current US guidelines for cooking chicken meat to achieve a 7-log reduction of Salmonella also would
effectively inactivate the AI strains tested. Both H5N2 viruses tested and HPAI H5N1 were effectively
inactivated in chicken meat held at 70 or 73.9°C for less than 1 s.
There are also alternative methods to heat inactivation. For instance, Brahmakshatriya et al. (2009)
performed a preliminary study using electron beam irradiation.
In case of AI outbreaks, on-farm composting seems to become an alternative method to destroy
infected carcasses without and reducing the risk of virus spread by limiting transport of infected
material (Bendfeldt et al., 2006; Flory and Peer, 2010; Ahmed et al., 2012). Khan et al. (2013)
reported that dialysis cassettes could be used as tools to analyse AI virus inactivation by exposing it to
Table F.3: Overview of identiﬁed publications reporting AI virus titres in meat of poultry
Virus type Species Infection Age
Virus titre in
meat (log10
EID50/g)
Reference
HPAI H5N1 Chicken Experimental 3–4 weeks 7.3 Swayne and Beck (2005)
HPAI H5N1 Chicken Experimental 4 weeks 7.5–8.0 Thomas and Swayne (2007)
HPAI H5N1 Chicken Experimental NS 8.9 Brown et al. (2008)
HPAI H5N1 Chicken Experimental 3–4 weeks 1.9–7.5 Das et al. (2008)
HPAI H5N1 Chicken Experimental NS 9.0–9.2 and 10.4
(both per 30 g)
Bertran and Swayne (2014)
HPAI H5N2 Chicken Experimental 3-to-4 weeks 2.7–3.2 Swayne and Beck (2005)
HPAI H7N3 Chicken Experimental NS 7.3–7.6 (per 30 g) Swayne and Beck (2005)
HPAI H7N7 Chicken Experimental NS 7.5–7.8 (per 30 g) Swayne and Beck (2005)
NS: not speciﬁed.
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temperature, gas and pH conditions. The availability of this kind of tools will facilitate the optimisation
of alternative culling (and manure treatment) methods and the evaluation of their biosafety aspects.
Transmission of AI via feeding of infected poultry meat
Swayne and Beck (2005) inoculated 3- to -4-week-old chickens by the intranasal route with LPAI
H7N2, HPAI H5N2 or HPAI H5N1 viruses. Viral titres of 2.7 and 3.2 log10 EID50/g were detected in
breast and thigh muscle tissue of the HPAI H5N2-infected chickens whereas no virus was detected in
muscle tissue of the LPAI H7N2 inoculated animals. Feeding meat of the HPAI H5N2-infected chickens
to chickens deprived from food for 12-h chickens did not result in the transmission of the virus to the
na€ıve animals: none of the chickens developed clinical signs or produced antibodies to the AIV. On the
other hand, on average 7.3 log10 EID50/g was detected in breast muscle of HPAI H5N1 intranasally
inoculated chickens. Feeding HPAI H5N1 contaminated breast meat to 10 na€ıve chickens resulted in
death of nine animals and presence of HPAI H5 virus was conﬁrmed in oropharyngeal and cloacal
swabs.
Swayne (2006) analysed HPAI H5N1 thermal inactivation in spiked breast or thigh chicken meat
using the heating block of a thermocycler. Virus concentrations ranging from 2.8 to 6.8 log10 EID50/g
were tested. The reduction of virus infectivity titres was dependent on virus concentration and no HPAI
virus was isolated after heating at 70°C for 1 s.
Brown et al. (2008) fed two herring gulls (Larus argentatus) 5 g meat (8.9 log10 EID50/g) taken
from a chicken that died after an intranasal HPAI H5N1 inoculation. Virus transmission took place since
HPAI H5N1 was isolated from oropharyngeal and cloacal swabs (both with a mean duration of 3 days).
Kwon et al. (2009) fed piglets with breast and thigh muscle meat from chickens that died from
infection with H5N1 virus. The piglets did not show clinical signs but virus was detected in nasal swabs
in two out of four animals on day 3 post-infection only. In addition, H5N1-neutralising antibodies were
detected in serum samples, suggesting that the animals became infected asymptomatically following
consumption of raw H5N1-infected poultry meat.
Bertran and Swayne (2014) performed an experiment to determine the mean infectious and lethal
doses for ferrets following consumption of breast meat from chickens that were infected with HPAI
H5N1 24 h earlier via the intranasal route. One out of three ferrets became ill when exposed to meat
containing 6.8 or 10.92 log10 EID50/g HPAI H5N1 Mong/05 virus and none of the animals died. Only
exposure to meat containing 10.96 log10 EID50/g HPAI H5N1 VN/04 resulted in clinical signs (3/3
animals) and mortality (2/3 animals). In a second experiment, fed ferrets with meat of chickens that
were infected with HPAI H5N1, H7N3 or H7N7. Seroconversion was detected 14 days post-meat
feeding in the ferrets exposed to meat containing HPAI H5N1, H7N3 (and virus isolation in nasal or
rectal samples of some animals) but not in the H7N7 exposed animals.
International trade and intra-EU transport
The OIE Terrestrial Code chapter 10.4 (OIE, 2010) describes the recommendations for importation
of fresh meat of poultry. In essence, poultry should have been kept in a HPAI-free area and have been
slaughtered in an approved abattoir in a HPAI-free area. However, trade in poultry meat from a
country, zone or compartment affected by LPAI is allowed, provided the animals did not exhibit any
sign suggestive of AI infection during ante and post-mortem inspection.
Imports into the EU of poultry meat should be done according to Commission Regulation (EC) No
798/2008. A limited number of countries are approved and health certiﬁcates contain guarantees that
the meat does not originate in a ﬂock with avian inﬂuenza. Nevertheless, no testing is required and
particularly in the case of duck or goose meat, there would be a residual risk that birds were consigned
to slaughter in good faith while incubating disease.
For EU trade in poultry meat and eggs and egg products, there is ‘placing on the market’ and no
veterinary certiﬁcation, e.g. for meat all slaughterhouse that trade within the EU must be approved
and are under competent authority supervision, no certiﬁcate is issued, but a commercial document
with stamp must accompany the products.
Poultry meat (fresh or frozen) and table eggs are frequently intercepted in passenger luggage
(information from UK Border Force seizures). However, even those may be expected to be infected
with a higher likelihood than their parallel legal commodities, the volumes involved are far lower.
The article 10.4.25 (OIE, 2016a,b) of the OIE Terrestrial Code describes that, for processed poultry
meat, a range of industry standard temperatures between 60.0°C and 73.9°C can inactivate the avian
inﬂuenza viruses, e.g. achieve a 7-log reduction, between 507 and 0.51 s, respectively.
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Reported AI introductions linked to meat of ducks
Mase et al. (2005) reported the isolation of HPAI H5N1 (approximately 0.5–4.5 log10 EID50/g) from
duck meat processed for human consumption, imported to Japan from China.
Beato et al. (2006) described the isolation of LPAI H10N7 virus from a duck carcass smuggled from
China into Italy.
Harder et al. (2009) reported an HPAI H5N1 (clade 2.2) outbreak during July–August 2007
involving several poultry holdings of which two were large duck-fattening farms. The infected ducks
did not show clinical signs, neither was mortality increased in the ﬂock. Some of the birds had already
been sent to slaughter prior to infection being detected and were not recalled as they were thought to
have been slaughtered before the incursion time point of the virus. Culling of more than 750,000
animals was done to terminate the outbreak. In December 2007, the same virus (with very high
sequence homology) was identiﬁed in three backyard chicken holdings in a different region of
Germany. Epidemiological analysis established the chickens had access to uncooked offal from
commercial deep-frozen duck carcasses. Phylogenetic analysis established a direct link between the
outbreaks in ducks in summer and in chickens in winter 2007, suggesting that infected duck meat
originating from the duck-fattening farms affected by the outbreaks in August 2007 might have caused
the outbreaks in December 2007.
F.12.2. Third country trade – HPAI
• Import volume: 0.15 million tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): NA.
• Probability of virus preservation during transport: non-negligible for frozen meat.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely.
F.12.3. Intra-EU movement – HPAI
• Import volume: 3 million tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): NA.
• Probability of virus preservation during transport: non-negligible for frozen meat.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely.
The probability of introduction of LPAI through the meat has not been assessed because
considered not relevant in both Third countries trade and intra-EU movements.
F.13. Table eggs (Traces code 040721, 29 or 90)
This commodity covers eggs and egg products for human consumption, which are produced by
fowl (Gallus gallus), turkeys, guinea fowl, ducks, geese, quails, pigeons, pheasants and partridges. It
regards fresh table eggs only and excludes anything which is processed.
F.13.1. Background information
This section provides scientiﬁc evidence relevant to assess the possible spread of HPAI via eggs or egg
products. An analysis of the risk for a food-borne infection to humans is beyond the scope of this opinion.
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title), egg and
contamination (topic) for the period 2005–2015. The abstract of 44 publications were screened and
the full text of relevant publications was screened. The extracted information is reported below.
AI detection in poultry eggs and egg products
HPAI virus has been detected and recovered in the internal contents of chicken, quail, duck and
geese eggs laid by infected birds or might remain infectious up to three days on contaminated
eggshells (Bean et al., 1985; Cappucci et al., 1985; Li et al., 2006; Promkuntod et al., 2006; Tiwari
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et al., 2006; Kilany et al., 2010). No virus was recovered in eggs collected during an HPAI H5N2
outbreak in turkeys (Cappucci et al., 1985). Exposure of birds to (broken) contaminated eggs may lead
to a new infection and further spread of the virus.
AI inactivation from eggs or egg products
HPAIV perseverance is reduced with increasing temperature, reduced humidity and acidic pH
(McDevitt et al., 2010; Beato et al., 2012)). Products with high percentage of egg white limit the
temperature of pasteurisation in order to maintain a desirable consistency and viscosity. A guidance on
‘good manufacturing practice for liquid, concentrated, frozen and dried egg products used as food
ingredients’ has been published by the European Egg Processors Association (EEPA, 2011).
Chmielewski et al. (2011) reported predicted reductions of 5.7 and 7.8 log10 for H5N2 HPAIV and
H7N2 LPAIV, respectively, in egg white achieved by applying the USDA pasteurisation standard of 57°C
for 6.3 min.
Chmielewski et al. (2013) described that the pasteurisation processes for fortiﬁed, sugared, plain,
salted egg yolk and homogenised whole egg products spiked with HPAI H5N2 resulted in more than
5-log reductions in virus at the lower temperature-longer times of USDA-approved Salmonella
pasteurisation processes. A more than 5-log reduction of HPAIV was detected for the ﬁve products at
the higher temperatures–shorter times of USDA-approved pasteurisation processes.
International trade and intra-EU transport
The OIE Terrestrial Code chapter 10.4 (OIE, 2010) describes the recommendations for importation
of eggs for human consumption. In essence, eggs should be produced and packed in an AI-free area
and are transported in new or appropriately sanitised packaging materials. If the eggs are produced in
HPAI-free areas, their surfaces should be sanitised (in accordance with OIE Code Chapter 6.4). For the
importation of egg products of poultry, regardless of the AI status of the country of origin, the
commodity fulﬁls the requirements for importation of eggs for human consumption or the commodity
has been processed to ensure the destruction of AI (heat inactivation achieving a 7-log reduction of
AI, see OIE Code Article 10.4.25 for technical information) and contact with any source of AIV is
prevented (OIE, 2010).
Reformulated egg products such as omelette mixes, noodles, cake mixes are usually made from
pasteurised egg products. Implementing of a second pasteurisation process after the reformulation is
considered a good practice.
In the US, analyses have been performed to simulate the effect of incorporating a holding time
before egg movement in conjunction with targeted active surveillance as a novel approach to move
eggs from ﬂocks within a control area with a low likelihood of them being contaminated with HPAI.
Malladi et al. (2012) used a stochastic disease transmission model to estimate the HPAI disease
prevalence, mortality and fraction of internally contaminated eggs at various days after the infection of
a layer ﬂock. The outcome suggested a signiﬁcant reduction in the number of internally contaminated
eggs moved from an HPAI-infected but undetected ﬂock with each additional day of holding time since
the likelihood to detect the outbreak in the ﬂock increases. Furthermore, Malladi et al. (2015) used
quantitative simulation models to evaluate the movement of potentially contaminated hatching eggs
from a breeder located in an HPAI-affected area, given that active surveillance, elevated biosecurity
and a 2-day on-farm holding were employed. The mean model predicted the number of internally
contaminated hatching eggs released per movement from an HPAI-infected turkey breeder ranged
from 0 to 0.008 under the tested scenarios.
Non-pasteurised liquid egg (NPLE) is a commodity for which movements from a HPAI-affected area
to a pasteurisation facility in a disease-free area may be permitted considering the inactivation of HPAI
virus via pasteurisation. Weaver et al. (2015) estimated HPAIV concentrations in NPLE for different
scenarios of disease detection in an affected holding. The HPAIV concentration seemed to be highest
when the disease was identiﬁed in a ﬂock based on high mortality recognised via passive surveillance.
The virus concentration was considered to be diluted in a tanker-truck containing eggs from diseased
and non-diseased ﬂocks when transported to the pasteurisation plant. In all simulation scenarios, the
HPAIV concentration was below 5 log10 EID50/mL NPLE.
Legislation: See hatching eggs.
Reported AI introductions linked to import of table eggs
Thomas et al. (2005) reported the outcome of an epidemiological investigation into the spread of
HPAI H7N7 in the Netherlands in 2003, and identiﬁed an increased risk of HPAIV introduction in layer
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ﬁnisher poultry holdings. The authors mention as possible explanation the high number of contacts
between these farms, in particular via cardboard egg trays used for removal of eggs during the
epidemic.
F.13.2. Third country trade – AI
• Import volume: Very variable – 700,000–2.5 million per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: very unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely.
F.13.3. Intra-EU movements – AI
• Import volume: Very variable – 15–50 million per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: very unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: as birds successfully
producing high quality table eggs are rarely viraemic, the eggs would not contain high levels of
virus and could be contaminated but not infected; therefore it is the fomite risk which leads to
a probability of very unlikely. Moreover, the probability of AIV incursion is considered very
unlikely, although the volumes are high.
F.14. Semen
This commodity includes mainly the semen of turkeys which is the most widely used one in the
poultry industry and can lead to AI infection through artiﬁcial insemination.
F.14.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ and semen (topic)
for the period 2005–2015. The abstract of 15 publications were screened but none of them was
considered relevant.
AI detection in poultry semen
No studies were identiﬁed in the period 2005–2015; however, there is scientiﬁc literature on the
infection of turkeys after being artiﬁcially inseminated and this was considered an important route for
transmission of pandemic inﬂuenza A (H1N1) into turkeys (Pantin-Jackwood et al., 2010).
International trade and intra-EU transport
For the semen used in the artiﬁcial insemination practices, there are no harmonised rules among
the MSs; speciﬁc national rules apply and they should take into account the OIE code: AIV for 21 day
freedom and no clinical signs at time of collection.
The OIE Terrestrial Code chapter 10.4 (OIE, 2010) describes the recommendations for importation
of poultry semen for human consumption. In essence, semen should be derived from donor poultry
without clinical signs of avian inﬂuenza and kept in an AI-free.
Reported AI introductions linked to import of poultry semen
Not identiﬁed for the period 2005–2015.
F.14.2. Third country trade – HPAI
• Import volume: no data available as there are no harmonised rules or certiﬁcates.
• Probability of testing (according to EU legislation): Extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
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• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: considering the lack of
data on the volumes used and the lack of trade rules the risk of this pathway for HPAI cannot
be rejected, hence the risk might be considered non-negligible, given the level of uncertainty.
It is important to emphasise that the probability of ‘non-negligible’ is between 10% and 100%,
and the high level of uncertainty is therefore reﬂected in this scoring.
F.14.3. Intra-EU movement – HPAI
• Import volume: no data available as there are no harmonised rules or certiﬁcates.
• Probability of testing (according to EU legislation): Extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: considering the lack of
data on the volumes used and the lack of trade rules the risk of this pathway for HPAI cannot
be rejected, hence the risk might be considered non-negligible, given the level of uncertainty.
It is important to emphasise that the probability of ‘non-negligible’ is between 10% and 100%,
hence the uncertainty.
The probability of introduction of LPAI through the semen has not been assessed because
considered not relevant in both Third countries trade and intra-EU movements, as there is no viraemia
associated with infection.
F.15. Manure
This commodity concerns the unprocessed manure of poultry, which is a category 2 animal by-
product.
F.15.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and ‘manure’
(topic) for the period 2005–2015. The abstract of 17 publications were screened and the full text of
relevant publications was screened. The extracted information is reported below.
AI tenacity and inactivation from manure
Chumpolbanchorn et al. (2006) spiked chicken manure with HPAI H5N1 and found that the virus
lost its infectivity within 24 h or 15 min when samples were kept at 25°C or 40°C, respectively.
Exposure to ultraviolet light at 4–5 ∞w/cm2 for 4 h did not destroy viral infectivity in manure.
Guan et al. (2009) reported that AIV infectivity was inactivated in compost within 7 days when
temperatures reached at least 50°C. Direct contact of the infectious specimens with compost (using
nylon mesh bags) speeded up the inactivation process.
Elving et al. (2012) spiked chicken manure with HPAI H7N1 and reported a 12-log10 reduction of
the virus after 6.4 h, 1.7 h or 29 min when the composting material consisted of manure and straw
and was kept at 35°C, 45°C or 55°C. A similar reduction was observed after 7.6 h, 9.8 h or 30 min
when embryonated eggs were added to the composting material. Similar inactivation rates were
observed for bacteriophage Ø6, suggesting that it might be used as an indicator of AI inactivation
during thermal treatments.
International trade and intra-EU transport
According to Commission Regulation (EU) No 142/2011, the importation into and the transit
through the Union of unprocessed poultry manure is prohibited, therefore this pathway is not relevant
in the case of Third-countries trade.
For intra-EU movements of unprocessed processed manure, the operator must apply by sending a
form set out in Regulation (EU) No 142/2011 (Annex XVI, Chapter III, Section 10) for the consent of
the competent authorities of the MS of origin and the MS of destination. If the movement is approved,
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the MS of origin should inform the MS of destination under Article 48(1) and (3) of (EC) No 1069/2009
(Annex XI, Chapter 1, Section 1 point 1) through the use of Traces by entering the commercial
document. Attached to the document is a model health attestation according to Regulation (EU) No
142/2011 (Annex XI, Chapter 1, Section 1 point 1). As a derogation to these requirements, two MSs
which share a common border may authorise the dispatch of manure between farms located in border
regions of those two MSs (subject to appropriate conditions for the control of any possible risks to
public or animal health, such as obligations for the operators concerned to keep appropriate records),
without the requirement for the health attestation and recording in Traces, but the volumes and
frequency of this event are not known, and it is this uncertainty which drives the risk level.
The product itself consists of a mixture of bird manure, poultry feed, sawdust and bedding material
that accumulates at the bottom of or on manure conveyor belts in poultry sheds and therefore can
potentially include dead poultry. If not treated or pelleted, it can contain high levels of virus if taken
from an infected poultry farm, and should always be stacked to reduce viral load (Avian Inﬂuenza
Directive 2005/94/EC), in accordance with disease control measures.
Therefore, for manure originating in holdings with HPAI-infected galliforme species, it would be
expected that the disease would have been conﬁrmed and all manure treated. For manure originating
from holdings with HPAI in anseriform species or LPAI in any poultry species, it is possible that disease
would not be detected.
Reported AI introductions linked to import of poultry manure
None
F.15.2. Third country trade – AI
Not relevant.
F.15.3. Intra-EU movement – AI
• Import volume: no data available as there are no harmonised rules or certiﬁcates.
• Probability of testing (according to EU legislation): Extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability AIV introduction into a poultry holding via the commodity: for manure originating
from holdings with HPAI in anseriform species or LPAI in any poultry species, it is considered a
non-negligible pathway taking also into account reduced virus perseverance in manure. In
terms of exposure directly to commercial poultry, it cannot be discounted as a potential
pathway if the manure is spread near a poultry farm or if there is access to wild waterfowl.
F.16. Skin, feathers and down (Traces code 0505)
This commodity regards two subcategories:
a) the raw feathers, with some treatment, and
b) the skin and feathers and down, which are unworked, but disinfected or treated.
The risk of AIV may be different between them two.
F.16.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and ‘feather’
(topic) for the period 2005–2015. The abstracts of 51 publications were screened and the full text of
relevant publications was extracted. The information is reported below. It was noticed that this search
strategy is missing studies that report for instance presence of viral antigen and RNA in feather follicles
as a diagnostic matrix when analysing the tissue distribution of viral antigens (e.g. Kalthoff et al.,
2008). Although such missed studies might conﬁrm the data presented below, it is considered that
that the most important studies are covered with the used search strategy.
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AI detection in feathers
A few papers describing the presence of viral antigen and/or infectious virus in feathers after a
natural or experimental HPAI infection (see Table F.4). On the other hand, LPAI induces localised
respiratory and gastrointestinal infections. Therefore, it is not surprising that no papers were identiﬁed
on the presence of LPAI in feathers.
AI tenacity in feathers
Busquets et al. (2010a,b) reported that the viral RNA load in feather pulp was statistically
signiﬁcantly higher than in oropharyngeal and cloacal swabs from 1 dpi to 6 days post-mortem.
Infectious HPAI H5N1 virus was detected in feather pulp from 2 days post-infection onwards and
retained its infectivity for as long as 5–6 days post-mortem at an environmental temperature of
22–23°C.
Yamamoto et al. (2010) sampled feather samples from HPAI H5N1-infected ducks at 3 days post-
infection. Infectious viruses persisted for the longest period in feathers, compared with drinking water
and faeces, at both 4°C and 20°C. Viral infectivity persisted in the feathers for 160 days s at 4°C and
for 10–15 days at 20°C, for both clades. Viral RNA in feathers was more stable than the infectivity.
Table F.4: Identiﬁed publications on avian inﬂuenza and feather for the period 2005–2015
Virus
type
Clade Species Infection Age birds
Viral
antigen
Virus
isolation
Reference
HPAI H5N1 2.2 Pekin ducks Experimental 4 and
24 weeks
Yes NS Aiello et al. (2013)
2.3.2
and
2.3.4
Chickens,
Pekin and
Muscovy
ducks
Natural NS Yes Yes(a) Slomka et al. (2012a),
Slomka et al. (2012b)
NS Sturm-Ramirez et al.
(2005)
NS Call ducks Experimental 1-day-old, 2
and 4 weeks
Yes NS Yamamoto et al.
(2007a), Yamamoto
et al. (2007b)
NS Japanese
domestic
ducks
Experimental 4 weeks Yes Yes Yamamoto et al.
(2008)
2.3.2 Whooper
swans
Natural Juvenile
and adult
Yes NS Yamamoto et al.
(2009)
2.2
and
2.3.2
Domestic
ducks
Experimental 4 weeks Yes Yes Yamamoto et al.
(2010)
HPAI H7N1 NA Chicken Experimental 8 and
12 weeks
Yes Yes(b) Busquets et al.
(2010a)
H4N6 NA Aythya ferina,
Anas clypeata,
Anas crecca
Natural Hatching
year age
Not
reported
Yes De Marco et al. (2014)
H3N8 NA Anas crecca Natural Not reported Not
reported
Yes De Marco et al. (2014)
H?N2 NA Anas crecca Natural Not reported Not
reported
Yes De Marco et al. (2014)
H2N? NA Anas
platyrhynchos
Natural Not reported Not
reported
Yes De Marco et al. (2014)
(a): Feather samples were collected at four HPAI H5N1-infected poultry holdings in Vietnam, virus was isolated from 19/23 and
19/20 chicken and 10/13 and 10/10 duck feather samples, respectively, in the 2011 and the 2012 study.
(b): Lower detection of viral RNA in 12 weeks old compared to 8 weeks old group; detection in the older group was related to
the level of calciﬁcation of the feather shaft.
NS, not speciﬁed; NA, not applicable
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Transmission of AI via feathers
Oral inoculation of nine 2-week-old call ducks with feathers collected from a call duck that died
4 days after an intravenous infection resulted in the infection of seven out of nine birds, conﬁrmed via
histological lesions with viral antigens, virus isolation from cloacal swabs and HI antibody production
(Yamamoto et al., 2007a,b). Similar clinical signs were observed as in call ducks infected via the
intranasal route with the same virus.
International trade and intra-EU transport
The OIE Terrestrial Code chapter 10.4 (2016) describes the recommendations for importation of
feathers and down (OIE, 2016b). In essence, the commodity should originate from poultry kept and
slaughtered in a HPAI-free area, have been processed to ensure destruction of AI virus (washed and
steam-dried at 100°C for 30 min, fumigation with formalin (10% formaldehyde) for 8 h, irradiation
with a dose of 20 kilogray, any equivalent treatment which has been demonstrated to inactivate AIV)
and precautions were taken to avoid contact of the commodity with any source of AI.
According to Commission Regulation (EU) No 142/2011, the importation into and the transit
through the Union of untreated feathers and parts of feathers and down is prohibited, while treated
feathers and down (hot steam at 100°C for 30 min) may be placed on the market with no restrictions.
Treatments comprise physical and/or chemical processes ensuring complete viral inactivation.
Therefore provided the treatment is carried out correctly, these products have a negligible risk. The
majority of such products are destined not only for technical use, in the furnishings and furniture
businesses but also for decorating clothing or ﬂy ﬁsh lures.
For imports of treated feathers, parts of feathers and down, no health certiﬁcate is required. For
LPAI, these commodities may be contaminated rather than infected.
There is an anomaly with the trade code. According to the Vet Checks Regulation (Commission
Decision 2007/275/EC) EX 0505), EX 0505 is described as ‘Skins and other parts of birds, with their
feathers or down, feathers and parts of feathers (whether or not with trimmed edges) and down, not
further worked than cleaned, disinfected or treated for preservation; powder and waste of feathers or
parts of feathers’. Therefore, it is considered that feathers and parts of feathers and down have been
treated by ‘another method’ but not undergone a full steam treatment. This is why, once imported,
these products have to go to an approved establishment in the EU for further treatment. Therefore
they may appear in the trade database as ‘raw’ as they haven’t been fully processed or if ‘other’ is a
viable option under the Combined Nomenclature (CN) codes (Council Regulation (EEC) No 2658/87).
Reported AI introductions linked to import of feathers
No report found.
F.16.2. Third country trade – HPAI
A) Raw feathers – (with some treatment)
• Import volume: 0.7–1 tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability virus preservation during transport: extreme unlikely.
• Probability poultry exposure to the commodity: extreme unlikely.
• Probability AIV introduction into a poultry holding via the commodity: extreme unlikely.
B) Skin and feathers or down unworked, but disinfected or treated
• Import volume: 10–11 tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability virus preservation during transport: extreme unlikely.
• Probability poultry exposure to the commodity: extreme unlikely.
• Probability AIV introduction into a poultry holding via the commodity: extreme unlikely.
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F.16.3. Intra-EU trade – HPAI
A) Raw feathers – (with some treatment)
• Import volume: 7–8 tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: very unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely, taking
into account the high volume.
B) Skin and feathers or down unworked, but disinfected or treated
• Import volume: 95,000–115,000 tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): n/a.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: very unlikely, taking
into account the high volume.
The probability of introduction of LPAI through raw feathers with some treatment and treated skin,
feathers and down has not been assessed because considered not relevant in both third countries
trade and intra-EU movements, as these commodities may be contaminated rather than infected.
F.17. Feed
Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002,
deﬁnes ‘feed’ (or ‘feedingstuff’) as any substance or product, including additives, whether processed,
partially processed or unprocessed, intended to be used for oral feeding to animals. For the scope of
this assessment, where the commodity refers to commercially available pelleted feed, this is
considered unlikely to be a risk for AIV transmission provided that no wild bird contact will occur
during storage.
This commodity also includes poultry products used for feeding other animal species (except for
poultry tallow), and feed speciﬁcally for poultry (pelleted or not).
F.17.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and ‘feed’
(topic) for the period 2005–2015 (restricting to documents in English only). The abstracts of two
relevant publications returned from this search string were screened and the extracted information is
reported below.
Conraths et al. (2016) conducted epidemiological outbreak investigations in highly pathogenic avian
inﬂuenza virus of the subtype H5N8 (HPAIV H5N8)-affected commercial holdings and a zoo in Germany,
for the period of 2014–2015, in order to identify potential routes of entry of the pathogen. The
epidemiological team assessed retrospectively the risk factors for introduction, in a qualitative manner
for risk analysis, with the World Organization for Animal Health (OIE) using risk scores (0, negligible; 1,
low; 2 medium; 3, high). The mean risk scores were agreed by the team for each risk factor, and the
risk of introduction of AIV into the affected premises by contaminated feed was negligible (0) with low
uncertainty. This is because feedstuff was heat-treated during the process of pelleting.
On the other hand, there is limited information available on the likelihood of AIV-contaminated
ingredients to become inactivated in non-pelleted chicken feed. It is known however that in general
the likelihood of the infectious virus to be introduced into ﬂocks via the feed seems to be very low to
low (Toro et al., 2016). Toro et al. (2016) describe that despite in the environment factors such as
heat, extreme pH values, dryness, and a diverse variety of disinfectants inactivate quickly the virus
(Shahid et al., 2009; Zou et al. 2013), the presence of organic material increases the virus resistance
to physical and chemical inactivation.
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This study (Toro et al., 2016), by conducting four different trials, showed that disinfection with
commercially available feed disinfectants – Termin-8 (a blend of formaldehyde, propionic acid,
terpenes, and surfactant) and Finio (a blend of approved phytochemicals and carboxylic acids) –
effectively inactivates the virus if present in non-pelleted chicken feed. Furthermore, since the stability
of the AI virus in chicken feed is known to be limited, it was evaluated the effect of protein to the
virus suspension, by adding skim milk powder. Results showed that although protein prolonged the
stability of the infectious virus in untreated feed to 24 h at 24°C, the feed disinfectants were
nevertheless capable of inactivating the virus.
Third country trade and intra-EU movements
The OIE Terrestrial Code chapter 10.4 (2016) describes the recommendations of products of
poultry origin, other than feather meal and poultry meal, intended for use in animal feeding, or for
agricultural or industrial use (OIE, 2016b). In essence, regardless of the avian inﬂuenza status of the
country of origin, an international veterinary certiﬁcate is required, attesting that: (i) these
commodities (e.g. live animals, products of animal origin, animal genetic material, biological products
an pathological material) were processed in an avian inﬂuenza free country, zone or compartment from
poultry which were kept in an avian inﬂuenza free country, zone or compartment from the time they
were hatched until the time of slaughter or for at least the 21 days preceding slaughter, (ii) these
commodities have been processed to ensure the destruction of avian inﬂuenza virus using: (a) moist
heat treatment for 30 min at 56°C, or (b) any equivalent treatment which has been demonstrated to
inactivate avian inﬂuenza virus. Also that (iii) the necessary precautions were taken to avoid contact of
the commodity with any source of avian inﬂuenza virus.
In general, this is considered extremely unlikely to be a suitable pathway for incursion of AI into
commercial poultry. However, the product itself could be exposed to virus-infected wild birds or virus-
contaminated environment while being transported or on arrival when stored; therefore, in these
circumstances, this pathway is considered likely. However, it is considered as part of the general wild
bird indirect exposure pathways, which highlights the importance of biosecurity around storing feed
away from possible contamination.
Reported AI introductions linked to feed trade
None have been directly ascribed to commercially available pelleted poultry feed. However the
contamination of feed at the poultry holding should always be considered a potential pathway in
epidemiological investigations (Avian Inﬂuenza Directive). It therefore stands to reason that if
contamination could occur at any point along the transport chain, this should also be considered.
F.17.2. Third country trade – AI
• Import volume: Around 700,000–900,000 tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: it is considered
extreme unlikely but feed might become contaminated during storage; therefore, under certain
circumstances it could be non-negligible.
F.17.3. Intra-EU movements – AI
• Import volume: Around 2.4–2.6 million tonnes per annum.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: it is considered
extreme unlikely but feed might become contaminated during storage; therefore, under certain
circumstances it could be non-negligible.
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F.18. Bedding
This commodity includes hay (CN code EX 1214 90) and straw (CN code EX 1213 00 00), which
means that of the entire commodity range, only hay or straw requires a vet check on arrival, as this
constitutes animal derived material.
F.18.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and bedding
(topic) for the period 2005–2016 (restricting to documents in English only). Only one abstract of three
publications found was considered relevant from this search string and the extracted information from
this paper is reported below.
Conraths et al. (2016) conducted epidemiological outbreak investigations in highly pathogenic avian
inﬂuenza virus of the subtype H5N8 (HPAIV H5N8)-affected commercial holdings and a zoo in
Germany, for the period of 2014–2015, in order to identify potential routes of entry of the pathogen.
The epidemiological team assessed retrospectively the risk factors for introduction of the virus, in a
qualitative manner for risk analysis, with the World Organization for Animal Health (OIE) using risk
scores (0, negligible; 1, low; 2 medium; 3, high). The mean risk scores were agreed by the team for
each risk factor, and the risk of introduction of the AIV via indirect contact with materials, such as
bedding material, contaminated with wild bird-infected faeces used from affected premises into the
commercial poultry holding was estimated to be highest (1.33) with the highest uncertainty (1.67),
than those from water and feed (negligible risk and low uncertainty). It should also be noted that
before the outbreak occurred in late October 2014, large aggregations of wild birds had been observed
on the pastures around the affected farms and the ground on the premise surroundings was
considerably contaminated.
Third country and intra-EU trade
The OIE Terrestrial Code chapter 10.4 (2016) for Avian Inﬂuenza does not describe any AI-speciﬁc
recommendation or measure, however EU rules requires all hay and straw imported from third
countries to be subject to veterinary checks on arrival at the BIP (2007/275/EC). The list of countries
which may export this commodity is limited to: Australia, Belarus, Canada, Switzerland, Chile,
Greenland, Iceland, New Zealand, Serbia, Ukraine, USA and parts of South Africa. For Serbia, Ukraine
and Belarus, only pelleted product intended for combustion (494/2014/EU amending 136/2004/EC).
Hay and straw must only enter the EU from third countries with a commercial document; however
there are no consignments notiﬁed in the UN Comtrade database from third countries.
For intra-EU movements, large volumes of such a commodity are moved in the EU.
In general, the risk of introduction of AIV via this pathways is considered extreme unlikely,
however, similarly to the feed pathway, if contamination occurs at time of harvest, during transport or
storage, through contact with infected wild birds or contaminated vermin and because of the intended
exposure to poultry, this pathway is scored as non-negligible, with some uncertainty based on the time
since harvest and the transport conditions which may affect viral perseverance.
Reported AI introductions linked to trade in bedding
None have been directly ascribed to commercially available bedding. However, the contamination of
bedding at the poultry holding should always be considered a potential pathway in epidemiological
investigations (Avian Inﬂuenza Directive). It therefore stands to reason that if contamination could
occur at any point along the transport chain, this should also be considered.
F.18.2. Third country trade – AI
Commission Regulation (EC) No 136/200465 regulates imports of hay and straw: they must be
certiﬁed, not necessarily treated. They may be subject to testing but not speciﬁed which pathogens.
• Import volume: 15–50 thousand tonnes.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
65 Commission Regulation (EC) No 136/2004 of 22 January 2004 laying down procedures for veterinary checks at Community
border inspection posts on products imported from third countries. OJ L 21, 28.1.2004, p. 11–23.
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• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: it is considered
extreme unlikely but contamination of imported bedding with wild bird faeces cannot currently
be eliminated as a potential pathway; therefore, under certain circumstances it could be
non-negligible.
F.18.3. Intra-EU movements AI
Bedding undergoes to MSs’ national rules; commercial documents are required for intra-EU
movements.
• Import volume: 850–900 thousand tonnes.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: non-negligible.
• Probability of poultry exposure to the commodity: non-negligible.
• Probability of AIV introduction into a poultry holding via the commodity: it is considered
extreme unlikely but contamination of imported bedding with wild bird faeces cannot currently
be eliminated as a potential pathway; therefore, under certain circumstances it could be non-
negligible.
F.19. Pharmaceuticals
This commodity refers to vaccines, which are approved by EMEA. All vaccinated birds and all
registered vaccines must be notiﬁed to the European Commission and each MS must submit plans for
approval indicating vaccine to be used and keep records of birds vaccinated (captive birds in zoos and
collections or in special circumstances, some poultry).
Only one vaccine for avian inﬂuenza is approved for use in the EU: the Nobilis Inﬂuenza H5N2 for
use in chickens. It is an inactivated vaccine manufactured in the EU. Nevertheless, other live vaccines
for use in poultry (e.g. against Newcastle Disease) are often produced in eggs (SPF eggs) and
contamination could occur, but is thought improbable given the controls in place with Good
Manufacturing Practices with pharmaceutical companies and veterinary medicine authorities.
All authorised vaccines are assessed for quality, safety and efﬁcacy. As part of the quality
assessment, the applicant has to provide information on any potential extraneous agents and there is a
monograph which outlines which agents to test for and ensure that there is no risk. Also, if material(s) of
animal origin is used during production of the vaccine then information has to be provided and a TSE
risk assessment performed. If they are live vaccines that have been attenuated in some way, the
potential to revert to virulence is assessed based on the safety data provided. Any concerns on safety
such that a product could revert to a virulent state would be noted and taken into account when
determining the beneﬁt/risk of the product, and whether an authorisation is given. The ﬁnal product
tests in place should give assurance that there is no contamination, but in case it does, there are steps in
place to manage the risk from such events. The tests that are performed on authorised live/inactivated
vaccines reassures that there is no risk of extraneous agents, and these tests include one for inﬂuenza A.
Finished medicinal products, such as vaccines, are not covered by veterinary legislation for import
and therefore there are no import data available. Intermediate products derived from Category 3
material and intended for technical uses in medical devices, in vitro diagnostics, laboratory reagents
and cosmetics are included (See Commission Decision 2007/275/EC) but these products are not
considered a risk of introducing avian inﬂuenza to poultry as they are destined for laboratories.
F.19.1. Background information
A search was performed in the Web of Science using the string ‘avian inﬂuenza’ (title) and
‘pharmaceutical’ (topic) for the period 2005–2015 (restricting to documents in English only). The
publications found from this search string were not considered relevant for this subject, mainly
because the risk of introduction of AIV to poultry via pharmaceuticals is unlikely to occur, therefore not
reported in this context.
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 187 EFSA Journal 2017;15(10):4991
Third country and intra-EU trade
The OIE Terrestrial Code chapter 10.4 (2016) (Infection with Avian Inﬂuenza viruses) does not
describe any recommendations or measures related to pharmaceuticals. However there are
recommendations in the OIE Terrestrial Manual chapter 1.1.8 (2015) on the principle of veterinary
vaccine production and in chapter 3.7.2 on the minimum requirements for the production and quality
control of vaccines. In addition, EU rules are in place for the trade and imports of pharmaceuticals
(Directive 2001/82/EC) which requires national authorities to authorise veterinary medicines, to carry
out any tests to ensure compliance and to grant market authorisation or EU marketing authorisation
Regulation (EC) No 726/2004.
Reported AI introductions linked to trade in pharmaceuticals
None identiﬁed from the available literature or a search of epidemiological reports into AI
outbreaks.
F.19.2. Third country trade – AI
• Import volume: no data available.
• Probability of testing (according to EU legislation): non-negligible if approved.
• Tests that can be used (according to EU legislation): PCR.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.19.3. Intra-EU movements – AI
• Import volume: no data available.
• Probability of testing (according to EU legislation): non-negligible if approved.
• Tests that can be used (according to EU legislation): PCR.
• Probability of virus detection (given AIV presence in commodity): non-negligible.
• Probability of virus preservation during transport: unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
F.20. Other animal by-products obtained by poultry
This commodity refers to the animal by-products as deﬁned by Regulation 2009/1069/EU of the
European Parliament and of the Council of 21 October 2009: animal by-products (ABPs) means entire
bodies or parts of animals, products of animal origin or other products obtained from animals, which
are not intended for human consumption, including oocytes, embryos and semen.
This section refers to ‘other ABPs’, such us: processed meat, processed parts of birds (including
feathers, skin, feet, casings, blood), but they were discounted as not being a signiﬁcant pathway (and
scored as extremely unlikely for HPAI and not relevant for LPAI) as they were either for treatment,
processing (e.g. for pet food) or for human consumption.
F.20.1. Background information
ABPs’ rules (Regulations (EC) No 1069/2009 and (EU) No 142/2011) about the disposal of category
1 and 2 waste means high-risk material will be rendered. Category 3 ABPs are also considered a very
low risk category for AIV transmission. Unprocessed pet food such as dog chews made of poultry meat
or frozen day-old chicks are frequently traded and imported, with health certiﬁcation. Both represent
an extremely unlikely pathway for the introduction of HPAIV (and not relevant for LPAIV) into
commercial poultry.
Third country and intra-EU trade
Not available.
Reported AI introductions linked to trade in ABMs
None attributed, according to a search of the literature and available epidemiological reports of
outbreaks.
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F.20.2. Third country trade and intra-EU movement – HPAI
• Import volume: no data available.
• Probability of testing (according to EU legislation): extreme unlikely.
• Tests that can be used (according to EU legislation): NA.
• Probability of virus detection (given AIV presence in commodity): extreme unlikely.
• Probability of virus preservation during transport: extreme unlikely.
• Probability of poultry exposure to the commodity: extreme unlikely.
• Probability of AIV introduction into a poultry holding via the commodity: extreme unlikely.
The probability of introduction of LPAI through the ABMs has not been assessed because
considered not relevant in both Third countries trade and intra-EU movements.
F.21. Overview imports of some commodities from third countries
Table F.5: Lists of countries which are approved for the import of certain live poultry, hatching eggs,
poultry meat and table eggs into the EU, according to Regulation (EC) No 798/2008:
X = Whole country; R = Regions only; Y = additional measures required
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Albania X X
Argentina X X X X X X
Australia X Y X Y X Y X X X Y Y X X
Brazil R R R R R R X R R R R R R R R
Botswana Y Y Y X Y X X
Belarus X X
Canada R R R R R R X R R R R R R X X
Switzerland
Chile X X X X X X X X X X X X X X X
China R R X
Greenland X X X
Hong Kong X
Israel Y Y Y Y Y Y X Y Y Y Y Y Y X
India X
Iceland X X X
Rep of Korea X X
Moldova X
Montenegro X
Madagascar X X X X
Malaysia R R
Macedonia X X
Mexico X X
Namibia X X X X X X X
New
Caledonia
X
New Zealand X X X X X X X X X X X X X X X
Saint Pierre
Michelon
X
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Serbia X
Russia X X X
Singapore X
Thailand X X X Y X X
Tunisia X X X X X X X X X X X
Turkey X
Ukraine X X X X X
United States R R R R R R X R R R R R R X X
Uruguay X X X X
South Africa Y Y Y X Y X X
Zimbabwe Y Y Y
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F.22. Overview of the qualitative assessment of the risk of introduction of AI via non-wild bird pathways
Table F.6: Overview of the qualitative assessment of the risk of introduction of AI via non-wild bird pathways
Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
PATHWAY: Live (non-poultry) birds
COMMODITY: Psittaciformes
Third country
trade
AI 600–1,000 per
annum
Non-Negligible Any ai test in
accordance to
diagnostic
manual
Non-negligible Extreme unlikely Extreme unlikely Extreme unlikely
Intra-EU
movement
AI 150,000–
200,000 birds
per year
Very Unlikely na na Non-negligible Extreme unlikely Very unlikely
COMMODITY: Birds of prey
Third country
trade
AI Fewer than 500
per annum
Non-Negligible Any AI test in
accordance to
diagnostic
manual
Non-negligible Extreme unlikely Extreme unlikely Extreme unlikely
Intra-EU
movement
AI Around
500–1,500 per
annum
Very Unlikely na na Non-negligible Extreme unlikely Very unlikely
COMMODITY: Other captive birds, destined for approved bodies
Third country
trade
AI ~ 600–1,000 per
annum
Non-negligible Any AI test in
accordance to
OIE diagnostic
manual
Non-negligible Extreme unlikely Extreme unlikely Extreme unlikely
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
Intra-EU
movement
AI 20,000–25,000
per annum of
birds other than
poultry,
Psittaciformes or
birds of prey
(each)
Very unlikely na na Non-negligible Extreme unlikely Very unlikely
COMMODITY: Birds as pets
Third country
trade
HPAI No requirement
to record Trade
statistics
Testing required
for H5N1 only
Either PCR or
serology, in
accordance to
diagnostic
manual
Non-negligible
only for H5N1
Extreme unlikely Extreme unlikely Extreme unlikely
LPAI No requirement
to record Trade
statistics
Testing required
for H5N1 only
Either PCR or
serology, in
accordance to
diagnostic
manual for
H5N1
Very unlikely Non-negligible Extreme unlikely Extreme unlikely
Intra-EU
movement
HPAI No requirement
to record Trade
statistics
Extreme unlikely na Very unlikely Non-negligible Extreme unlikely Very unlikely
LPAI No requirement
to record trade
statistics
Extreme unlikely na Very unlikely Non-negligible Extreme unlikely Very unlikely
PATHWAY: Live poultry
COMMODITY: Hatching eggs – Gallus gallus
Third country
trade
AI 25–30 million
eggs per year
Extreme unlikely,
but quarantine
required
na Very unlikely Extreme unlikely Non-negligible Very unlikely
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
Intra-EU
movement
HPAI 1.1 billion per
annum
Extreme unlikely na Very unlikely Very unlikely Non-negligible Unlikely
LPAI 1.1 billion per
annum
extreme unlikely na Unlikely Non-negligible for
fomite transfer
Non-negligible Unlikely
COMMODITY: Hatching eggs – other
Third country
trade
AI 5 million of non-
Gallus poultry;
200–300,000 for
both game birds
and non-poultry
Extreme unlikely,
but quarantine
required
na Very unlikely Extreme unlikely Non-negligible Very unlikely
Intra-EU
movement
AI 120–170 million
per annum of
which 15 million
non-poultry and
50 million for
game birds
Extreme unlikely na Very unlikely Very unlikely Non-negligible Unlikely
COMMODITY: Day-old chickens
Third country
trade
AI 200,000–
400,000 of birds
per year
Non-negligible,
but quarantine
required
According to
the diagnostic
manual
Non-negligible Extreme unlikely Non-negligible Extreme unlikely
Intra-EU
movement
HPAI 500–700 million
birds per year
Extreme unlikely na Very unlikely Very unlikely Non-negligible Unlikely
LPAI 500–700 million
birds per year
Extreme unlikely na Very unlikely Non-negligible Non-negligible Non-negligible
COMMODITY: Day-old poultry (ducks or geese)
Third country
trade
AI 50–200,000
birds per annum
Non-negligible According to
the diagnostic
manual
Non-negligible Extreme unlikely Non-negligible Extreme unlikely
Intra-EU
movement
HPAI 50–60 million
birds per annum
Extreme unlikely na Very unlikely Very unlikely Non-negligible Unlikely
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
LPAI 50–60 million
birds per annum
Extreme unlikely na Unlikely Non-negligible Non-negligible Non-negligible
COMMODITY: Breeding or production poultry – Gallus gallus
Third country
trade
AI 800,000–
1 million birds
per annum
Non-negligible Any AI test in
accordance to
diagnostic
manual
Non-negligible Extreme unlikely Non-negligible Extreme unlikely
Intra-EU
movement
HPAI 400–500 million
birds per annum
Very unlikely na Birds should
exhibit clinical
signs
Unlikely Non-negligible Unlikely
LPAI 400–500 million
birds per annum
Very unlikely na Clinical signs are
unlikely to be
observed
Non-negligible Non-negligible Non-negligible
COMMODITY: Breeding or production poultry – not Gallus gallus
Third country
trade
AI < 200 birds per
annum
Non-negligible Any AI test in
accordance to
diagnostic
manual
Non-negligible Extreme unlikely Non-negligible Extreme unlikely
Intra-EU
movement
HPAI 15–18 million
birds per annum
Very unlikely na Birds should
exhibit clinical
signs
Unlikely Non-negligible Unlikely
LPAI 15–18 million
birds per annum
Very unlikely na Clinical signs are
unlikely to be
observed
Non-negligible Non-negligible Non-negligible
PATHWAY: Meat and eggs for human consumption
COMMODITY: Meat
Third country
trade
HPAI 0.15 million
tonnes per
annum
Extreme unlikely na na Likely for frozen meat Extreme unlikely Very unlikely
LPAI Not relevant Not relevant
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
Intra-EU
movement
HPAI 3 million tonnes
per annum
Extreme unlikely na na Likely for frozen meat Extreme unlikely Very unlikely
LPAI Not relevant Not relevant
COMMODITY: Table eggs
Third country
trade
AI Very variable –
700,000–
2.5 million per
annum
Extreme unlikely na Extreme unlikely Non-negligible Very unlikely Very unlikely
Intra-EU
movement
AI Very variable –
15–50 million
per annum
Extreme unlikely na Extreme unlikely Non-negligible Very unlikely Very unlikely
PATHWAY: Semen
COMMODITY: Semen
Third country
trade
HPAI No data
available as
there are no
harmonised rules
or certiﬁcates
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Non-negligible
LPAI Not relevant Not relevant
Intra-EU
movement
HPAI No data
available as
there are no
harmonised rules
or certiﬁcates
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Non-negligible
LPAI Not relevant Not relevant
PATHWAY: Manure
COMMODITY: Manure
Third country
trade
AI Not relevant – only processed manure allowed
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
Intra-EU
movement
AI No data
available(a)
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Non-negligible
PATHWAY: Feathers, skin and down
COMMODITY: Raw feathers (with some treatment)
Third country
trade
HPAI 0.7–1 tonnes per
annum
Extreme unlikely na Extreme unlikely Extreme unlikely Extreme unlikely Extreme unlikely
LPAI Not relevant Not relevant
Intra-EU
movement
HPAI 7–8 tonnes per
annum
Extreme unlikely na Extreme unlikely Extreme unlikely Very unlikely Very unlikely
LPAI Not relevant Not relevant
COMMODITY: Treated skin feathers and down
Third country
trade
HPAI 10–11 tonnes
per annum
Extreme unlikely na Extreme unlikely Extreme unlikely Extreme unlikely Extreme unlikely
LPAI Not relevant Not relevant
Intra-EU
movement
95,000–
115,000 tonnes
per annum
Extreme unlikely na Extreme unlikely Extreme unlikely Extreme unlikely Very unlikely (same
score as raw feathers
to account for the
greater volume)
LPAI Not relevant Not relevant
PATHWAY: Feed
COMMODITY: Feed
Third country
trade
AI Around 700,000
–900,000 tonnes
per annum
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Extreme unlikely (Non-
negligible(a))
Intra-EU
movement
AI Around 2.4–
2.6 million
tonnes per
annum
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Extreme unlikely (Non-
negligible(a))
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Movement Virus type
Import
volume
Probability of
testing
Tests that
can be used
Probability of
virus detection
Probability of virus
preservation
during transport
Probability of
poultry exposure
to the commodity
Aggregated score:
probability of AIV
introduction into a
commercial poultry
holding via the
commodity (small
scale – large scale)
PATHWAY: Bedding
COMMODITY: Bedding
Third country
trade
AI 15–50 thousand
tonnes
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Extreme unlikely (Non-
negligible(a))
Intra-EU
movement
AI 850–900
thousand tonnes
Extreme unlikely na Extreme unlikely Non-negligible Non-negligible Extreme unlikely (Non-
negligible(a))
PATHWAY: Pharmaceuticals
COMMODITY: Vaccines
Third country
trade
AI No data
available
Non-negligible if
approved
PCR Non-negligible Unlikely Extreme unlikely Extreme unlikely
Intra-EU
movement
AI No data
available
Non-negligible if
approved
PCR Non-negligible Unlikely Extreme unlikely Extreme unlikely
PATHWAY: Other animal by-products
COMMODITY: Bones, feet, casings, pet food (not livestock feed)
Third country
trade
HPAI No data
available
Extreme unlikely na Extreme unlikely Extreme unlikely Extreme unlikely Extreme unlikely
LPAI No data available Not relevant
Intra-EU
movement
HPAI No data
available
Extreme unlikely na Extreme unlikely Extreme unlikely Extreme unlikely Extreme unlikely
LPAI No data available Not relevant
Na: not applicable.
(a): The health attestation for unprocessed manure traded between MSs is attached to the commercial document in TRACES, but the code cannot distinguish between other Cat 2 ABPs; therefore,
data are not available.
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Appendix G – AI transmission and spread parameters
Table G.1: Parameters of LPAI transmission between birds in a poultry population (data received as per procurement, coordinated by Linnaeus University
(SE), Erasmus Medical Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, De Koeijer et al., 2017). The
mean values are presented with the lower (L) and upper (U) limits. IP, infectious period (days)
Study Serotype Species Beta per day (L–U) IP (L–U) R0 (L–U) Design Virus origin
Gonzales (2011) H7N1 Chicken 0.49 (0.3–0.75) 7.7 (6.7–8.7) 3.8 (1.3–6.3) Transmission Poultry
Claes et al. (2013) H7N1 Chicken 0.38 (0.11–0.44) 6.1 (0.45–11.75) 2.32 (0.12–4.52) Transmission Poultry
Gonzales et al. (2012a) H7N7 Chicken 0.1 (0.04–0.18) 7.1 (6.5–7.8) 0.8 (0.4–1.8) Transmission Poultry
Gonzales et al. (2012b) H7N3 Chicken 0.91 (0.45–1.62) 10.03 (8.5–11.56) 9.1 (3.6–19.5) Transmission Poultry
Gonzales et al. (2012b) H7N3 Chicken 0.72 (0.68–0.77) 7.69 (5.88–11.11) 5.6 (4.3–7.7) Field Poultry
Gonzales et al. (2012b) H7N3 Chicken 0.5 (0.45–0.55) 9.09 (6.25–20) 4.7 (3–8.6) Field Poultry
Lee et al. (2012) H7N8(a) Chicken 0.78 (0.3–1.7) ND ND Challenge Wild bird
Lee et al. (2012) H7N8(a) Chicken 0.26 (0.07–0.7) ND ND Challenge Wild bird
van der Goot et al. (2003) H5N2 Chicken 0.24 (0.12–0.45) 4.25 (2.57–5.93) 1.17 (0.47–2.39) Transmission Poultry
Claes et al. (2013) H5N2 Chicken 0.37 (0.14–0.61) 5.5 (2.36–8.64) 2.04 (0.79–3.28) Transmission Poultry
Yee et al. (2009) H6N2(a) Chicken 2.46 (1.2–4.56) ND ND Transmission Poultry
Youn et al. (2012) H9N2(a) Chicken 1.57 (0.9–2.74) ND ND Challenge Poultry
Bonfante et al. (2014) H10N1(b) Chicken 0.43 (0.21–0.79) 7.4 (6.1–8.8) 3.2 (1.4–5.1) Challenge Wild bird
Li et al. (2010) H11N9(b) Chicken 1.42 (0.75–2.45) ND ND Transmission Poultry
Claes et al. (2015) H5N2 Chicken ND ND 2.11 (0.85–6.15) Transmission Poultry
Pillai et al. (2010a)(b) H5N2 Chicken ND ND 1.1 (0.5–3.8) Challenge Poultry
Pillai et al. (2010a) H5N2 Chicken ND ND 0.36 (0.1–1.9) Challenge Poultry
Pillai et al. (2010a) H5N2 Chicken ND ND 0.22 (0.005–1.2) Challenge Turkey
Pillai et al. (2010a) H5N3 Chicken ND ND 0.63 (0.22–3.08) Challenge Wild bird
Pillai et al. (2010a) H5N2 Chicken ND ND 0 (0–0.62) Challenge Wild bird
Pillai et al. (2010a) H5N2 Chicken ND ND 0 (0–0.62) Challenge Wild bird
Pillai et al. (2010a) H5N5 Chicken ND ND 0 (0–0.66) Challenge Wild bird
Pillai et al. (2010a) H5N1 Chicken ND ND 0.44 (0.01–2.28) Challenge Wild bird
Pillai et al. (2010a) H5N7 Chicken ND ND 0 (0–0.75) Challenge Wild bird
Pillai et al. (2010a) H5N9 Chicken ND ND 0 (0–0.75) Challenge Wild bird
Saenz et al. (2012) H7N1 Turkey 2.01 (1.6–2.5) 7.65 (7–8.3) 15.3 (11.8–19.7) Transmission Poultry
Mondal et al. (2013) H7N1(b) Turkey 0.08 (0.004–0.345) ND 0.56 (0.03–44.18) Challenge Wild bird
Mondal et al. (2013) H6N8(b) Turkey 0.2 (0.03–0.62) ND 0.88 (0.03–44.18) Challenge Wild bird
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Study Serotype Species Beta per day (L–U) IP (L–U) R0 (L–U) Design Virus origin
Comin et al. (2011) H7N1 Turkey ND 8.1 (6.4–10.5) 5.5 (3.36–18.33) Challenge Poultry
Pillai et al. (2010a)(b) H5N2 Turkey ND ND 1.3 (0.05–2.12) Challenge Wild bird
Pillai et al. (2010a) H5N2 Turkey ND ND Inf (1–inf) Challenge Poultry
Pillai et al. (2010a) H5N2 Turkey ND ND 2.1 (0.5–2.6) Challenge Poultry
Pillai et al. (2010a) H5N3 Turkey ND ND 0.9 (0.05–1.9) Challenge Poultry
Pillai et al. (2010a) H5N3 Turkey ND ND 1.83 (0.56–5.1) Challenge Wild bird
Pillai et al. (2010a) H5N5 Turkey ND ND 0 (0–1.04) Challenge Wild bird
Pillai et al. (2010a) H5N1 Turkey ND ND 1.6 (0.11–2.2) Challenge Wild bird
Pillai et al. (2010a) H5N8 Turkey ND ND 1.45 (0.07–4.45) Challenge Wild bird
Niqueux et al. (2014) H5N1 Duck (M) 1.84 (1.09–3.11) 8.1 (4.9–13.4) 14.9 (7.2–30.8) Transmission Duck
Niqueux et al. (2014) H5N1 Duck (M) ND 6.5 (3.9–10.7) ND Transmission Poultry
Niqueux et al. (2014) H5N2 Duck (M) 2.41 (1.41–4.13) 5.1 (3.1–8.5) 15.6 (7.4–32.7) Transmission Wild bird
Niqueux et al. (2014) H5N3 Duck (M) 1.07 (0.64–1.78) ND 5.5 (2.7–11.3) Transmission Poultry
Li et al. (2010) H11N9(b) Duck (P) 0.31 (0.13–0.6) ND ND Transmission Poultry
Pillai et al. (2010a) H5N3 Duck (P) ND ND 2.55 (0.33–4.8) Challenge Wild bird
Pillai et al. (2010a) H5N2 Duck (P) ND ND 0.7 (0.2–1.8) Challenge Poultry
Pillai et al. (2010a) H5N2 Duck (P) ND ND 0.7 (0.2–1.8) Challenge Poultry
Pillai et al. (2010a) H5N2 Duck (P) ND ND 2.7 (0.84–7.28) Challenge Poultry
Pillai et al. (2010a) H5N2 Duck (P) ND ND 1.3 (0.06–2.37) Challenge Wild bird
Pillai et al. (2010a) H5N5 Duck (P) ND ND 1.2 (0.04–1.7) Challenge Wild bird
Pillai et al. (2010a) H5N1 Duck (P) ND ND 1.6 (0.12–2.3) Challenge Wild bird
Pillai et al. (2010a) H5N7 Duck (P) ND ND 1.3 (0.05–1.95) Challenge Wild bird
Pillai et al. (2010a) H5N9 Duck (P) ND ND 1.24 (0.04–1.71) Challenge Wild bird
(a): These were challenge experiments where contacts were introduced. Parameters values were estimated from manuscript data.
(b): For all beta calculations 1 day latent period was assumed (the methodology used is described in the respective papers).
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Table G.2: Parameters of HPAI transmission between birds in a poultry population (data received as per procurement, coordinated by Linnaeus
University (SE), Erasmus Medical Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, De Koeijer et al., 2017).
The mean values are presented with the lower (L) and upper (U) limits. IP, infectious period (days)
Study Serotype Species Beta per day (L–U) IP (L–U) R0 (L–U) Design
Bouma et al. (2009) H5N1 Chicken 0.76 (0.42–1.2) 2.1 (1.8–2.3) 1.6 (0.9–2.5) Transmission
Spekreijse et al. (2011a) H5N1 Chicken 1.14 (0.7–1.72) 1.6 (0.9–2.2) 2.1 (0–5.2) Transmission
Spekreijse et al. (2011a) H5N1 Chicken ND 1.7 (0–4.5) 4.8 (0–7.5) Transmission
Spekreijse et al. (2011b) H5N1 Chicken 1.43 (0.27–7.56) ND ND Transmission
Spekreijse et al. (2013) H5N1 Chicken 1.45 (0.38–5.57) ND ND Transmission
Spekreijse et al. (2013) H5N1 Chicken 1.71 (0.38–5.57) ND ND Transmission
Tiensin et al. (2007) H5N1 Chicken 1.43 (1.2–1.71) ND 2.86 (2.41–3.41) Field
van der Goot et al. (2003) H5N2 Chicken 0.78 (0.42–1.47) 6.8 (4.91–8.69) 5.6 (2.9–8.4) Transmission
Bos et al. (2010) H7N1 Chicken 1.19 (0.93–1.52) ND ND Field
Bos et al. (2009) H7N7 Chicken 4.5 (2.68–7.57) ND ND Field
van der Groot et al. (2005) H7N7 Chicken 1.7 (0.8–3.9) 6.3 (3.9–8.7) 10.7 (5–17.7) Transmission
Saenz et al. (2012) H7N1 Turkey 2.04 (1.5–2.7) 1.47 (1.3–1.7) 3.01 (2.2–4) Transmission
Bos et al. (2010) H7N1 Turkey 1.43 (1.17–1.74) ND ND Field
Bos et al. (2008) H7N7 Turkey 1.26 (0.99–1.59) 6.2 (5–8) 7.8 (6–10.16) Transmission
van der Groot et al. (2008) H5N1 Duck (P) 4.7 (2.3–9.4) 4.3 (3.8–4.8) 20 (12.17–35.57) Transmission
Wibawa et al. (2014) H5N1 Duck (P) 1.6 (0.5–3.6) 13.4 (12.3–14.5) 21.5 (19.7–23.3) Transmission
Kang et al. (2015) H5N8 Duck (P) 1.22 (0.36–5.21) ND 1.22 (0.36–5.21) Challenge
van der Groot et al. (2007) H7N7 Pheasants 2.8 (1.4–5.5) 12.2 (7.7–16.7) 34 (17.18–64.77) Transmission
van der Groot et al. (2007) H7N7 Teals ND 10.4 (7.6–13.2) ND Transmission
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Table G.3: Parameters of HPAI and LPAI transmission between farms (data received as per procurement, coordinated by Linnaeus University (SE),
Erasmus Medical Centre (NL), OC/EFSA/ALPHA2015/01 supplemented with NP/EFSA/ALPHA/2015/04, De Koeijer et al., 2017). The mean
values are presented with the lower (L) and upper (U) limits
Study Virus Pathogenicity Country Beta per day (L–U) R0 (L–U)
Stegeman et al. (2004) H7N7 HPAI Netherlands 0.47 (0.3–0.7) 6.5 (3.1–9.9)
Stegeman et al. (2004) H7N7 HPAI Netherlands 0.39 (0.2–0.9) 3.1
Garske et al. (2007) H7N7 HPAI Netherlands ND 1.1 (0.9–1.5)
Garske et al. (2007) H7N7 HPAI Netherlands ND 1.9 (1–3)
Mannelli et al. (2007) H7N1 HPAI Italy 0.15 (0.09–0.25) 1.8
Mannelli et al. (2007) H7N1 HPAI Italy 0.13 (0.1–0.18) 1.5
Garske et al. (2007) H7N1 HPAI Italy ND 1.9 (1.2–2.7)
Garske et al. (2007) H7N3 HPAI Canada ND 2.4 (1.4–3.6)
Busani et al. (2007) H7N3 LPAI Italy ND 3 (2.3–3.9)
Mulatti et al. (2010) H7N1 LPAI Italy 0.4 2.15
Mulatti et al. (2010) H7N3 LPAI Italy 0.4 2.06
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Appendix H – LPAI to HPAI mutation
GISAID is acknowledged for making the genetic sequence information available that has been used
in this analysis (GISAID, 2017) (Figures H.1–H.4).
Figure H.1: Phylogenetic tree constructed by Bayesian analysis of the H5 haemagglutinin gene
segment of avian inﬂuenza viruses A collected in Europe, Asia, Africa and Oceania.
Posterior probability values (expressed as a percentage) of the main clusters identiﬁed
are indicated above the nodes (iTOL, 2016)
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Figure H.2: Phylogenetic tree constructed by Bayesian analysis of the H5 haemagglutinin gene
segment of avian inﬂuenza viruses A collected in the Americas. Posterior probability
values (expressed as a percentage) of the main clusters identiﬁed are indicated above
the nodes (iTOL, 2016)
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Figure H.3: Phylogenetic tree constructed by Bayesian analysis of the H7 haemagglutinin gene
segment of avian inﬂuenza viruses A collected in Europe, Asia, Africa and Oceania.
Human and environmental samples are identiﬁed in L1 by a white band. Posterior
probability values (expressed as a percentage) of the main clusters identiﬁed are
indicated above the nodes (iTOL, 2016)
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Figure H.4: Phylogenetic tree constructed by Bayesian analysis of the H7 haemagglutinin gene
segment of avian inﬂuenza viruses A collected in the Americas. Posterior probability
values (expressed as a percentage) of the main clusters identiﬁed are indicated above
the nodes (iTOL, 2016)
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Table H.1: Description of the genetic clusters identiﬁed in the H5 phylogeny of the H5 viruses collected in Europe, Asia, Africa and Oceania
Colour Group No. of viruses Location Date Spill over in poultry (based on sequence metadata)
E5-C 239 Europe, Asia, Africa 1959–2016 17 in Europe (6 evolved into HP)
3 in South Africa (2 evolved into HP)
3 China (1 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
Italy 1997–1998 H5N2 Domestic (poultry)
England 1991 H5N1 Domestic (poultry)
Ireland 1983 H5N8 Domestic (poultry)
France 2015 H5N1 Domestic (ck)
France 2015 H5N2 Duck
France 2015 H5N9 Duck
South Africa 2004–2006 H5N2 Domestic (ostrich)
South Africa 2011 H5N2 Domestic (ostrich)
Goose-Guangdong-96 1996–to date H5 Domestic/wild birds
South Africa 1959–1961 H5N3 Wild (tern)
Nigeria 2006–2007 H5N2 Wild (spur-winged goose)
Notes
Most widespread group
Highest number of spill over in domestic poultry (23)
Highest number of HP cases (11)
Unique group with HP in wild birds
Origin of the H5N1 goose-Guangdong
Colour Group N. of viruses Location Date Spill over in poultry
E5-C1 165 Europe, Asia 1993–2011 1 in Italy
1 in France
1 in China
Notes
This group circulates mainly in wild birds (160/165 cases)
It has never evolved into HP
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Colour Group N. of viruses Location Date Spill over in poultry
E5-B 52 China, Taiwan, Japan, 1984–2015 1 in Taiwan (1 evolved into HP)
New Zealand, Antarctica 1 in Japan
HPAI outbreaks
Country Date Subtype Host
Taiwan 2014 H5N2 Domestic (poultry)
Colour Group N. of viruses Location Date Spill over in poultry
E5-A 7 Vietnam, Korea, Japan 2004–2011
Notes
This group contains 7 viruses
It circulates only in wild birds/ducks
It has never evolved into HP
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Table H.2: Description of the genetic clusters identiﬁed in the H5 phylogeny of the H5 viruses collected in the Americas
Colour Group No. of viruses Location Date
A5-A 101 North America 2014–2016
Notes
This group includes only North American viruses collected between 2014 and 2016, deriving from the H5N1 A/goose/Guangdong/1/96
This group circulated both in domestic and wild birds
Colour Group N. of viruses Location Date Spill over in poultry*
A5-B 155 America 1966–2004 13 in North America (4 evolved into HP)
1 in Central America (1 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
Ontario 1966 H5N9 Domestic (tk)
Pennsylvania 1983–1986 H5N2 Domestic (ck)
Texas 2004 H5N2 Domestic (ck)
Texas 1993 H5N2 Wild (emu)
Mexico (Puebla) 1994 H5N2 Domestic (ck)
Notes
This is the only group where LPAI viruses evolved into HPAI
It can be divided into three subgroups. The 1st and the 2nd subgroups include North American viruses
The 3rd subgroup includes Central and South American viruses, from Mexico (mainly) and Chile (1)
This group circulated both in domestic and wild birds
Colour Group N. of viruses Location Date Spill over in poultry
A5-C 338 America 2000–2014 8 in North America
Notes
This group circulated mainly in wild birds (326/338 cases)
It never evolved into HP
*: Number of spill over should be considered as indicative as it is based on sequences available in public databases and on genetic clustering.
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Table H.3: Description of the genetic clusters identiﬁed in the H7 phylogeny of the H7 viruses collected in Europe, Asia, Africa and Oceania
E7-A 32 Europe, Asia, Africa, Oceania 1902–2007 5 in Europe (5 evolved into HP)
5 in Australia (5 evolved into HP)
1 in Asia (1 evolved into HP)
1 in Africa (1 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
Italy 1902 H7N7 Domestic (ck)
Netherland 1927 H7N7 Domestic (ck)
UK 1933 H7N7 Domestic (ck)
Germany 1933–1934 H7N1 Domestic (ck)
UK 1963 H7N3 Domestic (turkey)
Victoria 1976 H7N7 Domestic(poultry)
Victoria 1985 H7N7 Domestic(ck)/wild(starling)
Victoria 1992 H7N3 Domestic (ck)
Queensland 1994–1995 H7N3 Domestic (ck)
New South Wales 1997 H7N4 Domestic (ck)
Taiwan 1993 H7N7 Duck
Egypt 1945 H7N1 Domestic(poultry)
Notes
Most viruses of this group are very old
12 HP outbreaks
All the Australian viruses belong to group 1
The most recent viruses in this group (2005–2007) are from Australia
Colour Group N. of viruses Location Date Spill over in poultry
E7-B 84 Asia, Europa, Africa 1972–2009 5 in Asia (2 evolved into HP)
6 in Europa (1 evolved into HP)
2 in Africa
HPAI outbreaks
Country Date Subtype Host
Pakistan 1995–2004 H7N3 Domestic (ck)
Pakistan 2001 H7N3 Domestic (ck)
Germany 1979 H7N7 Domestic (ck/goose)
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Notes
This group gave origin to groups 2.1, 2.2, 2.3
Colour Group N. of viruses Location Date Spill over in poultry
E7-B1 166 Italy 1999–2001 1 in Italy
HPAI outbreaks
Country Date Subtype Host
Italy 1999–2000 H7N1 Domestic (poultry)
Notes
This group includes only Italian viruses collected during the 1999–2001 epidemic
Colour Group N. of viruses Location Date Spill over in poultry
E7-B2 867 Asia 1999–2015 5 in Asia (1 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
China 2016–2017 H7N9 Human/environment
Notes
This group circulated only in Asia
LPAI H7N9 viruses circulating in China, responsible of several human cases, belong to this group
H7N9 strain evolved into HP after several years of circulation in Asia. This HP strain caused human infection in China in 2016–2017
Colour Group N. of viruses Location Date Spill over in poultry
E7-B3 604 Europa, Africa, Asia 2000–2016 25 in Europe (5 evolved into HP)
1 in Asia
1 in Africa
HPAI outbreaks
Country Date Subtype Host
Netherland 2003 H7N7 Domestic (ck)
UK 2008 H7N7 Domestic (ck)
Italy 2013 H7N7 Domestic (ck)
UK 2015 H7N7 Domestic (ck)
Italy 2016 H7N7 Domestic (ck)
Notes
This sub-group is the most widespread within group 2
It is responsible of several recent HP epidemics in Europe
All the HP viruses of this group belong to H7N7 subtype and circulated mainly in chicken (260 chicken/279 HP cases)
*: Number of spill over should be considered as indicative as it is based on sequences available in public databases and on genetic clustering.
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Table H.4: Description of the genetic clusters identiﬁed in the H7 phylogeny of the H7 viruses collected in the Americas
Colour Group N. of viruses Location Date Spill over in poultry*
A7-A 6 North America 1927–1994 1 in Texas (Victoria)
Notes
Small group (6 viruses) constituted only by old viruses (1927–1994)
It has never evolved into HP
Colour Group N. of viruses Location Date Spill over in poultry*
A7-B 16 South America (Chile, Bolivia) 2001–2014 1 in Chile (1 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
Chile 2002 H7N3 Domestic (ck)
Notes
This group circulated only in South America, mainly in Chile (15 viruses)
The viruses of this group belong to H7N3 or H7N6 subtype
Colour Group N. of viruses Location Date Spill over in poultry
A7-C 30 America 1971–1994 4 in USA
Notes
This group gives origin to subgroups C1 and C2
Colour Group N. of viruses Location Date Spill over in poultry
A7-C1 310 North America 1994–2006 Many in USA
Notes
This group circulated mainly in domestic birds (212/310 cases)
It has never evolved into HP
This group circulated only in North America, mainly in NY (226/310 cases)
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Colour Group N. of viruses Location Date Spill over in poultry
A7-C2 533 America 1993–2015 8 North America (3 evolved into HP)
2 Central America (2 evolved into HP)
HPAI outbreaks
Country Date Subtype Host
Canada (British Columbia) 2004–2005 H7N3 Domestic (ck)
Canada (SK) 2007 H7N3 Domestic (ck)
Indiana 2016 H7N8 Domestic (tk)
Mexico (Jalisco) 2012 H7N3 Domestic (ck)
Mexico (Jalisco-Puebla) 2015 H7N3 Domestic (ck)
Notes
This group circulated mainly in wild birds (481/533 cases)
*: Number of spill over should be considered as indicative as it is based on sequences available in public databases and on genetic clustering.
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Appendix I – HPAI and LPAI surveillance
I.1. Surveillance components
I.1.1. Poultry passive surveillance
Passive surveillance for notiﬁable avian disease in domestic poultry relies on notiﬁcations of clinically
affected poultry to the competent authority by private veterinary surgeons or animal owners. Overall
sensitivity of this surveillance component is dictated by private veterinary services (PVS)’
understanding their responsibilities in the detection or exclusion of notiﬁable disease and the
engagement of different poultry sectors with national veterinary authorities.
Notiﬁable passive surveillance in poultry has very high sensitivity of detection of HPAI in
gallinaceous poultry as these species are particularly susceptible to HPAI and consistently show severe
clinical signs within 1–2 days of infection.66 The extent to which notiﬁable passive surveillance in
poultry is sensitive in other poultry species, in particular Anseriformes, is dependent on the virulence of
the circulating virus as well as host-speciﬁc and environmental factors.67 The H5N8 HPAI virus
circulating in Europe in 2014 (clade 2.3.4.4a) was not associated with enhanced mortality in wild birds
and as a corollary it is likely that notiﬁable passive surveillance was less sensitive in Anseriformes
during that event. However, in the H5N8 HPAI epizootic in 2016/2017 (clade 2.3.4.4b), anseriforme
poultry were more frequently identiﬁed by this surveillance component, and many migratory and
residential waterfowl were found dead due to HPAI (EFSA, ECDC, EURL, 2017).
The sensitivity of this surveillance component in the detection of LPAI follows a similar trend.
Passive notiﬁable surveillance in poultry is unlikely to detect circulating LPAI in poultry populations
unless the LPAI virus is unusually virulent causing non-negligible levels of mortality or associated with
considerable changes in production factors such as egg production, and/or feed and water intake.
Where industry is particularly engaged and levels of coordination between industry and the competent
authority are high, this sensitivity of detection of LPAI can be enhanced (see production monitoring
section below). In comparison, the likelihood of passive notiﬁable surveillance in poultry detecting LPAI
in farmed anseriforme populations is very low, unless there is signiﬁcant concurrent disease at the
holding which may serve to complicate the clinical picture.
Passive notiﬁable poultry surveillance is the front line methodology for early detection of HPAI in
gallinaceous and to a lesser extent anseriforme poultry. While it is difﬁcult to quantify its efﬁcacy at EU
level, Member State (MS) level or even between different poultry sectors within a MS, it should be
noted that this component has been responsible for the vast majority of the identiﬁcation of premises
infected with HPAI since 2005.
I.1.2. Testing To Exclude (TTE) notiﬁable avian disease
TTE is a surveillance component designed to complement existing passive notiﬁable surveillance. It
allows a PVS to send samples to either private or public laboratories to exclude the presence of
notiﬁable avian disease without notifying at the competent authority. This can only be done where the
PVS does not formally suspect notiﬁable disease otherwise the conventional passive notiﬁable cascade
must be carried out. It should also be used with particular caution when the risk of avian inﬂuenza
incursion into poultry premises is high, for example during an HPAI epizootic in that country or in
contiguous countries.
One of the major beneﬁts of TTE to producers is that while the classic notiﬁable disease
surveillance requires premises to be put under movement restrictions, testing to exclude the presence
of notiﬁable disease does not have this requirement. Should the holding subsequently test positive for
66 Initial clinical presentation of HPAI infection in chickens and turkeys may be sudden death with little or no other preceding
clinical signs or gross pathology. Alternatively, there may be acute disease with signs of systemic disease including respiratory
symptoms (ocular/nasal discharges, coughing, dyspnoea and swelling of infraorbital sinuses and/or head), apathy, depression,
lethargy, cyanosis and reductions in feed and water intake. Nervous signs such as ataxia, paralysis of the wings and pedalling
movements of the legs may be seen whilst in laying birds there may be a signiﬁcant drop in both the quantity and quality of
egg production. In these birds, ‘yolk peritonitis’ may be seen in gross pathology.
67 In other poultry species, clinical presentation can be more variable with ducks and geese generally unlikely to show the levels
of acute disease seen in gallinaceous poultry. However, it should be noted that infection of ducks with H5N1 (2.3.2.1c clade)
and H5N8 (2.3.4.4b clade) viruses can result in systemic infection and death. More often than in galliforme birds neurological
disorders will develop (ataxia, torticollis, shivering, etc.). Reductions of feed and water intake are not considered in ‘passive
surveillance’ but in ‘production parameter monitoring’.
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notiﬁable avian disease then this would trigger the usual notiﬁable disease response and would trigger
restrictions and conﬁrmatory testing if required.
TTE is a useful tool to increase LPAI surveillance sensitivity and helps to build trust among
government, producers and industry. The cost of TTE testing is usually covered by the private sector
and has a lower priority for testing than conventional notiﬁable disease testing.
TTE is not covered by existing EU legislation but is used by a number of (private and/or public)
organisations in some MSs (e.g. the UK, DE, the NL, IT) to empower decision making at PVS level and
improve the overall sensitivity of detection where atypical or mild clinical presentation can complicate a
successful differential diagnosis. This approach should only be used in case of non-speciﬁc clinical
signs (not to be used for instance with increased mortality or when AIV has been detected in the
area).
I.1.3. Production parameter monitoring
MSs are advised to use production parameter monitoring as a form of syndromic surveillance in
order to initiate the standard notiﬁable passive surveillance cascade described above. The legislation
(Commission Implementing Decision (EU) 2017/263)68 describes the monitoring of mortality data, egg
production records and feed/water intake as a method for the early detection of LPAI in gallinaceous
poultry and HPAI in anseriforme poultry. This is currently undertaken consistently by at least a few MSs
and would almost certainly result in higher sensitivity of detection of both notiﬁable and non-notiﬁable
disease. A research project in the NL is analysing this approach (no results available at this stage).
Moreover, increased usage of this form of surveillance would also be likely to affect timeliness of
detection, since production parameter monitoring, could also play a role in the detection of strains of
AI that may subsequently mutate from an LPAI variant to a HPAI variant and will help in tracing back
the incursion time point.
Adopting production parameter monitoring does come with an array of upfront costs as well as
requiring an engaged industry together with coordination with the competent authority that may limit
its use to heavily commercialised and intensively managed sectors. The requirements for managing
commercially sensitive production data at a suitably conﬁdential level alongside the cost in analysing
this data with an inconsistent threat of incursion from HPAI and LPAI is likely to have hindered its
earlier adoption. Furthermore, a non-negligible false alarm rate where production parameter
monitoring ﬂags up holdings where AI is not present could seriously damage conﬁdence in this
component and would require careful examination of baseline data and any threshold drops in
production that would ﬂag up further examination.
Production parameter monitoring and TTE act synergistically and could, if used together, provide a
useful approach to increasing LPAI surveillance sensitivity by using individual farm’s baseline data and
looking at production drops and empower PVS/Owner to trigger exclusion testing if necessary. The
reluctance of industry to share conﬁdential production data makes it unlikely that the public sector
would be involved in this monitoring and would therefore dictate industry responsibility in the
monitoring of production factors and take action when required.
Production parameter monitoring is a useful complement to the current system of notiﬁable disease
surveillance in poultry but would require signiﬁcant resource to set up for MSs that do not currently
capture the data required to implement it effectively. In future years, if epizootics of the size and
impact of the 2016/2017 event continue to occur, it may become a useful tool for particular sectors in
heavily impacted MSs for the early detection of disease.
I.1.4. Annual active serological surveillance
In addition to mandatory notiﬁable avian disease surveillance (see Appendix I, Section I.1.1), MSs
are also mandated to carry out annual serological testing on a number of poultry premises every year
(Commission Decision 2010/367/EU). This testing can either be carried out on a representative cross-
section of their poultry population or alternatively MSs can use a risk-based methodology designed to
target ‘sentinel’ or higher risk populations of poultry that may be more vulnerable depending on risk
strata such as geographical, demographic or ornithological factors. The objective of this surveillance
component is to inform the competent authority of circulating avian inﬂuenza virus with a view to
68 Commission Implementing Decision (EU) 2017/263 of 14 February 2017 on risk mitigating and reinforced biosecurity measures
and early detection systems in relation to the risks posed by wild birds for the transmission of highly pathogenic avian
inﬂuenza viruses to poultry. OJ L 39, 16.2.2017, p. 6–11.
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controlling the disease and to complement the existing notiﬁable disease surveillance by identifying
evidence of historical infection in populations that escaped previous detection. This is particularly
valuable for identiﬁcation of HPAI in anseriforme populations where subclinical infection may preclude
identiﬁcation by passive notiﬁable avian disease surveillance. This also applies to the detection of H5
and H7 LPAI in gallinaceous poultry which may also present subclinically. This active surveillance
programme in poultry is looking to identify AIV-speciﬁc antibodies against subtypes H5 and/or H7 in
the tested poultry and therefore is not designed as a method of early detection of AI infection and is
unlikely to detect LPAI early enough to prevent mutation to HPAI, particularly where this may occur on
a single farm. However, unlike passive surveillance where the number of investigations and the
populations sampled will vary substantially year to year within a given region or country, active
serological surveillance provides a consistent sampling frame (i.e. denominator data) which can
provide evidence towards disease freedom which can be useful for trade purposes.
To increase this component’s effectiveness, positive serological ﬁndings have to be followed up with
further epidemiological investigations and (where possible) further sampling and virological testing to
detect or rule out the presence of active virus infections. This programme of active serological
surveillance has been in place since 2003 (Commission Decision 2002/649/EC) and since that time a
minority of seropositive holdings have subsequently been found to have active virus on the holding. In
2013–2015 29.7% (33/111) of seropositive holdings were found to be infected with H5 or H7 virus on
follow-up testing (24.7% 23/93) for H5 seropositive holdings and 55.6% (10/18) for H7 seropositive
holdings). In the remainder of cases, either the poultry have been removed from the holding (e.g. to
slaughter) and could not be tested or no active virus infection was found on the premises. Serological
testing is unable to differentiate between antibodies to HPAI and LPAI of the same H-type, but given
that gallinaceous poultry are likely to present severe clinical disease if infected with HPAI, it
emphasises the need for testing anseriforme populations with this surveillance for detection of
exposure to both LPAI and HPAI.
In the 2015/2016 H5 HPAI incident in France, the signiﬁcant event of widespread AIV H5 infection
in the south-west of the country was preceded by several years of serological H5-positives in this area
of the country. Unfortunately, as these animals were tested prior to slaughter, further samples for
virological testing were only taken in around half of the cases although epidemiological investigations
were always conducted (see Annex A). It is still unclear as to when, where, or on how many occasions
this circulating LPAIV mutated into HPAIV; however, it is informative to note that there was some
evidence of H5 AI in this area before this extensive incident occurred (see Annex A). A key lesson from
the French surveillance programme and outbreaks is that stricter follow up of seropositive holdings and
implementation of measures is required to prevent AIV circulation on holdings over more than 1 year
to prevent mutation into HPAI.
As currently implemented, there is a wide range of interpretation of the sampling frame for this
surveillance component. This allows individual MSs to tailor their surveillance programme speciﬁc to
their requirements depending on their demographic and poultry sector composition or alternatively
to the sector which they decide is most vulnerable to introduction of AIV. While this has some beneﬁts
to MSs, it hinders effective surveillance evaluation of this component at EU level. For example, while
testing laying hens or other gallinaceous poultry may be of use in identifying past exposure to LPAI,
when there has been repeated exposure of HPAI in anseriforme populations which could show
subclinical disease, it may be more useful to monitor anseriforme populations using serological
surveillance given a limited amount of resource.
The criteria for risk-based sampling considered by MSs vary considerably but can be categorised as
follows:
• Geographical – including proximity to waterbodies, contiguous countries and proximity to high
density of migratory wild birds
• Demographic – densely populated poultry areas
• Production type/biosecurity level – free Range, Anseriforme and Game bird holdings, mixed
poultry species holdings
• Trade – targeting holdings with international trade (intra-EU and Third countries)
• Timing of sampling – timing sampling to coincide with seasonal production
• Reactive sampling – increasing burden of sampling if contiguous areas report AI
The scientiﬁc evidence regarding the relative importance of these risk strata is unclear and may
vary across the EU. The implementation of a risk-based approach is often difﬁcult as there are not
enough and/or not reliable data and knowledge available to determine the relevant weight of each risk
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factor. The data provided by France (see Annex A) show that only seropositive anseriforme ﬂocks were
detected in 2012–2015, but the sampling scheme was not changed accordingly. Having a good
knowledge of the poultry populations (number and location) is required to deﬁne an appropriate
sampling plan.
The annual serologically surveillance programme is a useful tool in monitoring the ongoing health of
poultry populations and is particularly useful following an outbreak to reassure the competent authority
and trading partners that disease is not circulating in poultry populations. However, when there is
evidence of HPAI circulating in Europe, MSs should focus their sampling on anseriforme populations or
game bird holdings which may harbour subclinical infection.
I.1.5. Passive wild bird surveillance
Passive wild bird surveillance describes the convenience sampling of dead or moribund wild birds
and was last described by Commission Decision 2010/367/EU. It often provides the initial evidence of
incursion of HPAIV into Europe (EFSA, ECDC, EURL, 2017). MS use a risk-based approach to identify
dead or moribund wild birds and identify a target number of birds they intend to submit over the year.
During epizootics where mortality in wild birds has been recorded, this component has a proven track
record of being very useful. Wild bird mortality was identiﬁed in this way during the 2005–2007 H5N1
HPAI (2.2 clade) and 2016/2017 H5 HPAI (2.3.4.4b clade). While this surveillance was less effective
during the 2014 H5N8 incursion (2.3.4.4a clade), there were detections of dead pelicans infected with
H5N1 HPAIV (2.3.2.1c clade) in Bulgaria and Romania.
In the recent 2016/2017 epizootic, poultry outbreaks and positive wild bird submissions showed a
strong spatial correlation (EFSA, ECDC, EURL, 2017); however, positive wild bird submissions were not
always indicative of subsequent poultry incursions. Passive wild surveillance is less useful in epizootics
not associated with high levels of wild bird mortality.
There are also some known unavoidable biases with this convenience sampling technique in that
larger wild birds (swans, geese, raptors, gulls, pelicans) are more likely to be detected and submitted.
Regional mass mortality events in smaller water birds may alleviate this bias, as these events are less
likely to remain unreported (nine reported incidents of > 50 dead wild birds in 2016/2017 H5 HPAI
epizootic). In addition to these biases, MSs take alternative approaches to sampling which will also
affect which wild birds are found and where they are found. The probability of ﬁnding wild bird
carcasses is also dependent on habitat types, which differ substantially across the EU. In addition, MSs
should (according to Commission Decision 2010/367/EU) target speciﬁc species with known
associations with HPAI. A list of ‘Target Species’ is provided in the legislation. Sampling and testing of
wild bird faeces from the environment has been carried out as a means of active surveillance and may
be considered as an approach that provokes little disturbance to natural habitats and birds. However,
detection rates are expected to be low and, in positive cases, would require determination of the bird
species by genetic means (mitochondrial DNA).
The risk-based approach used by MSs to inform their collection of wild birds for this component
helps to maximise sensitivity of detection by using geographical, ornithological and other ecological risk
factors. While empirical data on risk factors to drive risk-based sampling are lacking, there is some
scientiﬁc consensus on the important factors to be considered and these are explicitly stated in the
legislation. The inherent non-representative sampling also makes it not possible to extrapolate the
ﬁndings to the live wild bird population over any geographical region; this is also complicated by the
sheer volume of species of wild birds and their associated clinical response to AIV infection. It is
important to note that even in extensive epizootics such as the 2016/2017 H5 HPAI (2.3.4.4b clade)
virus, there will be signiﬁcant variation in the prevalence of AIV within wild bird populations and, as
such, negative results from dead wild birds can play an important role in establishing and withdrawing
interventions during an AI outbreak.
I.1.6. Active Wild Bird Surveillance
Active surveillance of clinically healthy wild birds was a legislative requirement for MSs between 2006
and 2010; however, since June 2010, there is no longer any formal requirement for this surveillance
component to be carried out. Nevertheless, many MSs do still carry out this activity as a complement to
their passive wild bird surveillance programme. The primary goal of this component is to detect changes
in the epidemiology of AIV subtypes. MSs could (according to Commission Decision 2010/367/EU)
target speciﬁc species with known associations with HPAI. These ‘target’ species include the species in
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which HPAI had been detected at the highest rate in the EU at the time of publication (i.e. June 2010),
plus raptor species with large breeding populations in Europe. Targeting these species may well be
more sensitive than testing wild birds at random. An update of the list of target species is suggested
(EFSA, ECDC, EURL, 2017).
Targeting healthy wild birds is also useful in epizootics where wild bird mortality is not a deﬁning
feature of the incursion and could be the only way of ﬁnding evidence that disease is present in wild
bird populations, as in 2014 with positive wild birds being found in Germany and the Netherlands
through active wild bird surveillance of clinically healthy birds. Unlike passive surveillance of dead
birds, active surveillance could potentially provide an evidence of infection prevalence in a deﬁned area
if sufﬁcient sampling is carried out and a sampling strategy with little bias would be available.
However, so far, at EU level, active surveillance of wild birds has a very low sensitivity of detection of
HPAIV with PCR testing of clinically healthy birds unlikely to ﬁnd active HPAIV. During the period where
active surveillance was mandatory (2006–2010), MSs found 39 HPAIV positives from 246,952
submissions. Serological surveillance could play a valuable role in informing which wild bird species are
more likely to be infected and shed HPAI, and even particular clades of H5 HPAI virus, when applied at
a few high-risk locations across the EU (Gilbert et al., 2014; Poen et al., 2016). While getting estimates
of disease prevalence in a deﬁned area can be useful, especially after an outbreak when case
detections have slowed, to see whether virus is possibly circulating in absence of clinical disease,
sufﬁcient testing of wild birds, so as to detect a minimum level of disease, could be prohibitively
expensive.
I.2. Poultry population densities
All MSs provided data to EFSA on the number of holdings for several poultry species. This is
described in the scientiﬁc report (EFSA, ECDC, EURL, 2017), from which the ﬁgures below are copied.
Figure I.1: Duck and geese production by region reported by MSs to EFSA (autumn 2016) (taken
from EFSA, ECDC, EURL, 2017)
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Figure I.2: Game bird production by region reported by MSs to EFSA (autumn 2016) (taken from
EFSA, ECDC, EURL, 2017)
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I.3. Serological surveillance data
Figure I.3: Breeding duck serological surveillance sampling and regions with positive holdings
detected, 2014–2016
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Figure I.4: Breeding goose serological surveillance sampling and regions with positive holdings
detected, 2014–2016
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Figure I.5: Fattening duck serological surveillance sampling and regions with positive holdings
detected, 2014–2016
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Figure I.6: Fattening goose serological surveillance sampling and regions with positive holdings
detected, 2014–2016
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Figure I.7: Game bird (Anseriformes) serological surveillance sampling and regions with positive
holdings detected, 2014–2016
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Figure I.8: Game bird (Gallinaceous) serological surveillance sampling and regions with positive
holdings detected, 2014–2016
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 224 EFSA Journal 2017;15(10):4991
Figure I.9: Map showing intensity of serological surveillance activity in farmed anseriforme poultry
and all game birds between 2014 and 2016
Figure I.10: Map showing regions with holdings showing prior exposure to AI in farmed anseriforme
poultry and all game birds, 2014–2016
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Appendix J – Biosecurity
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Figure J.1: Example average ranking of biosecurity measures calculated from the individual rankings of the 10 experts (panel A) and example of deviation
of the individual versus the average judgements (panel B)
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Table J.1: Description of the identiﬁed biosecurity measures commercial and non-commercial holdings with indoor housing only or with outdoor access
to poultry The table is based on the measures identiﬁed in the AI Statement (EFSA, 2017a), which was then edited and further elaborated
ID Biosecurity measure Indoor – commercial holdings Outdoor – commercial holdings Non-commercial holdings (backyards)
A Prevent access to pests and
mammals
Integrated pest control should actively be implemented in the all the zones of the holding
(guaranteeing no poultry access) and access of other domestic animals (such as dogs or
cats) and wild animals (such as fox, marten, badger) should be prevented by closing
doors of the buildings and use of covering material. Baits and/or chemical pest control
should always be used in accordance with the manufacturer’s instructions
Buildings should have a closing doors
system to prevent the access of other
animals and rodent control should be
implemented. Fences around the outdoor
area should be used
B Prevent direct wild bird
contact
It is assured by construction of bird proof
roof, walls, windows and/or fences when
poultry are housed indoors
In the outdoor area, fences and/or nets can be used with a maximum mesh diameter of
25 mm. Access of poultry to water bodies that could be visited by wild (water) birds
should always be prevented. Feed (provided in containers) and water for poultry must be
indoor to prevent the attraction of wild birds
C Prevention of direct contact
with faecal droppings from
ﬂying wild birds
It is provided by construction of a roof and
walls or fences when poultry are housed
indoors. This includes no contact with faecal
droppings entered with rain, etc.
In the outdoor area, horizontal fabric (e.g. canvas roof) should be used
D Make environment
unattractive to wild birds
Prevent roosting and nesting of wild birds by making the holding environment unattractive to them. For example, clean spilled feed,
keep grass on the holding cut (wild birds eat grass seeds, forage in long grass), select trees and shrubs to minimise wild bird
attraction, remove fallen fruit around the holding, use persuasive elements. Placing ﬂashing or rotating lights at the entry points will
deter wild birds from entering. Water drainage is implemented to prevent uncovered water accumulation. Ensure there are no hobby
poultry ﬂocks on the holding
E Contain poultry or fomites
that were in contact with
poultry during transport
Vehicles transporting poultry, (hatching) eggs, carcasses or waste products (e.g. manure,
litter) should be closed, preventing any loss of material (including via wind) during
transport
Ideally, access of these vehicles should be limited to small zones of the holding,
preventing contact with animals and materials that will be introduced in the poultry
houses. Rendering trucks should not enter a holding but instead remain on the public
road
The frequency of these transports should be reduced as much as possible (e.g. one visit
of large volume instead of two visits) and vehicles driving from one poultry holding to
another should be prevented where possible
All materials with contact to poultry and
poultry products should be transported in
boxes. All transport material should be
single use or cleaned and disinfected after
use
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ID Biosecurity measure Indoor – commercial holdings Outdoor – commercial holdings Non-commercial holdings (backyards)
F Clean and disinfect transport
vehicles
Vehicles transporting poultry, (hatching) eggs, carcasses or waste products (e.g. manure,
litter) should be empty (except for poultry and hatching egg delivery) clean and
disinfected when entering the zone of the holding where the poultry is present
Vehicles transporting feed or bedding have ideally only access to the zones of the holding
without presence of poultry and stop as close as possible to the place of destination (e.g.
storage building) on a paved ground surface. They should not have access to the zones
of the holding where the poultry is present
Cleaning and disinfection of the wheels, wheel arches and footsteps/rests is implemented
when entering/leaving the holding. Paths should be cleaned and disinfected after passage
of the vehicle. The frequency of these transports should be reduced as much as possible
(e.g. one visit of large volume instead of two visits) and vehicles driving from one poultry
holding to another should be prevented where possible. In cases where feed is supplied
in a recipient (e.g. big bag), it is recommended to use new recipients
Transport is mainly done by the owner.
Vehicles should be clean and must not go in
the outdoor area
G Restricted access Only staff and essential professional visitors (e.g. veterinarians, drivers, technicians,
inspectors or catchers) can access the holding. Ideally, the borders of the zones of the
holding without the presence of poultry are clearly marked with signs and the borders of
the zones where the poultry is present are physically separated (e.g. fence, barrier in
hygiene lock). Signs and physical separation have the scope to remind and enforce staff
and professional visitors to implement the necessary biosecurity measures
Only owners (resident family) and essential
professional visitors (e.g. veterinarians or
inspectors) can access the area where
poultry is present
H Biosecurity training Persons working at the holding or giving regular service to the holding, should have
participated in a general biosecurity training (e.g. via a course) adapted to poultry
production and understanding the implications to animal health and welfare, human
health and food safety. A holding-speciﬁc biosecurity plan should be available. The roles
and responsibilities of the staff should be clearly deﬁned/explained accordingly and
professional visitors should be informed on the holding’s layout and biosecurity plan
before entering the professional and production zones of the holding. Occasional visitors
should be instructed and escorted by trained persons
Owners should know recommended
biosecurity measures (e.g. via leaﬂet
information material)
I Previous poultry contact Persons can only enter the holding if they had no contact with poultry, poultry waste
and/or a poultry processing material at another holding (including backyard) within the
previous 24 h. This time could be enlarged in a high-risk situation, e.g. depending on the
production system, virus characteristics, contact with wild birds (e.g. bird ringing or
hunting), etc.
The farm should provide a visitor book to register. Professional visitors should record
their visit and keep their own record of poultry holding visits
Not applicable
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ID Biosecurity measure Indoor – commercial holdings Outdoor – commercial holdings Non-commercial holdings (backyards)
J Clean clothing and footwear Clothing and footwear should always be clean (=free of organic material) before entry of
the holding. Appropriate footwear hygiene measures can be applied (e.g. disposable
overshoes)
The owner must change clothing and
footwear after contacts or use protective
cloths (e.g. overalls, disposable overshoes)
during contact with poultry, poultry waste
and/or a poultry processing material at
another holding (including backyard) or wild
birds. Hands should be washed with soap
K Cleaning and disinfection
equipment
Any movable equipment should be cleaned and disinfected when entering and leaving a
poultry production unit (e.g. use colour codes per poultry house) and per holding (no
equipment should be used on multiple farms). All other stationary equipment should be
cleaned and disinfected after each production cycle
All stationary equipment should be cleaned
and disinfected at regular intervals (e.g.
feed container)
L Hygiene lock to production
unit
Clothing, footwear (capable of being washed or disinfected) should be changed, hands
should be washed and disinfected and hair should be covered before and after entry of
the production unit. Clothing and footwear should be production unit-speciﬁc. Persons
can enter the production unit only when wearing personal protection equipment such as
(disposable) coveralls or overalls, head covering and boots belonging to the holding.
These should be cleaned and disinfected before/after use. Providing tools for scraping
the soles of footwear will facilitate their cleaning. Place a hygiene line (a clear physical
barrier, e.g. bench or low wall) is suggested, as a line is very easily crossed and therefore
ignored) at the entrance of each poultry house: footwear and clothing have to remain at
each side of this line in the hygiene lock
These measures should be valid for all ‘entry’ points
Not applicable
M Closed bedding storage Should be achieved in closed facilities with concrete ﬂoor to prevent access of animals (including wild birds and rodents). In addition,
rodent control should be applied
N Potable drinking water Water supplied to poultry should be potable
or comply with the national water quality
standard. Poultry should not have access to
surface and rain water. Surface water
should not be used for cleaning
Feed and water supply should be provided
indoors. Water supplied to poultry should
be potable or comply with the national
water quality standard. Poultry should not
have access to surface and rain water.
Surface water should not be used for
cleaning
Supplied to poultry should be potable or
comply with the national water quality
standard. Poultry should not have access to
surface water
O Filtration of incoming air Filtration of incoming air can be achieved
per production unit in some speciﬁc housing
designs, via (e.g. HEPA) ﬁlters
Non-applicable Non-applicable
Avian inﬂuenza
www.efsa.europa.eu/efsajournal 229 EFSA Journal 2017;15(10):4991
ID Biosecurity measure Indoor – commercial holdings Outdoor – commercial holdings Non-commercial holdings (backyards)
P Protected waste storage Storage of manure and used bedding should not be stored on the premises and
immediately removed after a production cycle. Otherwise, it should be done in a way to
prevent access of animals. The collection of manure should also be done in a way to
prevent access of animals
Manure and used bedding/litter should be
stored covered
Q Carcass disposal Should be done in a vermin-proof structure, remote from the production units and close
to the public road (accessible from outside the farm). It should be on a solid surface to
allow proper cleaning and disinfection. Cooling is recommended as it facilitates longer
storage and subsequently less frequent carcass transport because frequent carcass
transport has a higher risk than keeping carcasses longer at a holding. The carcass
disposal area should be distanced/separated from poultry area of the holding
A veterinarian needs to be contacted in
case of increased mortality in the ﬂock or a
disease is suspected. Suspected carcasses
(except samples) should not be moved from
the backyard. Carcasses should be disposed
in a safe way, e.g. buried, after sampling
R Health monitoring Starts by checking the health certiﬁcates for new poultry and/or hatching eggs when
arriving at a holding. The place of origin should be documented and it is recommended
to keep the number of suppliers as limited as possible. Quarantine should be
implemented for new poultry and/or hatching eggs when arriving at a holding, in
particular when new animals will be introduced in a ﬂock. Monitoring of the poultry
health status should be continued throughout the production cycle under the supervision
of a veterinarian
The owner of the backyard should buy
poultry from professional suppliers with
regular health monitoring to assure the
birds are healthy, the invoice should be
kept. A veterinarian should be consulted in
case of clinical signs
S Flock management Should be based on the ‘all-in, all-out’
principle, preferably at holding level. This
means that all birds have a similar age and
the houses will be emptied, cleaned
(including removal of manure) and
disinfected after each production cycle.
Proper drying period after disinfection is
required. Movement of feed between ﬂocks
should be avoided. Removal of carcasses,
broken eggs and rejected eggs should be
done at least daily
Should be based on the ‘all-in, all-out’
principle, preferably at holding level. This
means that all birds have a similar age and
the houses will be emptied, cleaned
(including removal of manure) and
disinfected after each production cycle. A
sanitary vacuum of 14 days is
recommended. Movement of feed between
ﬂocks should be avoided. Removal of
carcasses, broken eggs and rejected eggs
should be done at least daily
Removal of carcasses, broken eggs and
rejected eggs should be done at least daily.
New birds should be isolated in quarantine
before being added to a ﬂock
T Separation of poultry species Mixing of poultry species should be prevented by keeping each species and production
type in a separate house. In particular mixing of ducks or geese with other poultry
species is forbidden. Separation of production systems on a holding is recommended
Mixing of poultry species should be
prevented by keeping each species in a
separate house/outdoor area. In particular
mixing of ducks or geese with other poultry
species should be prevented
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Some speciﬁc recommendations:
• Feed is in most cases stored in a closed environment. It is recommended that each holding
has his own bag to collect dust when feed is blown into silos.
• If closed bedding storage is not feasible, preventing of wild bird access is the minimum to
achieve (e.g. roof and netting).
• Catching crews are often visiting more than one holding per day. They should at least wash
their hands, change clothes and footwear and wear (single-use) hair rotection.
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Figure J.2: Average ranking of biosecurity measures applicable in a commercial chicken holding with
only indoor housing (the letter IDs are explained in Table J.1)
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Figure J.3: Average ranking of biosecurity measures applicable in a commercial chicken holding with
outdoor access (the letter IDs are explained in Table J.1)
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Figure J.4: Average ranking of biosecurity measures applicable in a non-commercial poultry holding
(backyard) (the letter IDs are explained in Table J.1)
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Annex A – Avian Inﬂuenza surveillance in France from 2012 to 2015
Annex A can be found in the online version of this output, under the section ‘Supporting
information’, at: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4991/full
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